485BPOS 1 d853575d485bpos.htm JHUSA A - MAJESTIC VULX JHUSA A - MAJESTIC VULX
Table of Contents
As filed with the U.S. Securities and Exchange Commission on April 23, 2015
Registration No. 333-151630

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-6
SEC File No 811-4834
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
POST EFFECTIVE AMENDMENT NO. 12 [X]
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
AMENDMENT NO. 59 [X]
John Hancock Life Insurance Company (U.S.A.) Separate Account A
(Exact Name of Registrant)
John Hancock Life Insurance Company (U.S.A.)
(Name of Depositor)
197 Clarendon Street
Boston, MA 02116
(Complete address of depositor’s principal executive offices)
Depositor's Telephone Number: 617-572-6000

JAMES C. HOODLET
John Hancock Life Insurance Company (U.S.A.)
U.S. INSURANCE LAW
JOHN HANCOCK PLACE
BOSTON, MA 02117
(Name and complete address of agent for service)

It is proposed that this filing will become effective (check appropriate box)
[ ] immediately upon filing pursuant to paragraph (b) of Rule 485
[X ] on April 27, 2015 pursuant to paragraph (b) of Rule 485
[ ] 60 days after filing pursuant to paragraph (a) (1) of Rule 485
[ ] on (date) pursuant to paragraph (a) (1) of Rule 485
If appropriate check the following box
[ ] this post-effective amendment designates a new effective date for a previously filed amendment
Pursuant to the provisions of Rule 24f-2, Registrant has registered an indefinite amount of the securities under the Securities Act of 1933.


Table of Contents
Prospectus dated April 27, 2015
for interests in
John Hancock Life Insurance Company (U.S.A.) Separate Account A
Interests are made available under
MAJESTIC VULX
a flexible premium variable universal life insurance policy
JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
(“John Hancock USA”)
The policy provides fixed account options with fixed rates of return declared by John Hancock USA
and the following investment accounts:
500 Index B
Active Bond
All Cap Core
Alpha Opportunities
American Asset Allocation
American Global Growth
American Growth
American Growth-Income
American International
American New World
Blue Chip Growth
Bond
Capital Appreciation
Capital Appreciation Value
Core Bond
Core Strategy
Emerging Markets Value
Equity-Income
Financial Industries
Franklin Templeton Founding Allocation
Fundamental All Cap Core
Fundamental Large Cap Value
Global
Global Bond
Health Sciences
High Yield
International Core
International Equity Index B
International Growth Stock
International Small Company
International Value
Investment Quality Bond
Lifestyle Aggressive MVP
Lifestyle Balanced MVP
Lifestyle Conservative MVP
Lifestyle Growth MVP
Lifestyle Moderate MVP
Mid Cap Index
Mid Cap Stock
Mid Value
Money Market B
PIMCO VIT All Asset
Real Estate Securities
Real Return Bond
Science & Technology
Short Term Government Income
Small Cap Growth
Small Cap Index
Small Cap Opportunities
Small Cap Value
Small Company Value
Strategic Income Opportunities
Total Bond Market B
Total Stock Market Index
Ultra Short Term Bond
U.S. Equity
Utilities
Value
M Capital Appreciation
M International Equity
M Large Cap Growth
M Large Cap Value
* * * * * * * * * * * *
Please note that the Securities and Exchange Commission (“SEC”) has not approved or disapproved these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

GUIDE TO THIS PROSPECTUS
This prospectus is arranged in the following way:
•  Starting on the next page is a Table of Contents for this prospectus.
•  The section after the Table of Contents is called “Summary of Benefits and Risks.” It contains a summary of the benefits available under the policy and of the principal risks of purchasing the policy. You should read this section before reading any other section of this prospectus.
•  Behind the Summary of Benefits and Risks section is a section called “Fee Tables” that describes the fees and expenses you will pay when buying, owning and surrendering the policy.
•  Behind the Fee Tables section is a section called “Detailed Information.” This section gives more details about the policy. It may repeat certain information contained in the Summary of Benefits and Risks section in order to put the more detailed information in proper context.
•  Finally, on the back cover of this prospectus is information concerning the Statement of Additional Information (the “SAI”) and how the SAI, audited financial statements for John Hancock USA and the Separate Account, personalized illustrations and other information can be obtained.
    
Prior to making any investment decisions, you should carefully review this product prospectus and all applicable supplements. In addition, you will receive the prospectuses for the underlying funds that we make available as investment options under the policies. The funds' prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the funds. In the case of any of the portfolios that are operated as feeder funds, the prospectus for the corresponding master fund is also provided. If you need to obtain additional copies of any of these documents, please contact your John Hancock USA representative or contact our Service Office at the address and telephone number on the back page of this product prospectus.
2

TABLE OF CONTENTS
        
  Page No.
SUMMARY OF BENEFITS AND RISKS

4
The nature of the policy

4
Summary of policy benefits

4
Death benefit

4
Surrender of the policy

4
Withdrawals

4
Policy loans

5
Optional supplementary benefit riders

5
Investment options

5
Summary of policy risks

5
Lapse risk

5
Investment risk

5
Transfer risk

6
Early surrender risk

6
Market timing and disruptive trading risks

6
Tax risks

6
FEE TABLES

7
DETAILED INFORMATION

13
Table of Investment Options and Investment Subadvisers

13
Description of John Hancock (USA)

18
Description of Separate Account A

18
The fixed account options

18
The death benefit

19
Limitations on payment of death benefit

19
Base Face Amount vs. Supplemental Face Amount

19
The minimum death benefit

20
When the insured person reaches 121

21
Requesting an increase in coverage

21
Requesting a decrease in coverage

21
Change of death benefit option

21
Tax consequences of coverage changes

22
Your beneficiary

22
Ways in which we pay out policy proceeds

22
Changing a payment option

22
Tax impact of payment option chosen

22
Premiums

22
Planned premiums

22
Minimum initial premium

23
Maximum premium payments

23
Processing premium payments

23
Ways to pay premiums

23
Lapse and reinstatement

24
Lapse

24
Early Lapse Protection

24
Cumulative premium test

25
Death during grace period

25
Reinstatement

25
The policy value

25
Asset credit

26
Allocation of future premium payments

26
Transfers of existing policy value

26
Marketing timing and disruptive trading practices

26
Surrender and withdrawals

28
Surrender

28
Withdrawals

28
Policy loans

28
Repayment of policy loans

29
  Page No.
Effects of policy loans

29
Description of charges at the policy level

29
Deductions from premium payments

29
Deductions from policy value

30
Additional information about how certain policy charges work

31
Sales expenses and related charges

31
Method of deduction

31
Reduced charges for eligible classes

31
Other charges we could impose in the future

31
Description of charges at the portfolio level

31
Other policy benefits, rights and limitations

32
Optional supplementary benefit riders you can add

32
Return of Premium Death Benefit Rider

32
Overloan Protection Rider

32
Long-Term Care Rider

32
Accelerated Benefit Rider

33
Enhanced Cash Value Rider

34
Enhanced Yield Fixed Account Rider

34
Variations in policy terms

35
Procedures for issuance of a policy

35
Commencement of insurance coverage

35
Backdating

35
Temporary coverage prior to policy delivery

35
Monthly deduction dates

36
Changes that we can make as to your policy

36
The owner of the policy

36
Policy cancellation right

36
Reports that you will receive

37
Assigning your policy

37
When we pay policy proceeds

37
General

37
Delay to challenge coverage

37
Delay for check clearance

37
Delay of separate account proceeds

37
Delay of general account surrender proceeds

38
How you communicate with us

38
General rules

38
Telephone, facsimile and internet transactions

38
Distribution of policies

39
Compensation

39
Tax considerations

40
General

40
Death benefit proceeds and other policy distributions

41
Policy loans

42
Diversification rules and ownership of the Separate Account

42
7-pay premium limit and modified endowment contract status

42
Corporate and H.R. 10 retirement plans

43
Withholding

44
Life insurance purchases by residents of Puerto Rico

44
Life insurance purchases by non-resident aliens

44
Life insurance owned by citizens or residents living abroad

44
Financial statements reference

44
Registration statement filed with the SEC

44
Independent registered public accounting firm

44
3

SUMMARY OF BENEFITS AND RISKS
The nature of the policy
The policy's primary purpose is to provide lifetime protection against economic loss due to the death of the insured person. The policy is unsuitable as a short-term savings vehicle because of the substantial policy-level charges. We are obligated to pay all amounts promised under the policy. The value of the amount you have invested under the policy may increase or decrease daily based on the investment results of the variable investment options that you choose. The amount we pay to the policy's beneficiary upon the death of the insured person (we call this the “death benefit”) may be similarly affected. That's why the policy is referred to as a “variable” life insurance policy. We call the investments you make in the policy “premiums” or “premium payments.” The amount we require as your first premium depends upon the specifics of your policy and the insured person. Except as noted in the Detailed Information section of this prospectus, you can make any other premium payments you wish at any time. That's why the policy is called a “flexible premium” policy.
In your application for the policy you will tell us how much life insurance coverage you want on the life of the insured person. This is called the “Total Face Amount.” The Total Face Amount is comprised of the Base Face Amount and any Supplemental Face Amount you elect. You choose the proportion of your policy’s Total Face Amount that is made up of Base Face Amount and Supplemental Face Amount based on your individual needs and objectives, which may change through time. Some of these considerations are discussed under “Base Face Amount vs. Supplemental Face Amount” in this prospectus; however, you should discuss your insurance needs and financial objectives with your registered representative before purchasing any life insurance product (see “Death benefit”).
If the life insurance protection described in this prospectus is provided under a master group policy, the term “policy” as used in this prospectus refers to the certificate we issue and not to the master group policy.
Summary of policy benefits
Death benefit
When the insured person dies, we will pay the death benefit minus any policy debt and unpaid fees and charges. There are two ways of calculating the death benefit (Option 1 and Option 2). You choose which one you want in the application. The two death benefit options are:
•  Option 1 - The death benefit will equal the greater of (1) the Total Face Amount plus any amount payable under a supplementary benefit rider, or (2) the minimum death benefit (as described under “The minimum death benefit” provision in the “Detailed Information” section of this prospectus).
•  Option 2 - The death benefit will equal the greater of (1) the Total Face Amount plus any amount payable under a supplementary benefit rider, plus the policy value on the date of death, or (2) the minimum death benefit.
Surrender of the policy
You may surrender the policy in full at any time. If you do, we will pay you the policy value less any outstanding policy debt. This is called your “net cash surrender value.” You must return your policy when you request a surrender.
If you have not taken a loan on your policy, the “policy value” of your policy will, on any given date, be equal to:
•  the amount you invested,
•  plus any gain or minus any loss of the investment experience of the investment options you’ve chosen,
•  minus all charges we deduct, and
•  minus all withdrawals you have made.
If you take a loan on your policy, your policy value will be computed somewhat differently (see “Effects of policy loans”).
Withdrawals
You may make a withdrawal of part of your net cash surrender value once in each policy month. Each withdrawal must be at least $500. Your policy value is automatically reduced by the amount of the withdrawal. A withdrawal may also reduce
4

the Total Face Amount (see “Surrender and withdrawalsWithdrawals”). We reserve the right to refuse any withdrawal that would cause the policy's Total Face Amount to fall below $250,000 or the Base Face Amount to fall below $100,000.
Policy loans
If your policy is in force and has sufficient policy value, you may borrow from it at any time by completing the appropriate form. Generally, the minimum amount of each loan is $500. The maximum amount you can borrow is determined by a formula as described in your policy. Interest is charged on each loan. You can pay the interest or allow it to become part of the outstanding loan balance. You can repay all or part of a loan at any time. If there is an outstanding loan when the insured person dies, it will be deducted from the death benefit. Policy loans permanently affect the calculation of your policy value, and may also result in adverse tax consequences.
Optional supplementary benefit riders
When you apply for the policy, you can request any of the optional supplementary benefit riders that we make available. Availability of riders varies from state to state. Charges for most riders will be deducted monthly from the policy value. Some riders may not be available in combination with other riders or benefits (see “Other policy benefits, rights and limitations— Optional supplementary benefit riders you can add”).
Investment options
The policy offers a number of investment options, as listed on page 1 of this prospectus. These investment options are subaccounts of John Hancock Life Insurance Company (U.S.A.) Separate Account A (“Separate Account”), a separate account operated by us under Michigan law. We also currently offer two “fixed account” options - the standard fixed account option, and the enhanced yield fixed account option offered as a supplementary benefit rider. The variable investment options have returns that vary depending upon the investment results of underlying portfolios. These options are referred to in this prospectus as “investment accounts.” The fixed accounts and the investment accounts are sometimes collectively referred to in this prospectus as the “accounts.” The investment accounts cover a broad spectrum of investment styles and strategies. Although the portfolios of the series funds that underlie those investment accounts operate like publicly traded mutual funds, there are important differences between the investment accounts and publicly traded mutual funds. You can transfer money from one investment account to another without tax liability. Moreover, any dividends and capital gains distributed by each underlying portfolio are automatically reinvested and reflected in the portfolio’s value and create no taxable event for you. If and when policy earnings are distributed (generally as a result of a surrender or withdrawal), they will be treated as ordinary income instead of as capital gains. Also, you must keep in mind that you are purchasing an insurance policy and you will be assessed charges at the policy level as well as at the fund level. Such policy level charges, in aggregate, are significant and will reduce the investment performance of your policy.
Summary of policy risks
Lapse risk
If the net cash surrender value is insufficient to pay the charges when due and the Early Lapse Protection is not in effect, your policy can terminate (i.e. “lapse”). This can happen because you haven't paid enough premium or because the investment performance of the investment accounts you’ve chosen has been poor or because of a combination of both factors. You will be given a “grace period” within which to make additional premium payments to keep the policy in effect. If lapse occurs, you may be given the opportunity to reinstate the policy by making the required premium payments and satisfying certain other conditions (see “Lapse and reinstatement”).
Since withdrawals reduce your policy value, withdrawals increase the risk of lapse. Policy loans also increase the risk of lapse.
Investment risk
As mentioned above, the investment performance of any investment account may be good or bad. Your policy value will rise or fall based on the investment performance of the investment accounts you’ve chosen. Some investment accounts are riskier than others. These risks (and potential rewards) are discussed in detail in the prospectuses of the underlying portfolios.
5

Transfer risk
There is a risk that you will not be able to transfer your policy value from one investment account to another because of limitations on the dollar amount or frequency of transfers you can make. The limitations on transfers out of the fixed account options are more restrictive than those that apply to transfers out of investment accounts.
Early surrender risk
Depending on the policy value at the time you are considering surrender, there may be little or no surrender value payable to you.
Market timing and disruptive trading risks
The policy is not designed for professional market timers or highly active traders, including persons or entities that engage in programmed, large or frequent transfers among the investment accounts or between the investment accounts and any available fixed account. The policy is also not designed to accommodate trading that result in transfers that are large in relation to the total assets of the underlying portfolio.
To discourage market timing and disruptive trading activity, we impose restrictions (see “Market timing and disruptive trading practices”) on transfers and reserve the right to change, suspend or terminate telephone, facsimile and internet transaction privileges (see “How you communicate with us”).
While we seek to identify and prevent disruptive trading activity, it may not always be possible to do so. Therefore, no assurance can be given that the restrictions we impose will be successful in preventing all disruptive trading and avoiding harm to long term investors.
Tax risks
Life insurance death benefits are ordinarily not subject to income tax. Other Federal and state taxes may apply as further discussed below. In general, you will be taxed on the amount of lifetime distributions that exceed the premiums paid under the policy. Any taxable distribution will be treated as ordinary income (rather than as capital gains) for tax purposes.
In order for you to receive the tax benefits extended to life insurance under the Internal Revenue Code, your policy must comply with certain requirements of the Code. We will monitor your policy for compliance with these requirements, but a policy might fail to qualify as life insurance in spite of our monitoring. If this were to occur, you would be subject to income tax on the income credited to your policy for the period of disqualification and all subsequent periods. The tax laws also contain a so-called “7 pay limit” that limits the amount of premium that can be paid in relation to the policy’s death benefit. If the limit is violated, the policy will be treated as a “modified endowment contract,” which can have adverse tax consequences. There are also certain Treasury Department rules referred to as the “investor control rules” that determine whether you would be treated as the “owner” of the assets underlying your policy. If that were determined to be the case, you would be taxed on any income or gains those assets generate. In other words, you would lose the value of the so-called “inside build-up” that is a major benefit of life insurance.
There is a tax risk associated with policy loans. Although no part of a loan is treated as income to you when the loan is made unless your policy is a “modified endowment contract,” surrender or lapse of the policy would result in the loan being treated as a distribution at the time of lapse or surrender. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans and an insured person of advanced age, you might find yourself having to choose between high premium requirements to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.
Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws can vary greatly depending upon the circumstances of each owner or beneficiary. There can also be unfavorable tax consequences on such things as the change of policy ownership or assignment of ownership interests. For these and all the other reasons mentioned above, we recommend you consult with a qualified tax adviser before buying the policy and before exercising certain rights under the policy.
6

FEE TABLES
This section contains tables that describe all of the fees and expenses that you will pay when buying, owning and surrendering the policy. In the first three tables, certain entries show the maximum charge, the minimum charge and the charge for the representative insured person. Other entries show only the maximum charge we can assess. Except where necessary to show a rate greater than zero, all rates shown in the tables have been rounded to two decimal places as required by prospectus disclosure rules. Consequently, the actual rates charged may be slightly higher or lower than those shown in the tables.
The first table below describes the fees and expenses that you will pay at the time that you pay a premium, transfer policy value between investment accounts or request an unscheduled increase in Supplemental Face Amount. A portion of the premium charge is used to cover premium taxes. Premium taxes vary by jurisdiction and are subject to change. Currently, premium tax levels range from 0% to 3.5%.
Transaction Fees
Charge When Charge is Deducted Amount Deducted
Premium charge(1) Upon payment of premium 20% of Target Premium and 12% of premium paid in excess of Target Premium in policy year 1
10% of Target Premium and 7% of premium paid in excess of Target Premium in policy years 2-10
6% of all premiums paid in policy years 11 and thereafter
Transfer fee(2) Upon each transfer into or out of an investment account beyond an annual limit of not less than twelve $25
Unscheduled Supplemental Face Amount increase charge Upon unscheduled increase in Supplemental Face Amount for ten years from the date of the increase $0.22 per $1,000 of unscheduled increase in Supplemental Face Amount
    
(1)  The current charges differ from those shown above as follows: A premium charge of 15% is deducted from each premium paid up to the Target Premium in the first policy year. A premium charge of 8% is deducted from each premium paid up to the Target Premium in policy years 2-10. A premium charge of 9% is deducted from premium in excess of the Target Premium in the first policy year and a charge of 5% is deducted from each premium in excess of Target Premium in policy years 2-10. A premium charge of 4% is deducted from all premiums paid in policy years 11 and thereafter. The Target Premium appears in the Policy Specifications section of the policy and is based on the amount of Base Face Amount at issue.
(2)  This charge is not currently imposed, but we reserve the right to do so in the policy.
7

The next two tables describe the charges and expenses that you will pay periodically during the time you own the policy. These tables do not include fees and expenses paid at the portfolio level. The second table is devoted only to optional supplementary rider benefits. For more information about the cost of insurance rates and other charges talk to your John Hancock USA representative.
Periodic Charges Other Than Fund Operating Expenses
Charge When Charge is Deducted Amount Deducted
Cost of insurance charge(1) Monthly  
Maximum charge   $83.33 per $1,000 of NAR
Minimum charge   $0.02 per $1,000 of NAR
Charge for representative insured person   $0.52 per $1,000 of NAR
Base Face Amount charge(2) Monthly for ten policy years from the Policy Date  
Maximum charge   $0.36 per $1,000 of Base Face Amount
Minimum charge   $0.03 per $1,000 of Base Face Amount
Charge for representative insured person   $0.17 per $1,000 of Base Face Amount
Administrative charge(3) Monthly $15.00
Asset-based risk charge(4) Monthly 0.15% of policy value in policy years 1-30
0.06% of policy value in policy years 31 and thereafter
Policy loan interest rate(5) Accrues daily
Payable annually
4.25%
    
(1)  The cost of insurance charge is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable cost of insurance rate. The rates vary widely depending upon the length of time the policy has been in effect, the insurance risk characteristics of the insured person and (generally) the sex of the insured person. The maximum rate shown is the rate in the first policy year for a 90 year old male substandard smoker underwriting risk. The minimum rate shown is the rate in the first policy year for a 5 year old female standard non-smoker underwriting risk. The representative insured person rate shown is the rate in the first policy year for a 55 year old male standard non-smoker underwriting risk. These charges may not be particularly relevant to your current situation. For more information, contact your John Hancock USA representative.
(2)  This charge is determined by multiplying the Base Face Amount at issue by the applicable rate. The rates vary by sex, issue age, and risk classification of the insured person. The maximum rate shown is for a 90 year old male standard smoker. The minimum rate shown is for a 0 year old female standard non-smoker. The representative insured person rate shown is for a 55 year old male standard non-smoker underwriting risk. These charges may not be particularly relevant to your current situation. For more information, contact your John Hancock USA representative.
(3)  This charge is currently not imposed, but we reserve the right to do so in the policy.
(4)  This charge only applies to the portion of the policy value held in the investment accounts. The charge determined does not apply to any policy value held in a fixed account. The maximum charge varies based on the amount of Base Fact Amount and Supplemental Face Amount elected at issue. The maximum charge shown in the table is for a policy with 20% Base Face Amount and 80% Supplemental Face Amount at issue. The current charge is 0.02% of policy value in policy years 1-15, 0.00% in policy years 16 and thereafter. The current charge is the same for all policies, regardless of the Base Face Amount and the Supplemental Face Amount at issue. For more information, contact your John Hancock USA representative.
(5)  4.25% is the maximum effective annual interest rate we can charge and applies only during policy years 1-10. The effective annual interest rate is 3.00% thereafter (although we reserve the right to increase the rate after the tenth policy year to as much as 3.25%). The amount of any loan is transferred from the accounts to a special loan account which earns interest at an effective annual rate of 3.00%. Therefore, the cost of a loan is the difference between the loan interest we charge and the interest we credit to the special loan account.
8

Rider Charges
Charge When Charge is Deducted Amount Deducted
Return of Premium Death Benefit Rider(1) Monthly  
Maximum charge   $83.33 per $1,000 of NAR
Minimum charge   $0.02 per $1,000 of NAR
Charge for representative insured person   $0.52 per $1,000 of NAR
Overloan Protection Rider(2) At exercise of benefit  
Maximum charge   8.00%
Minimum charge   0.04%
Long-Term Care Rider(3) Monthly  
Maximum charge   $4.51 per $1,000 of NAR
Minimum charge   $0.01 per $1,000 of NAR
Accelerated Benefit Rider(4) At exercise of benefit $150
Enhanced Cash Value Rider(5) Upon payment of premium 2% of premium paid up to the Target Premium
    
(1)  The charge for this rider is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable cost of insurance rate. The rates vary widely depending upon the length of time the policy has been in effect, the insurance risk characteristics of the insured person and (generally) the sex of the insured person. The maximum rate shown is the rate in the first policy year for a 90 year old male substandard smoker underwriting risk. The minimum rate shown is the rate in the first policy year for a 5 year old female standard non-smoker underwriting risk. The representative insured person rate shown is for a 55 year old male standard non-smoker underwriting risk. These charges may not be particularly relevant to your current situation. For more information, contact your John Hancock USA representative.
(2)  The charge for this rider is determined as a percentage of unloaned account value. The rates vary by the attained age of the younger insured person at the time of exercise. The rates also differ according to the tax qualification test elected at issue. The maximum rate shown is for the insured person who has reached or would have reached age 75 and the cash value accumulation test has been elected. The minimum rate shown is for the insured person who has reached or would have reached age 120 and either the guideline premium text or the cash value accumulation test has been elected. These charges may not be particularly relevant to your current situation. For more information, contact your John Hancock USA representative.
(3)  The charge for this rider is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable rate. The rates vary by the long-term care insurance risk characteristics of the insured person and the rider benefit level selected. The maximum rate shown is for an 80 year old male substandard smoker underwriting risk with a 4% Monthly Acceleration Percentage. The minimum rate shown is for a 20 year old female super preferred non-smoker underwriting risk with a 1% Monthly Acceleration Percentage. The Monthly Acceleration Percentage is stated in the Policy Specifications page of your policy. The representative insured person rate shown is for a 45 year old male standard non-smoker underwriting risk with a 4% Monthly Acceleration Percentage. These charges may not be particularly relevant to your current situation. For more information, contact your John Hancock USA representative.
(4)  This charge is not currently imposed, but we reserve the right to do so in the policy.
(5)   Premiums received in the second policy year will only be included in calculating the charge until all premiums received in the first and second policy years equals the Target Premium.
9

The next table describes the minimum and maximum portfolio level fees and expenses charged by any of the portfolios underlying a variable investment option offered through this prospectus, expressed as a percentage of average net assets (rounded to two decimal places). These expenses are deducted from portfolio assets. For more information, please refer to the prospectus for the underlying portfolio.
Total Annual Portfolio Operating Expenses Minimum Maximum
Range of expenses, including management fees, distribution and/or service (12b-1) fees, and other expenses1 0.49% 1.68%
    
1Certain of the portfolios’ advisers or subadvisers have contractually agreed to reimburse or waive certain portfolio level expenses. The minimum and maximum expenses shown do not reflect these contractual expense reimbursements or waivers. If such reimbursements or waivers were reflected, the minimum and maximum expenses would be 0.25% and 1.53%, respectively.
The next table describes the fees and expenses for each portfolio underlying a variable investment option offered through this prospectus. None of the portfolios charge a sales load or surrender fee. The fees and expenses do not reflect the fees and expenses of any variable insurance contract or qualified plan that may use the portfolio as its underlying investment medium. Except for the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International, American New World and PIMCO VIT All Asset portfolios, all of the portfolios shown in the table are NAV class shares that are not subject to Rule 12b-1 fees. Except as indicated in the footnotes appearing at the end of the table, the expense ratios are based upon the portfolio's actual expenses for the year ended December 31, 2014.
Portfolio Annual Expenses
(as a percentage of portfolio average net assets, rounded to two decimal places)
Portfolio   Management
Fees
  12b-1
Fees
  Other
Expenses
  Acquired
Fund Fees
and Expenses
  Total Fund
Operating
Expenses
500 Index B1

  0.46%   0.00%   0.03%   0.00%   0.49%
Active Bond

  0.60%   0.00%   0.04%   0.00%   0.64%
All Cap Core

  0.77%   0.00%   0.05%   0.00%   0.82%
Alpha Opportunities

  0.97%   0.00%   0.03%   0.00%   1.00%
American Asset Allocation2

  0.28%   0.60%   0.04%   0.00%   0.92%
American Global Growth2

  0.52%   0.60%   0.06%   0.00%   1.18%
American Growth2

  0.33%   0.60%   0.04%   0.00%   0.97%
American Growth-Income2

  0.27%   0.60%   0.04%   0.00%   0.91%
American International2

  0.50%   0.60%   0.06%   0.00%   1.16%
American New World2

  0.72%   0.60%   0.13%   0.00%   1.45%
Blue Chip Growth

  0.78%   0.00%   0.03%   0.00%   0.81%
Bond

  0.56%   0.00%   0.03%   0.00%   0.59%
Capital Appreciation

  0.70%   0.00%   0.03%   0.00%   0.73%
Capital Appreciation Value3

  0.81%   0.00%   0.05%   0.01%   0.87%
Core Bond

  0.59%   0.00%   0.03%   0.00%   0.62%
Core Strategy3

  0.04%   0.00%   0.02%   0.54%   0.60%
Emerging Markets Value

  0.95%   0.00%   0.08%   0.00%   1.03%
Equity-Income3

  0.78%   0.00%   0.03%   0.01%   0.82%
Financial Industries3

  0.77%   0.00%   0.10%   0.08%   0.95%
Franklin Templeton Founding Allocation3

  0.04%   0.00%   0.02%   0.90%   0.96%
Fundamental All Cap Core

  0.68%   0.00%   0.03%   0.00%   0.71%
Fundamental Large Cap Value

  0.63%   0.00%   0.03%   0.00%   0.66%
Global

  0.81%   0.00%   0.05%   0.00%   0.86%
Global Bond4

  0.70%   0.00%   0.06%   0.00%   0.76%
Health Sciences

  0.97%   0.00%   0.04%   0.00%   1.01%
High Yield

  0.67%   0.00%   0.06%   0.00%   0.73%
International Core

  0.88%   0.00%   0.08%   0.00%   0.96%
International Growth Stock3

  0.79%   0.00%   0.06%   0.01%   0.86%
International Equity Index B1

  0.53%   0.00%   0.08%   0.00%   0.61%
International Small Company

  0.95%   0.00%   0.13%   0.00%   1.08%
10

Portfolio   Management
Fees
  12b-1
Fees
  Other
Expenses
  Acquired
Fund Fees
and Expenses
  Total Fund
Operating
Expenses
International Value

  0.80%   0.00%   0.06%   0.00%   0.86%
Investment Quality Bond

  0.58%   0.00%   0.06%   0.00%   0.64%
Lifestyle Aggressive MVP3,5

  0.05%   0.00%   0.03%   0.85%   0.93%
Lifestyle Balanced MVP3,5

  0.05%   0.00%   0.01%   0.69%   0.75%
Lifestyle Conservative MVP3,5,

  0.05%   0.00%   0.02%   0.65%   0.72%
Lifestyle Growth MVP3,5

  0.05%   0.00%   0.02%   0.71%   0.78%
Lifestyle Moderate MVP3,5

  0.05%   0.00%   0.02%   0.68%   0.75%
Mid Cap Index6

  0.47%   0.00%   0.04%   0.00%   0.51%
Mid Cap Stock

  0.83%   0.00%   0.04%   0.00%   0.87%
Mid Value3

  0.95%   0.00%   0.04%   0.01%   1.00%
Money Market B1

  0.50%   0.00%   0.04%   0.00%   0.54%
PIMCO VIT All Asset7

  0.43%   0.45%   0.00%   0.80%   1.68%
Real Estate Securities

  0.70%   0.00%   0.04%   0.00%   0.74%
Real Return Bond8

  0.70%   0.00%   0.25%   0.00%   0.95%
Science and Technology

  1.02%   0.00%   0.03%   0.00%   1.05%
Short Term Government Income

  0.56%   0.00%   0.05%   0.00%   0.61%
Small Cap Growth

  1.05%   0.00%   0.04%   0.00%   1.09%
Small Cap Index3,9

  0.49%   0.00%   0.03%   0.06%   0.58%
Small Cap Opportunities3,10

  1.00%   0.00%   0.04%   0.01%   1.05%
Small Cap Value3

  1.04%   0.00%   0.03%   0.06%   1.13%
Small Company Value3

  1.03%   0.00%   0.04%   0.18%   1.25%
Strategic Income Opportunities

  0.64%   0.00%   0.05%   0.00%   0.69%
Total Bond Market B1

  0.47%   0.00%   0.04%   0.00%   0.51%
Total Stock Market Index

  0.48%   0.00%   0.04%   0.01%   0.53%
Ultra Short Term Bond

  0.55%   0.00%   0.06%   0.00%   0.61%
U.S. Equity

  0.75%   0.00%   0.04%   0.00%   0.79%
Utilities

  0.83%   0.00%   0.04%   0.00%   0.87%
Value3

  0.69%   0.00%   0.04%   0.04%   0.77%
M Capital Appreciation11

  0.90%   0.00%   0.17%   0.00%   1.07%
M International Equity11

  0.70%   0.00%   0.23%   0.00%   0.93%
M Large Cap Growth11

  0.59%   0.00%   0.16%   0.00%   0.75%
M Large Cap Value11

  0.45%   0.00%   0.23%   0.00%   0.68%
    
1John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its advisory fee (or, if necessary, reimburse expenses of the portfolio) in an amount so that the portfolio's net Total Fund Operating Expenses do not exceed its “Total Fund Operating Expenses” as shown in the table above. A portfolio's “Total Fund Operating Expenses” includes all of its operating expenses including advisory and Rule 12b-1 fees, but excludes taxes, brokerage commissions, interest, short dividends, acquired fund fees, litigation and indemnification expenses and extraordinary expenses of the portfolio not incurred in the ordinary course of the portfolio's business. JHIMS’ obligation to provide this waiver or reimbursement will remain in effect until April 30, 2016 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expense” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the portfolio.
Portfolio   Total Fund
Operating Expenses
500 Index B

  0.25%
International Equity Index B

  0.34%
Portfolio   Total Fund
Operating Expenses
Money Market B

  0.28%
Total Bond Market B

  0.25%
2 The table reflects the combined fees of the feeder fund and the master fund.
3 “Acquired Fund Fees and Expenses” are based on indirect net expenses associated with the portfolio’s investments in underlying funds (each an “Acquired Fund”) and are included in the portfolio’s “Total Fund Operating Expenses.” The “Total Fund Operating Expenses”
11

shown may not correlate to the portfolio’s ratio of expenses to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.
4“Other Expenses” reflect interest expense resulting from the portfolio’s use of certain investments such as reverse repurchase agreements or sale-buybacks. Such expense is required to be treated as a portfolio expense for accounting purposes. Any interest expense amount will vary based on the portfolio’s use of those investments as an investment strategy. Had these expenses been excluded, “Other Expenses” would have been 0.05%. For more information, please refer to the prospectus for the portfolio.
5John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to reduce its management fee and/or make payment to the portfolio in an amount equal to the amount by which “Other Expenses” of the portfolio exceed 0.00% of the average annual net assets (on an annualized basis) of the portfolio. “Other Expenses” means all of the expenses of the portfolio, excluding certain expenses such as advisory fees, taxes, brokerage commissions, interest expense, litigation and indemnification expenses and other extraordinary expenses not incurred in the ordinary course of the portfolio’s business, distribution and service (Rule 12b-1) fees, underlying fund expenses (acquired fund fees), and short dividend expense. The current expense limitation agreement expires on April 30, 2017 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. JHIMS may recapture operating expenses reimbursed or fees waived under previous expense limitation or waiver arrangements for a period of three years following the month in which the reimbursements or waivers occurred to the extent that the portfolio is below its expense limitation during this period. The fees shown in the table do not reflect this expense waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expenses” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the underlying portfolio.
Portfolio   Total Fund
Operating Expenses
Lifestyle Aggressive MVP

  0.90%
Lifestyle Balanced MVP

  0.74%
Lifestyle Conservative MVP

  0.70%
Portfolio   Total Fund
Operating Expenses
Lifestyle Growth

  0.76%
Lifestyle Moderate

  0.73%
6 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.10% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2016 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.41%. For more information, please refer to the prospectus for the portfolio.
7 Pacific Investment Management Company LLC (“PIMCO”) has contractually agreed through May 1, 2016, to reduce its management fee to the extent that the underlying fund expenses attributable to management, supervisory and administrative fees exceeds 0.64% of the total assets invested in the underlying funds. PIMCO may recoup these waivers in future periods, not exceeding three years, provided total expenses, including such recoupment, do not exceed the annual expense limit. The fee reduction is implemented based on a calculation of underlying fund expenses attributable to management, supervisory and administrative fees that is different from the calculation of “Acquired Fund Fees and Expenses” shown in the table. “Acquired Fund Fees and Expenses” include interest expense of 0.01%. Interest expense is based on the amount incurred during an underlying fund’s most recent fiscal year as a result of entering into certain investments, such as reverse repurchase agreements. Interest expense is required to be treated as an expense of the underlying fund for accounting purposes and is not payable to PIMCO. The amount of interest expense (if any) will vary based on the underlying fund’s use of such investments as an investment strategy. “Total fund Operating Expenses” excluding interest expense of the underlying fund is 1.68%. The fees shown in the table do not reflect the expense waiver. If this expense waiver had been reflected, the “Total Fund Operating Expenses” shown (excluding the interest expense of the underlying funds) would be 1.53%. The “Total Fund Operating Expenses” shown may not correlate to the portfolio’s ratio of expense to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.
8 “Other Expenses” reflect interest expense resulting from the portfolio’s use of certain investments such as reverse repurchase agreements or sale-buybacks. Such expense is required to be treated as a portfolio expense for accounting purposes. Any interest expense amount will vary based on the portfolio’s use of those investments as an investment strategy. Had these expenses been excluded, “Other Expenses” would have been 0.14%. For more information, please refer to the prospectus for the portfolio.
9 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.05% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2016 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.53%. For more information, please refer to the prospectus for the portfolio.
10 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fees so that the amount retained by JHIMS after payment of the subadvisory fees for the portfolio does not exceed 0.45% of the portfolio’s average net assets. The current expense limitation agreement expires on April 30, 2016 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waive had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.96%. For more information, please refer to the prospectus for the portfolio.
11 Until April 30, 2016, M Financial Investment Advisers, Inc. has contractually agreed to reimburse the portfolio for any ordinary expenses (other than advisory fees, brokerage, or other portfolio transaction expenses or expenses for litigation, indemnification, taxes or other extraordinary expenses) to the extent that such expenses exceed 0.25% of the portfolio's average annual net assets. For more information, please refer to the prospectus for the portfolio.
12

DETAILED INFORMATION
This section of the prospectus provides additional detailed information that is not contained in the Summary of Benefits and Risks section.
Table of Investment Options and Investment Subadvisers
When you select a Separate Account investment option, we invest your money in shares of a corresponding portfolio of the John Hancock Variable Insurance Trust (the “Trust” or “JHVIT”) (or the PIMCO Variable Insurance Trust (the “PIMCO Trust”) or M Fund, Inc. (the “M Fund”)), and hold the shares in a subaccount of the Separate Account. The Fee Tables show the investment management fees, Rule 12b-1 fees and other operating expenses for these portfolio shares as a percentage (rounded to two decimal places) of each portfolio’s average net assets for 2014, except as indicated in the footnotes appearing at the end of the table. Fees and expenses of the portfolios are not fixed or specified under the terms of the policies and may vary from year to year. These fees and expenses differ for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any Separate Account investment options you select.
The JHVIT, the PIMCO Trust, and the M Fund are so-called “series” type mutual funds and each is registered under the Investment Company Act of 1940 (“1940 Act”) as an open-end management investment company. John Hancock Investment Management Services, LLC (“JHIMS”) provides investment advisory services to the Trust and receives investment management fees for doing so. JHIMS pays a portion of its investment management fees to other firms that manage the Trust’s portfolios. We are affiliated with JHIMS and may indirectly benefit from any investment management fees JHIMS retains. The PIMCO VIT All Asset portfolio of the PIMCO Trust receives investment advisory services from Pacific Investment Management Company LLC (“PIMCO”) and pays investment management fees to PIMCO.
Each of the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios invests in Series 1 shares of the corresponding investment portfolio of the Trust. The American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios (“American Portfolios”) operate as “feeder funds,” which means that the portfolios do not buy investment securities directly. Instead, they invest in a “master fund” which in turn purchases investment securities. Each of the American feeder fund portfolios has the same investment objective and limitations as its master fund. The prospectus for the American Fund master fund is included with the prospectuses for the underlying funds. We pay American Funds Distributors, Inc., the principal underwriter for the American Funds Insurance Series, a percentage of some or all of the amounts allocated to the American Portfolios of the Trust for the marketing support services it provides.
The M Capital Appreciation, M International Equity, M Large Cap Growth and M Large Cap Value portfolios are series of the M Fund, an open-end management investment company registered under the 1940 Act. The assets of these subaccounts are invested in the corresponding portfolios of the M Fund. M Financial Investment Advisers, Inc. (“M Financial”) is the investment adviser for all portfolios of the M Fund. The entities shown in the table below as “Portfolio Managers” of the M Fund portfolios are sub-investment advisers selected by M Financial and are the entities that manage the portfolio’s assets.
The portfolios pay us or certain of our affiliates compensation for some of the distribution, administrative, shareholder support, marketing and other services we or our affiliates provide to the portfolios. The amount of this compensation is based on a percentage of the assets of the portfolios attributable to the variable insurance products that we and our affiliates issue. These percentages may differ from portfolio to portfolio and among classes of shares within a portfolio. In some cases, the compensation is derived from the Rule 12b-1 fees that are deducted from a portfolio’s assets for the services we or our affiliates provide to that portfolio. These compensation payments do not, however, result in any charge to you in addition to what is shown in the Fee Tables.
The following table provides a general description of the portfolios that underlie the variable investment options we make available under the policy. You bear the investment risk of any portfolio you choose as an investment option for your policy. You can find a full description of each portfolio, including the investment objectives, policies, restrictions, and risks, in the prospectus for that portfolio. You should read the portfolio’s prospectus carefully before investing in the corresponding variable investment option.
The investment options in the Separate Account are not publicly traded mutual funds. The investment options are only available to you as investment options in the policies, or in some cases through other variable annuity contracts or variable life insurance policies issued by us or by other life insurance companies. In some cases, the investment options also may be
13

available through participation in certain qualified pension or retirement plans. The portfolios' investment advisers and managers (i.e. subadvisers) may manage publicly traded mutual funds with similar names and investment objectives. However, the portfolios are not directly related to any publicly traded mutual fund. You should not compare the performance of any investment option described in this prospectus with the performance of a publicly traded mutual fund. The performance of any publicly traded mutual fund could differ substantially from that of any of the investment options of our Separate Account.
The portfolios available under the policies, the investment subadvisers (engaged by JHIMS, M Financial or PIMCO) and the investment objective for each portfolio are described in the table below. For additional information regarding these portfolios' investment objectives, policies and restrictions of and the risks relating to investment in the portfolios, please refer to the prospectus for the underlying portfolio.
Portfolio Subadviser Investment Objective
500 Index B John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To approximate the aggregate total return of a broad-based U.S. domestic equity market index.
Active Bond Declaration Management & Research LLC; and John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide income and capital appreciation.
All Cap Core QS Investors, LLC To seek to provide long-term growth of capital.
Alpha Opportunities Wellington Management Company, LLP To seek to provide long-term total return.
American Asset Allocation Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide high total return (including income and capital gains) consistent with preservation of capital over the long-term.
American Global Growth Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term growth of capital.
American Growth Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide growth of capital.
American Growth–Income Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide growth of capital and income.
American International Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term growth of capital.
American New World Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term capital appreciation.
Blue Chip Growth T. Rowe Price Associates, Inc. To seek to provide long-term growth of capital. Current income is a secondary objective.
Bond John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide income and capital appreciation.
Capital Appreciation Jennison Associates LLC To seek to provide long-term growth of capital.
Capital Appreciation Value T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
Core Bond Wells Capital Management, Incorporated To seek to provide total return consisting of income and capital appreciation.
Core Strategy John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital. Current income is also a consideration.
14

Portfolio Subadviser Investment Objective
Emerging Markets Value Dimensional Fund Advisors LP To seek to provide long-term capital appreciation.
Equity-Income T. Rowe Price Associates, Inc. To seek to provide substantial dividend income and also long-term growth of capital.
Financial Industries John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide growth of capital.
Franklin Templeton Founding Allocation John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term growth of capital.
Fundamental All Cap Core John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term growth of capital.
Fundamental Large Cap Value John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term capital appreciation.
Global Templeton Global Advisors Limited To seek to provide long-term capital appreciation.
Global Bond Pacific Investment Management Company LLC To seek to provide maximum total return, consistent with preservation of capital and prudent investment management.
Health Sciences T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
High Yield Western Asset Management Company To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk.
International Core Grantham, Mayo, Van Otterloo & Co. LLC To seek to provide high total return.
International Equity Index B SSgA Funds Management, Inc. To seek to track the performance of a broad-based equity index of foreign companies primarily in developed countries and, to a lesser extent, in emerging markets.
International Growth Stock Invesco Advisers, Inc. To seek to provide long-term growth of capital.
International Small Company Dimensional Fund Advisors LP To seek to provide long-term capital appreciation.
International Value Templeton Investment Counsel, LLC To seek to provide long-term growth of capital.
Investment Quality Bond Wellington Management Company, LLP To seek to provide a high level of current income consistent with the maintenance of principal and liquidity.
Lifestyle Aggressive MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Balanced MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide growth of capital and current income while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Conservative MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Growth MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
15

Portfolio Subadviser Investment Objective
Lifestyle Moderate MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Mid Cap Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a medium-capitalization U.S. domestic equity market index.
Mid Cap Stock Wellington Management Company, LLP To seek to provide long-term growth of capital.
Mid Value T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
Money Market B John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to obtain maximum current income consistent with preservation of principal and liquidity. Certain market conditions may cause the return of the portfolio to become low or possibly negative.
PIMCO VIT All Asset (a series of PIMCO Variable Insurance Trust) (only Class M is available) Pacific Investment Management Company LLC To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management.
Real Estate Securities Deutsche Investment Management Americas Inc. To seek to provide a combination of long-term capital appreciation and current income.
Real Return Bond Pacific Investment Management Company LLC To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management.
Science & Technology T. Rowe Price Associates, Inc.; and Allianz Global Investors U.S. LLC To seek to provide long-term growth of capital. Current income is incidental to the portfolio’s objective.
Short Term Government Income John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income consistent with preservation of capital. Maintaining a stable share price is a secondary goal.
Small Cap Growth Wellington Management Company, LLP To seek to provide long-term capital appreciation.
Small Cap Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a small-capitalization U.S. domestic equity market index.
Small Cap Opportunities Dimensional Fund Advisors LP; and Invesco Advisers, Inc. To seek to provide long-term capital appreciation.
Small Cap Value Wellington Management Company, LLP To seek to provide long-term capital appreciation.
Small Company Value T. Rowe Price Associates, Inc. To seek to provide long-term growth of capital.
Strategic Income Opportunities John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income.
Total Bond Market B Declaration Management & Research LLC To seek to track the performance of the Barclays U.S. Aggregate Bond Index.*
Total Stock Market Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a broad U.S. domestic equity market index.
Ultra Short Term Bond John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income consistent with the maintenance of liquidity and the preservation of capital.
U.S. Equity Grantham, Mayo, Van Otterloo & Co. LLC To seek to provide long-term capital appreciation.
Utilities Massachusetts Financial Services Company To seek to provide capital growth and current income (income above that available from the portfolio invested entirely in equity securities).
Value Invesco Advisers, Inc. To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk.
16

Portfolio Subadviser Investment Objective
M Capital Appreciation (a series of M Fund, Inc.) Frontier Capital Management Company, LLC To seek to provide maximum capital appreciation.
M International Equity (a series of M Fund, Inc.) Northern Cross, LLC To seek to provide long-term capital appreciation.
M Large Cap Growth (a series of M Fund, Inc.) DSM Capital Partners LLC To seek to provide long-term capital appreciation.
M Large Cap Value (a series of M Fund, Inc.) AJO, LP To seek to provide long-term capital appreciation.
    
*The U.S. Aggregate Bond Index is a broad-based benchmark that measures the investment grade, U.S. dollar-denominated, fixed-rate taxable bond market, including Treasuries, government-related and corporate securities, MBS (agency fixed-rate and hybrid ARM pass throughs), ABS, and CMBS.
If the shares of a portfolio are no longer available for investment or in our judgment investment in a portfolio becomes inappropriate, we may eliminate the shares of a portfolio and substitute shares of another portfolio of the Trust or another open-end registered investment company. Substitution may be made with respect to both existing investments and the investment of future purchase payments. However, we will make no such substitution without first notifying you and obtaining approval of the appropriate insurance regulatory authorities and the SEC (to the extent required by the 1940 Act).
Valuation
We will purchase and redeem series fund shares for the Separate Account at their net asset value without any sales or redemption charges. Shares of a series fund represent an interest in one of the funds of the series fund which corresponds to a subaccount of the Separate Account. Any dividend or capital gains distributions received by the Separate Account will be reinvested in shares of that same fund at their net asset value as of the dates paid.
On each business day, shares of each series fund are purchased or redeemed by us for each subaccount based on, among other things, the amount of net premiums allocated to the subaccount, distributions reinvested, and transfers to, from and among subaccounts, all to be effected as of that date. Such purchases and redemptions are effected at each series fund's net asset value per share determined for that same date. A “business day” is any date on which the New York Stock Exchange is open for trading. We compute policy values for each business day as of the close of that day (usually 4:00 p.m. Eastern time).
Voting interest
We will vote shares of the portfolios held in the Separate Account at the shareholder meetings according to voting instructions timely received from persons having the voting interest under the policies. We will determine the number of portfolio shares for which voting instructions may be given not more than 90 days prior to the meeting. Proxy material will be distributed to each person having the voting interest under the policy together with appropriate forms for giving voting instructions. We will vote all portfolio shares that we hold in the Separate Account for policy owners in proportion to the instructions timely received by us from policy owners from all our Separate Accounts that are registered with the SEC under the 1940 Act. We will vote all portfolio shares that we otherwise are entitled to vote (including our own shares) on any matter in proportion to the instructions timely received by us and any affiliated insurance companies with respect to the matter from policy owners in Separate Accounts of these insurance companies that are registered with the SEC under the 1940 Act. The effect of this proportional voting is that a small number of policy owners can determine the outcome of a vote.
We determine the number of a series fund's shares held in a subaccount attributable to each owner by dividing the amount of a policy's investment account value held in the subaccount by the net asset value of one share in the series fund. Fractional votes will be counted. We determine the number of shares as to which the owner may give instructions as of the record date for a series fund's meeting. Owners of policies may give instructions regarding the election of the Board of Trustees or Board of Directors of a series fund, ratification of the selection of independent auditors, approval of series fund investment advisory agreements and other matters requiring a shareholder vote. We will furnish owners with information and forms to enable owners to give voting instructions. However, we may, in certain limited circumstances permitted by the SEC's rules, disregard voting instructions. If we do disregard voting instructions, you will receive a summary of that action and the reasons for it in the next semi-annual report to owners.
The voting privileges described above reflect our understanding of applicable Federal securities law requirements. To the extent that applicable law, regulations or interpretations change to eliminate or restrict the need for such voting privileges, we reserve the right to proceed in accordance with any such revised requirements. We also reserve the right, subject to
17

compliance with applicable law, including approval of owners if so required, (1) to transfer assets determined by John Hancock USA to be associated with the class of policies to which your policy belongs from the Separate Account to another separate account or subaccount, (2) to deregister the Separate Account under the 1940 Act, (3) to substitute for the fund shares held by a subaccount any other investment permitted by law, and (4) to take any action necessary to comply with or obtain any exemptions from the 1940 Act. Any such change will be made only if, in our judgment, the change would best serve the interests of owners of policies in your policy class or would be appropriate in carrying out the purposes of such policies. We would notify owners of any of the foregoing changes and to the extent legally required, obtain approval of affected owners and any regulatory body prior thereto. Such notice and approval, however, may not be legally required in all cases.
Description of John Hancock (USA)
We are a stock life insurance company incorporated in Maine on August 20, 1955 by a special act of the Maine legislature and redomesticated under the laws of Michigan. We are a licensed life insurance company in the District of Columbia and all states of the United States except New York. Our ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of John Hancock USA and its subsidiaries. However, neither John Hancock USA nor any of its affiliated companies guarantees the investment performance of the Separate Account.
We are ranked and rated by independent financial rating services, which may include Moody's, Standard & Poor's, Fitch and A.M. Best. The purpose of these ratings is to reflect the financial strength or claims-paying ability of the company, but they do not specifically relate to its products, the performance (return) of these products, the value of any investment in these products upon withdrawal or to individual securities held in any portfolio. These ratings do not apply to the safety and performance of the Separate Account.
Description of Separate Account A
The investment accounts shown on page 1 are in fact subaccounts of the John Hancock Life Insurance Company (U.S.A.) Separate Account A, a separate account operated by us under Michigan law. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the 1940 Act. Such registration does not involve supervision by the SEC of the management of the Separate Account or of us.
The Separate Account’s assets are our property. Each policy provides that amounts we hold in the Separate Account pursuant to the policies cannot be reached by any other persons who may have claims against us and can’t be used to pay any indebtedness of John Hancock USA other than those arising out of policies that use the Separate Account. Income, gains and losses credited to, or charged against, the Separate Account reflect the Separate Account's own investment experience and not the investment experience of John Hancock USA's other assets. John Hancock USA is obligated to pay all amounts promised to policy owners under the policies.
New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.
The fixed account options
Our obligations under any fixed account option are backed by our general account assets. Our general account consists of assets owned by us other than those in the Account and in other separate accounts that we may establish. Subject to applicable law, we have sole discretion over the investment of assets of the general account and policy owners do not share in the investment experience of, or have any preferential claim on, those assets. Instead, we guarantee that the policy value allocated to any fixed account will accrue interest daily at an effective annual rate that we determine without regard to the actual investment experience of the general account. We currently offer two fixed account optionsthe standard fixed account, and the enhanced yield fixed account offered as a supplementary benefit rider. The effective annual rate we declare for the fixed account options will never be less than 2%. We reserve the right to offer one or more additional fixed accounts with characteristics that differ from those of the current fixed account options, but we are under no obligation to do so.
Because of exemptive and exclusionary provisions, interests in our fixed account options have not been and will not be registered under the Securities Act of 1933 (“1933 Act”) and our general account has not been registered as an investment company under the 1940 Act. Accordingly, neither the general account nor any interests therein are subject to the provisions
18

of these acts, and we have been advised that the staff of the SEC has not reviewed the disclosure in this prospectus relating to any fixed account. Disclosure regarding fixed accounts, however, is subject to certain generally-applicable provisions of the Federal securities laws relating to accuracy and completeness of statements made in prospectuses.
The death benefit
In your application for the policy, you will tell us how much life insurance coverage you want on the life of the insured person. This is called the “Total Face Amount.” Total Face Amount is composed of the Base Face Amount and any Supplemental Face Amount you elect. The Supplemental Face Amount you can have generally cannot exceed 400% of the Base Face Amount at the Issue Date. The Issue Date is shown in the Policy Specifications page of the policy. Thereafter, increases to the Supplemental Face Amount in any one policy year cannot exceed 25% of the Total Face Amount at the Issue Date. There are a number of factors you should consider in determining whether to elect coverage in the form of Base Face Amount or in the form of Supplemental Face Amount. These factors are discussed under “Base Face Amount vs. Supplemental Face Amount” below.
When the insured person dies, we will pay the death benefit minus any outstanding policy debt and unpaid fees and charges. There are two ways of calculating the death benefit. You must choose which one you want in the application. The two death benefit options are described below.
•  Option 1 - The death benefit will equal the greater of (1) the Total Face Amount plus any amount payable under a supplementary benefit rider, or (2) the minimum death benefit (as described below).
•  Option 2 - The death benefit will equal the greater of (1) the Total Face Amount plus any amount payable under a supplementary benefit rider, plus the policy value on the date of death, or (2) the minimum death benefit.
For the same premium payments, the death benefit under Option 2 will tend to be higher than the death benefit under Option 1. On the other hand, the Face Amount charge and resulting cost of insurance charges (based on the higher net amount at risk) will be higher under Option 2. Because of that, the policy value will tend to be higher under Option 1 than under Option 2 for the same premium payments.
Limitations on payment of death benefit
If the insured person commits suicide within certain time periods (generally within two years from the Issue Date of the policy), the amount payable will be equal to the premiums paid, less the amount of any policy debt on the date of death, and less any withdrawals.
Also if an application misstated the age or sex of the insured person, we will adjust, if necessary, the Base Face Amount, any Supplemental Face Amount, and every other benefit to that which would have been purchased at the correct age or sex by the most recent cost of insurance charge.
Base Face Amount vs. Supplemental Face Amount
As noted above, you should consider a number of factors in determining whether to elect coverage in the form of Base Face Amount or in the form of Supplemental Face Amount. Some of these factors include the following:
•  As shown in the Fee Tables, we calculate the premium charge as a percentage of premiums paid up to and in excess of the Target Premium. Your Target Premium appears in the Policy Specifications section of your policy and is based on the amount of Base Face Amount you elect at issue. This means for the same amount of premium paid, your premium charges deducted from premium payments will be higher if you elect greater proportions of Base Face Amount at issue versus Supplemental Face Amount. For example, a premium payment of $10,000 on a policy with 20% Base Face Amount coverage and a Target Premium of $2,000 will have a premium charge of $1,020 in policy year 1. The same premium payment on a policy with 50% Base Face Amount coverage and a Target Premium of $5,000 will have a premium charge of $1,200 and a policy with 100% Base Face Amount coverage and a Target Premium of $10,000 will have a premium charge of $1,500.
•  While there is a charge per $1,000 of Base Face Amount, as shown in the Fee Tables, there is no similar per $1,000 charge for Supplemental Face Amount. This means for the same amount of Total Face Amount, your Face Amount charges deducted from policy value will be higher if you elect greater proportions of Base Face Amount at issue versus Supplemental Face Amount.
19

•  However, if you elect greater proportions of Supplemental Face Amount coverage at issue, the guaranteed limit upon the asset-based risk charge we provide will be higher. As shown in the Fee Tables, the “maximum” guaranteed charge of 0.15% of policy value in policy years 1-30 is for a policy with 80% Supplemental Face Amount at issue. A policy with 50% Supplemental Face Amount at issue would have a guaranteed charge of 0.10%; whereas a policy with 100% Base Face Amount at issue would have a guaranteed charge of 0.025%. Please see the Fee Tables for a description of the guaranteed and current asset-based risk charges in all policy years. The asset-based risk charge percentages assessed on a current basis may be the same for both Base Face Amount and Supplemental Face Amount.
•  Also, after the insured person reaches or would have reached age 121, any Supplemental Face Amount will terminate. If your priority is to maximize the death benefit when the insured person reaches or would have reached age 121, then you may wish to maximize the proportion of the Base Face Amount.
•  Your policy includes an Early Lapse Protection feature, which applies to the Base Face Amount only (see “Early Lapse Protection”). If your priority is to take advantage of the Early Lapse Protection feature, you may wish to maximize the amount of Base Face Amount coverage you elect at issue.
The lower premium charges applied to Supplemental Face Amount will tend to result in higher cash value accumulation, or alternatively lower premium payments, for the same amount of death benefit compared to Base Face Amount coverage. However, if the company should increase the asset-based risk charges under your policy to the maximum limits, the higher guaranteed asset-based risk charge resulting from a higher amount of Supplemental Face Amount at issue could increase the policy’s risk of lapse, requiring additional premium payments. Also, any Supplemental Face Amount is subject to termination during the Early Lapse Protection Period. You should also consider that the amount of compensation paid to the selling broker-dealer will be higher if you elect greater proportions of Base Face Amount coverage at issue.
Ultimately, individual needs and objectives vary. You should discuss your individual needs with your registered representative.
The minimum death benefit
In order for a policy to qualify as life insurance under Federal tax law, there has to be a minimum amount of insurance in relation to policy value. There are two tests that can be applied under Federal tax law — the “guideline premium test” and the “cash value accumulation test.” You must elect which test you wish to have applied at issue. Once elected, the test cannot be changed without our approval.
Under the guideline premium test, we compute the minimum death benefit each business day by multiplying the policy value on that date by the death benefit factor applicable on that date. Factors for some ages are shown in the table below:
Attained Age   Applicable Factor
40 and under

  250%
45

  215%
50

  185%
55

  150%
60

  130%
65

  120%
70

  115%
75

  105%
90

  105%
95 and above

  100%
A table showing the factor for each age will appear in the policy.
Under the cash value accumulation test, we compute the minimum death benefit each business day by multiplying the policy value on that date by the death benefit factor applicable on that date. The factor decreases as attained age increases. A table showing the factor for each age will appear in the policy.
The cash value accumulation test may be preferable if you want to fund the policy so that the minimum death benefit will increase earlier than would be required under the guideline premium test, or if you want to fund the policy at the “7 pay” limit for the full seven years (see “Tax considerations”).
To the extent that the calculation of the minimum death benefit under the selected life insurance qualification test causes the death benefit to exceed our limits, we reserve the right to return premiums or distribute a portion of the policy value so
20

that the resulting amount of insurance is maintained within our limits. Alternatively, if we should decide to accept the additional amount of insurance, we may require additional evidence of insurability.
When the insured person reaches 121
If the policy is still in effect on the policy anniverary nearest the 121st birthday of the insured person, the following things will happen (whether or not there is any net cash surrender value):
•  We will stop any monthly deduction charges.
•  We will stop accepting any premium payments.
•  We will no longer process withdrawals.
•  We will continue to credit interest to a fixed account.
•  Any Supplemental Face Amount will terminate (see “Base Face Amount vs. Supplemental Face Amount”).
Generally, we will not allow any new loans. However, we will continue to accept loan repayments on existing loans and interest will continue to be charged if there is an outstanding loan.
Requesting an increase in coverage
After the first policy year, you may make a written request for an unscheduled increase in Supplemental Face Amount. We must receive your written request within two months of your next policy anniversary. Unscheduled increases are also subject to a charge for 10 years from the date of the increase, as described in the Fee Tables. Generally, each such increase must be at least $50,000. Scheduled increases in any one policy year can not exceed 25% of the Total Face Amount at issue. We will require evidence that the insured person qualifies for the same risk classification that applied to them at issue. Generally, an approved increase will take effect on the policy anniversary on or next following the date we approve the request. If you elect scheduled increases to your Supplemental Face Amount when you apply for the policy you may not elect to purchase the Return of Premium Death Benefit Rider or the Long Term Care Rider. Any unscheduled increase in Supplemental Face Amount after issue would first require that you terminate the Return of Premium Death Benefit Rider and the Long Term Care Rider you may have elected at issue.
Requesting a decrease in coverage
After the first policy year, we may approve a reduction in the Base Face Amount or the Supplemental Face Amount, but only if:
•  the remaining Total Face Amount is at least $250,000 and Base Face Amount will be at least $100,000, and
•  the remaining Total Face Amount will at least equal the minimum required by the tax laws to maintain the policy’s life insurance status.
We reserve the right to require that the Supplemental Face Amount be fully depleted before the Base Face Amount can be reduced.
Change of death benefit option
Under our current administrative rules, we permit the death benefit option to be changed from Option 2 to Option 1 after the first policy year. If you request in writing, and we approve a change from Option 2 to Option 1, your Face Amount after the change will equal your Face Amount before the change plus the policy value as of the effective date of the change. If you change from Option 2 to Option 1, your death benefit will change from one that may increase over time due to the investment experience of the underlying investment accounts to one that is a level death benefit. Changing from Option 2 to Option 1 can also lower the monthly Cost of Insurance charge since this charge is lowered when the Net Amount At Risk is reduced; all other charges under the policy would remain the same. We reserve the right to limit a request for a change if the change would cause the policy to fail to qualify as life insurance for tax purposes.
A change in the death benefit option will result in a change in the policy's Total Face Amount, in order to avoid any change in the amount of the death benefit. The new Total Face Amount will be equal to the Total Face Amount prior to the change plus the policy value as of the date of the change. The change will take effect on the monthly deduction date on or next following the date the written request for the change is received at our Service Office.
21

Notwithstanding other policy limits, if the change from Option 2 to 1 yields a Total Face Amount that is larger than 400% of the Total Face Amount at issue, we will allow for the increase.
Tax consequences of coverage changes
If you change the death benefit option, the Federal tax law test (“guideline premium test” or “cash value accumulation test”) that you elected at issue will continue to apply. Please read “The minimum death benefit” for more information about these Federal tax law tests.
A change in the death benefit option or Total Face Amount will often change the policy's limits under the Federal tax law test that you elected. To avoid having the policy cease to qualify as life insurance for tax purposes, we reserve the right to (i) refuse or limit a change in the death benefit option or Total Face Amount and (ii) change the Guideline Single Premium or Guideline Level Premium, as applicable. Please read “Tax considerations” to learn about possible tax consequences of changing your insurance coverage under the policy.
Your beneficiary
You name your beneficiary when you apply for the policy. The beneficiary is entitled to the proceeds we pay following the death of the insured person. Until the death of the insured person you can change your beneficiary by written request. Such a change requires the consent of any named irrevocable beneficiary. A new beneficiary designation will not affect any payments we make before we receive it. If no beneficiary is living when the insured person dies, we will pay the insurance proceeds to the owner or the owner’s estate.
Ways in which we pay out policy proceeds
You may choose to receive proceeds from the policy as a single sum. This includes proceeds that become payable because of death or surrender. As permitted by state law and our current administrative procedures, death claim proceeds may be placed into an interest-bearing John Hancock retained asset account in the beneficiary’s name. The interest earned in a John Hancock retained asset account is normally subject to income tax. You should consult with your tax advisor if you have any questions regarding taxation of the interest earned. We will provide the beneficiary with a checkbook, so checks may be written for all or a part of the proceeds. The retained asset account is part of our general account and is subject to the claims of our creditors. It is not a bank account and it is not insured by the FDIC. We may receive a benefit from managing proceeds held in a retained asset account. Alternatively, you can elect to have proceeds of $1,000 or more applied to any of the other payment options we may offer at the time. You cannot choose an option if the monthly payments under the option would be less than $50. We will issue a supplementary agreement when the proceeds are applied to any alternative payment option. That agreement will spell out the terms of the option in full. Please contact our Service Office for more information.
Changing a payment option
You can change the payment option at any time before the proceeds are payable. If you haven’t made a choice, the payee of the proceeds has a prescribed period in which he or she can make that choice.
Tax impact of payment option chosen
There may be tax consequences to you or your beneficiary depending upon which payment option is chosen. You should consult with a qualified tax adviser before making that choice.
Premiums
Planned premiums
The Policy Specifications page of your policy will show the “Planned Premium” for the policy. You choose this amount in the policy application. You will also choose how often to pay premiumsannually, semi-annually or quarterly. You may also choose to pay premiums by monthly electronic funds transfers. The premium reminder notice we send you is based on the amount and period you choose. However, payment of Planned Premiums is not necessarily required. You need only pay enough premium to keep the policy in force (see “Lapse and reinstatement”).
22

Minimum initial premium
The Minimum Initial Premium is set forth in the Policy Specifications page of your policy. After the payment of the initial premium, premiums may be paid at any time and in any amount until the insured person's attained age 121, subject to the need to pay enough premium to keep the policy in force, and to the limitations on maximum premium amount described below.
Maximum premium payments
Federal tax law limits the amount of premium payments you can make relative to the amount of your policy’s insurance coverage. We will not knowingly accept any amount by which a premium payment exceeds this limit. If you exceed certain other limits, the law may impose a penalty on amounts you take out of your policy. More discussion of these tax law requirements is provided under “Tax considerations.”
Large premium payments may expose us to unanticipated investment risk. In order to limit our investment risk exposure under certain market conditions, we may refuse to accept additional premium payments. This may be the case, for example, in an environment of decreasing interest rates, where we may not be able to acquire investments for our general account that will sufficiently match the liabilities we are incurring under our fixed account guarantees. Excessive allocations may also interfere with the effective management of our variable investment account portfolios, if we are unable to make an orderly investment of the additional premium into the portfolios. Also, we may refuse to accept or limit an amount of premium if the amount of the premium would increase our insurance risk exposure, and the insured person doesn't provide us with adequate evidence that he or she continues to meet our requirements for issuing insurance.
We will notify you in writing of our refusal to accept premium under these provisions within three days following the date that it is received by us, and will promptly thereafter take the necessary steps to return the premium to you. Notwithstanding the foregoing limits on the premium that we will accept, we will not refuse to accept any premium necessary to prevent the policy from terminating.
Processing premium payments
No premiums will be accepted prior to our receipt of a completed application at our Service Office. All premiums received prior to the Issue Date of the policy will be held in the general account and credited with interest from the date of receipt at the rate of return then being earned on amounts allocated to the Money Market B investment account. After the Issue Date but prior to the Allocation Date, premiums received are allocated to the Money Market B investment account. The “Allocation Date” of the policy is the tenth day after the Issue Date. The Issue Date is shown on the Policy Specifications page of the policy. On the Allocation Date, the Net Premiums paid plus interest credited, if any, will be allocated among the investment accounts or the fixed accounts in accordance with the policy owner's instructions. The “Net Premium” is the premium paid less the applicable premium charges we deduct from it.
Any Net Premium received on or after the Allocation Date will be allocated among investment accounts or the fixed accounts as of the business day on or next following the date the premium is received at the Service Office. Monthly deductions are normally due on the Policy Date and at the beginning of each policy month thereafter. However, if the monthly deductions are due prior to the Contract Completion Date, they will be deducted from policy value on the Contract Completion Date instead of the dates they were due (see “Procedures for issuance of a policy” for the definition of “Contract Completion Date”).
Payment of premiums will not guarantee that the policy will stay in force. Conversely, failure to pay premiums will not necessarily cause the policy to lapse.
Ways to pay premiums
If you pay premiums by check or money order, they must be drawn on a U.S. bank in U.S. dollars and made payable to “John Hancock.” We will not accept credit card checks. We will not accept starter or third party checks if they fail to satisfy our administrative requirements. Premiums after the first must be sent to the John Hancock USA Service Office at the appropriate address shown on the back cover of this prospectus.
We will also accept premiums:
•  by wire or by exchange from another insurance company, or
23

•  via an electronic funds transfer program (any owner interested in making monthly premium payments must use this method).
Lapse and reinstatement
Lapse
Unless the Early Lapse Protection is in effect, a policy will go into default if at the beginning of any policy month the policy's net cash surrender value would be zero or below after deducting the monthly deductions then due. Therefore, a policy could lapse eventually if increases in policy value (prior to deduction of policy charges) are not sufficient to cover policy charges. A lapse could have adverse tax consequences as described under “Tax considerations.” We will notify you of the default and will allow a 61 day grace period in which you may make a premium payment sufficient to bring the policy out of default. The required payment will be equal to the amount necessary to bring the net cash surrender value to zero, if it was less than zero on the date of default, plus an amount equal to three times the monthly deductions due on the date of default, plus any applicable premium charge. If the required payment is not received by the end of the grace period, the policy will terminate (i.e., “lapse”) with no value.
Early Lapse Protection
Your policy includes an Early Lapse Protection feature, which applies to the Base Face Amount only. In those states where it is permitted, as long as the cumulative premium test is satisfied during the Early Lapse Protection Period, as described below, we will guarantee that the Base Face Amount will not go into default, even if adverse investment experience or other factors should cause the policy's surrender value to fall to zero or below during such period.
The monthly Early Lapse Protection Premium is one-twelfth of the Early Lapse Protection Premium. There is no charge for the Early Lapse Protection feature. The Early Lapse Protection Premium is an amount used in determining whether the cumulative premium test has been satisfied.
The Early Lapse Protection Premium is set at issue based on the Face Amount at issue and reflects the age and sex of the proposed insured, as well as any additional ratings and supplementary benefits, if applicable. It is subject to change if:
(a)  you add, terminate, or change a supplementary benefit rider;
(b)  you change the death benefit option under your policy;
(c)  there is a change in the Base Face Amount or the Supplemental Face Amount; or
(d)  there is a change in the life insured's risk classification or, if applicable, additional rating.
A change in the Early Lapse Protection Premium may impact the cumulative premium test described below for determining whether or not the Base Face Amount is protected from lapsing. We will inform you of any change to the Early Lapse Protection Premium resulting from such change. The revised Early Lapse Protection Premium will be effective from the date of the change. For the purpose of performing the cumulative premium test, we will use the Early Lapse Premium in effect as of the Policy Date up to the date of the change, including any revised premium in effect as of the date of a prior change.
The Early Lapse Protection Period is set at issue and is stated in the policy. Certain state limitations may apply, but generally the Early Lapse Protection Period for the Base Face Amount is the first fifteen policy years. The Early Lapse Protection does not apply to Supplemental Face Amount or any Return of Premium Death Benefit Rider amount, if elected.
While the Early Lapse Protection Period is in effect, we will determine at the beginning of the policy month that your policy would otherwise be in default, whether the cumulative premium test, described below, has been met. If the test has not been satisfied, we will notify you of that fact and allow a 61-day grace period in which you may make a premium payment sufficient to keep the policy from going into default. This required payment, as described in the notification, will be equal to the lesser of:
(a)  the outstanding premium requirement to satisfy the cumulative premium test at the date of default, plus the monthly Early Lapse Protection Premium due for the next three policy months; or
(b)  the amount necessary to bring the net cash surrender value to zero plus an amount equal to three times the monthly deductions due on the date of default, plus the applicable premium charge.
24

If the required payment is not received by the end of the grace period, the Early Lapse Protection and the policy will terminate. If you make the required payment under (a) described above, only the Base Face Amount will remain in effect, and any Supplemental Face Amount and any supplementary benefit riders (unless otherwise stated therein) will terminate as of the end of the grace period.
Cumulative premium test
The cumulative premium test is satisfied if, as of the beginning of the policy month that your policy would otherwise be in default, the sum of all premiums paid to date less any withdrawals taken on or before the date of the test and less any policy debt is equal to or exceeds the sum of the monthly Early Lapse Protection Premium due from the policy date to the date of the test.
Death during grace period
If the insured person should die during the grace period, the policy value used in the calculation of the death benefit will be the policy value as of the date of default and the death benefit will be reduced by any outstanding monthly deductions due at the time of death.
Reinstatement
By making a written request, you can reinstate a policy that has gone into default and terminated at any time within the three-year period following the date of termination subject to the following conditions:
(a)  You must provide evidence satisfactory to us of the insurability of the insured person, and of any insured person covered under any supplementary benefit rider that you wish to reinstate; and
(b)  You must pay a premium equal to the amount that was required to bring the policy out of default immediately prior to termination, plus the amount needed to keep the policy in force for the next three policy months.
If the reinstatement is approved, the date of reinstatement will be the later of the date we approve your request or the date the required payment is received at our Service Office. The policy value on the date of reinstatement, prior to the crediting of any Net Premium paid in connection with the reinstatement, will be equal to the policy value on the date the policy terminated. Any policy debt not paid upon termination of a policy will be reinstated if the policy is reinstated.
Generally, the suicide exclusion and incontestability provisions will apply from the effective date of reinstatement. A surrendered policy cannot be reinstated.
The policy value
From each premium payment you make, we deduct the applicable premium charges described under “Deduction from premium payments.” We invest the rest (known as the “Net Premium”) in the accounts (fixed or investment) you've elected. Special investment rules apply to premiums processed prior to the Allocation Date (see “Processing premium payments”).
Over time, the amount you've invested in any investment account will increase or decrease the same as if you had invested the same amount directly in the corresponding underlying portfolio and had reinvested all portfolios' dividends and distributions in additional portfolio shares, except that we will deduct certain additional charges which will reduce your policy value. We describe these charges under “Description of charges at the policy level.” Starting in the sixteenth policy year, we may also credit your policy value with an asset credit (see “Asset credit”).
We calculate the unit values for each investment account once every business day as of the close of trading on the New York Stock Exchange, usually 4:00 p.m. Eastern time. Sales and redemptions within any investment account will be transacted using the unit value next calculated after we receive your request either in writing or other form that we specify. If we receive your request before the close of our business day, we'll use the unit value calculated as of the end of that business day. If we receive your request at or after the close of our business day, we'll use the unit value calculated as of the end of the next business day. If a scheduled transaction falls on a day that is not a business day, we'll process it as of the end of the next business day.
The amount you've invested in any fixed account will earn interest at the rates we declare from time to time. For any fixed account, we guarantee that this rate will be at least 2%. If you want to know what the current declared rate is for any fixed account, just call or write to us. The asset-based risk charge only applies to that portion of the policy value held in the
25

investment accounts. The charge determined does not apply to any fixed account. Otherwise, the policy level charges applicable to any fixed account are the same as those applicable to the investment accounts. We reserve the right to offer one or more additional fixed accounts with characteristics that differ from those of the current fixed accounts, but we are under no obligation to do so.
Asset credit
Starting in the sixteenth policy year, we may credit your policy value monthly, on the date we calculate your monthly deductions, with an amount equal to the percentage credit listed below multiplied by the policy value in your investment accounts on this date. The asset credit does not apply to the loan account or either fixed account. The asset credit percentage is 0.0125% per month in policy year sixteen and thereafter. We add the credit to the same investment accounts from which we take your monthly deductions. This credit is not guaranteed and we reserve the right to discontinue it at any time.
Allocation of future premium payments
At any time, you may change the accounts (fixed or investment) in which future premium payments will be invested. You make the original allocation in the application for the policy. The percentages you select must be in whole numbers and must total 100%.
Transfers of existing policy value
You may also transfer your existing policy value from one account (fixed or investment) to another, subject to the limitations discussed below. To do so, you must tell us how much to transfer, either as a whole number percentage or as a specific dollar amount. A confirmation of each transfer will be sent to you. Without our approval, the maximum amount you may transfer to or from any account (fixed or investment) in any policy year is $1,000,000.
Marketing timing and disruptive trading practices
Variable investment accounts in variable life insurance products can be a prime target for abusive transfer activity because these products value their investment accounts on a daily basis and allow transfers among investment accounts without immediate tax consequences. As a result, some investors may seek to frequently transfer into and out of investment accounts or to make large transfers in reaction to market news or to exploit a perceived pricing inefficiency. Whatever the reason, long-term investors in an investment account can be harmed by large or frequent transfer activity. For example, such activity may expose the investment account's underlying portfolio to increased portfolio transaction costs and/or disrupt the portfolio manager's ability to effectively manage the portfolio's investments in accordance with the portfolio's investment objectives and policies. This could include causing the portfolio to maintain higher levels of cash than would otherwise be the case, or liquidating investments prematurely. Accordingly, frequent or large transfers may result in dilution with respect to interests held for long-term investment and adversely affect policy owners, beneficiaries and the underlying portfolios.
To discourage market timing and disruptive trading activity, we impose restrictions on transfers and reserve the right to change, suspend or terminate telephone, facsimile and internet transaction privileges (see “How you communicate with us”). We also reserve the right to impose a fee of up to $25 for any transfer beyond an annual limit (which will not be less than twelve). No transfer fee will be imposed on any transfer from an investment account into a fixed account if the transfer occurs during the following periods:
•  within 18 months after the policy's Issue Date, or
•  within 60 days after the later of the effective date of a material change in the investment objectives of any investment account or the date you are notified of the change.
In addition to the actions described above, we also reserve the right to take other actions at any time to restrict trading, including, but not limited to: (i) restricting the number of transfers made during a defined period, (ii) restricting the dollar amount of transfers, (iii) restricting transfers into and out of certain investment accounts, (iv) restricting the method used to submit transfers, and (v) deferring a transfer at any time we are unable to purchase or redeem shares of the underlying portfolio.
We may also impose additional administrative conditions upon, or prohibit a transfer request made by a third party giving instructions on behalf of multiple policies, whether owned by the same owner or different owners. If you engage a third party for asset allocation services, then you may be subject to these transfer restrictions because of the actions of that party in providing those services. We will notify the third party you have engaged if we exercise this right. While we seek to
26

identify and prevent disruptive trading activity, it may not always be possible to do so. Therefore, no assurance can be given that the restrictions we impose will be successful in preventing all disruptive trading and avoiding harm to long-term investors.
Limitations on transfers to or from an investment account. Our current practice is to restrict transfers into or out of investment accounts to two per calendar month (except with respect to those policies described in the following paragraphs). For purposes of this restriction, and in applying the limitation on the number of free transfers, any transfers made during the period from the opening of a business day (usually 9:00 a.m. Eastern time) to the close of that business day (usually 4:00 p.m. Eastern time) are considered one transfer. You may, however, transfer to the Money Market B investment account even if the two transfers per month limit has been reached, but only if 100% of the account value in all investment accounts is transferred to the Money Market B investment account. If such a transfer to the Money Market B investment account is made, then for the 30 calendar day period after such transfer no transfers from the Money Market B investment account to any other accounts (fixed or investment) may be made. If your policy offers a dollar cost averaging or automatic asset allocation rebalancing program, any transfers pursuant to such program are not considered transfers subject to these restrictions on frequent trading. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.
Policies such as yours may be purchased by a corporation or other entity as a means to informally finance the liabilities created by an employee benefit plan, and to this end the entity may aggregately manage the policies purchased to match its liabilities under the plan. Policies sold under these circumstances are subject to special transfer restrictions. In lieu of the two transfers per month restriction, we will allow the policy owner under these circumstances to rebalance the investment options in its policies within the following limits: (i) during the 10 calendar day period after any policy values are transferred from one investment account into a second investment account, the values can only be transferred out of the second investment account if they are transferred into the Money Market B investment account; and (ii) any policy values that would otherwise not be transferable by application of the 10 day limit described above and that are transferred into the Money Market B investment account may not be transferred out of the Money Market B investment account into any other accounts (fixed or investment) for 30 calendar days. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.
Subject to our approval, we may offer policies purchased by a corporation or other entity that has purchased policies to match its liabilities under an employee benefit plan, as described above, the ability to electronically rebalance the investment options in its policies. Under these circumstances, in lieu of imposing any specific limit upon the number and timing of transfers, we will monitor aggregate trades among the subaccounts for frequency, pattern and size for potentially harmful investment practices. If we detect trading activity that we believe may be harmful to the overall operation of any investment account or underlying portfolio, we may impose conditions on policies employing electronic rebalancing to submit trades, including setting limits upon the number and timing of transfers, and revoking privileges to make trades by any means other than written communication submitted via U.S. mail.
While we seek to identify and prevent disruptive frequent trading activity, it may not always be possible to do so. Therefore no assurance can be given that the restrictions we impose will be successful in preventing all disruptive frequent trading and avoiding harm to long-term investors. The restrictions described in these paragraphs will be applied uniformly to all policy holders subject to the restrictions.
Rule 22c-2 under the 1940 Act requires us to provide tax identification numbers and other policy owner transaction information to the Trust or to other investment companies in which the Separate Account invests, at their request. An investment company will use this information to identify any pattern or frequency of investment account transfers that may violate their frequent trading policy. An investment company may require us to impose trading restrictions in addition to those described above if violations of their frequent trading policy are discovered.
Limitations on transfers out of the fixed account. The most you can transfer out of the enhanced yield fixed account in any one policy year is the greater of (i) the fixed account maximum transfer amount of $2,000, (ii) the enhanced yield fixed account maximum transfer percentage of 10% multiplied by the amount in the enhanced yield fixed account on the immediately preceding policy anniversary, or (iii) the amount transferred out of the enhanced yield fixed account during the previous policy year. Transfers out of the fixed account option in any one policy year are limited to the greater of (i) the fixed account maximum transfer amount of $2,000, (ii) the fixed account maximum transfer percentage of 15% multiplied by the amount of the fixed account on the immediately preceding policy anniversary, or (iii) the amount transferred out of the fixed account during the previous policy year. Any transfer that involves a transfer out of the fixed account may not involve a transfer to the Money Market B investment account.
27

We reserve the right to impose a minimum amount limit on transfers out of any fixed account. We also reserve the right to impose different restrictions on any additional fixed account that we may offer in the future.
We may waive the transfer restrictions on the fixed account. Please contact us or your John Hancock USA representative to find out if a waiver is currently in effect.
Dollar cost averaging. We may offer policy owners a dollar cost averaging (“DCA”) program. Under the DCA program, you will designate an amount that will be transferred monthly from one investment account into any other investment account(s) or the fixed account(s). If insufficient funds exist to effect a DCA transfer, the transfer will not be effected and you will be so notified. No fee is charged for this program.
We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.
Asset allocation balancer transfers. Under the asset allocation balancer program you will designate an allocation of policy value among investment accounts. We will move amounts among the investment accounts at specified intervals you select - annually, semi-annually, quarterly or monthly. A change to your premium allocation instructions will automatically result in a change in asset allocation balancer instructions so that the two are identical unless you either instruct us otherwise or have elected the dollar cost averaging program. No fee is charged for this program.
We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.
Surrender and withdrawals
Surrender
You may surrender your policy in full at any time. If you do, we will pay you the policy value less any policy debt. This is called your “Net Cash Surrender Value.” You must return your policy when you request a surrender. We will process surrenders on the day we receive the surrender request (unless such day is not a business day, in which case we will process surrenders as of the business day next following the date of the receipt).
Withdrawals
You may make a withdrawal of part of your net cash surrender value once in each policy month. Generally, each withdrawal must be at least $500. We will automatically reduce the policy value of your policy by the amount of the withdrawal. Unless otherwise specified by you, each account (fixed and investment) will be reduced in the same proportion as the policy value is then allocated among them. We will not permit a withdrawal if it would cause your surrender value to fall below three months’ worth of monthly deductions (see “Deductions from policy value”). We also reserve the right to refuse any withdrawal that would cause the policy’s Total Face Amount to fall below $250,000 or the Base Face Amount to fall below $100,000.
Because it reduces the policy value, any withdrawal will reduce your death benefit under either Option 1 or Option 2 (see “The death benefit”). Under Option 1, such a withdrawal may also reduce the Total Face Amount. Generally, any such reduction in the Total Face Amount will be implemented by first reducing any Supplemental Face Amount then in effect. If such a reduction in Total Face Amount would cause the policy to fail the Internal Revenue Code’s definition of life insurance, we will not permit the withdrawal.
For example, assume a policy owner that has elected death benefit Option 1 requests a withdrawal of $5,000 on a policy with a Total Face Amount of $300,000. The $5,000 withdrawal would reduce the Total Face Amount from $300,000 to $295,000.
Policy loans
You may borrow from your policy at any time by completing a form satisfactory to us. The maximum amount you can borrow is the greater of (i) 90% of net cash surrender value and (ii) the amount determined as set out below.
•  We first determine the net cash surrender value of your policy.
•  We then subtract an amount equal to the monthly deductions then being deducted from policy value times the number of full policy months until the next policy anniversary.
28

•  We then multiply the resulting amount by 1.25% in policy years 1 through 10 and 0% thereafter (although we reserve the right to increase the percentage after the tenth policy year to as much as .25%).
•  We then subtract the third item above from the second item above.
The minimum amount of each loan is $500. The interest charged on any loan is currently an effective annual rate of 4.25% in the first ten policy years and 3.00% thereafter. However, we reserve the right to increase the percentage after the tenth policy year to as much as 3.25%. Accrued interest will be added to the loan daily and will bear interest at the same rate as the original loan amount. Unless otherwise specified by you, the amount of the loan is deducted from the accounts (fixed and investment) in the same proportion as the policy value is then allocated among them. The amount of the loan is then placed in a special loan account. This special loan account will earn interest at an effective annual rate of 3%. The tax consequences of a loan interest credited differential of 0% are unclear. You should consult a tax adviser before effecting a loan to evaluate possible tax consequences. If we determine that a loan will be treated as a taxable distribution because of the differential between the loan interest rate and the rate being credited on the special loan account, we reserve the right to increase the rate charged on the loan to a rate that would, in our reasonable judgment, result in the transaction being treated as a loan under Federal tax law. The right to increase the rate charged on the loan is restricted in some states. Please see your John Hancock USA representative for details. We process policy loans as of the business day on or next following the day we receive the loan request.
Repayment of policy loans
You can repay all or part of a loan at any time. Each repayment will be allocated among the accounts as set out below:
•  The same proportionate part of the loan as was borrowed from any fixed account will be repaid to that fixed account.
•  The remainder of the repayment will be allocated among the accounts in the same way a new premium payment would be allocated (unless otherwise specified by you).
If you want a payment to be used as a loan repayment, you must include instructions to that effect. Otherwise, all payments will be assumed to be premium payments. We process loan repayments as of the day we receive the repayment.
Loan repayments received prior to the close of the New York Stock Exchange will be applied on the same day it was received. Loan repayments received after the close of the New York Stock Exchange will be applied as of the next business day.
Effects of policy loans
The policy value, the net cash surrender value, and any death benefit are permanently affected by any loan, whether or not it is repaid in whole or in part. This is because the amount of the loan is deducted from the investment accounts or any fixed account and placed in a special loan account. The investment accounts or any fixed account and the special loan account will generally have different rates of investment return.
The amount of the outstanding loan (which includes accrued and unpaid interest) is subtracted from the amount otherwise payable when the policy proceeds become payable.
Taking out a loan on the policy increases the risk that the policy may lapse because of the difference between the interest rate charged on the loan and the interest rate credited to the special loan account. When a loan is outstanding, the amount in the loan account is not available to help pay for any policy charges. If, after deducting your policy loan, there is not enough policy value to cover the policy charges, your policy could lapse. Also, whenever the outstanding loan equals or exceeds your policy value after the insured person reaches age 121, the policy will terminate 31 days after we have mailed notice of termination to you (and to any assignee of record at such assignee’s last known address) specifying the amount that must be paid to avoid termination, unless a repayment of at least the amount specified is made within that period. Policy loans may also result in adverse tax consequences under certain circumstances (see “Tax considerations”).
Description of charges at the policy level
Deductions from premium payments
Premium charge
A charge to help defray our sales costs and related taxes.
29

Deductions from policy value
Administrative charge
A monthly charge to help cover our administrative costs. This charge is not currently imposed but we reserve the right to do so.
Base Face Amount charge
A monthly charge for the first ten policy years to primarily help cover sales costs. To determine the charge we multiply the amount of Base Face Amount at issue by a rate that varies by gender, issue age, and risk classification of the insured person.
Unscheduled Supplemental Face Amount increase charge
A monthly charge assessed against the policy value for each unscheduled increase in Supplemental Face Amount. The charge is determined by multiplying the amount of the unscheduled increase in Supplemental Face Amount by the applicable rate for ten years from the date of the increase.
Cost of insurance charge
A monthly charge for the cost of insurance. To determine the charge, we multiply the net amount of insurance for which we are then at risk by a cost of insurance rate. The rate is derived from an actuarial table. The table in your policy will show the maximum cost of insurance rates. The cost of insurance rates that we currently apply are generally less than the maximum rates, and the current rates will never be more than the maximum rates shown in the policy. The cost of insurance rates we use will depend on the age at issue, the insurance risk characteristics and (usually) sex of the insured person, and the length of time the policy has been in effect. Regardless of the table used, cost of insurance rates generally increase each year that you own your policy, as the insured person's age increases. (The insured person's “age” on any date is his or her age on the birthday nearest that date.) For death benefit Option 1, the net amount at risk is equal to the greater of zero, or the result of (a) minus (b) where:
(a)  is the death benefit as of the first day of the Policy Month, divided by 1.0024663; and
(b)  is the policy value as of the first day of the Policy Month after the deduction of all other monthly deductions.
Since the net amount at risk for death benefit Option 1 is based on a formula that includes as factors the death benefit and the policy value, the net amount at risk is affected by the investment performance of the investment accounts chosen, payment of premiums and charges assessed.
If the minimum death benefit is greater than the death benefit, the cost of insurance charge will reflect the amount of that additional benefit.
For death benefit Option 2, the net amount at risk is equal to the death benefit, divided by 1.0024663.
Asset-based risk charge
A monthly charge to help cover sales, administrative and other costs. The charge is a percentage of that portion of your policy value allocated to investment accounts. This charge only applies to that portion of the policy value held in the investment accounts. The charge determined does not apply to any fixed account or loan account.
Loan interest rate
We will charge interest on any amount you borrow from your policy. The interest current interest charged on any loan is an effective annual rate of 4.25% in the first ten policy years. After the tenth policy year the effective annual rate will be 3.00%, although we reserve the right to increase the percentage after the tenth policy year to as much as 3.25% (see “Policy loans”).
Transfer fee
We currently do not impose a fee upon transfers of policy value among the investment options, but reserve the right to impose a fee of up to $25 for any transfer beyond an annual limit (which will not be less than 12) to compensate us for the costs of processing these transfers (see “Market timing and disruptive trading practices”).
30

Supplementary benefits charges
A charge for any supplementary insurance benefits added to the policy by means of a rider.
Additional information about how certain policy charges work
Sales expenses and related charges
The premium and Face Amount charges help to compensate us for the cost of selling our policies (see “Description of charges at the policy level”). The amount of the charges in any policy year does not specifically correspond to sales expenses for that year. We expect to recover our total sales expenses over the life of the policies. To the extent that the premium and Face Amount charges do not cover total sales expenses, the sales expenses may be recovered from other sources, including the asset-based risk charge and other charges with respect to the policies, or from our general assets. Similarly, administrative expenses not fully recovered by the administrative charge may also be recovered from such other sources.
Method of deduction
We deduct the monthly deductions described in the Fee Tables section from your policy’s accounts (fixed and investment) in proportion to the amount of policy value you have in each, unless otherwise specified by you.
Reduced charges for eligible classes
The charges otherwise applicable may be reduced with respect to policies issued to a class of associated individuals or to a trustee, employer or similar entity where we anticipate that the sales to the members of the class will result in lower than normal sales or administrative expenses, lower taxes or lower risks to us. We will make these reductions in accordance with our rules in effect at the time of the application for a policy. The factors we consider in determining the eligibility of a particular group for reduced charges, and the level of the reduction, are as follows: the nature of the association and its organizational framework; the method by which sales will be made to the members of the class; the facility with which premiums will be collected from the associated individuals and the association’s capabilities with respect to administrative tasks; the anticipated lapse and surrender rates of the policies; the size of the class of associated individuals and the number of years it has been in existence; the aggregate amount of premiums paid; and any other such circumstances which result in a reduction in sales or administrative expenses, lower taxes or lower risks. Any reduction in charges will be reasonable and will apply uniformly to all prospective policy purchasers in the class and will not unfairly discriminate against any owner.
The Statement of Additional Information (“SAI”) contains additional information about any special purchase programs we currently make available. For information as to how you may obtain a copy of the SAI, please see the last page of this prospectus.
Other charges we could impose in the future
Except for a portion of the premium charge, we currently make no charge for our Federal income taxes. However, if we incur, or expect to incur, income taxes attributable to any subaccount of the Account or this class of policies in future years, we reserve the right to make a charge for such taxes. Any such charge would reduce what you earn on any affected accounts. However, we expect that no such charge will be necessary.
We also reserve the right to increase the premium charge in order to correspond with changes in premium tax levels or in the Federal income tax treatment of the deferred acquisition costs for this type of policy. Premium taxes vary by jurisdiction and are subject to change. Currently, premium tax levels range from 0% to 3.5%.
Under current laws, we may incur state and local taxes (in addition to premium taxes) in several states. At present, these taxes are not significant. If there is a material change in applicable state or local tax laws, we may make charges for such taxes.
Description of charges at the portfolio level
The portfolios must pay investment management fees and other operating expenses. These fees and expenses (shown in the tables of portfolio annual expenses under “Fee Tables”) are different for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any investment accounts you select. Expenses of the portfolios are not fixed or specified under the terms of the policy, and those expenses may vary from year to year.
31

Other policy benefits, rights and limitations
Optional supplementary benefit riders you can add
When you apply for a policy, you can request any of the optional supplementary benefit riders that we then make available. Availability of any rider, the benefits it provides and the charges for it may vary by state. Our rules and procedures will govern eligibility for any rider and, in some cases, the configuration of the actual rider benefits. You should consider how an optional rider may impact your overall insurance and financial objectives. Each rider contains specific details that you should review before you decide to choose the rider. Your registered representative can provide you with additional information regarding these riders. Charges for most riders will be deducted from the policy value. We may change these charges (or the rates that determine them), but not above any applicable maximum amount stated in the Policy Specifications page of your policy. We may add to, delete from or modify the list of optional supplementary benefit riders.
Return of Premium Death Benefit Rider
You may elect to have your policy issued with an optional Return of Premium Death Benefit Rider. This rider provides an additional death benefit payable upon the death of the insured person. The Return of Premium Death Benefit has an initial value equal to your initial premium times the “Percentage of Premium” you select (which may range between 0% and 100%). We show the Percentage of Premium you select in the Policy Specifications page. If you elected increases to your Supplemental Face Amount, you may not elect this rider.
You may increase the initial Return of Premium Death Benefit in two ways:
•  You may make additional premium payments. We will apply the Percentage of Premium stated in the Policy Specifications page to the premium payment and increase your Return of Premium Death Benefit by that amount at the time you make the payment.
•  You may elect a Return of Premium Death Benefit Increase Rate. You may elect an annual effective rate from 0 - 5% to increase your Return of Premium Death Benefit. We show the rate you elect in the Policy Specifications page. The Return of Premium Death Benefit will accumulate monthly at the Return of Premium Death Benefit Increase Rate you select.
This benefit is only available to you if you elect death benefit Option 1.
Overloan Protection Rider
This rider will prevent your policy from lapsing on any date if policy debt exceeds the death benefit. The benefit is subject to a number of eligibility requirements relating to, among other things, the number of years the policy has been in force, the attained age of the insured person, the death benefit option elected and the tax status of the policy.
When the Overloan Protection Benefit in this rider is invoked, all values in the investment accounts are immediately transferred to the standard fixed account and will continue to grow at the current fixed account interest rate. Transfer fees do not apply to these transfers. Thereafter, policy changes and transactions are limited as set forth in the rider; for example, death benefit increases or decreases, additional premium payments, policy loans, withdrawals, surrender and transfers are no longer allowed. Any outstanding policy debt will remain. Interest will continue to be charged at the policy's specified loan interest rate, and the policy's loan account will continue to be credited with the policy's loan interest credited rate. Any applicable Early Lapse Protection under the policy no longer applies, and any supplementary benefit rider requiring a monthly deduction will automatically be terminated.
When the Overloan Protection Rider causes the policy to be converted into a fixed policy, there is risk that the Internal Revenue Service could contend that the policy has been effectively terminated and that the outstanding loan balance should be treated as a distribution. Depending on the circumstances, all or part of such deemed distribution may be taxable as income. You should consult a tax adviser as to the risks associated with the Overloan Protection Rider.
Long-Term Care Rider
This rider provides for periodic advance payments to you of a portion or all of the death benefit if the insured person becomes “chronically ill” so that such person: (1) is unable to perform at least two activities of daily living without substantial human assistance or has a severe cognitive impairment; and (2) is receiving certain qualified long-term care
32

services described in the rider. The decision to add this rider must be made at issuance of the policy. If you elect this rider, you will also have an option to apply to have a portion of the policy's death benefit advanced to you in the event of terminal illness.
Payments under the Long-Term Care Rider will not begin until we receive proof that the insured person qualifies and has received “qualified long-term care services,” while the policy was in force. You must continue to submit evidence during the insured person's lifetime of the insured person's eligibility for rider benefits.
We determine a maximum amount of death benefit that we will advance for each month of qualification. This amount, called the “Maximum Monthly Benefit Amount,” is equal to the amount of the death benefit that may be accelerated under the rider (as of the day the insured qualifies for benefits) multiplied by the Monthly Acceleration Percentage, which is the percentage of the death benefit you can accelerate each month. The Monthly Acceleration Percentage must be selected when you apply for the policy. The actual amount of any advance is based on the expense incurred by the insured person, up to the Maximum Monthly Benefit Amount, for each day of qualified long-term care service in a calendar month, as described in the rider. We will recalculate the Maximum Monthly Benefit Amount if you make a withdrawal of policy value, and for other events described in the rider. Each advance reduces the remaining death benefit under your policy, and causes a proportionate reduction in your policy value. If you have a policy loan, we will use a pro-rata portion of each death benefit advance to repay indebtedness. For example, if current indebtedness is $10,000, the death benefit is $100,000, and the gross advance is $2,000, then the net advance would be $1,800 = $2,000 X (1 - ($10,000/ $100,000)). As a result of the advance, the indebtedness will be reduced by $200.
We restrict your policy value's exposure to market risk when benefits are paid under the Long-Term Care Rider. We do this in several ways. First, before we begin paying any Monthly Benefit, we will transfer all policy value from the investment accounts to the fixed account. (The amount to be transferred will be determined on the business day immediately following the date we approve a request for benefits under the rider.) In addition, you will not be permitted to transfer policy value or allocate any additional premium payment to an investment account while rider benefits are paid. Your participation in any of the automatic investment plans will also be suspended during this period.
If the insured person no longer qualifies for rider benefits and your policy remains in force, you will be permitted to invest new premium payments or transfer existing policy value in the investment accounts. (The restriction on transfers from the fixed account will continue to apply.) Any unscheduled increase in Supplemental Face Amount would first require that you terminate this rider (See “Requesting an increase in coverage.”)
Benefits under this rider do not reduce the No-Lapse Guarantee Premium requirements or the Extended No-Lapse Guarantee Premium requirements that may be necessary for the No-Lapse Guarantee or the Extended No-Lapse Guarantee to remain in effect after a termination of rider benefits.
Finally, please note that there is a significant risk that ownership of a policy with this rider by anyone other than the insured person will cause adverse tax consequences. If the owner of the policy is not the insured person, benefit payments may be included in the owner's income, and the death benefit may be part of the estate of the insured person for purposes of Federal estate tax (see “Tax considerations”).
Accelerated Benefit Rider
This rider provides for acceleration of payment of a portion of the death benefit should the insured person become terminally ill and have a life expectancy of one year or less. You must meet the following conditions before we pay the benefit.
•  You must provide written evidence satisfactory to us that the life insured is terminally ill and has a life expectancy of one year or less.
•  We must have a signed consent of any irrevocable beneficiary and any assignee.
•  You must claim the benefit voluntarily. We will not pay the benefit if you are claiming it to satisfy creditors or for government benefits.
If you satisfy the above conditions, we will pay you 50% of the eligible death benefit, up to a maximum of $1,000,000 on the life insured. We will not make a payment if it would be less than $10,000. Payment of the benefit will reduce your death benefit and any cash value or loan value under your policy. You should consult your tax adviser and social service agencies before you decide to receive the benefit under this rider. This rider is only available with policies that are individually owned.
33

Enhanced Cash Value Rider
This rider provides an enhanced cash value benefit (in addition to the surrender value) if you surrender the policy within the first nine years. The enhanced cash value benefit is determined by multiplying the sum of cumulative premiums paid in the first two policy years up to the Target Premium by the percentage shown in the table below.
Policy Year(s)   Percentage
1

  20%
2 and 3

  25%
4

  20%
5

  15%
6

  10%
7 thru 9

  5%
10+

  0%
In computing any policy death benefit to be paid within the first nine years, the policy value will be increased by the amount of the enhanced cash value benefit. This can increase the death benefit either by increasing the minimum death benefit, or by increasing the amount of insurance benefit payable under Death Benefit Option 2. Since this may increase the amount of insurance for which we are at risk, it may increase the amount of insurance charge described under “Deductions from policy value.” The maximum amount you may borrow from the policy or withdraw from the policy through partial withdrawals is not affected by this rider.
In order for a policy to qualify as life insurance under Federal tax law, there has to be a minimum amount of insurance in relation to policy value. If you elect this rider, the test that will be used to determine if your policy qualifies as life insurance is the cash value accumulation test (also known as CVAT). In addition, at the time of policy issuance, we will determine whether the Planned Premium scheduled will exceed the so-called 7-pay limit, which can have adverse tax consequences.
If we determine that the enhanced cash value benefit would require us to change our internal testing or the interest rate or mortality assumptions used in determining the CVAT death benefit factors and 7-pay limits, then we reserve the right to reduce the percentage of the enhanced cash value benefit to as low as zero, but not until at least 30 days after we have sent you a revised Policy Specifications page for this rider that shows the reduced value. However, in no event will the enhanced cash value benefit be less than the rider charge shown in the Policy Fee table. If this should occur, the only benefit that you would receive under the rider would be the return of the rider charge that you paid. This rider can only be elected at the time of application for the policy.
We may defer the payment of any enhanced cash value benefit in the same manner that we may defer payment of any net cash surrender value under the policy.
This rider will terminate without value, on the earliest of:
(a) the end of the ninth policy year;
(b) the exchange, or termination of the policy;
(c) absolute assignment of the policy;
(d) death of the Life Insured; or
(e) your written request to discontinue this rider.
This rider will be reinstated if it terminated with the policy at the end of a grace period in which we did not receive the amount necessary to bring the policy out of default, and the policy is reinstated prior to the end of the ninth policy year. This rider may not be available in all states.
Enhanced Yield Fixed Account Rider
You may elect to allocate your premiums or policy value to the enhanced yield fixed account that we offer by rider. Obligations under the enhanced yield fixed account are backed by our general account. We will credit interest at the rate we declare prospectively. The rate of interest will be based on our expectations for the enhanced yield fixed account's future investment earnings, persistency, mortality, expenses and reinsurance costs and future tax, reserve and capital requirements, but in no event will the minimum amount be less than the rate shown in your policy and as described under “The fixed
34

account options” in this prospectus. Additional transfer restrictions apply to amounts in an enhanced yield fixed account (see “Transfers of existing policy value”). We currently do not charge a separate fee for this rider.
Variations in policy terms
Insurance laws and regulations apply to us in every state in which our policies are sold. As a result, terms and conditions of your insurance coverage may vary depending on where you purchase a policy. We disclose all material variations in this prospectus.
We may vary the charges and other terms of our policies where special circumstances result in sales or administrative expenses, mortality risks or other risks that are different from those normally associated with the policies. These include the type of variations discussed under “Reduced charges for eligible classes.” No variation in any charge will exceed any maximum stated in this prospectus with respect to that charge.
Any variation discussed above will be made only in accordance with uniform rules that we adopt and that we apply fairly to our customers.
Procedures for issuance of a policy
Generally, the policy is available with a minimum Total Face Amount at issue of $250,000 and a minimum Base Face Amount at issue of $100,000. At the time of issue, the insured person must have an attained age of no more than 90. The insured person must meet certain health and other insurance risk criteria called “underwriting standards.”
Policies issued in Montana or in connection with certain employee plans will not directly reflect the sex of the insured person in either the premium rates or the charges or values under the policy.
Commencement of insurance coverage
After you apply for a policy, it can sometimes take up to several weeks for us to gather and evaluate all the information we need to decide whether to issue a policy to you and, if so, what the insured person's risk classification should be. After we approve an application for a policy and assign an appropriate insurance risk classification, we will prepare the policy for delivery. We will not pay a death benefit under a policy unless the policy is in effect when the insured person dies (except for the circumstances described under “Temporary coverage prior to policy delivery” below).
The policy will take effect only if all of the following conditions are satisfied:
•  The policy is delivered to and received by the applicant.
•  The Minimum Initial Premium is received by us.
•  The insured person is living and there has been no deterioration in the insurability of the insured person since the date of the application.
The date all of the above conditions are satisfied is referred to in this prospectus as the “Contract Completion Date.” If all of the above conditions are satisfied, the policy will take effect on the date shown in the policy as the “Policy Date.” That is the date on which we begin to deduct monthly charges. Policy months, policy years and policy anniversaries are all measured from the Policy Date.
Backdating
Under limited circumstances, we may backdate a policy, upon request, by assigning a Policy Date earlier than the date the application is signed. However, in no event will a policy be backdated earlier than the earliest date allowed by state law, which is generally three months to one year prior to the date of application for the policy. The most common reasons for backdating are to preserve a younger age at issue for the insured person or to retain a common monthly deduction date in certain corporate-owned life insurance cases involving multiple policies issued over time. If used to preserve age, backdating will result in lower insurance charges. However, monthly deductions will begin earlier than would otherwise be the case. Monthly deductions for the period the Policy Date is backdated will actually be deducted from policy value on the Contract Completion Date.
Temporary coverage prior to policy delivery
If a specified amount of premium is paid with the application for a policy and other conditions are met, we will provide temporary term life insurance coverage on the insured person for a period prior to the time coverage under the policy takes
35

effect. Such temporary term coverage will be subject to the terms and conditions described in the Temporary Life Insurance Agreement and Receipt attached to the application for the policy, including conditions to coverage and limits on amount and duration of coverage.
Monthly deduction dates
Each charge that we deduct monthly is assessed against your policy value at the close of business on the Policy Date and at the close of the first day in each subsequent policy month.
Changes that we can make as to your policy
We reserve the right to make any changes in the policy necessary to ensure the policy is within the definition of life insurance under the Federal tax laws and is in compliance with any changes in Federal or state tax laws.
In our policies, we reserve the right to make certain changes if they would serve the best interests of policy owners or would be appropriate in carrying out the purposes of the policies. These changes include the following:
•  Changes necessary to comply with or obtain or continue exemptions under the Federal securities laws.
•  Combining or removing fixed accounts or investment accounts.
•  Changes in the form of organization of any separate account.
Any such changes will be made only to the extent permitted by applicable laws and only in the manner permitted by such laws. When required by law, we will obtain your approval of the changes and the approval of any appropriate regulatory authority.
The owner of the policy
Who owns the policy? That's up to the person who applies for the policy. The owner of the policy is the person who can exercise most of the rights under the policy, such as the right to choose the accounts in which to invest or the right to surrender the policy. In many cases, the person buying the policy is also the person who will be the owner. However, the application for a policy can name another person or entity (such as a trust) as owner. Whenever we've used the term “you” in this prospectus, we've assumed that the reader is the person who has whatever right or privilege is being discussed. There may be tax consequences if the owner and the insured person are different, so you should discuss this issue with your tax adviser.
While the insured person is alive, you will have a number of options under the policy. These options include those listed below:
•  Determine when and how much you invest in the various accounts.
•  Borrow or withdraw amounts you have in the accounts.
•  Change the beneficiary who will receive the death benefit.
•  Change the amount of insurance.
•  Turn in (i.e., “surrender”) the policy for the full amount of its net cash surrender value.
•  Choose the form in which we will pay out the death benefit or other proceeds.
It is possible to name so-called “joint owners” of the policy. If more than one person owns a policy, all owners must join in most requests to exercise rights under the policy.
Policy cancellation right
You have the right to cancel your policy within ten days after you receive it (the period may be longer in some states). This is often referred to as the “free look” period. During this period, your premiums will be allocated as described under “Processing premium payments” in this prospectus. To cancel your policy, simply deliver or mail the policy to:
•  John Hancock USA at either of the addresses shown on the back cover of this prospectus, or
•  the John Hancock USA representative who delivered the policy to you.
The date of cancellation will be the date of such mailing or delivery. In most states, you will receive a refund of any premiums you’ve paid. In some states, the refund will be your policy value on the date of cancellation.
36

Reports that you will receive
At least annually, we will send you a statement setting forth at least the following information as of the end of the most recent reporting period: the amount of the death benefit, the portion of the policy value in either fixed account and in each investment account, premiums received and charges deducted from premiums since the last report, any outstanding policy loan (and interest charged for the preceding policy year), and any further information required by law. Moreover, you also will receive confirmations of premium payments, transfers among accounts, policy loans, partial withdrawals and certain other policy transactions.
Semi-annually we will send you a report containing the financial statements of the portfolios, including a list of securities held in each portfolio.
Assigning your policy
You may assign your rights in the policy to someone else as collateral for a loan or for some other reason. Assignments do not require the consent of any revocable beneficiary. A copy of the assignment must be forwarded to us. We are not responsible for any payment we make or any action we take before we receive a copy of the assignment at our Service Office. Nor are we responsible for the validity of the assignment or its efficacy in meeting your objectives. An absolute assignment is a change of ownership. All collateral assignees of record must usually consent to any surrender, withdrawal or loan from the policy.
When we pay policy proceeds
General
We will ordinarily pay any death benefit, withdrawal, surrender value or loan within seven days after we receive the last required form or request (and, with respect to the death benefit, any other documentation that may be required). As permitted by state law and our current administrative procedures, death claim proceeds may be placed into an interest-bearing John Hancock retained asset account in the beneficiary’s name. The interest earned in a John Hancock retained asset account is normally subject to income tax. You should consult with your tax advisor if you have any questions regarding taxation of the interest earned. We will provide the beneficiary with a checkbook, so checks may be written for all or a part of the proceeds. The retained asset account is part of our general account and is subject to the claims of our creditors. It is not a bank account and it is not insured by the FDIC. We may receive a benefit from managing proceeds held in a retained asset account. Please contact our Service Office for more information.
Delay to challenge coverage
We may challenge the validity of your insurance policy based on any material misstatements made to us in the application for the policy. We cannot make such a challenge, however, beyond certain time limits that are specified by the laws of the state in which your policy was issued.
Delay for check clearance
We reserve the right to defer payment of that portion of your policy value that is attributable to a premium payment made by check for a reasonable period of time (not to exceed fifteen days) to allow the check to clear the banking system. We will not delay payment longer than necessary for us to verify a check has cleared the banking system.
Delay of separate account proceeds
We reserve the right to defer payment of any death benefit, loan or other distribution that is derived from an investment account if (1) the New York Stock Exchange is closed (other than customary weekend and holiday closings) or trading on the New York Stock Exchange is restricted; (2) an emergency exists, as determined by the SEC, as a result of which disposal of securities is not reasonably practicable or it is not reasonably practicable to fairly determine the policy value; or (3) the SEC by order permits the delay for the protection of owners. Transfers and allocations of policy value among the investment accounts may also be postponed under these circumstances. If we need to defer calculation of separate account values for any of the foregoing reasons, all delayed transactions will be processed at the next values that we do compute.
37

Delay of general account surrender proceeds
State laws allow us to defer payment of any portion of the net cash surrender value derived from any fixed account for up to six months. These laws were enacted many years ago to help insurance companies in the event of a liquidity crisis.
How you communicate with us
General rules
You should mail or express all checks and money orders for premium payments and loan repayments to the John Hancock USA Service Office at the appropriate address shown on the back cover.
Under our current rules, certain requests must be made in writing and be signed and dated by you. Those requests include the following.
•  loans
•  surrenders or withdrawals
•  change of death benefit option
•  increase or decrease in Total Face Amount
•  change of beneficiary
•  election of payment option for policy proceeds
•  tax withholding elections
•  election of telephone/internet transaction privilege
The following requests may be made either in writing (signed and dated by you) or by telephone or fax or through the Company's secured website, if a special form is completed (see “Telephone, facsimile and internet transactions” below).
•  transfers of policy value among accounts
•  change of allocation among accounts for new premium payments
You should mail or express all written requests to our Service Office at the appropriate address shown on the back cover. You should also send notice of the insured person's death and related documentation to our Service Office. We do not consider that we’ve “received” any communication until such time as it has arrived at the proper place and in the proper and complete form.
We have special forms that should be used for a number of the requests mentioned above. You can obtain these forms from our Service Office or your John Hancock USA representative. Each communication to us must include your name, your policy number and the name of the insured person. We cannot process any request that doesn’t include this required information. Any communication that arrives after the close of our business day, or on a day that is not a business day, will be considered “received” by us on the next following business day. Our business day currently closes at 4:00 p.m. Eastern time, but special circumstances (such as suspension of trading on a major exchange) may dictate an earlier closing time.
Telephone, facsimile and internet transactions
If you complete a special authorization form, you can request transfers among accounts and changes of allocation among accounts simply by telephoning us at 1-800-521-1234 or by faxing us at 1-617-572-1571 or through the Company's secured website. Any fax or internet request should include your name, daytime telephone number, policy number and, in the case of transfers and changes of allocation, the names of the accounts involved. We will honor telephone and internet instructions from anyone who provides the correct identifying information, so there is a risk of loss to you if this service is used by an unauthorized person. However, you will receive written confirmation of all telephone/internet transactions. There is also a risk that you will be unable to place your request due to equipment malfunction or heavy phone line or internet usage. If this occurs, you should submit your request in writing.
If you authorize telephone or internet transactions, you will be liable for any loss, expense or cost arising out of any unauthorized or fraudulent telephone or internet instructions which we reasonably believe to be genuine, unless such loss, expense or cost is the result of our mistake or negligence. We employ procedures which provide safeguards against the execution of unauthorized transactions which are reasonably designed to confirm that instructions received by telephone or internet are genuine. These procedures include requiring personal identification, the use of a unique password for internet
38

authorization, recording of telephone calls, and providing written confirmation to the owner. If we do not employ reasonable procedures to confirm that instructions communicated by telephone or internet are genuine, we may be liable for any loss due to unauthorized or fraudulent instructions.
As stated earlier in this prospectus, the policies are not designed for professional market timing organizations or other persons or entities that use programmed, large or frequent transfers among investment options. To discourage disruptive trading, we have imposed certain transfer restrictions (see “Transfers of existing policy value”). In addition, we also reserve the right to change our telephone, facsimile and internet transaction privileges outlined in this section at any time, and to suspend or terminate any or all of those privileges with respect to any owners who we feel are abusing the privileges to the detriment of other owners.
Distribution of policies
John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with us, is the principal distributor and underwriter of the securities offered through this prospectus and of other annuity and life insurance products we and our affiliates offer. JH Distributors also acts as the principal underwriter of the Trust, whose securities are used to fund certain investment accounts under the policies and under other annuity and life insurance products we offer.
JH Distributors' principal address is 601 Congress Street, Boston, MA 02210 and it also maintains offices with us at 197 Clarendon Street, Boston, Massachusetts 02116. JH Distributors is a broker-dealer registered under the Securities Exchange Act of 1934 (the “1934 Act”) and a member of the Financial Industry Regulatory Authority (“FINRA”).
We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate, Signator Investors, Inc., is one such broker-dealer. In addition, we, either directly or through JH Distributors, have entered into agreements with other financial intermediaries that provide marketing, sales support and certain administrative services to help promote the policies (“financial intermediaries”). In a limited number of cases, we have entered into loans, leases or other financial agreements with these broker-dealers or financial intermediaries or their affiliates.
Compensation
The broker-dealers and other financial intermediaries that distribute or support the marketing of our policies may be compensated by means of various compensation and revenue sharing arrangements. A general description of these arrangements is set out below under “Standard compensation” and “Additional compensation and revenue sharing.” These arrangements may differ between firms, and not all broker-dealers or financial intermediaries will receive the same compensation and revenue sharing benefits for distributing our policies. Also, a broker-dealer may receive more or less compensation or other benefits for the promotion and sale of our policy than it would expect to receive from another issuer.
Under their own arrangements, broker-dealers determine how much of any amounts received from us is to be paid to their registered representatives. Our affiliated broker-dealer, Signator Investors, Inc., may pay its registered representatives additional compensation and benefits, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.
Policy owners do not pay any compensation or revenue sharing benefits directly. These payments are made from JH Distributors’ and our own revenues, profits or retained earnings, which may be derived from a number of sources, such as fees received from an underlying fund’s distribution plan (“12b-1 fees”), the fees and charges imposed under the policy and other sources.
You should contact your registered representative for more information on compensation arrangements in connection with your purchase of a policy. We provide additional information on special compensation or reimbursement arrangements involving broker-dealers and other financial intermediaries in the SAI, which is available upon request.
Standard compensation. JH Distributors pays compensation to broker-dealers for the promotion and sale of the policies, and for providing ongoing service in relation to policies that have already been purchased. We may also pay a limited number of broker-dealers commissions or overrides to “wholesale” the policies; that is, to provide marketing support and training services to the broker-dealer firms that do the actual selling.
The compensation JH Distributors pays to broker-dealers may vary depending on the selling agreement. The compensation paid is not expected to exceed the following schedule: policy year 1, 110% of the premium paid up to the
39

Target Premium and 5% of any premium paid in excess of Target Premium; policy years 2-5, 6% of the premium paid up to the Target Premium and 4% of any premium paid in excess of Target Premium; policy years 6-10, 5% of the premium paid up to the Target Premium and 4% of any premium paid in excess of Target Premium; and policy years 11+, 2% of premium paid up to the Target Premium and 2% of any premium paid in excess of Target Premium. In addition, JH Distributors will pay compensation in all policy years of 0.02% of the net cash surrender value, with the net cash surrender value determined as of the end of each previous policy anniversary. In addition, a broker-dealer may receive compensation in an amount per $1,000 of unscheduled increase in Supplemental Face Amount. This compensation schedule is exclusive of additional compensation and revenue sharing and inclusive of overrides and expense allowances paid to broker-dealers for sale of the policies (not including riders).
Additional compensation and revenue sharing. To the extent permitted by SEC and FINRA rules and other applicable laws and regulations, we may enter into special compensation or reimbursement arrangements (“revenue sharing”), either directly or through JH Distributors, with selected broker-dealers and other financial intermediaries. In consideration of these arrangements, a firm may feature our policy in its sales system, give us preferential access to sales staff, or allow JH Distributors or its affiliates to participate in conferences, seminars or other programs attended by the firm’s sales force. We hope to benefit from these revenue sharing and other arrangements through increased sales of our policies.
Selling broker-dealers and other financial intermediaries may receive, directly or indirectly, additional payments in the form of cash, other compensation or reimbursement. These additional compensation or reimbursement arrangements may include, for example, payments in connection with the firm's “due diligence” examination of the policies, payments for providing conferences or seminars, sales or training programs for invited registered representatives and other employees, payment for travel expenses, including lodging, incurred by registered representatives and other employees for such seminars or training programs, seminars for the public or client seminars, advertising and sales campaigns regarding the policies, payments to assist a firm in connection with its systems, operations and marketing expenses and/or other events or activities sponsored by the firms. We may contribute to, as well as sponsor, various educational programs, sales promotions, and/or other contests in which participating firms and their sales persons may receive gifts and prizes such as merchandise, cash or other rewards as may be permitted under FINRA rules and other applicable laws and regulations.
Tax considerations
This description of Federal income tax consequences is only a brief summary and is neither exhaustive nor authoritative. It was written to support the promotion of our products. It does not constitute legal or tax advice, and it is not intended to be used and cannot be used to avoid any penalties that may be imposed on you. Tax consequences will vary based on your own particular circumstances, and for further information you should consult a qualified tax adviser. Federal, state and local tax laws, regulations and interpretations can change from time to time. As a result, the tax consequences to you and the beneficiary may be altered, in some cases retroactively. The policy may be used in various arrangements, including non-qualified deferred compensation or salary continuation plans, split dollar insurance plans, executive bonus plans, retiree medical benefit plans and others. The tax consequences of such plans may vary depending on the particular facts and circumstances of each individual arrangement. Therefore, if the value of using the policy in any such arrangement depends in part on the tax consequences, a qualified tax adviser should be consulted for advice.
General
We are taxed as a life insurance company. Under current tax law rules, we include the investment income (exclusive of capital gains) of the Separate Account in our taxable income and take deductions for investment income credited to our policy holder reserves. We are also required to capitalize and amortize certain costs instead of deducting those costs when they are incurred. We do not currently charge the Separate Account for any resulting income tax costs, other than a charge we may impose against the Separate Account to compensate us for the cost of a delay in the deductibility of deferred acquisition costs (the “DAC tax” adjustment) pursuant to section 848 of the Internal Revenue Code. We also claim certain tax credits or deductions relating to foreign taxes paid and dividends received by the series funds. These benefits can be material. We do not pass these benefits through to the Separate Account, principally because: (i) the deductions and credits are allowed to us and not the policy owners under applicable tax law; and (ii) the deductions and credits do not represent investment return on the Separate Account assets that is passed through to policy owners.
The policies permit us to deduct a charge for any taxes we incur that are attributable to the operation or existence of the policies or the Separate Account. Currently, we do not anticipate making any specific charge for such taxes other than any DAC tax charge and premium taxes where applicable. If the level of the current taxes increases, however, or is expected to increase in the future, we reserve the right to make a charge in the future.
40

Death benefit proceeds and other policy distributions
Generally, death benefits paid under policies such as yours are not subject to income tax unless policy ownership has been transferred in exchange for payment. Earnings on your policy value are ordinarily not subject to income tax as long as we don’t pay them out to you. If we do pay out any amount of your policy value upon surrender or partial withdrawal, all or part of that distribution would generally be treated as a return of the premiums you’ve paid and not subjected to income tax. Any portion not treated as a return of your premiums would be includible in your income.
Please note that certain distributions associated with a reduction in death benefit or other policy benefits within the first fifteen years after issuance of the policy are ordinarily taxable in whole or in part. Amounts you borrow are generally not taxable to you.
However, some of the tax rules change if your policy becomes a modified endowment contract. This can happen if you’ve paid premiums in excess of limits prescribed by the tax laws. In that case, additional taxes and penalties may be payable for policy distributions of any kind, including loans. (See “7-pay premium limit and modified endowment contract status” below.)
We expect the policy to receive the same Federal income and estate tax treatment as fixed benefit life insurance policies. Section 7702 of the Internal Revenue Code defines a life insurance contract for Federal tax purposes. For a policy to be treated as a life insurance contract, it must satisfy either the cash value accumulation test or the guideline premium test. These tests limit the amount of premium that you may pay into the policy. We will monitor compliance with these standards. If we determine that a policy does not satisfy section 7702, we may take whatever steps are appropriate and reasonable to bring it into compliance with section 7702.
If the policy complies with section 7702, the death benefit proceeds under the policy ordinarily should be excludable from the beneficiary’s gross income under section 101 of the Internal Revenue Code. (As noted above, a transfer of the policy for valuable consideration may limit the exclusion of death benefits from the beneficiary's income.) In addition, if you have elected a Long-Term Care Rider, the rider's benefits generally will be excludable from gross income under the Internal Revenue Code. The tax-free nature of these accelerated benefits is contingent on the rider meeting specific requirements under section 101 and/or section 7702B of the Internal Revenue Code. The riders are intended to meet these standards.
If you have elected a Long-Term Care Rider, we caution you that there is a significant risk that ownership by anyone other than the person insured by the policy will cause adverse tax consequences. If the owner of the policy is not the insured person, benefit payments may be included in the owner's income, and the death benefit may be part of the insured person's estate for purposes of the Federal estate tax. A policy with a Long-Term Care Rider should not be purchased by or transferred to a person other than the insured person unless you have carefully reviewed the tax implications with your tax adviser.
Increases in policy value as a result of interest or investment experience will not be subject to Federal income tax unless and until values are received through actual or deemed distributions. In general, unless the policy is a modified endowment contract, the owner will be taxed only on the amount of distributions that exceed the premiums paid under the policy. An exception to this general rule occurs in the case of a decrease in the policy's death benefit or any other change that reduces benefits under the policy in the first fifteen years after the policy is issued and that results in a cash distribution to the policy owner. Changes that reduce benefits include partial withdrawals, death benefit option changes, and distributions required to keep the policy in compliance with section 7702. For purposes of this rule any distribution within the two years immediately before a reduction in benefits will also be treated as if it were a result of the reduction. A cash distribution that reduces policy benefits will be taxed in whole or in part (to the extent of any gain in the policy) under rules prescribed in section 7702. The taxable amount is subject to limits prescribed in section 7702(f)(7). Any taxable distribution will be ordinary income to the owner (rather than capital gain).
Distributions for tax purposes include amounts received upon surrender or partial withdrawals. You may also be deemed to have received a distribution for tax purposes if you assign all or part of your policy rights or change your policy’s ownership. If you have elected a Long-Term Care Rider, as described in “Optional supplementary benefit riders you can add,” deductions from policy value to pay the rider charges will reduce your investment in the contract but will not be included in income even if you have recovered all of your investment in the contract.
It is possible that, despite our monitoring, a policy might fail to qualify as a life insurance contract under the Internal Revenue Code. This could happen, for example, if we inadvertently failed to return to you any premium payments that were in excess of amounts permitted under section 7702, or if any of the funds failed to meet certain investment diversification or other requirements of the Internal Revenue Code. If this were to occur, you would be subject to income tax on the income credited to the policy from the date of issue to the date of the disqualification and for subsequent periods.
41

Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws will depend on the circumstances of each owner or beneficiary. If the person insured by the policy is also its owner, either directly or indirectly through an entity such as a revocable trust, the death benefit will be includible in his or her estate for purposes of the Federal estate tax. If the owner is not the person insured, the value of the policy will be includible in the owner's estate upon his or her death. Even if ownership has been transferred, the death proceeds or the policy value may be includible in the former owner's estate if the transfer occurred less than three years before the former owner's death or if the former owner retained certain kinds of control over the policy. You should consult your tax adviser regarding these possible tax consequences.
Because there may be unfavorable tax consequences (including recognition of taxable income and the loss of income tax-free treatment for any death benefit payable to the beneficiary), you should consult a qualified tax adviser prior to changing the policy’s ownership or making any assignment of ownership interests.
Policy loans
We expect that, except as noted below (see “7-pay premium limit and modified endowment contract status”), loans received under the policy will be treated as indebtedness of an owner and that no part of any loan will constitute income to the owner. However, if the policy terminates for any reason other than the payment of the death benefit, an amount equal to any outstanding loan that was not previously considered income will be treated as if it had been distributed to the owner upon such termination. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans, you might find yourself having to choose between high premiums required to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.
Diversification rules and ownership of the Separate Account
Your policy will not qualify for the tax benefits of a life insurance contract unless the Separate Account follows certain rules requiring diversification of investments underlying the policy. In addition, the rules require that the policy owner not have “investor control” over the underlying assets.
In certain circumstances, the owner of a variable life insurance policy may be considered the owner, for Federal income tax purposes, of the assets of the Separate Account used to support the policy. In those circumstances, income and gains from the Separate Account assets would be includible in the policy owner's gross income. The Internal Revenue Service (“IRS”) has stated in published rulings that a variable policy owner will be considered the owner of Separate Account assets if the policy owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets. A Treasury Decision issued in 1986 (T.D. 8101) stated that guidance would be issued in the form of regulations or rulings on “the extent to which policyholders may direct their investments to particular sub-accounts of a Separate Account without being treated as owners of the underlying assets.” As of the date of this prospectus, no comprehensive guidance on this point has been issued. In Rev. Rul. 2003-91, however, the IRS ruled that a contract holder would not be treated as the owner of assets underlying a variable life insurance or annuity contract despite the owner’s ability to allocate funds among as many as twenty subaccounts.
The ownership rights under your policy are similar to, but different in certain respects from, those described in IRS rulings in which it was determined that policyholders were not owners of Separate Account assets. Since you have greater flexibility in allocating premiums and policy values than was the case in those rulings, it is possible that you would be treated as the owner of your policy’s proportionate share of the assets of the Separate Account.
We do not know what future Treasury Department regulations or other guidance may require. We cannot guarantee that the funds will be able to operate as currently described in the series funds' prospectuses, or that a series fund will not have to change any fund's investment objectives or policies. We have reserved the right to modify your policy if we believe doing so will prevent you from being considered the owner of your policy's proportionate share of the assets of the Separate Account, but we are under no obligation to do so.
7-pay premium limit and modified endowment contract status
At the time of policy issuance, we will determine whether the Planned Premium schedule will exceed the 7-pay limit discussed below. If so, our standard procedures prohibit issuance of the policy unless you sign a form acknowledging that fact.
The 7-pay limit at any time during the first seven contract years is the total of net level premiums that would have been payable at or before that time under a comparable fixed policy that would be fully “paid-up” after the payment of seven equal annual premiums. “Paid-up” means that no further premiums would be required to continue the coverage in force until
42

maturity, based on certain prescribed assumptions. If the total premiums paid at any time during the first seven policy years exceed the 7-pay limit, the policy will be treated as a modified endowment contract, which can have adverse tax consequences.
Policies classified as modified endowment contracts are subject to the following tax rules:
•  First, all withdrawals from such a policy are treated as ordinary income subject to tax up to the amount equal to the excess (if any) of the policy value immediately before the withdrawal over the investment in the policy at such time. If you own any other modified endowment contracts issued to you in the same calendar year by the same insurance company or its affiliates, their values will be combined with the value of the policy from which you take the withdrawal for purposes of determining how much of the withdrawal is taxable as ordinary income.
•  Second, loans taken from or secured by such a policy and assignments or pledges of any part of its value are treated as partial withdrawals from the policy and taxed accordingly. Past-due loan interest that is added to the loan amount is treated as an additional loan.
•  Third, a 10% additional penalty tax is imposed on the portion of any distribution (including distributions on surrender) from, or loan taken from or secured by, such a policy that is included in income except where the distribution or loan:
•  is made on or after the date on which the policy owner attains age 59½;
•  is attributable to the policy owner becoming disabled; or
•  is part of a series of substantially equal periodic payments for the life (or life expectancy) of the policy owner or the joint lives (or joint life expectancies) of the policy owner and the policy owner’s beneficiary.
These exceptions to the 10% additional tax do not apply in situations where the policy is not owned by an individual.
Furthermore, any time there is a “material change” in a policy, the policy will begin a new 7-pay testing period as if it were a newly-issued policy. The material change rules for determining whether a policy is a modified endowment contract are complex. In general, however, the determination of whether a policy will be a modified endowment contract after a material change depends upon the relationship among the death benefit of the policy at the time of such change, the policy value at the time of the change, and the additional premiums paid into the policy during the seven years starting with the date on which the material change occurs.
Moreover, under a policy insuring a single life, if there is a reduction in benefits (such as a reduction in the death benefit or the reduction or cancellation of certain rider benefits) during a 7-pay testing period, the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, from the beginning of the 7-pay testing period using the lower limit. If the premiums paid to date at any point during the 7-pay testing period are greater than the recalculated 7-pay limit, the policy will become a modified endowment contract. If your policy is a survivorship policy, a reduction in benefits under the policy at any time will require re-testing. For such a policy the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, using the lower limit, from the date it was issued. You should consult your tax adviser if you have questions regarding the possible impact of the 7-pay limit on your policy.
If your policy is issued as a result of an exchange subject to section 1035 of the Internal Revenue Code, it may be considered to be a modified endowment contract if the death benefit under the new policy is smaller than the death benefit under the exchanged policy, or if you reduce coverage in your new policy after it is issued. Therefore, if you desire to reduce the face amount as part of a 1035 exchange, a qualified tax adviser should be consulted for advice. A new policy issued in exchange for a modified endowment contract will also be a modified endowment contract regardless of any change in the death benefit.
All modified endowment contracts issued by the same insurer (or its affiliates) to the same owner during any calendar year generally are required to be treated as one contract for the purpose of applying the rules on taxation of withdrawals from modified endowment contracts. You should consult your tax adviser if you have questions regarding the possible impact of the 7-pay limit on your policy.
Corporate and H.R. 10 retirement plans
The policy may be acquired in connection with the funding of retirement plans satisfying the qualification requirements of section 401 of the Internal Revenue Code. If so, the Internal Revenue Code provisions relating to such plans and life insurance benefits thereunder should be carefully scrutinized. We are not responsible for compliance with the terms of any such plan or with the requirements of applicable provisions of the Internal Revenue Code.
43

Withholding
To the extent that policy distributions to you are taxable, they are generally subject to withholding for your Federal income tax liability. However if you reside in the United States, you can generally choose not to have tax withheld from distributions. Electing to have no withholding will not reduce your tax liability and may expose you to penalties under the rules governing payment of estimated taxes.
Life insurance purchases by residents of Puerto Rico
In Rev. Rul. 2004-75, 2004-31 I.R.B. 109, the Internal Revenue Service ruled that income received by residents of Puerto Rico under a life insurance policy issued by a United States company is U.S.-source income that is subject to United States Federal income tax.
Life insurance purchases by non-resident aliens
If you are not a U.S. citizen or resident, you will generally be subject to U.S. Federal withholding tax on taxable distributions from life insurance policies at a 30% rate, unless a lower treaty rate applies. In addition, you may be subject to state and/or municipal taxes and taxes imposed by your country of citizenship or residence. You should consult with a qualified tax adviser before purchasing a policy.
Life insurance owned by citizens or residents living abroad
If you are a U.S. citizen or permanent resident living outside the United States, you are still subject to income taxation by the United States. Since many countries tax on the basis of domicile, you may also be subject to tax in the country or territory in which you are living. The tax-deferred accumulation of gain that a life insurance policy provides under United States tax law may not be available under the tax laws of the country in which you are living. If you are living outside the United States or planning to do so, you should consult with a qualified tax adviser before purchasing or retaining ownership of a policy.
Financial statements reference
The financial statements of John Hancock USA and the Separate Account can be found in the SAI. The financial statements of John Hancock USA should be distinguished from the financial statements of the Separate Account and should be considered only as bearing upon the ability of John Hancock USA to meet its obligations under the policies. Our general account is comprised of securities and other investments, the value of which may decline during periods of adverse market conditions.
Registration statement filed with the SEC
This prospectus omits certain information contained in the Registration Statement which has been filed with the SEC. More details may be obtained from the SEC upon payment of the prescribed fee.
Independent registered public accounting firm
The statutory-basis financial statements of John Hancock Life Insurance Company (U.S.A.) at December 31, 2014 and 2013, and for each of the three years in the period ended December 31, 2014, and the financial statements of John Hancock Life Insurance Company (U.S.A.) Separate Account A at December 31, 2014, and for each of the two years in the period ended December 31, 2014, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
44

In addition to this prospectus, John Hancock USA has filed with the SEC an SAI that contains additional information about John Hancock USA and the Separate Account, including information on our history, services provided to the Separate Account, legal and regulatory matters and the audited financial statements for John Hancock USA and the Separate Account. The SAI and personalized illustrations of death benefits, policy values and surrender values are available, without charge, upon request. You may obtain the personalized illustrations from your John Hancock USA representative. The SAI may be obtained by contacting the John Hancock USA Service Office. You should also contact the John Hancock USA Service Office to request any other information about your policy or to make any inquiries about its operation.
JOHN HANCOCK USA SERVICE OFFICE
Principal Office & Express Delivery Mail Delivery
Specialty Products & Distribution
200 Berkeley St., B-3-24
Boston, MA 02116-5022
Specialty Products & Distribution
PO Box 192
Boston, MA 02217-0192
Phone: Fax:
1-800-521-1234 1-617-572-1571
Information about the Separate Account (including the SAI) can be reviewed and copied at the SEC’s Public Reference Branch, 100 F Street, NE, Room 1580, Washington, DC, 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 202-551-8090. Reports and other information about the Account are available on the SEC’s Internet website at http://www.sec.gov. Copies of such information may be obtained, upon payment of a duplicating fee, by writing the Public Reference Section of the SEC at 100 F Street, NE, Washington, DC 20549-0102.
1940 Act File No. 811-4834 1933 Act File No. 333-151630


Table of Contents

Statement of Additional Information
dated April 27, 2015

for interests in

John Hancock Life Insurance Company (U.S.A.) Separate Account A
(Name of Registrant)

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
(“John Hancock USA”)
(Name of Depositor)

This is a Statement of Additional Information (“SAI”). It is not the prospectus. The prospectus, dated the same date as this SAI, may be obtained from a John Hancock USA representative or by contacting the John Hancock USA Service Office by mail or telephone at the address or telephone number listed on the back page of the prospectus.


TABLE OF CONTENTS

Contents of this SAI Page No.
Description of the Depositor
2
Description of the Registrant
2
Services
2
Independent registered public accounting firm
2
Legal and Regulatory Matters
2
Principal Underwriter/Distributor
3
Additional Information About Charges
3
Reduction in Charges
4
Financial Statements of Registrant and Depositor
F-1

Description of the Depositor

Under the Federal securities laws, the entity responsible for organization of the registered separate account underlying the variable life insurance policy is known as the “Depositor.” John Hancock USA (“Depositor”) is a stock life insurance company organized under the laws of Maine on August 20, 1955 by a special act of the Maine legislature and redomesticated under the laws of Michigan. The Depositor is a licensed life insurance company in the District of Columbia and all states of the United States except New York. Until 2004, the Depositor was known as The Manufacturers Life Insurance Company (U.S.A.).

The Depositor’s ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of The Manufacturers Life Insurance Company and its subsidiaries, collectively known as Manulife Financial.

Description of the Registrant

Under the Federal securities laws, the registered separate account underlying the variable life insurance policy is known as the “Registrant.” John Hancock Life Insurance Company (U.S.A.) Separate Account A (the “Registrant” or “Separate Account”), is a separate account established by the Depositor under Michigan law. The variable investment options shown on page 1 of the prospectus are subaccounts of the Separate Account. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the Investment Company Act of 1940 (“1940 Act”). Such registration does not involve supervision by the Securities and Exchange Commission (“SEC”) of the management of the Separate Account or of the Depositor.

New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.

Services

Administration of policies issued by the Depositor and of registered separate accounts organized by the Depositor may be provided by other affiliates. Neither the Depositor nor the separate accounts are assessed any charges for such services.

Custodianship and depository services for the Registrant are provided by State Street Investment Services (“State Street”). State Street’s address is State Street Financial Center, One Lincoln Street, Boston, Massachusetts, 02111.

Independent registered public accounting firm

The statutory-basis financial statements of John Hancock Life Insurance Company (U.S.A.) at December 31, 2014 and 2013, and for each of the three years in the period ended December 31, 2014, and the financial statements of John Hancock Life Insurance Company (U.S.A.) Separate Account A at December 31, 2014, and for each of the two years in the period ended December 31, 2014, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

Legal and Regulatory Matters

There are no legal proceedings to which the Depositor, the Separate Account or the principal underwriter is a party or to which the assets of the Separate Account are subject that are likely to have a material adverse effect on the Separate Account or the ability of the principal underwriter to perform its contract with the Separate Account or of the Depositor to meet its obligations under the policies.

Principal Underwriter/Distributor

John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with the Depositor, is the principal distributor and underwriter of the securities offered through the prospectus. JH Distributors acts as the principal distributor of a number of other life insurance and annuity products we and our affiliates offer or maintain. JH Distributors also acts as the principal underwriter of John Hancock Variable Insurance Trust (the “Trust”), whose securities are used to fund certain variable investment options under the policies and under other life insurance and annuity products we offer or maintain.

JH Distributors’ principal address is 601 Congress Street, Boston, MA 02210, and it also maintains offices with us at 197 Clarendon Street, Boston, MA 02116. JH Distributors is a broker-dealer registered under the Securities Act of 1934 (the “1934 Act”) and is a member of the Financial Industry Regulatory Authority (“FINRA”).

We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate Signator Investors, Inc. is one such broker-dealer.

The aggregate dollar amount of underwriting commissions paid to JH Distributors by the Depositor and its affiliates in connection with the sale of variable life products in 2014, 2013, and 2012 was $132,392,739, $119,574,297 and $156,801,522, respectively. JH Distributors did not retain any of these amounts during such periods.

The registered representative through whom your policy is sold will be compensated pursuant to the registered representative’s own arrangement with his or her broker-dealer. Compensation to broker-dealers for the promotion and sale of the policies is not paid directly by policy owners but will be recouped through the fees and charges imposed under the policy.

Additional compensation and revenue sharing arrangements may be offered to certain broker-dealer firms and other financial intermediaries. The terms of such arrangements may differ among firms we select based on various factors. In general, the arrangements involve three types of payments or any combination thereof:

  • Fixed dollar payments: The amount of these payments varies widely. JH Distributors may, for example, make one or more payments in connection with a firm’s conferences, seminars or training programs, seminars for the public, advertising and sales campaigns regarding the policies, to assist a firm in connection with its systems, operations and marketing expenses, or for other activities of a selling firm or wholesaler. JH Distributors may make these payments upon the initiation of a relationship with a firm, and at any time thereafter.
  • Payments based upon sales: These payments are based upon a percentage of the total amount of money received, or anticipated to be received, for sales through a firm of some or all of the insurance products that we and/or our affiliates offer. JH Distributors makes these payments on a periodic basis.
  • Payments based upon “assets under management”: These payments are based upon a percentage of the policy value of some or all of our (and/or our affiliates’) insurance products that were sold through the firm. JH Distributors makes these payments on a periodic basis.

Our affiliated broker-dealer, Signator Investors, Inc., may pay its respective registered representatives additional cash incentives, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.

Additional Information About Charges

A policy will not be issued until the underwriting process has been completed to our satisfaction. The underwriting process generally includes the obtaining of information concerning your age, medical history, occupation and other personal information. This information is then used to determine the cost of insurance charge.

Reduction in Charges

The policy may be available for purchase by corporations and other groups or sponsoring organizations. Group or sponsored arrangements may include reduction or elimination of withdrawal charges and deductions for employees, officers, directors, agents and immediate family members of the foregoing. We reserve the right to reduce any of the policy’s charges on certain cases where it is expected that the amount or nature of such cases will result in savings of sales, underwriting, administrative, commissions or other costs. Eligibility for these reductions and the amount of reductions will be determined by a number of factors, including the number of lives to be insured, the total premiums expected to be paid, total assets under management for the policyowner, the nature of the relationship among the insured individuals, the purpose for which the policies are being purchased, expected persistency of the individual policies, and any other circumstances which we believe to be relevant to the expected reduction of its expenses. Some of these reductions may be guaranteed and others may be subject to withdrawal or modifications, on a uniform case basis. Reductions in charges will not be unfairly discriminatory to any policyowners. We may modify from time to time, on a uniform basis, both the amounts of reductions and the criteria for qualification.


333-85284 333-131299 333-157212
333-88748 333-141692 333-179570
333-71136 333-148991 333-193994
333-100597 333-151630 333-194818
333-124150 333-153252
4


Table of Contents

AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS

John Hancock Life Insurance Company (U.S.A.)

For the Years Ended December 31, 2014, 2013 and 2012

With Report of Independent Auditors


Table of Contents

AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

Years Ended December 31, 2014, 2013 and 2012

Contents

 

Report of Independent Auditors

     F-1   

Statutory-Basis Financial Statements

  

Balance Sheets-

Statutory-Basis

     F-3   

Statements of Operations-

Statutory-Basis

     F-5   

Statements of Changes in Capital and Surplus-

Statutory-Basis

     F-6   

Statements of Cash Flow-

Statutory-Basis

     F-7   

Notes to Statutory-Basis Financial Statements

     F-8   


Table of Contents

Report of Independent Auditors

The Board of Directors and Shareholder

John Hancock Life Insurance Company (U.S.A.)

We have audited the accompanying statutory-basis financial statements of John Hancock Life Insurance Company (U.S.A.) (the Company), which comprise the balance sheets as of December 31, 2014 and 2013, and the related statements of operations, changes in capital and surplus, and cash flow for each of the three years in the period ended December 31, 2014, and the related notes to the financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with accounting practices prescribed or permitted by the Michigan Office of Financial and Insurance Regulation. Management also is responsible for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the financial statements, to meet the requirements of Michigan the financial statements have been prepared in conformity with accounting practices prescribed or permitted by the Michigan Office of Financial and Insurance Regulation, which practices differ from U.S. generally accepted accounting principles. The variances between such practices and U.S. generally accepted accounting principles and the effects on the accompanying financial statements are described in Note 2.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the effects of the matter described in the preceding paragraph, the statutory-basis financial statements referred to above do not present fairly, in conformity with U.S. generally accepted accounting principles, the financial position of the Company at December 31, 2014 and 2013, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2014.

 

F-1


Table of Contents

Opinion on Statutory-Basis of Accounting

However, in our opinion, the statutory-basis financial statements referred to above present fairly, in all material respects, the financial position of the Company at December 31, 2014 and 2013, and the results of its operations and its cash flows for each of the three years in the period December 31, 2014 in conformity with accounting practices prescribed or permitted by the Michigan Office of Financial and Insurance Regulation.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 25, 2015

 

F-2


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

BALANCE SHEETS – STATUTORY BASIS

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions)  

Admitted assets

     

Cash and invested assets:

     

Bonds

       $ 49,226           $ 47,948   

Stocks:

     

Preferred stocks

     26         33   

Common stocks

     477         343   

Investments in affiliates

     2,911         2,866   

Mortgage loans on real estate

     11,519         12,221   

Real estate:

     

Company occupied

     300         305   

Investment properties

     5,203         5,304   

Cash, cash equivalents and short-term investments

     7,702         4,749   

Policy loans

     5,039         5,189   

Derivatives

     10,458         5,709   

Receivable for collateral on derivatives

     400         -   

Receivable for securities

     10         19   

Other invested assets

     5,978         5,275   
  

 

 

    

 

 

 

Total cash and invested assets

     99,249         89,961   

Investment income due and accrued

     887         892   

Premiums due and deferred

     388         410   

Amounts recoverable from reinsurers

     196         172   

Funds held by or deposited with reinsured companies

     1,958         1,984   

Other reinsurance receivable

     439         666   

Amounts due from affiliates

     247         358   

Other assets

     2,364         1,887   

Assets held in separate accounts

       140,164           142,766   
  

 

 

    

 

 

 

Total admitted assets

       $   245,892           $   239,096   
  

 

 

    

 

 

 

 

The accompanying notes are an integral part of these statutory-basis financial statements.

 

F-3


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

BALANCE SHEETS – STATUTORY BASIS – (CONTINUED)

 

     December 31,  
     2014     2013  
  

 

 

 
     (in millions)  

Liabilities and capital and surplus

    

Liabilities:

    

Policy and contract obligations:

    

Policy reserves

       $ 69,184          $ 67,065   

Policyholders’ and beneficiaries funds

     3,834        3,919   

Consumer notes

     411        644   

Dividends payable to policyholders

     574        585   

Policy benefits in process of payment

     556        547   

Other amount payable on reinsurance

     1,039        443   

Other policy obligations

     78        77   
  

 

 

   

 

 

 

Total policy and contract obligations

     75,676        73,280   

Payable to parent and affiliates

     3,073        1,713   

Transfers to (from) separate account, net

     (1,390     (1,368

Asset valuation reserve

     1,927        1,374   

Reinsurance in unauthorized companies

     3        6   

Funds withheld from unauthorized reinsurers

     8,873        6,681   

Interest maintenance reserve

     1,745        1,790   

Current federal income taxes payable

     -        215   

Net deferred tax liability

     456        204   

Derivatives

     5,229        4,046   

Payables for collateral on derivatives

     2,939        734   

Payables for securities

     26        111   

Other general account obligations

     1,843        1,735   

Obligations related to separate accounts

     140,164        142,766   
  

 

 

   

 

 

 

Total liabilities

       240,564          233,287   

Capital and surplus:

    

Preferred stock (par value $1; 50,000,000 shares authorized; 100,000 shares issued and outstanding at December 31, 2014 and 2013)

     -        -   

Common stock (par value $1; 50,000,000 shares authorized; 4,728,939 shares issued and outstanding at December 31, 2014 and 2013)

     5        5   

Paid-in surplus

     3,196        3,196   

Surplus notes

     990        990   

Unassigned surplus

     1,137        1,618   
  

 

 

   

 

 

 

Total capital and surplus

     5,328        5,809   
  

 

 

   

 

 

 

Total liabilities and capital and surplus

       $   245,892          $   239,096   
  

 

 

   

 

 

 

 

The accompanying notes are an integral part of these statutory-basis financial statements.

 

F-4


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

STATEMENTS OF OPERATIONS – STATUTORY-BASIS

 

     Years Ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Premiums and other revenues:

      

Life, long-term care and annuity premiums

       $ 12,738          $   12,882          $ 7,554   

Consideration for supplementary contracts with life contingencies

     183        266        342   

Net investment income

     4,297        4,551        4,221   

Amortization of interest maintenance reserve

     176        183        180   

Commissions and expense allowance on reinsurance ceded

     817        1,224        749   

Reserve adjustment on reinsurance ceded

       (10,652     (9,775       (8,936

Separate account administrative and contract fees

     1,841        1,848        1,815   

Other revenue

     467        188        201   
  

 

 

   

 

 

   

 

 

 

Total premiums and other revenues

     9,867        11,367        6,126   

Benefits paid or provided:

      

Death, surrender and other contract benefits, net

     9,064        7,710        6,728   

Annuity benefits

     1,733        1,784        1,602   

Disability and long-term care benefits

     584        542        514   

Interest and adjustments on policy or deposit-type funds

     125        132        123   

Payments on supplementary contracts with life contingencies

     170        159        137   

Increase (decrease) in life and long-term care reserves

     2,161        1,017        (3,915
  

 

 

   

 

 

   

 

 

 

Total benefits paid or provided

        13,837          11,344           5,189   

Insurance expenses and other deductions:

      

Commissions and expense allowance on reinsurance assumed

     1,203        1,360        1,323   

General expenses

     972        1,092        1,088   

Insurance taxes, licenses and fees

     138        150        151   

Net transfers to (from) separate accounts

     (8,229     (6,388     (3,608

Investment income ceded

     4,954        (1,356     851   

Other deductions

     21        14        40   
  

 

 

   

 

 

   

 

 

 

Total insurance expenses and other deductions

     (941     (5,128     (155

Income (loss) from operations before dividends to policyholders, federal income taxes and net realized capital gains (losses)

     (3,029     5,151        1,092   

Dividends to policyholders

     77        81        57   
  

 

 

   

 

 

   

 

 

 

Income (loss) from operations before federal income taxes and net realized capital gains (losses)

     (3,106     5,070        1,035   

Federal income tax expense (benefit)

     (716     262        (752
  

 

 

   

 

 

   

 

 

 

Income (loss) from operations before net realized capital gains (losses)

     (2,390     4,808        1,787   

Net realized capital gains (losses)

     (74     (1,793     (1,566
  

 

 

   

 

 

   

 

 

 

Net income (loss)

       $   (2,464       $ 3,015          $ 221   
  

 

 

   

 

 

   

 

 

 

 

The accompanying notes are an integral part of these statutory-basis financial statements.

 

F-5


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

STATEMENTS OF CHANGES IN CAPITAL AND SURPLUS – STATUTORY-BASIS

 

     Preferred
and
Common
Stock
     Paid-in
Surplus
     Surplus
Notes
     Unassigned
Surplus
(Deficit)
    Total
Capital
and
Surplus
 
  

 

 

 
     (in millions)  

Balances at January 1, 2012

       $ 5       $ 3,196       $ 989       $ 781      $ 4,971   

Net income (loss)

              221        221   

Change in net unrealized capital gains (losses)

              698        698   

Change in net deferred income tax

              71        71   

Decrease (increase) in non-admitted assets

              10        10   

Change in liability for reinsurance in unauthorized reinsurance

              2        2   

Decrease (increase) in asset valuation reserves

              130        130   

Change in surplus as a result of reinsurance

              (240     (240

Other adjustments, net

           1         (70     (69
  

 

 

 

Balances at December 31, 2012

     5         3,196         990         1,603        5,794   

Net income (loss)

              3,015        3,015   

Change in net unrealized capital gains (losses)

              (1,455     (1,455

Change in net deferred income tax

              (347     (347

Decrease (increase) in non-admitted assets

              (12     (12

Change in liability for reinsurance in unauthorized reinsurance

              -        -   

Decrease (increase) in asset valuation reserves

              (180     (180

Dividend paid to Parent

              (300     (300

Change in surplus as a result of reinsurance

              (573     (573

Other adjustments, net

           -         (133     (133
  

 

 

 

Balances at December 31, 2013

     5         3,196         990         1,618        5,809   

Net income (loss)

              (2,464     (2,464

Change in net unrealized capital gains (losses)

              2,389        2,389   

Change in net deferred income tax

              973        973   

Decrease (increase) in non-admitted assets

              56        56   

Change in liability for reinsurance in unauthorized reinsurance

              3        3   

Decrease (increase) in asset valuation reserves

              (553     (553

Dividend paid to Parent

              (500     (500

Change in surplus as a result of reinsurance

              (252     (252

Other adjustments, net

           -         (133     (133
  

 

 

 

Balances at December 31, 2014

       $   5       $   3,196       $   990       $    1,137      $    5,328   
  

 

 

 

 

The accompanying notes are an integral part of these statutory-basis financial statements.

 

F-6


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

STATEMENTS OF CASH FLOW – STATUTORY-BASIS

 

     Years Ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Operations

      

Premiums and other considerations collected, net of reinsurance

       $ 12,924      $ 13,205      $ 13,046   

Net investment income received

     4,399        4,635        4,402   

Separate account fees

     1,841        1,848        1,815   

Commissions and expenses allowance on reinsurance ceded

     817        1,224        962   

Miscellaneous income

     450        (172     6   

Benefits and losses paid

     (21,960     (20,462     (18,213

Net transfers from (to) separate accounts

     8,206        6,493        3,587   

Commissions and expenses (paid) recovered

     (7,147     (1,572     (3,637

Dividends paid to policyholders

     (89     (91     (180

Federal and foreign income and capital gain taxes (paid) recovered

     (382     (1,195     477   
  

 

 

 

Net cash provided by (used in) operating activities

     (941     3,913        2,265   

Investment activities

      

Proceeds from sales, maturities, or repayments of investments:

      

Bonds

     20,471        19,130        16,404   

Stocks

     130        149        122   

Mortgage loans on real estate

     1,789        1,660        1,514   

Real estate

     1,053        22        17   

Other invested assets

     941        498        575   

Miscellaneous proceeds

     3        (2     2   
  

 

 

 

Total investment proceeds

        24,387           21,457           18,634   

Cost of investments acquired:

      

Bonds

     21,430        17,853        16,178   

Stocks

     234        78        195   

Mortgage loans on real estate

     1,088        1,813        1,644   

Real estate

     539        743        859   

Other invested assets

     1,281        882        1,223   

Derivatives

     739        1,916        1,399   
  

 

 

 

Total cost of investments acquired

     25,311        23,285        21,498   

Net increase (decrease) in receivable/payable for securities and collateral on derivatives

     (1,729     1,197        (631

Net increase (decrease) in policy loans

     (150     140        34   
  

 

 

 

Net cash provided by (used in) investment activities

     955        (3,165     (2,267

Financing and miscellaneous activities

      

Borrowed funds

     (232     (48     (19

Net deposits (withdrawals) on deposit-type contracts

     (85     (134     20   

Dividend paid to Parent

     (500     (300     -   

Repurchase agreements

     -        (437     -   

Other cash provided (applied)

     3,756        14        976   
  

 

 

 

Net cash provided by (used in) financing and miscellaneous activities

     2,939        (905     977   

Net increase (decrease) in cash, cash equivalents and short-term investments

     2,953        (157     975   

Cash, cash equivalents and short-term investments at beginning of year

     4,749        4,906        3,931   
  

 

 

 

Cash, cash equivalents and short-term investments at end of year

       $ 7,702      $ 4,749      $ 4,906   
  

 

 

 

Non-cash investing activities during the year:

      

Transfer of assets for FDA reinsurance transaction

       $ -      $ -      $ (4,984

 

The accompanying notes are an integral part of these statutory-basis financial statements.

 

F-7


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

 

1. Organization and Nature of Operations

John Hancock Life Insurance Company (U.S.A.) (“JHUSA” or the “Company”) is a wholly-owned subsidiary of The Manufacturers Investment Corporation (“MIC”). MIC is a wholly-owned subsidiary of John Hancock Financial Corporation (“JHFC”), which is an indirect, wholly-owned subsidiary of The Manufacturers Life Insurance Company (“MLI”). MLI, in turn, is a wholly-owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian-based, publicly traded financial services holding company.

The Company provides a wide range of financial protection and wealth management products and services to both individual and institutional customers located primarily in the United States. Through its insurance operations, the Company offers a variety of individual life insurance and individual and group long-term care insurance products that are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing. The Company also offers mutual fund products and services which include a variety of retirement products to retirement plans. The Company distributes these products through multiple distribution channels, including insurance agents and affiliated brokers, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks. In 2013, the Company discontinued sales of its structured settlements and single premium immediate annuity products. In 2012, the Company suspended new sales of its individual fixed and variable annuity products. The Company is licensed to sell insurance in 49 states, the District of Columbia, Guam, Puerto Rico and the U.S. Virgin Islands.

John Hancock Distributors LLC (“JHD”), a registered broker-dealer and a wholly-owned subsidiary of the Company, acts as the principal underwriter of variable life contracts pursuant to a distribution agreement with the Company.

The Company has two wholly-owned life insurance subsidiaries, John Hancock Life Insurance Company of New York (“JHNY”) and John Hancock Life & Health Insurance Company (“JHLH”).

2. Significant Accounting Policies

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes known and may impact the amounts reported and disclosed herein.

Basis of Presentation

These financial statements have been prepared in conformity with accounting practices prescribed or permitted by the Michigan Department of Insurance and Financial Services (the “Insurance Department”). The National Association of Insurance Commissioners’ (“NAIC”) Accounting Practices and Procedures Manual (“NAIC SAP”) has been adopted as a component of practices prescribed or permitted by the State of Michigan. The Michigan Director of the Department of Insurance and Financial Services (the “Director”) has the authority to prescribe or permit other specific practices that deviate from prescribed practices. NAIC SAP practices differ from accounting principles generally accepted in the United States (“GAAP”) as described below.

Investments: Investments in bonds not backed by other loans are principally stated at amortized cost using the constant yield (interest) method. Bonds can also be stated at the lesser of amortized cost or fair value based on their NAIC designated rating. Non-redeemable preferred stocks, which have characteristics of equity securities, are reported at cost or lower of cost or market value as determined by the Securities Valuation Office of the NAIC (“SVO”) rating, and the related net unrealized capital gains (losses) are reported in unassigned surplus along with any adjustment for federal income taxes. Redeemable preferred stocks, which have characteristics of debt securities and are rated as medium quality or better, are reported at cost or amortized cost. All other redeemable preferred stocks are reported at the lower of cost, amortized cost, or fair value.

For bonds other than loan-backed and structured securities, the Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. The Company recognizes other-than-temporary impairment losses on bonds with unrealized losses when either of the following two conditions exist: the entity either (1) has the intent to sell the debt security or (2) is more likely than not to be required to sell the debt security before its anticipated recovery. Declines in value due to credit difficulties are also considered to be other-than-temporarily impaired when the

 

F-8


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

2. Significant Accounting Policies - (continued)

 

Company does not have the intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. The entire difference between amortized cost and fair value on such bonds with credit difficulties is recognized as an impairment loss in income.

Loan-backed and structured securities (i.e., collateralized mortgage obligations) are adjusted for the effects of changes in prepayment assumptions on the related accretion of discounts or amortization of premiums of such securities using either the retrospective or prospective methods. The retrospective adjustment method is used to value all such securities, except principal-only and interest-only securities and such securities with NAIC designations of 3-6, which are valued using the prospective method. If it is determined that a decline in fair value is other-than-temporary, the cost basis of the security is written down to the present value of estimated future cash flows using the original effective interest rate inherent in the security.

Common stocks are primarily reported at fair value based on quoted market prices and the related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustment for federal income taxes. There are no restrictions on common and preferred stocks.

Insurance subsidiaries are reported at their underlying statutory equity. Non-insurance subsidiaries, which have significant ongoing operations other than for the benefit of the Company and its affiliates, are reported at GAAP equity. Non-insurance subsidiaries, which have no significant ongoing operations other than for the benefit of the Company and its affiliates, are reported based on the underlying equity adjusted to a statutory-basis, plus the admitted portion of goodwill. Dividends from subsidiaries are included in net investment income. The remaining net change in the subsidiaries’ equity is included in the change in net unrealized capital gains (losses).

Realized capital gains (losses) on sales of securities are recognized using the first in first out (“FIFO) method. The cost basis of bonds and common and preferred stocks is adjusted for impairments in value deemed to be other-than-temporary and such adjustments are reported as a component of net realized capital gains (losses).

Mortgage loans on real estate are reported at unpaid principal balances, less an allowance for impairments. Valuation allowances, if necessary, are established for mortgage loans on real estate based on the difference between the net value of the collateral, determined as the fair value of the collateral less estimated costs to obtain and sell, and the recorded investment in the mortgage loan. The initial valuation allowance and subsequent changes in the allowance for mortgage loans are charged or credited directly to unassigned surplus. A mortgage loan is considered to be impaired when, based on current information and events, it is probable that the Company will be unable to collect all principal and interest amounts due according to the contractual terms of the mortgage agreement. When management determines foreclosure is probable and the impairment is other-than-temporary, the mortgage loan is written down and a realized loss is recognized.

Real estate occupied by the Company and real estate held for the production of income are reported at depreciated cost, net of related obligations. Real estate that the Company has the intent to sell is reported at the lower of depreciated cost or fair value, net of related obligations. Depreciation is calculated on a straight-line basis over the estimated useful lives of the properties. Investment income and operating expenses include rent for the Company’s occupancy of Company-owned properties

Cash equivalents are short-term highly liquid investments with original maturities of three months or less and are principally stated at amortized cost. Short-term investments include investments with maturities of one year or less and greater than three months at the date of acquisition and are principally stated at amortized cost.

Policy loans are reported at unpaid principal balances.

Derivative instruments that meet the criteria to qualify for hedge accounting are accounted for in a manner consistent with the item hedged (i.e., amortized cost or fair value with the related net unrealized capital gains (losses) reported in unassigned surplus along with any adjustment for federal income taxes). Derivative instruments that are entered into for other than hedging purposes or that do not meet the criteria to qualify for hedge accounting are accounted for at fair value, and the related changes in fair value are recognized as net unrealized capital gains (losses) reported in unassigned surplus, net of any adjustments for federal income taxes. Embedded derivatives are not accounted for separately from the host contract.

Other invested assets consist of ownership interests in partnerships and limited liability corporations (“LLCs”) which are carried based on the underlying GAAP equity, with the exception of affordable housing tax credit properties, which are

 

F-9


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

2. Significant Accounting Policies - (continued)

 

carried at amortized cost. The related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustments for federal income taxes.

Interest Maintenance and Asset Valuation Reserves: Under a formula prescribed by the NAIC, the Company defers the portion of realized capital gains (losses) on sales of fixed income investments, principally bonds and mortgage loans, and interest-related hedging activities that are attributable to changes in the general level of interest rates and amortizes those deferrals over the remaining period to maturity based on groupings of individual securities sold in five-year bands. That net deferral is reported as the interest maintenance reserve (“IMR”) in the accompanying Balance Sheets. Realized capital gains (losses) are reported in income, net of federal income tax and transferred to the IMR. The asset valuation reserve (“AVR”) provides a valuation allowance for invested assets. The AVR is determined by an NAIC prescribed formula with changes reflected directly in unassigned surplus.

Subsidiaries: The accounts and operations of the Company’s subsidiaries are not consolidated with the accounts and operations of the Company.

Goodwill: Goodwill is admitted subject to an aggregate limitation of 10% of the capital and surplus in the most recently filed quarterly statement, excluding EDP equipment, operating system software, net deferred tax assets, and net positive goodwill. Goodwill is amortized over the period the Company benefits economically, not to exceed 10 years. Goodwill held by non-insurance subsidiaries is assessed in accordance with GAAP, subject to certain limitations for holding companies and foreign insurance subsidiaries.

Separate Accounts: Separate account assets and liabilities reported in the accompanying Balance Sheets represent funds that are separately administered, principally for annuity contracts and variable life insurance policies, and for which the contract holder, rather than the Company, bears the investment risk. Separate account obligations are intended to be satisfied from separate account assets and not from assets of the general account. Separate accounts are generally reported at fair value. The operations of the separate accounts are not included in the Statements of Operations; however, income earned on amounts initially invested by the Company in the formation of new separate accounts is included in other revenue. Fees charged to contract holders, principally mortality, policy administration, and surrender charges are included in separate account administrative and contract fees. The assets in the separate accounts are not pledged to others as collateral or otherwise restricted. For the years ended December 31, 2014, 2013 and 2012, there were no gains (losses) on transfers of assets from the general account to the separate account.

Nonadmitted Assets: Certain assets designated as nonadmitted, principally furniture and equipment, past due agents’ balances, and other assets not specifically identified as an admitted asset within the NAIC SAP are excluded from the accompanying Balance Sheets and are charged directly to unassigned surplus.

Policy Acquisition Costs: The costs of acquiring and renewing business are expensed when incurred.

Policy Reserves: Reserves for life, long-term care, annuity, and deposit-type contracts are developed by actuarial methods and are determined based on interest rates, mortality tables and valuation methods prescribed by the NAIC that will provide, in the aggregate, reserves that are greater than or equal to the maximum of guaranteed policy cash values or the amounts required by the Insurance Department.

 

   

The Company waives deduction of deferred fractional premiums on the death of lives insured and annuity contract holders and returns any premium beyond the date of death. Surrender values on policies do not exceed the corresponding benefit reserves. Additional reserves are established when the results of asset adequacy testing indicate the need for such reserves or the net premiums exceed the gross premiums on any insurance in-force. This includes asset adequacy testing required under NAIC Actuarial Guideline 38 Section 8D (“AG 38 8D”). The Company held gross reserves of $641 million and $325 million for the calculation required under AG 38 8D, of which $446 million and $0 million was ceded to Manulife Reinsurance Limited (“MRL”) under an existing coinsurance transaction at December 31, 2014 and 2013, respectively. At December 31, 2014 and 2013, the Company held reserves of $1,030 million and $1,018 million, respectively, on insurance in-force for which gross premiums were less than net premiums according to the standard of valuation set by the State of Michigan.

 

   

Reserves for individual life insurance policies are maintained using the 1941, 1958, 1980, and 2001 Commissioner’s Standard Ordinary and American Experience Mortality Tables. Methods used include the net level premium method

 

F-10


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

2. Significant Accounting Policies - (continued)

 

 

principally for policies issued prior to 1978, a modified preliminary term method, and the Commissioner’s Reserve Valuation Method.

 

   

Annuity and supplementary contracts with life contingency reserves are based principally on modifications of the 1937 Standard Annuity Table, the Group Annuity Mortality Tables for 1951, 1971, 1983, and 1994, the 1971 Individual Annuity Mortality Table, the 1983 Individual Annuity Mortality Table, and the 2000 Individual Annuity Mortality Table.

 

   

Liabilities related to policyholder funds left on deposit with the Company are generally equal to fund balances.

 

   

Long-term care reserves are generally calculated using the one-year preliminary term method based on various mortality, morbidity, and lapse tables.

 

   

The mean reserve method is used to adjust the calculated terminal reserve to the appropriate reserve at December 31, 2014 or 2013. Mean reserves are determined by computing the terminal reserve for the plan at the rated age and assuming annual premiums have been paid as of the valuation date. For certain policies with substandard table ratings, mean reserves are based on rated mortality from 125% to 500% of standard rating; for certain policies with flat extra ratings, mean reserves are based on standard mortality rates increased by 1 to 25 deaths per thousand. An asset is recorded for deferred premiums, net of loading, to adjust the reserve for modal premium payments.

 

   

For long-term care, the interpolated reserve method is used to adjust the calculated terminal reserve, and in addition an unearned premium reserve is held.

 

   

Tabular interest, tabular less actual reserve released, and tabular costs have been determined by formula. Tabular interest on funds not involving life contingencies is calculated as one percent of the product of such valuation rate of interest times the mean of the amount of funds subject to such valuation rate of interest held at the beginning and end of the valuation year.

 

   

From time to time, the Company finds it appropriate to modify certain required policy reserves because of changes in actuarial assumptions. Reserve modifications resulting from such determinations are recorded directly to unassigned surplus.

 

   

Reserves for variable deferred annuity contracts are calculated in accordance with NAIC Actuarial Guideline 43, and primarily use the 1994 Minimum Guaranteed Death Benefit or Annuity 2000 tables. The reserve is based on the present value of accumulated losses from the perspective of the Company. The liability is evaluated under both a standard scenario and stochastic scenario, and the Company holds the higher of the standard or stochastic values.

Reinsurance: Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders. The Company remains liable to its policyholders for the portion reinsured to the extent that any reinsurer does not meet its obligations for reinsurance ceded to it under the reinsurance agreements. Failure of the reinsurers to honor their obligations could result in losses to the Company; consequently, estimates are established for amounts deemed or estimated to be uncollectible. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics of the insurer.

Premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured business are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums ceded to other companies have been reported as a reduction of premium income. Amounts applicable to reinsurance ceded for future policy benefits, unearned premium reserves, and claim liabilities have been reported as reductions of these items.

The Company records a liability for unsecured policy reserves ceded to reinsurers not authorized in the State of Michigan to assume such business. Changes to those amounts are credited or charged directly to unassigned surplus. Policy and contract liabilities ceded to reinsurers have been reported as reductions of the related reserves. Commissions allowed by reinsurers on business ceded are reported as income when received. Investment income ceded includes separate account fee income, net investment income and realized investment and other gains (losses), which was ceded to the affiliated reinsurers. NAIC SAP

 

F-11


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

2. Significant Accounting Policies - (continued)

 

prescribes that no gain be recognized upon inception of a reinsurance treaty. The initial consideration is recorded directly to unassigned surplus and released into income over the life of the treaty.

Federal Income Taxes: Total federal income taxes are based upon the Company’s best estimate of its current and deferred tax assets or liabilities. Current tax expense is reported in the statements of operations as federal income tax expense if resulting from operations and within net unrealized capital gains (losses) if resulting from capital transactions. Changes in the balances of deferred taxes, which provide for book versus tax temporary differences, are subject to limitations and are reported within various lines within surplus. Accordingly, the reporting of statutory to tax temporary differences, such as reserves and policy acquisition costs, and of statutory to tax permanent differences, such as tax-exempt interest and tax credits, results in effective tax rates in the statements of operations that differ from the federal statutory tax rate.

Participating Insurance and Policyholder Dividends: Participating business represented approximately 26% and 27% of the Company’s aggregate reserve for life contracts at December 31, 2014 and 2013. The amount of policyholders’ dividends to be paid is approved annually by the Company’s Board of Directors. Policyholder dividends are recognized when declared rather than over the term of the related policies. The determination of the amount of policyholder dividends is complex and varies by policy type. In general, the aggregate amount of policyholders’ dividends is calculated based upon actual interest, mortality, morbidity, persistency, and expense experience for the year, as well as management’s judgment as to the appropriate level of statutory surplus to be retained by the Company. John Hancock Life Insurance Company (“JHLICO”) was a predecessor company that was merged into JHUSA on December 31, 2009. For additional information on the closed blocks, see the Closed Blocks Note.

Surplus Notes: Surplus notes are reported in capital and surplus, and the interest expense is not accrued unless approved for payment by the Insurance Department.

Statements of Cash Flow: Cash, cash equivalents and short-term investments in the statements of cash flow represent movements of cash and highly liquid debt investments with initial maturities of one year or less.

Premiums and Benefits: Premiums for whole, term, and universal life, long-term care, annuity policies, guaranteed interest, and group annuity contracts with any mortality and morbidity risk are recognized as revenue when due. Revenues for universal life and annuity policies with mortality or morbidity risk, except for guaranteed interest, term certain supplementary contracts, and funding agreements, consist of the entire premium received. Premiums received for annuity policies, guaranteed interest, funding agreements, variable universal life, and group annuity contracts without mortality or morbidity risk are recorded using deposit accounting and are credited directly to an appropriate policy reserve account, without recognizing premium revenue. Benefits incurred represent the total of death benefits paid, annuity benefits paid and the change in policy reserves.

Policy and Contract Claims: Policy and contract claims are determined on an individual-case basis for reported losses. Estimates of incurred but not reported losses are developed on the basis of past experience.

Guaranty Fund Assessments: Guaranty fund assessments are accrued when the Company receives knowledge of an insurance insolvency.

Reclassifications: Certain prior year amounts in the Company’s statutory-basis financial statements have been reclassified to conform to the current year financial statement presentation.

Variances Between NAIC SAP and GAAP: The more significant variances from GAAP are: (a) bonds would generally be reported at fair value; (b) changes in the fair value of derivative financial instruments would generally be reported as revenue unless deemed an effective hedge; (c) embedded derivatives would be bifurcated from the underlying contract or security and accounted for separately at fair value; (d) income recognition on partnerships and LLCs, which are accounted for under the equity method, would not be limited to the amount of cash distribution; (e) majority-owned noninsurance subsidiaries, variable interest entities where the Company is the primary beneficiary, and certain other controlled entities would be consolidated; (f) changes in the balances of deferred income taxes would generally be included in net income; (g) market value adjusted (“MVA”) annuity products would be reported in the general account of the Company; (h) all assets, subject to valuation allowances, would be recognized; (i) reserves would generally be based upon the net level premium method or the estimated gross margin method with estimates of future mortality, morbidity, persistency and interest; (j) reinsurance ceded, unearned ceded premium and unpaid ceded claims would be reported as an asset; (k) AVR and IMR would not be recorded; (l) changes to the mortgage loan valuation allowance would be reported in income; (m) surplus notes would be reported as

 

F-12


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

2. Significant Accounting Policies - (continued)

 

liabilities; (n) premiums received in excess of policy charges for universal life and annuity policies would not be recognized as premium revenue and benefits would represent the excess of benefits paid over the policy account value and interest credited to the account values; (o) certain acquisition costs, such as commissions and other variable costs, directly related to acquiring new business are charged to current operations as incurred, would generally be capitalized and amortized based on profit emergence over the expected life of the policies or over the premium payment period; and (p) changes in unrealized capital gains (losses) and foreign currency translations would be presented as other comprehensive income.

3. Permitted Statutory Accounting Practices

The financial statements of the Company are presented in conformity with accounting practices prescribed or permitted by the Insurance Division.

For determining the Company’s solvency under the State of Michigan’s insurance laws and regulations, the Insurance Department recognizes only statutory accounting practices prescribed or permitted by the State of Michigan for determining and reporting the financial condition and results of operations of the Company. NAIC SAP has been adopted as a component of prescribed or permitted practices by the State of Michigan. The Director has the authority to prescribe or permit other specific practices that deviate from prescribed practices.

As of December 31, 2014 and 2013, the Director had not prescribed or permitted the Company to use any accounting practices that would result in the Company’s income or financial position to deviate from NAIC SAP.

4. Accounting Changes

Accounting changes adopted to conform to the provisions of NAIC SAP are reported as changes in accounting principles. The cumulative effect of changes in accounting principles is reported as an adjustment to unassigned surplus in the period of the change in accounting principle. The cumulative effect is the difference between the amount of unassigned surplus at the beginning of the year and the amount of unassigned surplus that would have been reported at that date if the new accounting principle had been applied retrospectively.

Adoption of New Accounting Standards

In March 2014, the NAIC adopted updated guidance regarding derivatives. The new guidance permits a company to designate the Fed Funds Effective Swap Rate (also referred to as the “Overnight Index Swap Rate” or “OIS”) as the hedged risk (or benchmark interest rate) in both cash flow and fair values hedges. The updated guidance also removed the requirement that similar hedges designate the same benchmark rate. The adoption of this guidance did not impact the Company’s Balance Sheets or Statements of Operations.

Future Adoption of New Accounting Standards

In December 2014, the NAIC adopted Actuarial Guideline 48 (“AG 48”) which intends to bring uniformity to the regulation of XXX and AXXX business subject to life insurer-owned captive reinsurance arrangements. The guidance requires the appointed actuary of the ceding company to perform an analysis of the amount and type of assets backing collateral. AG 48’s actuarial method determines the amount of “high quality assets” which must back collateral and is based on calculations from the NAIC principle based reserving valuation manual. Certified reinsurers as well as licensed and accredited reinsurers with no permitted practices will be exempt from AG 48. Additionally, AG 48 does not apply to policies that were issued prior to January 1, 2015 and included in a reserve financing arrangement as of December 31, 2014. As such, the adoption of AG 48 is not expected to have any material impact on the Company’s Balance Sheets or Statements of Operations.

Reconciliation Between Audited Financial Statements and NAIC Annual Statements

There were no differences in net income (loss) or capital and surplus between the audited financial statements and the NAIC statements as filed as of and for the years ended December 31, 2014, 2013 and 2012.

 

F-13


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments

Bonds

The carrying value and fair value of the Company’s investments in bonds are summarized as follows:

 

     Carrying
Value
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
    Fair Value  
  

 

 

 
     (in millions)  

December 31, 2014:

          

U.S. government and agencies

       $ 5,420       $ 863       $ (1   $ 6,282   

States and political subdivisions

     2,842         606         -        3,448   

Foreign governments

     2,849         205         (10     3,044   

Corporate bonds

     31,347         3,633         (140     34,840   

Mortgage-backed and asset-backed securities

     6,768         618         (49     7,337   
  

 

 

 

Total bonds

       $   49,226       $   5,925       $ (200   $   54,951   
  

 

 

 

December 31, 2013:

          

U.S. government and agencies

       $ 6,988       $ 90       $ (356   $ 6,722   

States and political subdivisions

     2,721         213         (36     2,898   

Foreign governments

     3,000         137         (37     3,100   

Corporate bonds

     28,367         2,252         (574     30,045   

Mortgage-backed and asset-backed securities

     6,872         498         (108     7,262   
  

 

 

 

Total bonds

       $   47,948       $ 3,190       $   (1,111   $ 50,027   
  

 

 

 

A summary of the carrying value and fair value of the Company’s investments in bonds at December 31, 2014, by contractual maturity, is as follows:

 

     Carrying
Value
     Fair Value  
  

 

 

 
     (in millions)  

Due in one year or less

       $ 1,399       $ 1,429   

Due after one year through five years

     6,929         7,287   

Due after five years through ten years

     7,282         7,645   

Due after ten years

     26,848         31,253   

Mortgage-backed and asset-backed securities

     6,768         7,337   
  

 

 

 

Total

       $   49,226       $   54,951   
  

 

 

 

The expected maturities in the foregoing table may differ from the contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties.

The Company maintains assets which are pledged as collateral in connection with various agreements and transactions. Additionally, the Company holds assets on deposit with government authorities as required by state law. The following table summarizes the carrying value or fair value, as applicable, of the pledged or deposited assets:

 

F-14


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions)  

At fair value:

     

Bonds pledged in support of over-the-counter derivative instruments

       $ 125       $ 831   

Bonds pledged in support of exchange-traded futures

     498         264   

Bonds and cash pledged in support of cleared interest rate swaps

     551         253   
  

 

 

 

Total fair value

       $   1,174       $   1,348   
  

 

 

 

At carrying value:

     

Bonds on deposit with government authorities

       $ 16       $ 26   

Mortgage loans pledged in support of real estate

     45         47   

Bonds held in trust

     132         92   

Pledged collateral under reinsurance agreements

     2,800         2,510   
  

 

 

 

Total carrying value

       $   2,993       $   2,675   
  

 

 

 

At December 31, 2014 and 2013, the Company held below investment grade corporate bonds of $2,096 million and $2,428 million, with an aggregate fair value of $2,197 million and $2,551 million, respectively. The Company performs periodic evaluations of the relative credit standing of the issuers of these bonds.

The Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. This process involves monitoring market events that could impact issuers’ credit ratings, business climate, management changes, litigation and government actions, and other similar factors. This process also involves monitoring late payments, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts, and cash flow projections as indicators of credit issues.

At the end of each quarter, the MFC Loan Review Committee reviews all securities where there is evidence of impairment or a significant unrealized loss at the Balance Sheet date. Generally, securities with market value less than 60 percent of amortized cost for six months or more indicate an impairment is present. Accordingly, securities in this category are normally deemed impaired unless there is clear evidence they should not be impaired. The analysis focuses on each company’s or project’s ability to service its debts in a timely fashion and the length of time the security has been trading below amortized cost. The results of this analysis are reviewed by the Transaction and Portfolio Review Committee at MFC. This committee includes MFC’s Chief Financial Officer, Chief Investment Officer, Chief Risk Officer, Chief Credit Officer, and other senior management. This quarterly process includes a fresh assessment of the credit quality of each investment in the entire fixed maturity security portfolio.

The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances considered include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer, including the current and future impact of any specific events; and (3) the Company’s ability and intent to hold the security to maturity or until it recovers in value. To the extent the Company determines that a security, other than loan-backed and structured securities, is deemed to be other-than-temporarily impaired, the difference between amortized cost and fair value would be charged to income. For loan-backed and structured securities in an unrealized loss position, where the Company does not intend to sell or is not likely to be required to sell the security, the Company calculates an other-than-temporary impairment loss by subtracting the net present value of the projected future cash flows of the security from the amortized cost of the security. The net present value is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security prior to impairment. The projection of future cash flows is subject to the same analysis the Company applies to its overall impairment evaluation process, as noted above, which incorporates security specific information such as late payments, downgrades by rating agencies, key financial ratios, financial statements, and fundamentals of the industry and geographic area in which the issuer operates, as well as overall macroeconomic conditions. The cash flow estimates, including prepayment assumptions, are based on data from third-party data sources or internal estimates, and are driven by assumptions regarding the underlying collateral, including default rates, recoveries, and changes in value.

There are a number of significant risks and uncertainties inherent in the process of monitoring impairments and determining if impairment is other-than-temporary. These risks and uncertainties include (1) the risk that the Company’s assessment of an

 

F-15


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

issuer’s ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer; (2) the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated; (3) the risk that fraudulent information could be provided to the Company’s investment professionals who determine the fair value estimates and other-than-temporary impairments; and (4) the risk that new information obtained by the Company or changes in other facts and circumstances lead the Company to change its intent to hold the security to maturity or until it recovers in value. Any of these situations could result in a charge to income in a future period.

The impact of Other-Than-Temporary Impairments (OTTI) on Carrying Values (CV), including the Present Value (PV) of Cash Flows (CF) less than Book Value (BV), is as follows:

 

                                    
  

 

 

 
     December 31, 2014  
             CV Before OTTI      Interest OTTI      Credit OTTI      CV After OTTI      Fair Value          
  

 

 

 
     (in millions)  

Aggregate PV of CFs less than BV

       $     33             $ -             $   5             $   28             $ 28     

Aggregate intent to sell

     -           -           -           -           -     

Aggregate lack of intent or inability to sell

     -           -           -           -           -     
  

 

 

 

Total

       $     33             $   -             $   5             $     28             $   28     
  

 

 

 
              
  

 

 

 
     December 31, 2013  
             CV Before OTTI      Interest OTTI      Credit OTTI      CV After OTTI      Fair Value          
  

 

 

 
     (in millions)  

Aggregate PV of CF’s less than BV

       $ 106             $   8             $   50             $   56             $ 48     

Aggregate intent to sell

     -           -           -           -           -     

Aggregate lack of intent or inability to sell

     -           -           -           -           -     
  

 

 

 

Total

       $     106             $   8             $     50             $     56             $     48     
  

 

 

 

 

F-16


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

The following tables disclose the impact of Other-Than-Temporary Impairments (OTTI) on Carrying Values (CV), including the Net Present Value (NPV) of Projected Cash Flows (CF) less than Book Value (BV) by CUSIP:

Year Ended December 31, 2014

 

                CUSIP#                     CV Before
OTTI
     NPV of
Projected
CFs
     Credit OTTI
Recognized in
Loss
     CV After
OTTI
     Fair        
Value        
 

 

 

      00075XAE7

     $ 1       $ 1       $ -       $ 1       $ 1     

      12669FUY7

     -         -         -         -         -     

      361849RK0

     15         14         1         14         14     

      126670AJ7

     -         -         -         -         -     

      126673WJ7

     -         -         -         -         -     

      126673WK4

     -         -         -         -         -     

      12669ERQ1

     4         3         1         3         3     

      12669FD67

     -         -         -         -         -     

      50180LAP5

     4         3         1         3         3     

      55265KS42

     -         -         -         -         -     

      75970NAR8

     1         1         -         1         1     

      75970NBK2

     1         1         -         1         1     

      126673WJ7

     -         -         -         -         -     

      12669FD59

     2         1         1         1         1     

      55265KS34

     1         1         -         1         1     

      59020UAZ8

        -         -         -         -     

      75970NAR8

     1         1         -         1         1     

      75970NBK2

     -         -         -         -         -     

      94981QAZ1

     -         -         -         -         -     

      50180LAP5

     3         2         1         2         2     

      75970NBK2

     -         -         -         -         -     
  

 

 

 

          Total

     $         33       $         28       $         5       $         28       $         28     
  

 

 

 

 

F-17


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

Year Ended December 31, 2013

 

CUSIP#    CV Before
OTTI
     NPV of
Projected
CFs
     Credit OTTI
Recognized in
Loss
     CV After
OTTI
     Fair        
Value        
 

 

 

      03927RAC8

       $ 1       $ -       $ 1       $ -       $ -     

      07387BEN9

     1         -         -         -         -     

      12669E7D2

     1         -         -         -         -     

      20047NAM4

     2         -         2         -         -     

      22541SWR5

     3         -         3         -         -     

      22608WAP4

     7         -         6         -         -     

      36170UCA7

     1         -         1         -         -     

      36170UCR0

     1         -         1         -         -     

      36828QLA2

     3         2         1         2         1     

      396789KD0

     6         5         2         5         3     

      46625M7D5

     1         1         -         1         1     

      46625YBQ5

     2         1         1         1         1     

      48123HAA1

     7         3         4         3         3     

      50211NAG4

     6         -         6         -         -     

      52108H3R3

     1         -         1         -         -     

      55265KS42

     1         1         -         1         -     

      949808BE8

     1         -         -         -         -     

      07388NAH9

     7         5         3         5         5     

      396789KD0

     5         3         3         3         3     

      46625YDU4

     4         1         3         1         1     

      55265KS42

     1         1         -         1         1     

      75970NBK2

     1         1         1         1         1     

      00764MDY0

     3         2         -         2         2     

      396789KD0

     2         1         1         1         1     

      46625YDS9

     6         4         3         4         4     

      52108HL28

     13         9         4         9         5     

      07383F4H8

     3         2         1         2         2     

      07388NAH9

     5         5         -         5         5     

      07388PAL5

     5         4         1         4         4     

      52108HL28

     6         5         1         5         5     
  

 

 

 

          Total

       $         106       $         56       $         50       $         56       $         48     
  

 

 

 

 

F-18


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

All impaired securities which have fair value less than cost or amortized cost, for which an other-than-temporary impairment has not been recognized in income as a realized loss, including securities with a recognized other-than-temporary impairment for non-interest related declines when a non-recognized interest related impairment remains:

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions)  

Continuous Unrealized Losses

     

Less than 12 months

       $   -       $   (1)   

12 months or longer

     -         -   

Fair Value of Securities with Continuous Unrealized Losses

     

Less than 12 months

     3         7   

12 months or longer

     4         2   

 

F-19


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

The following table shows gross unrealized losses and fair values of bonds, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

 

    Less than 12 months     12 months or more     Total  
   
    Fair Value     Gross
Unrealized
Losses
    Fair
Value
    Gross
Unrealized
Losses
    Fair Value     Gross
Unrealized
Losses
 
   
                (in millions)              

December 31, 2014:

               

U.S. government and agencies

      $ 94      $ -      $ 58      $ (1   $ 152      $ (1

States and political subdivisions

    8        -        8        -        16        -   

Foreign governments

    80        -        52        (10     132        (10

Corporate bonds

      2,033        (45     2,651        (95     4,684        (140

Mortgage-backed and asset-backed securities

    412        (8     459        (41     871        (49

Total

      $ 2,627      $   (53   $   3,228      $   (147   $   5,855      $   (200
                                               


    

           
    Less than 12 months     12 months or more     Total  
   
    Fair Value     Gross
Unrealized
Losses
    Fair
Value
    Gross
Unrealized
Losses
    Fair Value     Gross
Unrealized
Losses
 
   
                (in millions)              

December 31, 2013:

               

U.S. government and agencies

      $ 4,485      $ (283   $ 301      $ (73   $ 4,786      $ (356

States and political subdivisions

    405        (21     65        (15     470        (36

Foreign governments

    1,738        (25     284        (12     2,022        (37

Corporate bonds

    6,654        (376     1,528        (198     8,182        (574

Mortgage-backed and asset-backed securities

    1,268        (40     589        (68     1,857        (108

Total

      $   14,550      $   (745   $   2,767      $   (366   $   17,317      $   (1,111
                                               

At December 31, 2014 and 2013, there were 574 and 945 bonds that had a gross unrealized loss, of which the single largest unrealized loss was $12 million and $87 million, respectively. The Company anticipates that these bonds will perform in accordance with their contractual terms and the Company currently has the ability and intent to hold these bonds until they recover or mature. Unrealized losses can be created by rising interest rates or by rising credit concerns and hence widening credit spreads. Credit concerns are apt to play a larger role in the unrealized loss on below investment grade securities. Unrealized losses on investment grade securities principally relate to changes in interest rates or changes in credit spreads since the securities were acquired. Credit rating agencies’ statistics indicate that investment grade securities have been found to be less likely to develop credit concerns.

For the years ended December 31, 2014, 2013 and 2012, realized capital losses include $24 million, $88 million, and $108 million related to bonds that have experienced an other-than-temporary decline in value and were comprised of 21, 43, and 78 securities, respectively. These are primarily made up of impairments on public and private bonds and sub-prime mortgage-backed securities.

The total recorded investment in restructured corporate bonds at December 31, 2014, 2013 and 2012 was $17 million, $0 million, and $0 respectively. There were 2, 0, and 0 restructured corporate bonds for which an impairment was recognized during 2014, 2013 and 2012, respectively. The Company accrues interest income on impaired securities to the extent deemed

 

F-20


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

collectible and the loan continues to perform under its original or restructured contractual terms. Interest income on non-performing loans generally is recognized on a cash basis.

The sales of investments in bonds resulted in the following:

 

     December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Proceeds

       $   18,292          $   14,555          $   14,297   

Realized gross gains

     579        244        529   

Realized gross losses

     (111     (483     (79

The Company had no nonadmitted accrued investment income from bonds (unaffiliated) at December 31, 2014 and 2013.

Affiliate Transactions

In 2014, JHUSA sold certain bonds to an affiliate, MLI. These bonds had a book value of $178 million and a fair value of $206 million at the date of the transaction. The Company recognized $28 million in pre-tax realized gains which was deferred in IMR.

In 2014, JHUSA sold certain bonds to an affiliate, Manufacturers International Limited (Hong Kong) (“MIL”). These bonds had a book value of $371 million and a fair value of $433 million in exchange for certain bonds from MIL with a book value of $389 million and fair value of $435 million at the date of the transaction. The Company recognized $62 million in pre-tax realized gains which was deferred in IMR.

In 2014, JHUSA sold certain bonds to an affiliate, John Hancock Reassurance Company Limited (“JHRECO”). These bonds had a book value of $244 million and fair value of $284 million in exchange for certain bonds from JHRECO with a book value of $282 million and fair value of $291 million at the date of the transaction. The Company recognized $41 million in pre-tax realized gains which was deferred in IMR.

In 2014, JHUSA acquired certain and sold certain bonds from an affiliate, JHNY. These bonds had a net book value of $165 million and a fair value of $188 million at the date of the transactions. The Company recognized $1 million in pre-tax realized gains before transfer to IMR.

In 2014, JHUSA acquired certain bonds from an affiliate, JHLH. These bonds had a book value of $69 million and a fair value of $72 million at the date of the transaction.

In 2013, JHUSA sold certain bonds to an affiliate, Manulife International Limited. These bonds had a book value of $397 million and a fair value of $454 million at the date of the transaction. The Company recognized $57 million in pre-tax realized gains before transfer to IMR.

In 2013, JHUSA sold certain bonds to an affiliate, JHRECO. These bonds had a book value of $184 million and a fair value of $181 million at the date of the transaction. The Company recognized $3 million in pre-tax realized losses before transfer to IMR.

In 2013, JHUSA sold certain and acquired certain bonds from an affiliate, MLI (Bermuda Branch). The bonds had a net book value of $338 million and a fair value of $372 million at the date of the transaction. The Company recognized $27 million in pre-tax realized gains before transfer to IMR.

 

F-21


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

Preferred and Common Stocks

Unrealized gains and losses on investments in preferred and common stocks are reported directly in unassigned surplus and do not affect operations. The gross unrealized gains and losses on, and the cost and fair values of, those investments are summarized as follows:

 

     Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Fair
Value
 
  

 

 

 
     (in millions)  

December 31, 2014:

           

Preferred stocks:

           

Nonaffiliated

       $ 29       $ 18       $ (1)       $ 46   

Affiliates

     3         -         (3)         -   

Common stocks:

           

Nonaffiliated

     420         71         (14)         477   

Affiliates*

     971         1,947         (7)         2,911   
  

 

 

 

Total stocks

       $   1,423       $   2,036       $   (25)       $   3,434   
  

 

 

 
     Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Fair
Value
 
  

 

 

 
     (in millions)  

December 31, 2013:

           

Preferred stocks:

           

Nonaffiliated

       $ 35       $ 17       $ (2)       $ 50   

Affiliates

     3         -         (3)         -   

Common stocks:

           

Nonaffiliated

     290         60         (7)         343   

Affiliates*

     952         1,922         (8)         2,866   
  

 

 

 

Total stocks

     $ 1,280       $   1,999       $   (20)       $   3,259   
  

 

 

 
* Affiliates — fair value represents the carrying value

At December 31, 2014 and 2013, there were 134 and 110 nonaffiliated equity securities that had a gross unrealized loss excluding securities that have been written down to zero. The single largest unrealized loss was $3 million and $3 million at December 31, 2014 and 2013, respectively. The Company anticipates that these equity securities will recover in value in the near term.

The Company has a process in place to identify equity securities that could potentially have an impairment that is other-than-temporary. The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer; and (3) the Company’s ability and intent to hold the security until it recovers. To the extent the Company determines that a security is deemed to be other-than-temporarily impaired, the difference between book value and fair value would be charged to income.

For the years ended December 31, 2014, 2013 and 2012, realized capital losses include $2 million, $5 million, $5 million and related to preferred and common stocks that have experienced an other-than-temporary decline in value and were comprised of 33, 69, and 124 securities, respectively. These are primarily made up of impairments on public and private common stocks.

 

F-22


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

Mortgage Loans on Real Estate

At December 31, 2014 and 2013, the mortgage loan portfolio was diversified by geographic region and specific collateral property type as displayed below. The Company controls credit risk through credit approvals, limits, and monitoring procedures.

 

December 31, 2014:                     
Property Type    Carrying
Value
      

Geographic

Concentration

   Carrying
Value
 

 

      

 

 
     (in millions)             (in millions)  

Apartments

       $ 2,136         East North Central        $   1,394   

Industrial

     920         East South Central      83   

Office buildings

     3,347         Middle Atlantic      1,997   

Retail

     3,209         Mountain      511   

Agricultural

     405         New England      682   

Agribusiness

     516         Pacific      3,310   

Mixed use

     22         South Atlantic      2,459   

Other

     974         West North Central      468   

Allowance

     (10)         West South Central      533   
        Canada / Other      92   
        Allowance      (10)   
  

 

 

         

 

 

 

Total mortgage loans on real estate

       $   11,519         Total mortgage loans on real estate        $   11,519   
  

 

 

         

 

 

 

 

December 31, 2013:                     
Property Type    Carrying
Value
      

Geographic

Concentration

   Carrying
Value
 

 

      

 

 
     (in millions)             (in millions)  

Apartments

       $ 2,001         East North Central        $ 1,396   

Industrial

     997         East South Central      142   

Office buildings

     3,914         Middle Atlantic      2,148   

Retail

     3,261         Mountain      530   

Agricultural

     441         New England      844   

Agribusiness

     666         Pacific      3,704   

Mixed use

     21         South Atlantic      2,422   

Other

     930         West North Central      391   

Allowance

     (10      West South Central      553   
        Canada / Other      101   
        Allowance      (10
  

 

 

         

 

 

 

Total mortgage loans on real estate

       $   12,221         Total mortgage loans on real estate        $   12,221   
  

 

 

         

 

 

 

The aggregate mortgages outstanding to any one borrower do not exceed $240 million.

During 2014, the respective maximum and minimum lending rates for mortgage loans issued were 4.64% and 2.18% for agricultural loans and 5.40% and 3.62% for commercial loans. The Company issued no purchase money mortgages in 2014 and 2013. At the issuance of a loan, the percentage of any one loan to value of security, exclusive of insured, guaranteed, or purchase money mortgages does not exceed 75%. Impaired mortgage loans without an allowance for credit losses were $0 million, $0 million, and $0 million at December 31, 2014, 2013 and 2012, respectively. The average recorded investment in impaired loans was $41 million, $60 million, and $90 million at December 31, 2014, 2013 and 2012, respectively. The Company recognized $3 million, $0 million, and $5 million of interest income during the period the loans were impaired for the years ended December 31, 2014, 2013 and 2012, respectively.

 

F-23


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

Generally, the terms of the restructured mortgage loans call for the Company to receive some form or combination of an equity participation in the underlying collateral, excess cash flows or an effective yield at the maturity of the loans sufficient to meet the original terms of the loans. There are no contractual commitments made to extend credit to debtors owning receivables whose terms have been modified in troubled debt restructurings. The Company accrues interest income on impaired loans to the extent deemed collectible and the loan continues to perform under its original or restructured contractual terms. Interest income on non-performing loans generally is recognized on a cash basis.

The following table provides a reconciliation of the beginning and ending balances for allowance for losses for the periods indicated.

 

     2014     2013     2012  
  

 

 

 
     (in millions)  

Balance at beginning of year

       $ 10      $ 19      $ 36   

Additions, net

     10        13        20   

Recoveries of amounts previously charged off

       (10       (22       (37
  

 

 

 

Balance at end of year

       $ 10      $ 10      $ 19   
  

 

 

 

For mortgage loans, the Company evaluates credit quality through regular monitoring of credit related exposures, considering both qualitative and quantitative factors in assigning an internal risk rating (“IRR”). These ratings are updated at least annually.

The carrying value of mortgage loans by IRR was as follows:

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions)  

AAA

       $ 436       $ 357   

AA

     1,594         1,470   

A

     4,141         3,965   

BBB

     4,979         5,896   

BB

     267         403   

B and lower and unrated

     102         130   
  

 

 

 

Total

       $   11,519       $ 12,221   
  

 

 

 

Real Estate

The composition of the Company’s investment in real estate is summarized as follows:

 

     December 31,  
     2014     2013  
  

 

 

 
     (in millions)  

Properties occupied by the company

       $ 374            $      372   

Properties held for the production of income

     5,764        5,658   

Properties held for sale

     -        185   

Less accumulated depreciation

     (635     (606
  

 

 

 

Total

       $   5,503            $   5,609   
  

 

 

 

The Company recorded $0 million, $0 million, and $3 million of impairments on real estate investments during the years ended December 31, 2014, 2013 and 2012, respectively.

 

F-24


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

In 2014, JHUSA acquired real estate from an affiliate, JHNY. The real estate had a book value of approximately $32 million and was recorded at fair value of approximately $33 million at the date of the transaction.

On December 12, 2014, the Company announced it entered into an arrangement with Allianz to co-invest up to $1 billion in the U.S. real estate market. As part of this arrangement, the Company sold 100% of certain real estate holding to an unaffiliated joint venture limited partnership (“LP”) in return for cash and a 20% equity interest in the LP. These properties have a book value of $343 million and fair value of $545 million, which resulted in a gain to operations of $161 million (after 20% deferral of realized gain). Going forward, the Company will provide the LP with property management services and through a wholly-owned subsidiary will provide the LP with asset management services.

Other Invested Assets

The Company had no investments in partnerships or LLCs that exceed 10% of its admitted assets at December 31, 2014 and 2013.

Other invested assets primarily consist of investments in partnerships and LLCs. The Company recorded $3 million, $0 million, and $3 million of impairments on partnerships and limited liability companies during the years ended December 31, 2014, 2013 and 2012, respectively. A periodic review of projected discounted cash flows was performed and the analysis provided evidence of the resulting impairments.

Other

The subprime lending sector, also referred to as B-paper, near-prime, or second chance lending, is the sector of the mortgage lending industry which lends to borrowers who do not qualify for prime market interest rates because of poor or insufficient credit history.

For purposes of this disclosure, subprime exposure is defined as the potential for financial loss through direct investment, indirect investment, or underwriting risk associated with risk from the subprime lending sector. For purposes of this note, subprime exposure is not limited solely to the risk associated with holding direct mortgage loans, but also includes any indirect risk through investments in asset-backed or structured securities, hedge funds, common stock, subsidiaries and affiliates, and insurance product issuance.

Although it can be difficult to determine the indirect risk exposures, it should be noted that not only does it include expected losses, it also includes the potential for losses that could occur due to significantly depressed fair value of the related assets in an illiquid market.

The Company had no direct exposure through investments in subprime mortgage loans as of December 31, 2014 or 2013.

Management considers several factors when classifying a structured finance or residential mortgage-backed security holding as “subprime” or placing a security in the highest risk category. These factors include the transaction’s weighted average FICO or credit score, loan-to-value ratio (LTV), geographic composition, lien position, loan purpose, and loan documentation.

The Company has entered into certain repurchase agreements with an aggregate carrying value of $0 million and $0 million as of December 31, 2014 and 2013, respectively. For such agreements, the Company agrees to a specified term, price, and interest rate through the date of the repurchase.

The Company’s practice is to require a minimum of 102% of the fair value of securities loaned under securities lending agreements to be maintained as non-cash collateral. Positions are marked to market and adjusted on a daily basis to ensure the 102% margin requirement is maintained. Any cash collateral received is not re-invested nor is a rebate paid to the lending counterparty. There were no securities on loan as of December 31, 2014 and 2013.

 

F-25


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

5. Investments - (continued)

 

Net Investment Income and Net Realized and Other Gains (Losses)

Major categories of the Company’s net investment income are summarized as follows:

 

     Years Ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Income:

      

Bonds

       $ 2,378          $ 2,577          $ 2,406   

Preferred stocks

     2        -        -   

Common stocks

     76        4        4   

Mortgage loans on real estate

     738        730        776   

Real estate

     669        605        537   

Policy loans

     287        283        290   

Cash, cash equivalents and short-term investments

     7        5        6   

Other invested assets

     464        620        548   

Derivatives

     452        464        346   

Other income

     23        25        23   
  

 

 

 

Total investment income

     5,096        5,313        4,936   

Expenses

      

Investment expenses

     (516     (493     (472

Investment taxes, licenses and fees, excluding federal income taxes

     (85     (83     (68

Investment interest expense

     (91     (97     (103

Depreciation on real estate and other invested assets

     (107     (89     (72
  

 

 

 

Total investment expenses

     (799     (762     (715
  

 

 

 

Net investment income

       $   4,297          $   4,551          $   4,221   
  

 

 

 
Realized capital losses and amounts transferred to the IMR are as follows:              
     Years Ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Realized capital gains (losses)

       $   431          $   (1,701       $   (591

Less amount transferred to the IMR (net of related tax benefit (expense) of $(66) in 2014, $(8) in 2013, and $334 in 2012)

     123        (16     621   
  

 

 

 

Realized capital gains (losses) before tax

     308        (1,685     (1,212

Less federal income taxes on realized capital gains (losses) before effect of transfer to the IMR

     382        108        354   
  

 

 

 

Net realized capital gains (losses)

       $ (74       $ (1,793       $   (1,566
  

 

 

 

6. Derivatives

Derivatives are financial contracts, the value of which is derived from underlying interest rates, foreign exchange rates, credit, equity price movements, indices or other market risks arising from on-balance sheet financial instruments and selected anticipated transactions. The Company uses derivatives including swaps, forward and futures agreements, floors, and options to manage current and anticipated exposures to changes in interest rates, foreign exchange rates, credit and equity market prices.

 

F-26


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

Over-the-counter (“OTC”) swaps are contractual agreements between the Company and a counterparty to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency. Cross currency swaps involve the exchange of principal amounts between parties as well as the exchange of interest payments in one currency for the receipt of interest payments in another currency. Total return swaps are contracts that involve the exchange of payments based on changes in the values of a reference asset, including any returns such as interest earned on these assets, in return for amounts based on reference rates specified in the contract.

Cleared interest rate swaps are contractual agreements between the Company and a counterparty whereby the transaction must be cleared through a central clearing house, and subject to mandatory margin and reporting requirements.

Forward and futures agreements are contractual obligations to buy or sell a financial instrument or foreign currency on a predetermined future date at a specified price. Forward contracts are OTC contracts negotiated between counterparties, whereas futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.

Interest rate floors are contracts with counterparties which require payment of a premium for the right to receive payments when the market interest rate on specified future dates falls below the agreed upon strike price. Interest rate treasury lock contracts are customized agreements securing current interest rates on Treasury securities for payment on a future date.

Options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) a security, exchange rate, interest rate, or other financial instrument at a predetermined price/rate within a specified time.

Types of Derivatives and Derivative Strategies

Interest Rate Contracts. The Company uses interest rate futures contracts, OTC interest rate swap agreements, cleared interest rate swap agreements, pre-payable interest rate swap agreements, and interest rate treasury locks as part of its overall strategies of managing the duration of assets and liabilities or the average life of certain asset portfolios to specified targets. Interest rate swap agreements are contracts with counterparties to exchange interest rate payments of a differing character (i.e., fixed-rate payments exchanged for variable-rate payments) based on an underlying principal balance (notional principal). The net differential to be paid or received on interest rate swap agreements is accrued and recognized as a component of net investment income.

The Company uses interest rate swap agreements in effective hedge accounting relationships. These derivatives hedge the variable cash flows associated with future fixed income asset acquisitions, which will support the Company’s long-term care and life insurance businesses. These agreements will reduce the impact of future interest rate changes on the cost of acquiring adequate assets to support the investment income assumptions used in pricing these products.

The Company also uses interest rate swap agreements in effective hedge accounting relationships designed to hedge the variable cash flows associated with payments that it will receive on certain floating rate bonds.

In addition, the Company uses interest rate swap agreements in effective hedge accounting relationships to hedge the risk of changes in fair value of fixed rate assets and liabilities arising from changes in benchmark interest rates.

The Company also enters into basis swaps to better match the cash flows from assets and related liabilities. Basis swaps are included in interest rate swaps for disclosure purposes. The Company utilizes basis swaps in other hedging relationships.

Inflation swaps are used to reduce inflation risk generated from inflation-indexed liabilities. Inflation swaps are classified within interest rate swaps for disclosure purposes. The Company utilizes inflation swaps in effective hedge accounting relationships and other hedging relationships.

The Company uses exchange-traded interest rate futures primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating U.S. Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in other hedging relationships.

 

F-27


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

The Company also purchases interest rate floors primarily to protect against interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate floors in other hedging relationships.

Foreign Currency Contracts. Foreign currency derivatives, including foreign currency swaps, foreign currency forwards, and foreign currency futures are used by the Company to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies.

Cross currency rate swap agreements are used to manage the Company’s exposure to foreign exchange rate fluctuations, interest rate fluctuations, or both, on foreign currency financial instruments. Cross currency rate swap agreements are contracts to exchange the currencies of two different countries at the same rate of exchange at specified future dates. The net differential to be paid or received on cross currency rate swap agreements is accrued and recognized as a component of net investment income.

Under foreign currency forwards, the Company agrees with other parties to deliver a specified amount of an identified currency at a specified future date. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. The maturities of these forwards correspond with the future periods in which the foreign currency transactions are expected to occur. The Company utilizes currency forwards in effective hedge accounting relationships and other hedging relationships.

Foreign currency futures are contractual obligations to buy or sell a foreign currency on a predetermined future date at a specified price. These contracts are standardized contracts traded on an exchange. The Company utilizes foreign exchange futures in other hedging relationships.

Equity Market Contracts. Total return swaps are contracts that involve the exchange of payments based on changes in the value of a reference asset, including any returns such as interest earned on these assets, in exchange for amounts based on reference rates specified in the contract. The Company utilizes total return swaps in effective hedge accounting relationships and other hedging relationships.

Equity index options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) an underlying equity market index on or before a specified future date at a specified price. The Company utilizes equity index options that are exchange-traded in other hedging relationships.

Equity index futures contracts are contractual obligations to buy or sell a specified amount of an underlying equity index at an agreed contract price on a specified date. Equity index futures are contracts with standard amounts and settlement dates that are traded on regulated exchanges. The Company utilizes equity index futures in other hedging relationships.

Credit Contracts. The Company manages credit risk through the issuance of credit default swaps (“CDS”). A CDS is a derivative instrument representing an agreement between two parties to exchange the credit risk of a single specified entity or an index based on the credit risk of a group of entities (all commonly referred to as the “reference entity” or a portfolio of “reference entities”), in return for a periodic premium. CDS contracts typically have a five-year term.

Replication Synthetic Assets. Replication synthetic asset transactions (“RSATs”) are derivative transactions made in combination with a cash instrument in order to reproduce the investment characteristic of an otherwise permissible investment. The Company uses interest rate swaps and credit default swaps in these transactions when direct investments are either too expensive to acquire or otherwise unavailable in the market. Such derivatives can only be RSATs and not hedging vehicles.

 

F-28


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

The table below provides a summary of the gross notional amount and fair value of derivatives contracts for all derivatives in effective hedge accounting relationships, other hedging relationships, and RSATs:

 

          December 31, 2014  
          Notional
Amount
     Carrying
Value Assets
     Carrying
Value
Liabilities
    

Fair

Value

Assets

    

Fair

Value
Liabilities

 
     

 

 

 
          (in millions)  

Effective Hedge Accounting Relationships

  

           

Fair value hedges

  

Interest rate swaps

       $ 5,461           $ -           $ 1           $ 496           $ 641   
  

Foreign currency swaps

     169         1         29         -         62   

Cash flow hedges

  

Interest rate swaps

     12,053         -         -         1,543         263   
  

Foreign currency swaps

     1,640         29         15         266         261   
  

Foreign currency forwards

     102         -         -         -         4   
  

Equity total return swaps

     27         -         -         6         -   
     

 

 

 

Total Derivatives in Effective Hedge Accounting Relationships

       $ 19,452           $ 30           $ 45           $ 2,311           $ 1,231   
     

 

 

 

Other Hedging Relationships

              
  

Interest rate swaps

       $ 128,704           $ 9,059           $ 5,154           $ 9,059           $ 5,154   
  

Interest rate treasury locks

     6,323         938         -         938         -   
  

Interest rate options

     3,362         93         -         93         -   
  

Interest rate futures

     3,697         -         -         -         -   
  

Foreign currency swaps

     978         43         30         43         30   
  

Foreign currency forwards

     43         4         -         4         -   
  

Foreign currency futures

     1,775         -         -         -         -   
  

Equity total return swaps

     31         11         -         11         -   
  

Equity options

     3,940         277         -         277         -   
  

Equity index futures

     8,323         -         -         -         -   
  

Credit default swaps

     -         -         -         -         -   
     

 

 

 

Total Derivatives in Other Hedging Relationships

       $ 157,176           $ 10,425           $ 5,184           $ 10,425           $ 5,184   
     

 

 

 

Replication Synthetic Asset Transactions

              
  

Interest rate swaps

       $ 1,040           $ -           $ -           $ 61           $ -   
  

Credit default swaps

     315         3         -         6         -   
     

 

 

 

Total Derivatives in Replication Synthetic Asset Transactions

       $ 1,355           $ 3           $ -           $ 67           $ -   
     

 

 

 

Total Derivatives

       $   177,983           $   10,458           $   5,229           $   12,803           $   6,415   
     

 

 

 

 

F-29


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

          December 31, 2013  
          Notional
Amount
     Carrying
Value
Assets
     Carrying
Value
Liabilities
     Fair Value
Assets
     Fair Value
Liabilities
 
     

 

 

 
          (in millions)  

Effective Hedge Accounting Relationships

  

           

Fair value hedges

  

Interest rate swaps

       $ 7,847           $ -           $ 1           $ 416           $ 528   
  

Foreign currency swaps

     184         -         49         -         85   

Cash flow hedges

  

Interest rate swaps

     14,439         -         -         910         670   
  

Foreign currency swaps

     1,666         51         93         52         121   
  

Foreign currency forwards

     125         -         -         -         1   
  

Equity total return swaps

     29         -         -         15         -   
     

 

 

 

Total Derivatives in Effective Hedge Accounting Relationships

       $ 24,290           $ 51           $ 143           $ 1,393           $ 1,405   
     

 

 

 

Other Hedging Relationships

              
  

Interest rate swaps

       $ 106,050           $ 5,299           $ 3,436           $ 5,299           $ 3,436   
  

Interest rate treasury locks

     5,425         -         385         -         385   
  

Interest rate options

     2,683         21         -         21         -   
  

Interest rate futures

     2,687         -         -         -         -   
  

Foreign currency swaps

     1,274         65         82         65         82   
  

Foreign currency forwards

     11         -         -         -         -   
  

Foreign currency futures

     968         -         -         -         -   
  

Equity total return swaps

     31         21         -         21         -   
  

Equity options

     3,228         248         -         248         -   
  

Equity index futures

     4,465         -         -         -         -   
  

Credit default swaps

     -         -         -         -         -   
     

 

 

 

Total Derivatives in Other Hedging Relationships

       $ 126,822           $ 5,654           $ 3,903           $ 5,654           $ 3,903   
     

 

 

 

Replication Synthetic Asset Transactions

              
  

Interest rate swaps

       $ -           $ -           $ -           $ -           $ -   
  

Credit default swaps

     315         4         -         8         -   
     

 

 

 

Total Derivatives in Replication Synthetic Asset Transactions

       $ 315           $ 4           $ -           $ 8           $ -   
     

 

 

 

Total Derivatives

       $   151,427           $   5,709           $   4,046           $   7,055           $   5,308   
     

 

 

 

Hedging Relationships

The Company generally does not enter into derivative contracts for speculative purposes. In certain circumstances, these hedges also meet the requirements for hedge accounting and are reported in a manner consistent with the hedged asset or liability. For the years ended December 31, 2014, 2013 and 2012, respectively, the Company recorded unrealized gains of $1,215 million, $168 million, and $750 million, respectively, related to derivatives that no longer qualify for hedge accounting.

Fair Value Hedges. The Company uses interest rate swaps to manage its exposure to changes in fair value of fixed-rate financial instruments caused by changes in interest rates. The Company also uses cross currency swaps and currency forwards to manage its exposure to foreign exchange rate fluctuations and interest rate fluctuations.

Cash Flow Hedges. The Company uses interest rate swaps and interest rate treasury locks to hedge the variability in cash flows from variable rate financial instruments and forecasted transactions. The Company also uses cross currency swaps and forward agreements to hedge currency exposure on foreign currency financial instruments and foreign currency denominated

 

F-30


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

expenses, respectively. Total return swaps are used to hedge the variability in cash flows associated with certain stock-based compensation awards. Inflation swaps are used to reduce inflation risk generated from inflation-indexed liabilities.

In 2012, the Company de-designated $1.6 billion (notional principal) of forward-starting interest rate swaps for the life insurance business. The de-designation of these interest rate swaps resulted in an increase to unassigned surplus of $288 million, net of tax, as of December 31, 2012.

In 2014, the Company concluded that a portion of the hedged transactions for its long-term care business and life insurance business were probable not to occur resulting in the de-designation of $2.7 billion (notional principal) of forward-starting interest rate swaps. The de-designation of these interest rate swaps resulted in an increase to unrealized capital gains (losses) of $445 million, net of tax. In addition as part of our affiliate reinsurance agreement with JHRECO, we were required as part of the net investment income component of the treaty settlement calculation to cede $440 million, net of tax, and therefore the overall impact of this transaction was not material to capital and surplus.

For the year ended December 31, 2014, all of the Company’s hedged forecast transactions qualified as cash flow hedges and no cash flow hedges were discontinued because it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship.

The maximum time frame for which variable cash flows are hedged is 32 years.

Derivatives Not Designated as Hedging Instruments in Effective Hedge Accounting or RSAT Relationships. The Company enters into interest rate swap agreements, cancelable interest rate swap agreements, and interest rate futures contracts to manage interest rate risk, total return swap agreements to manage equity risk, and CDS to manage credit risk. The Company also uses interest rate treasury locks and interest rate floor agreements to manage exposure to interest rates without designating the derivatives as hedging instruments. Interest rate floor agreements hedge the interest rate risk associated with minimum interest rate guarantees in certain life insurance and annuity businesses.

The Company offers certain variable annuity products with a guaranteed minimum withdrawal benefit (“GMWB”) and guaranteed minimum death benefit (“GMDB”). These guarantees are effectively an embedded option on the basket of mutual funds offered to contract holders. The Company manages a hedging program to reduce its exposure to certain contracts with the GMWB and GMDB guarantees. This dynamic hedging program uses interest rate swap agreements, equity index futures (including but not limited to the Dow Jones Industrial, Standard & Poor’s 500, Russell 2000, and Dow Jones Euro Stoxx 50 indices), equity index options, and U.S. Treasury futures to match the sensitivities of the GMWB and GMDB liabilities to the market risk factors.

The Company also has a macro equity risk hedging program using equity and currency futures, as well as equity index options. This program is designed to reduce the Company’s overall exposure to public equity markets arising from several sources including, but not limited to, variable annuity guarantees not dynamically hedged, separate account fees not associated with guarantees, and Company equity holdings.

The Company uses foreign currency swaps and foreign currency forwards to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies.

 

F-31


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

For the years ended December 31, 2014, 2013 and 2012 net gains and losses related to derivatives in other hedging relationships were recognized by the Company, and the components were recorded in net unrealized and net realized gains (losses) as follows:

 

     Years ended December 31,  
     2014     2013      2012  
  

 

 

 
     (in millions)  

Other Hedging Relationships

       

Net unrealized capital gain (loss):

       

Interest rate swaps

       $   2,043      $   (2,530)       $ 512   

Interest rate treasury locks

     1,323        (385)         -   

Interest rate options

     67        (46)         (8)   

Foreign currency swaps

     (5     (9)         (12)   

Foreign currency forwards

     4        (1)         2   

Equity total return swaps

     -        -         -   

Equity options

     (23     (39)         -   

Credit default swaps

     -        -         1   
  

 

 

 

Total net unrealized capital gain (loss)

       $ 3,409      $ (3,010)       $ 495   
  

 

 

 

Net realized capital gain (loss):

       

Interest rate swaps

       $ (178   $ 164        $ 157   

Interest rate treasury locks

     157        -         -   

Interest rate options

     -        -         -   

Interest rate futures

     (141     78          (48)   

Foreign currency swaps

     18        (10)         (8)   

Foreign currency forwards

     1                (12)   

Foreign currency futures

     165        74          -   

Equity total return swaps

     24                (4)   

Equity options

     5                -   

Equity index futures

     (692     (1,892)         (1,474)   

Credit default swaps

     -        -         (2)   

Commodity futures

     -        -         -   
  

 

 

 

Total net realized capital gain (loss)

       $ (641   $ (1,573)       $   (1,391)   
  

 

 

 

Total gain (loss) from derivatives in other hedging relationships

       $ 2,768      $ (4,583)       $ (896)   
  

 

 

 

The Company also deferred net realized gains (losses) of ($192) million, $146 million, and $156 million (including ($174) million of losses, $148 million, and $157 million of gains for derivatives in other hedging relationships, respectively) related to interest rates for the years ended December 31, 2014, 2013 and 2012, respectively. Deferred net realized gains and losses are reported in IMR and amortized over the remaining period to expiration date.

Credit Default Swaps

The Company replicates exposure to specific issuers by selling credit protection via CDS in order to complement its cash bond investing. The Company does not employ leverage in its CDS program and therefore, does not write CDS protection in excess of its government bond holdings.

 

F-32


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

The following table provides details of the CDS protection sold by type of contract and external agency rating for the underlying reference security, as of December 31, 2014 and 2013, respectively.

 

     December 31, 2014      December 31, 2013  
  

 

 

    

 

 

 
     Notional
Amount2
     Fair
Value
    

Weighted

average

maturity

(in years)3

     Notional
Amount2
     Fair
Value
    

Weighted

average

maturity

(in years)3

 
  

 

 

    

 

 

 
     (in millions)  

Single name CDS1

                 

Corporate debt

                 

AAA

       $ 35       $ 1         2           $ 35       $ 1         3   

AA

     95         2         2         95         3         3   

A

     185         3         2         185         4         3   

BBB

     -         -            -         -         -   
  

 

 

       

 

 

    

Total CDS protection sold

       $   315       $ 6              $   315       $   8      
  

 

 

       

 

 

    
1 

The rating agency designations are based on S&P where available followed by Moody’s, Dominion Bond Rating Services (DBRS), and Fitch. If no rating is available from a rating agency, then an internally developed rating is used.

2 

Notional amount represents the maximum future payments the Company would have to pay its counterparties assuming a default of the underlying credit and zero recovery on the underlying issuer obligation.

3 

The weighted average maturity of the CDS is weighted based on notional amounts.

The Company holds no purchased credit protection at December 31, 2014 and 2013. The average credit rating of the counterparties guaranteeing the underlying credits is A+ and the weighted average maturity is 3 years.

Credit Risk

The Company’s exposure to loss on derivatives is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in negative positions and the impact of collateral on hand. The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to the derivative financial instruments. The current credit exposure of the Company’s derivative contracts is limited to the fair value in excess of the collateral held at the reporting date.

The Company manages its credit risk by entering into transactions with creditworthy counterparties, obtaining collateral where appropriate, and entering into master netting agreements that provide for a netting of payments and receipts with a single counterparty. The Company enters into credit support annexes with its OTC derivative dealers in order to manage its credit exposure to those counterparties. As part of the terms and conditions of those agreements, the pledging and accepting of collateral in connection with the Company’s derivative usage is required. As of December 31, 2014 and 2013, the Company accepted collateral consisting of cash of $2,939 million and $640 million, and various securities with a fair value of $3,895 million and $2,155 million, respectively, which is held in separate custodial accounts. In addition, the Company has pledged collateral to support both the OTC derivative instruments, exchange traded futures and cleared interest rate swap transactions. For further details regarding pledged collateral see the Investments Note.

Under U.S. regulations, certain interest rate swap agreements and credit default swap agreements are required to be cleared through central clearing houses. These transactions are contractual agreements that require initial and variation margin collateral postings and are settled on a daily basis through a clearing house. As such, they reduce the credit risk exposure in the event of default by a counterparty.

 

F-33


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

6. Derivatives - (continued)

 

Transactions with Affiliates

The Company has entered into two currency swap agreements with JHFC which are recorded at fair value. JHFC utilizes the currency swaps to hedge currency exposure on foreign currency financial instruments. The Company has also entered into two currency agreements with external counterparties which offset the currency swap agreements with JHFC. As of December 31, 2014 and 2013, the currency swap agreements with JHFC and the external counterparties had offsetting fair values of $238 million and $19 million, respectively.

7. Fair Value

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

 

   

Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition — This category includes assets and liabilities measured at fair value. Financial instruments in this category include bonds and preferred stocks carried at the lower of cost or fair value due to their SVO quality rating, common stocks, derivatives, and separate account assets.

 

   

Other Financial Instruments Not Reported at Fair Value After Initial Recognition — This category includes assets and liabilities which do not require the additional disclosures as follows:

Bonds — For bonds, including corporate debt, U.S. Treasury, commercial and residential mortgage-backed securities, asset-backed securities, collateralized debt obligations, issuances by foreign governments, and obligations of state and political subdivisions, fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). The significant inputs into these models include, but are not limited to, yield curves, credit risks and spreads, measures of volatility, and prepayment speeds.

Mortgage Loans on Real Estate — The fair value of unimpaired mortgage loans is estimated using discounted cash flows and takes into account the contractual maturities and discount rates, which were based on current market rates for similar maturity ranges and adjusted for risk due to the property type. The fair value of impaired mortgage loans is based on the net of the collateral less estimated cost to obtain and sell.

Cash, Cash Equivalents and Short-Term Investments — The carrying values for cash, cash equivalents, and short-term investments approximate their fair value due to the short-term maturities of these instruments.

Policy Loans — These loans are carried at unpaid principal balances, which approximate their fair values.

Policy Reserves — Policy reserves consists of guaranteed investment contracts. The fair values associated with these financial instruments are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC’s corporate spread. The fair value attributable to credit risk represents the present value of the spread.

Policyholders’ and Beneficiaries Funds — Includes term certain contracts, funding agreements, supplementary contracts without life contingencies and those balances that can be withdrawn by the policyholder at any time without prior notice or penalty. The fair values associated with the term certain contracts, funding agreements and supplementary contracts without life contingencies are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC’s corporate spread. The fair value attributable to credit risk represents the present value of the spread. For those balances that can be withdrawn by the policyholder at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the policyholder as of the reporting date, which is generally the carrying value.

Consumer Notes — The fair value of consumer notes is determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC’s corporate spread. The fair value attributable to credit risk represents the present value of the spread.

 

F-34


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition

Valuation Hierarchy

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

 

   

Level 1 — Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Active markets are defined as having the following characteristics for the measured asset/liability; (i) many transactions, (ii) current prices, (iii) price quotes not varying substantially among market makers, (iv) narrow bid/ask spreads, and (v) most information is publicly available. Valuations are based on quoted prices reflecting market transactions involving assets or liabilities identical to those being measured. Level 1 assets primarily include exchange traded equity securities and certain separate account assets.

 

   

Level 2 — Fair value measurements using inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.), and inputs that are derived from or corroborated by observable market data. Certain of the Company’s separate account assets and derivative assets and liabilities are included within Level 2. A description of valuation techniques used to measure the fair value of derivatives is described below.

 

   

Level 3 — Fair value measurements using significant nonmarket observable inputs. These include valuations for assets and liabilities that are derived using data, some or all of which is not market observable data, including assumptions about risk. Level 3 securities include impaired bonds and less liquid securities, such as structured asset-backed securities, commercial mortgage-backed securities, and other securities that have little or no price transparency. The valuation techniques used to measure the fair value of derivative assets and separate account investments in timber and agriculture are included in Level 3 as described below.

Determination of Fair Value

The fair value of an asset is the amount at which that asset could be bought or sold in a current transaction between willing parties that is other than in a forced or liquidation sale. The fair value of a liability is the amount at which that liability could be incurred or settled in a current transaction between willing parties that is other than in a forced or liquidation sale.

Fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). In instances where there is little or no market activity for the same or similar instruments, the Company estimates fair value using methods, models and assumptions that management believes market participants would use to determine a current transaction price. These valuation techniques involve some level of management estimation and judgment which becomes significant with increasingly complex instruments or pricing models. Where appropriate, adjustments are included to reflect the risk inherent in a particular methodology, model or input used.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

Bonds

Refer to the previous page for the determination of fair value of bonds. Generally, impaired bonds with a NAIC designation rating of 6 whose cost is greater than its fair value are reported at fair value and are classified within Level 3.

Preferred Stocks

Preferred stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Preferred stocks not traded in active markets are classified within Level 3.

 

F-35


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

Common Stocks

Common stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Common stocks not traded in active markets are classified within Level 3.

Derivatives

The fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC derivatives. The pricing models used are based on market standard valuation methodologies, and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, currency exchange rates, financial indices, credit spreads, default risk (including the counterparties to the contract), and volatility. The Company’s derivatives are generally classified within Level 2 given the significant inputs to the pricing models for most OTC derivatives are observable or can be corroborated by observable market data. Inputs that are observable generally include interest rates, foreign currency exchange rates, and interest rate curves; however, certain OTC derivatives may rely on inputs that are significant to the fair value, but are unobservable in the market or cannot be derived principally from or corroborated by observable market data and would be classified within Level 3. Inputs that are unobservable generally include broker quotes, volatilities, and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation.

Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all OTC derivatives after taking into account the effects of netting agreements and collateral arrangements.

Separate Account Assets and Liabilities

For separate accounts structured as a non-unitized fund, the fair value of separate account assets is based on the fair value of the underlying assets owned by the separate account. For separate accounts structured as a unitized fund, the fair value of the separate account assets is based on the fair value of the underlying funds owned by the separate account. Assets owned by the Company’s separate accounts primarily include: investments in mutual funds, bonds, common stock, short-term investments, real estate, and cash and cash equivalents. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose interest in the separate account assets is recorded by the Company as separate account liabilities. Separate account liabilities are set equal to the fair value of separate account assets.

The fair value of fund investments is based upon quoted market prices or reported net asset value (“NAV”). Fund investments that are traded in an active market and have a NAV that the Company can access at the measurement date are classified within Level 1. Level 2 assets consist primarily of bonds which are valued using matrix pricing with independent pricing data.

Separate account assets classified as Level 3 consist primarily of fixed maturity and equity investments in private companies, which own timber and agriculture and carry them at fair value. The values of the timber and agriculture investments are estimated using generally accepted valuation techniques. A comprehensive appraisal is performed shortly after initial purchase and at two or three-year intervals thereafter. Appraisal updates are conducted according to client contracts, generally at one-year or six-month intervals. In the quarters in which an investment is not independently appraised or its valuation updated, the market value is reviewed by management. The valuation of an investment is adjusted only if there has been a significant change in economic circumstances related to the investment since acquisition or the most recent independent valuation and upon the independent appraiser’s review and concurrence with management. Further, these valuations are prepared giving consideration to the income, cost, and sales comparison approaches of estimating asset value. The significant unobservable inputs used in the fair value measurement of the Company’s timberland investments are harvest volumes, timber prices, operating costs and discount rates. Significant changes to any one of these inputs in isolation could result in a significant change to fair value measurement. Holding other factors constant, an increase to either harvest volumes or timber prices would tend to increase the fair value of a timberland investment, while an increase in operating costs or discount rate would have the opposite effect. These investments are classified as Level 3 by the companies owning them, and therefore the equity investments in these companies are considered to be Level 3 by the Company.

 

F-36


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

The following table presents the Company’s assets and liabilities that are measured and reported at fair value in the Balance Sheets after initial recognition by fair value hierarchy level:

 

     December 31, 2014  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Bond with NAIC 6 rating:

              

Industrial and misc

       $ -       $ -       $ -       $ -       $ -   

Loan-backed and structured securities

     39         39         -         18         21   
  

 

 

 

Total bonds with NAIC 6 rating

     39         39         -         18         21   

Preferred stocks:

              

Industrial and misc

     -         -         -         -         -   
  

 

 

 

Total preferred stocks

     -         -         -         -         -   

Common stocks:

              

Industrial and misc

     477         477         379         -         98   
  

 

 

 

Total common stocks

     477         477         379         -         98   

Derivatives:

              

Interest rate swaps

     9,059         9,059         -         9,058         1   

Interest rate treasury locks

     938         938         -         168         770   

Interest rate options

     93         93         -         -         93   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     43         43         -         43         -   

Foreign currency forwards

     4         4         -         4         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     11         11         -         -         11   

Equity options

     277         277         -         61         216   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   
  

 

 

 

Total derivatives

     10,425         10,425         -         9,334         1,091   

Assets held in separate accounts

     140,164         140,164         134,070         3,756         2,338   
  

 

 

 

Total assets

       $   151,105       $   151,105       $   134,449       $   13,108       $   3,548   
  

 

 

 

Liabilities:

              

Derivatives:

              

Interest rate swaps

       $ 5,154       $ 5,154       $ -       $ 5,113       $ 41   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     30         30         -         30         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   
  

 

 

 

Total derivatives

     5,184         5,184         -         5,143         41   

Liabilities held in separate accounts

     140,164         140,164         134,070         3,756         2,338   
  

 

 

 

Total liabilities

       $ 145,348       $ 145,348       $ 134,070       $ 8,899       $ 2,379   
  

 

 

 

 

F-37


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

 

     December 31, 2013  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Bond with NAIC 6 rating:

              

Industrial and misc

       $ 26       $ 26       $ -       $ -       $ 26   

Loan-backed and structured securities

     34         34         -         -         34   
  

 

 

 

Total bonds with NAIC 6 rating

     60         60         -         -         60   

Preferred stocks:

              

Industrial and misc

     -         -         -         -         -   
  

 

 

 

Total preferred stocks

     -         -         -         -         -   

Common stocks:

              

Industrial and misc

     343         343         257         -         86   
  

 

 

 

Total common stocks

     343         343         257         -         86   

Derivatives:

              

Interest rate swaps

     5,299         5,299         -         5,292         7   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     21         21         -         -         21   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     65         65         -         65         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     21         21         -         -         21   

Equity options

     248         248         -         26         222   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   
  

 

 

 

Total derivatives

     5,654         5,654         -         5,383         271   

Assets held in separate accounts

     142,766         142,766         136,707         3,838         2,221   
  

 

 

 

Total assets

       $ 148,823       $ 148,823       $ 136,964       $ 9,221       $ 2,638   
  

 

 

 

Liabilities:

              

Derivatives:

              

Interest rate swaps

       $ 3,436       $ 3,436       $ -       $ 3,436       $ -   

Interest rate treasury locks

     385         385         -         -         385   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     82         82         -         82         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   
  

 

 

 

Total derivatives

     3,903         3,903         -         3,518         385   

Liabilities held in separate accounts

     142,766         142,766         136,707         3,838         2,221   
  

 

 

 

Total liabilities

       $   146,669       $   146,669       $   136,707       $   7,356       $   2,606   
  

 

 

 

 

F-38


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

The table below presents the carrying amounts and fair value by fair value hierarchy level for certain assets and liabilities that are not reported at fair value in the Balance Sheets:

 

     December 31, 2014  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Bonds (1)

       $ 49,187       $ 52,644       $ -       $ 48,392       $ 4,252   

Preferred stocks

     26         46         -         -         46   

Mortgage loans on real estate

     11,519         12,785         -         -         12,785   

Cash, cash equivalents and short term investments

     7,702         7,702         4,407         3,295         -   

Policy loans

     5,039         5,039         -         5,039         -   

Derivatives in effective hedge accounting and RSAT relationships

     33         2,378         -         2,372         6   
  

 

 

 

Total assets

       $   73,506       $   80,594       $   4,407       $   59,098       $   17,089   
  

 

 

 

Liabilities:

              

Consumer notes

       $ 411       $ 454       $ -       $ -       $ 454   

Borrowed money

     290         290         -         290         -   

Policy reserves

     1,661         1,648         -         -         1,648   

Policyholders’ and beneficiaries funds

     3,901         4,352         -         1,457         2,895   

Derivatives in effective hedge accounting and RSAT relationships

     45         1,231         -         964         267   
  

 

 

 

Total liabilities

       $ 6,308       $ 7,975       $ -       $ 2,711       $ 5,264   
  

 

 

 
     December 31, 2013  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Bonds (1)

       $ 47,888       $ 47,682       $ -       $ 44,154       $ 3,528   

Preferred stocks

     33         50         -         -         50   

Mortgage loans on real estate

       12,221         13,337         -         -         13,337   

Cash, cash equivalents and short term investments

     4,749         4,749         1,895         2,854         -   

Policy loans

     5,189         5,189         -         5,189         -   

Derivatives in effective hedge accounting and RSAT relationships

     55         1,401         -         1,386         15   
  

 

 

 

Total assets

       $ 70,135       $ 72,408       $ 1,895       $ 53,583       $ 16,930   
  

 

 

 

Liabilities:

              

Consumer notes

       $ 644       $ 685       $ -       $ -       $ 685   

Borrowed money

     290         290         -         290         -   

Policy reserves

     1,740         1,739         -         -         1,739   

Policyholders’ and beneficiaries funds

     3,997         4,227         -         1,263         2,964   

Derivatives in effective hedge accounting and RSAT relationships

     143         1,405         -         1,386         19   
  

 

 

 

Total liabilities

       $ 6,814       $ 8,346       $ -       $ 2,939       $ 5,407   
  

 

 

 
(1) Bonds are carried at amortized cost unless they have NAIC designation rating of 6. Fair value of bonds exclude leveraged leases of $ 2,268 million and $ 2,285 million at December 31, 2014 and 2013, respectively. The Company calculates the carrying value by accruing income at its expected internal rate of return.

 

F-39


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

Transfers of Level 1 and Level 2 Assets and Liabilities

The Company’s policy is to record transfers of assets and liabilities between Level 1 and Level 2 at their fair values as of the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. During the years ended December 31, 2014 and 2013, the Company did not have any transfers from Level 1 to Level 2. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. The Company did not transfer assets from Level 2 to Level 1 during the years ended December 31, 2014 and 2013.

 

F-40


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

Level 3 Financial Instruments

The changes in Level 3 financial instruments measured and reported at fair value for the years ended December 31, 2014, 2013 and 2012, are summarized as follows:

 

          Net
realized/unrealized
gains (losses) included in:
                                  Transfers        
   

Balance at
January 1,

2014

    Net
income (1)
    Surplus     Amounts
credited to
separate
account
liabilities (2)
    Purchases     Issuances     Sales     Settlements     Into
Level 3 (3)
    Out of
Level 3 (3)
    Balance at
December
31, 2014
 
 

 

 

 
    (in millions)  

Bonds with NAIC 6 rating:

                     

Impaired corporate bonds

      $ 26      $ -      $ (3   $ -      $ -      $ -      $ -      $ -      $ -      $ (23   $ -   

Impaired mortgage-backed and asset-backed securities

    34        -        1        -        -        -        -        -        11        (25     21   
 

 

 

 

Total bonds with NAIC 6 rating

    60        -        (2     -        -        -        -        -        11        (48     21   

Preferred stocks:

                     

Industrial and misc

    -        -        -        -        -        -        -        -        -        -        -   
 

 

 

 

Total preferred stocks

    -        -        -        -        -        -        -        -        -        -        -   

Common stocks:

                     

Industrial and misc

    86        -        (1     -        14        -        (1     -        -        -        98   
 

 

 

 

Total common stocks

    86        -        (1     -        14        -        (1     -        -        -        98   

Net derivatives

    (114     26        1,088        -        72        -        (25     -        41        (38     1,050   

Separate account assets/liabilities

    2,221        162        -        -        68        -        (270     -        163        (6     2,338   
 

 

 

 

Total

      $   2,253      $   188      $   1,085      $   -      $   154      $   -      $   (296   $   -      $   215      $   (92   $   3,507   
 

 

 

 

 

F-41


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

 

          Net realized/
unrealized gains
(losses) included in:
                                  Transfers        
   

Balance at
January 1,

2013

    Net
income (1)
    Surplus    

Amounts
credited to
separate
account

liabilities (2)

    Purchases     Issuances     Sales     Settlements    

Into

Level 3 (3)

    Out of
Level 3 (3)
    Balance at
December
31, 2013
 
 

 

 

 
    (in millions)  

Bonds with NAIC 6 rating:

                     

Impaired corporate bonds

      $ 12      $ (2   $ -      $ -      $ -      $ -      $ -      $ -      $ 23      $ (7   $ 26   

Impaired mortgage-backed and asset-backed securities

    53        (37     39        -        -        -        (23     (5     16        (9     34   
 

 

 

 

Total bonds with NAIC 6 rating

    65        (39     39        -        -        -        (23     (5     39        (16     60   

Preferred stocks:

                     

Industrial and misc

    4        -        -        -        -        -        -        -        -        (4     -   
 

 

 

 

Total preferred stocks

    4        -        -        -        -        -        -        -        -        (4     -   

Common stocks:

                     

Industrial and misc

    44        -        (2     -        58        -        (18     -        4        -        86   
 

 

 

 

Total common stocks

    44        -        (2     -        58        -        (18     -        4        -        86   

Net derivatives

    58        6        (459     -        287        -        (7     -        -        1        (114

Separate account assets/liabilities

    2,223        160        -        -        31        -        (195     -        3        (1     2,221   
 

 

 

 

Total

      $   2,394      $   127      $   (422   $   -      $   376      $   -      $   (243   $   (5   $   46      $   (20   $   2,253   
 

 

 

 

 

F-42


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

 

          Net realized/
unrealized gains
(losses) included in:
                                  Transfers        
   

Balance at
January 1,

2012

    Net
income (1)
    Surplus     Amounts
credited to
separate
account
liabilities (2)
    Purchases     Issuances     Sales     Settlements     Into
Level 3 (3)
    Out of
Level 3 (3)
    Balance at
December 31,
2012
 
 

 

 

 
    (in millions)  

Bonds with NAIC 6 rating:

                     

Impaired corporate bonds

      $ 44      $ (4   $ 4      $ -      $ -      $ -      $ -      $ (44   $ 12      $ -      $ 12   

Impaired mortgage-backed and asset-backed securities

    34        (44     45        -        -        -        (6     -        47        (23     53   
 

 

 

 

Total bonds with NAIC 6 rating

    78        (48     49        -        -        -        (6     (44     59        (23     65   

Preferred stocks:

                     

Industrial and misc

    4        -        -        -        -        -        (1     -        1        -        4   
 

 

 

 

Total preferred stocks

    4        -        -        -        -        -        (1     -        1        -        4   

Common stocks:

                     

Industrial and misc

    71        55        (28     -        -        -        (54     -        -        -        44   
 

 

 

 

Total common stocks

    71        55        (28     -        -        -        (54     -        -        -        44   

Net derivatives

    21        (1     (8     -        44        -        -        -        -        2        58   

Separate account assets/liabilities

    2,152        100        -        -        112        -        (141     -        -        -        2,223   
 

 

 

 

Total

      $   2,326      $   106      $   13      $   -      $   156      $   -      $   (202   $   (44   $   60      $   (21   $   2,394   
 

 

 

 
(1) This amount is included in net realized capital gains (losses) on the Statements of Operations.
(2) Changes in the fair value of separate account assets are credited directly to separate account liabilities in accordance with NAIC SAP and are not reflected in income.
(3) For financial instruments that are transferred into and/or out of Level 3, the Company uses the fair value of the instruments at the beginning of the reporting period.

 

F-43


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

7. Fair Value - (continued)

 

The transfers into Level 3 primarily result from securities that were impaired during the year or securities where a lack of observable market data (versus the previous year) resulted in reclassifying instruments into Level 3. The transfers out of Level 3 primarily result from observable market data becoming available for that instrument, thus eliminating the need to extrapolate market data beyond observable points. Additionally, securities carried at fair value at the beginning of the period but carried at amortized cost at the end of the period due to rating change or change in fair value relative to amortized cost, are included in transfers out of Level 3. Conversely, any securities carried at amortized cost at the beginning of the period and carried at fair value at the end of the year due to SVO rating change or change in fair value relative to amortized cost, are included into transfers into Level 3.

8. Reinsurance

Certain premiums and benefits are assumed from or ceded to affiliate and other insurance companies under various reinsurance agreements. The Company entered into these reinsurance agreements to shift underlying risk on certain of its products, and to improve cash flow and statutory capital. The ceded reinsurance agreements provide the Company with increased capacity to write larger risks and maintain its exposure to loss within its capital resources.

Total reinsurance amounts included in the Company’s accompanying statutory-basis financial statements were as follows:

 

     Years ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Premiums earned

      

Direct

       $ 19,525      $   20,311      $    21,716   

Assumed

     792        1,062        942   

Ceded

     (7,579     (8,491     (15,104
  

 

 

 

Net

       $   12,738      $ 12,882      $ 7,554   
  

 

 

 

Benefits to policyholders ceded

       $ 18,500      $ 17,988      $   18,235   

Reserve amounts ceded to reinsurers not authorized in the State of Michigan are mostly covered by letters of credit or trust agreements. Amounts payable or recoverable for reinsurance on policy and contract liabilities are not subject to periodic or maximum limits. At December 31, 2014, any material recoveries were secured by letters of credit or assets placed in trust by the assuming company.

Neither the Company nor any of its related parties control, directly or indirectly, any external reinsurers with whom the Company conducts business. No policies issued by the Company have been reinsured with a foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company does not have any reinsurance agreements in effect under which the reinsurer may unilaterally cancel the agreement. At December 31, 2014, there was no reinsurance agreements in effect such that the amount of losses paid or accrued exceed the total direct premium collected.

As of December 31, 2014, if all reinsurance agreements were cancelled the estimated aggregate reduction in unassigned surplus is $898 million.

 

F-44


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

8. Reinsurance - (continued)

 

Affiliated Reinsurance

The table and commentary below consist of the impact of the reinsurance agreements with JHNY:

 

     Years ended December 31,  
     2014      2013      2012  
  

 

 

 
     (in millions)  

Premiums ceded, net

   $ 192       $ 216       $ 208   

Benefits ceded, net

     394         483         428   

Funds held by or deposited with reinsured companies

     1,952         1,978         2,018   

Other reinsurance receivable

     86         124         109   

Other amounts payable on reinsurance

     10         15         5   

On January 1, 2010, the assets supporting the policyholders who reside in the state of New York (“NY business”) were transferred to JHNY from the Company. The transfer included participating traditional life insurance, universal life insurance, fixed deferred and immediate annuities, participating pension contracts, and variable annuities. The NY business was transferred using assumption reinsurance, modified coinsurance and coinsurance with cut-through provisions.

The NY business related to participating traditional life insurance policies was transferred from JHUSA to JHNY under a coinsurance agreement and was immediately retroceded back to JHUSA using a coinsurance funds withheld agreement. JHNY retained the invested assets supporting this block of business. The NY business related to variable universal life was reinsured through coinsurance and modified coinsurance. The NY business related to universal life was transferred from the Company to JHNY under coinsurance agreements.

The NY business related to a majority of the fixed deferred annuity business was transferred from the Company to JHNY under an assumption reinsurance agreement. The NY business related to variable annuities and some participating pension contracts where assets were held in separate accounts were reinsured through modified coinsurance. The NY business related to fixed deferred and immediate annuities and participating pension contracts was transferred from the Company to JHNY under a coinsurance agreement.

The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, JHRECO:

 

     Years ended December 31,  
     2014      2013      2012  
  

 

 

 
     (in millions)  

Premiums ceded

   $ 546       $ 570       $ 573   

Benefits ceded

     759         730         691   

Other amounts payable on reinsurance

     58         45         30   

Funds withheld from unauthorized reinsurers

     7,409         5,425         5,600   

The Company reinsures certain portions of its long-term care insurance business with JHRECO through coinsurance funds withheld transactions. Under reinsurance treaties covering life insurance business, the Company cedes to JHRECO on a coinsurance funds withheld basis to the death benefits from the no-lapse guarantee on a small block of policies. The Company also reinsures a portion of the risk related to certain annuity policies and during 2013 a small number of these policies were recaptured for administration purposes. This recapture did not have a material impact on the Company’s results of operations. The reinsurance agreement is written on a modified coinsurance basis where the assets supporting the reinsured policies remain invested with the Company.

The Company’s total settlement amount was $489 million, $55 million, and $82 million for the years ended December 31, 2014, 2013 and 2012, respectively, and the settlement calculation consisted primarily of ceded investment income, ceded benefit payments and ceded statutory reserves.

 

F-45


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

8. Reinsurance - (continued)

 

The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, Manulife Reinsurance (Bermuda) Limited (“MRBL”):

 

     Years ended December 31,  
     2014      2013      2012  
  

 

 

 
     (in millions)  

Premiums ceded

   $ 4,599       $ 5,128       $ 6,218   

Benefits ceded

     14,303         13,966         13,649   

Other reinsurance receivable

     40         398         44   

Other amounts payable on reinsurance

     837         55         112   

Funds withheld from unauthorized reinsurers

     1,251         1,256         1,507   

The Company reinsures 87% of certain group annuity contracts in-force with MRBL. The reinsurance agreement covers all contracts, excluding the guaranteed benefit rider. As the underlying contracts being reinsured are considered investment contracts, the agreement does not meet the criteria for reinsurance accounting and was classified as a financial instrument.

The Company reinsures 90% of a significant block of variable annuity contracts in-force with MRBL. All substantial risks, including all guaranteed benefits, related to certain specified policies not already reinsured to third parties, are reinsured under the agreement. The base contracts are reinsured on a modified coinsurance basis, while the guaranteed benefit reinsurance coverage is apportioned in accordance with the reinsurance agreement provisions between modified coinsurance and coinsurance funds withheld. The assets supporting the reinsured policies remain invested with the Company. Since the inception of the treaty in 2008, several amendments have been enacted to refine certain aspects of the treaty. The net MRBL reinsurance recoverable includes the impact of ongoing reinsurance cash flows and is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies with changes to ceded reserves and cost of reinsurance recognized as a component of benefits to policyholders on the Statements of Operations. The Company paid / (received) from MRBL $1,907 million, ($1,174) million, and $259 million for the years ended December 31, 2014, 2013 and 2012, respectively, and the settlement consisted primarily of ceded investment income related to non-qualifying hedging strategies and changes in the modified coinsurance and coinsurance reserves.

The Company reinsures 90% of the non-reinsured risk of the JHLICO closed block. The reinsurance agreement is written on a modified coinsurance basis where the related financial assets remain invested with the Company. As the reinsurance agreement does not subject the reinsurer to the reasonable possibility of significant loss, it was classified as structured reinsurance and given deposit-type accounting treatment with only the reinsurance risk fee being reported in other operating costs and expenses in the Statements of Operations.

The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, Manulife Reinsurance Limited (“MRL”):

 

     Years ended December 31,  
     2014      2013      2012  
  

 

 

 
     (in millions)  

Premiums ceded

   $ 338       $ 536       $ 618   

Benefits ceded

     298         338         362   

Other reinsurance receivable

     82         18         31   

Other amounts payable on reinsurance

     -         -         19   

Funds withheld from unauthorized reinsurers

     213         -         -   

The Company entered into a coinsurance/modified coinsurance agreement with an affiliate, Manulife Reinsurance Limited (“MRL”), to reinsure 90% of all risks not already reinsured to third parties on various universal life contracts effective December 15, 2000. Subsequent amendments added further UL and some term contracts. The Company amended the

 

F-46


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

8. Reinsurance - (continued)

 

agreement during 2014 to simplify treaty administration and to modify the structure of the treaty to a modified coinsurance funds withheld structure.

On July 31, 2013, MFC signed an agreement to sell its life insurance business in Taiwan to CTBC Life Insurance Company (CTBC Life). Under the agreement, CTBC Life will assume all of the life insurance business related obligations. In connection with this transaction, on December 31, 2013, the Company paid $111 million in fees to an affiliate, Manufacturers Life Reinsurance Limited for the recapture of certain traditional life business reserves and net liabilities of $42 million, which resulted in a pre-tax loss of $69 million.

Non-Affiliated Reinsurance

The Company entered into a coinsurance agreement with Reinsurance Group of America (“RGA”) to reinsure 90% of its fixed deferred annuity business with an effective date of April 1, 2012. The transaction was structured such that the Company transferred the actuarial liabilities and related invested assets which included $387 million in cash and $5 billion in bonds and mortgage loans. Under the terms of the agreement, the Company will maintain responsibility for servicing of the policies and managing some of the assets. The transaction resulted in a charge to pre-tax income of $257 million, which included a ceding commission paid of $218 million and a decrease of $123 million to statutory surplus.

On September 30, 2012, the Company entered into a transaction with Commonwealth Annuity and Life Insurance Company (“CWA”), in which CWA recaptured a block of universal life policies, with an effective date of July 1, 2012. The transaction included the transfer to CWA of $378 million in actuarial liabilities and $309 million of cash and policy loans. The transaction resulted in a gain to pre-tax income of $60 million which included a ceding commission received of $57 million and an increase of $33 million to statutory surplus.

On July 1, 2011, JHUSA entered into a sale of its Life Retrocession business by way of a coinsurance treaty with Pacific Life Insurance Company that resulted in the recognition of approximately $432 million deferred gain (net of deferred taxes) recorded to surplus. During 2013, JHUSA novated 95% of the underlying reinsurance agreements to Pacific Life Insurance Company. Based on this novation, the Company recorded a gain of $352 million to the Statements of Operations (pre-tax). In 2014, the Company completed the novation of the remaining 5% of the agreements and recorded $20 million to the Statements of Operations (pre-tax).

 

F-47


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes

The components of the net deferred tax asset/(liability) are as follows:

 

     December 31, 2014  
     (1)     (2)     (3)  
                 (Col 1 + 2)  
     Ordinary     Capital     Total  
  

 

 

 
     (in millions)  

(a) Gross deferred tax assets

       $ 4,300      $ 479      $ 4,779   

(b) Statutory valuation allowance adjustments

     50        -        50   
  

 

 

 

(c) Adjusted gross deferred tax assets (a — b)

       4,250          479          4,729   

(d) Deferred tax assets nonadmitted

     -        -        -   
  

 

 

 

(e) Subtotal net admitted deferred tax asset (c — d)

     4,250        479        4,729   

(f) Deferred tax liabilities

     4,871        314        5,185   
  

 

 

 

(g) Net admitted deferred tax asset / (net deferred tax liability) (e — f)

       $ (621   $ 165      $ (456
  

 

 

 
     December 31, 2013  
     (4)     (5)     (6)  
                 (Col 4 + 5)  
     Ordinary     Capital     Total  
  

 

 

 
     (in millions)  

(a) Gross deferred tax assets

       $ 3,963      $ 606      $ 4,569   

(b) Statutory valuation allowance adjustments

     50        -        50   
  

 

 

 

(c) Adjusted gross deferred tax assets (a — b)

     3,913        606        4,519   

(d) Deferred tax assets nonadmitted

     -        -        -   
  

 

 

 

(e) Subtotal net admitted deferred tax asset (c — d)

     3,913        606        4,519   

(f) Deferred tax liabilities

     4,311        412        4,723   
  

 

 

 

(g) Net admitted deferred tax asset / (net deferred tax liability) (e — f)

       $ (398   $ 194      $ (204
  

 

 

 
     Change  
     (7)     (8)     (9)  
     (Col 1 - 4)     (Col 2 - 5)     (Col 7 + 8)  
     Ordinary     Capital     Total  
  

 

 

 
     (in millions)  

(a) Gross deferred tax assets

       $ 337      $ (127   $ 210   

(b) Statutory valuation allowance adjustments

     -        -        -   
  

 

 

 

(c) Adjusted gross deferred tax assets (a — b)

     337        (127     210   

(d) Deferred tax assets nonadmitted

     -        -        -   
  

 

 

 

(e) Subtotal net admitted deferred tax asset (c — d)

     337        (127     210   

(f) Deferred tax liabilities

     560        (98     462   
  

 

 

 

(g) Net admitted deferred tax asset / (net deferred tax liability) (e — f)

       $ (223   $ (29   $ (252
  

 

 

 

The Company has recorded a valuation allowance against specific general business tax credit carryforwards of $50 million for the year ended December 31, 2014. These tax credits were generated by the legacy JHFC group and are subject to the separate return limitation rules. These credits will not expire until 2019, however due to restrictions on the utilization, management believes that it is more likely than not that the Company will not realize the benefit. In assessing the need for a valuation allowance, management considered the future reversal of taxable temporary differences, future taxable income exclusive of reversing temporary differences, taxable income in the carry back period, as well as tax planning strategies. Tax

 

F-48


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

planning strategies were considered to the extent they were both prudent and feasible and if implemented, would result in the realization of deferred tax assets.

The amount of adjusted gross deferred tax assets admitted under each component and the resulting increase in deferred tax assets by character are as follows:

 

     December 31, 2014  
     (1)      (2)      (3)  
                   (Col 1 + 2)  
     Ordinary      Capital      Total  
  

 

 

 
     (in millions)  

2. Admission calculation components SSAP No. 101

        

(a) Federal income taxes paid in prior years recoverable through loss carrybacks.

       $ -       $ -       $ -   

(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.

(The lesser of 2(b)1 and 2(b)2 below)

     521         276         797   

1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.

     1,197         276         1,473   

2. Adjusted gross deferred tax assets allowed per limitation threshold.

     521         276         797   

(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.

     3,729         203         3,932   
  

 

 

 

(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))

       $   4,250       $   479       $   4,729   
  

 

 

 
     December 31, 2013  
     (4)      (5)      (6)  
                   (Col 4 + 5)  
     Ordinary      Capital      Total  
  

 

 

 
     (in millions)  

2. Admission calculation components SSAP No. 101

        

(a) Federal income taxes paid in prior years recoverable through loss carrybacks.

       $ -       $ -       $ -   

(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.

(The lesser of 2(b)1 and 2(b)2 below)

     650         194         844   

1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.

     650         194         844   

2. Adjusted gross deferred tax assets allowed per limitation threshold.

     675         194         869   

(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.

     3,263         412         3,675   
  

 

 

 

(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))

       $   3,913       $   606       $   4,519   
  

 

 

 

 

F-49


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

 

     Change  
     (7)     (8)     (9)  
     (Col 1 - 4)     (Col 2 - 5)     (Col 7 + 8)  
     Ordinary     Capital     Total  
  

 

 

 
     (in millions)  

2. Admission calculation components SSAP No. 101

      

(a) Federal income taxes paid in prior years recoverable through loss carrybacks.

       $ -      $ -      $ -   

(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.

(The lesser of 2(b)1 and 2(b)2 below)

     (129     82        (47

1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.

     547        82        629   

2. Adjusted gross deferred tax assets allowed per limitation threshold.

     (154     82        (72

(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.

     466        (209     257   
  

 

 

 

(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))

       $ 337      $ (127   $ 210   
  

 

 

 

 

     2014     2013  
  

 

 

 
     (in millions)  

(a) Ratio percentage used to determine recovery period and threshold limitation amount

     917     860

(b) Amount of adjusted capital and surplus used to determine recovery period and threshold limitation in 2(b)2 above

       $   5,315      $ 5,796   

Impact of tax planning strategies is as follows:

 

     December 31, 2014  
     (1)     (2)  
     Ordinary     Capital  
  

 

 

 
     (in millions)  

(a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.

    

1. Adjusted Gross DTAs Amount From Note 9A1(c)

   $ 4,250      $ 479   

2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies

     0     32

3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)

   $ 4,250      $ 479   

4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies

     0     32

 

F-50


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

 

     December 31, 2013  
     (3)     (4)  
     Ordinary     Capital  
  

 

 

 
     (in millions)  

(a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.

    

1. Adjusted Gross DTAs Amount From Note 9A1(c)

   $ 3,913      $ 606   

2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies

     0     32

3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)

   $ 3,913      $ 606   

4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies

     0     75
     Change  
     (5)     (6)  
     (Col 1 - 3)     (Col 2 - 4)  
     Ordinary     Capital  
  

 

 

 
     (in millions)  

(a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.

    

1. Adjusted Gross DTAs Amount From Note 9A1(c)

   $ 337      $ (127

2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies

     0     0

3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)

   $ 337      $ (127

4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies

     0     (43 %) 

The Company’s tax planning strategies do not include the use of reinsurance.

There are no unrecognized deferred tax liabilities for amounts described in ASC 740-10-25-3.

 

F-51


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

Current income taxes incurred consist of the following major components:

 

     Years Ended December 31,  
     (1)     (2)      (3)  
                  (Col 1 - 2)  
     2014     2013      Change  
  

 

 

 
     (in millions)  

1. Current income tax

       

(a) Federal

       $ (716   $ 262       $ (978

(b) Foreign

     -        -         -   
  

 

 

 

(c) Subtotal

     (716     262         (978

(d) Federal income tax on net capital gains

         382          108            274   

(e) Utilization of capital loss carryforwards

     -        -         -   

(f) Other

     -        -         -   
  

 

 

 

(g) Federal and foreign income taxes incurred

       $ (334   $ 370       $ (704
  

 

 

 

 

F-52


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows:

 

     December 31,  
     (1)      (2)      (3)  
                   (Col 1 - 2)  
     2014      2013      Change  
  

 

 

 
     (in millions)  

2. Deferred tax assets:

        

(a) Ordinary:

        

(1) Discounting of unpaid losses

     $ -       $ -       $ -   

(2) Unearned premium reserve

     -         -         -   

(3) Policyholder reserves

       1,034         883         151   

(4) Investments

     147         113         34   

(5) Deferred acquisition costs

     755         759         (4

(6) Policyholder dividends accrual

     111         112         (1

(7) Fixed assets

     -         -         -   

(8) Compensation and benefits accrual

     54         64         (10

(9) Pension accrual

     -         -         -   

(10) Receivables — nonadmitted

     49         176         (127

(11) Net operating loss carryforward

     1,218         915             303   

(12) Tax credit carry-forward

     860         865         (5

(13) Other (including items <5% of total ordinary tax assets)

     72         76         (4
  

 

 

 

(99) Subtotal

     $ 4,300       $   3,963       $ 337   

(b) Statutory valuation allowance adjustment

     50         50         -   

(c) Nonadmitted

     -         -         -   
  

 

 

 

(d) Admitted ordinary deferred tax assets (2(a)(99) — 2(b) — 2(c))

     $ 4,250       $ 3,913       $ 337   

(e) Capital:

        

(1) Investments

     $ 479       $ 606       $ (127

(2) Net capital loss carryforward

     -         -         -   

(3) Real estate

     -         -         -   

(4) Other (including items <5% of total capital tax assets)

     -         -         -   
  

 

 

 

(99) Subtotal

     $ 479       $ 606       $ (127

(f) Statutory valuation allowance adjustment

     -         -         -   

(g) Nonadmitted

     -         -         -   
  

 

 

 

(h) Admitted capital deferred tax assets (2(e)(99) — 2(f) — 2(g))

     $ 479       $ 606       $ (127

(i) Admitted deferred tax assets (2(d)+2(h))

     $ 4,729       $ 4,519       $ 210   

 

F-53


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

 

3. Deferred tax liabilities:

      

(a) Ordinary:

      

(1) Investments

       $ 4,202      $ 3,610      $ 592   

(2) Fixed assets

     -        -        -   

(3) Deferred and uncollected premium

     148        152        (4

(4) Policyholder reserves

     -        -        -   

(5) Other (including items <5% of total ordinary tax liabilities)

     521        549        (28
  

 

 

 

(99) Subtotal

       $ 4,871      $ 4,311      $     560   

(b) Capital:

      

(1) Investments

       $ 276      $ 368      $ (92

(2) Real estate

     -        -        -   

(3) Other (including items <5% of total capital tax liabilities)

     38        44        (6
  

 

 

 

(99) Subtotal

       $ 314      $ 412      $ (98
  

 

 

 

(c) Deferred tax liabilities (3(a)(99) + 3(b)(99))

       $     5,185      $   4,723      $ 462   
  

 

 

 

4. Net deferred tax assets/liabilities (2(i) — 3(c))

       $ (456   $ (204   $ (252
  

 

 

 

The change in net deferred income taxes is comprised of the following:

 

     December 31,  
     2014     2013     Change  
  

 

 

 
     (in millions)  

Total deferred tax assets

       $   4,729      $   4,519      $ 210   

Total deferred tax liabilities

     5,185        4,723        462   
  

 

 

 

Net deferred tax assets (liabilities)

       $ (456   $ (204   $ (252
  

 

 

   

Tax effect of unrealized gains and losses

           (1,263

Tax effect of unrealized foreign exchange gains (losses)

         38   
      

 

 

 

Change in net deferred income taxes

       $ 973   
      

 

 

 

 

F-54


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

The provision for federal and foreign income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate of 35% to income before income tax (including realized capital gains). The significant items causing this difference are as follows:

 

     Years Ended December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Ordinary provisions computed at statutory rate

       $ (1,087   $   1,775      $ 362   

Net realized capital gains (losses) before IMR at statutory rate

     151        (595     (207

Change in nonadmitted assets

     -        -        -   

Reinsurance

     (91     (206     (142

Valuation allowance

     -        50        -   

Tax-exempt income

     (16     (2     (21

Nondeductible expenses

     1        7        3   

Foreign tax expense gross up

     9        8        9   

Amortization of IMR

     (62     (64     (63

Tax recorded in surplus

     15        (18     (25

Dividend received deduction

     (129     (102     (106

Investment in subsidiaries

     (32     (35     (34

Prior year adjustment

     (23     16        (53

Tax credits

     (52     (61     (73

Change in tax reserve

     11        (55     (119

Pension

     -        -        -   

Other

     (2     (1     -   
  

 

 

 

Total

       $ (1,307   $ 717      $ (469
  

 

 

 

Federal and foreign income taxes incurred

       $ (716   $ 262      $   (752

Capital gains tax

     382        108        354   

Change in net deferred income taxes

     (973     347        (71
  

 

 

 

Total statutory income tax expense (benefit)

       $   (1,307   $ 717      $ (469
  

 

 

 

 

F-55


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

As of December 31, 2014, the Company had the following carry forwards:

 

    Origination
Year
  Expiration
Year
   Amount  
 

 

 
    (in millons)  

Net operating losses

  2008   2023        $ 1,594   
  2009   2024      259   
  2010   2025      63   
  2013   2028      1,080   
  2014   2029      484   
      

 

 

 
           $ 3,480   
      

 

 

 

Affordable housing tax credits

  2001   2021        $ -   
  2002   2022      26   
  2003   2023      49   
  2004   2024      56   
  2005   2025      59   
  2006   2026      55   
  2007   2027      64   
  2008   2028      60   
  2009   2029      40   
  2010   2030      52   
  2011   2031      53   
  2012   2032      46   
  2013   2033      37   
  2014   2034      26   
      

 

 

 
           $ 623   
      

 

 

 

Foreign tax credits

  2002   2012        $ 6   
  2003   2013      9   
  2004   2014      13   
  2005   2015      5   
  2006   2016      9   
  2007   2017      27   
  2008   2018      18   
  2009   2019      11   
  2010   2020      9   
  2011   2021      28   
  2012   2022      28   
  2013   2023      27   
  2014   2024      23   
      

 

 

 
           $         213   
      

 

 

 

Alternative minimum tax credits

  2002          $ 2   
  2006        7   
      

 

 

 
           $ 9   
      

 

 

 

 

F-56


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

Rehabilitation credits

  2003   2023        $ 4   
  2006   2026      1   
      

 

 

 
           $ 5   
      

 

 

 

Other credits

  2005   2025        $ 1   
  2007   2027      1   
  2008   2028      1   
  2009   2029      1   
  2010   2030      2   
  2011   2031      2   
  2013   2033      2   
      

 

 

 
           $             10   
      

 

 

 

There are no federal income taxes incurred available for recoupment in the event of future net losses for 2014, 2013 and 2012 respectively.

The Company has no deposits under Section 6603 of the Internal Revenue Code.

The Company is included in the consolidated federal income tax return of JHFC with the following entities:

 

Essex Corporation   John Hancock Real Estate Finance Inc.
Hancock Forest Management Inc.   John Hancock Realty Advisors Inc.
Hancock Natural Resource Group Inc.   John Hancock Realty Mgt. Inc.
Hancock Venture Partners Inc.   John Hancock Signature Services Inc.
Hancock Venture Partners Inc. Russia   John Hancock Timber Resource Corp.
HVP-Special Purpose Sub I Inc.   Manulife Reinsurance (Bermuda) Limited
HVP-Special Purpose Sub II Inc.   Manulife Reinsurance Limited
JH Networking Insurance Agency Inc.   Manulife Service Corporation
JHFS One Corp.   MCC Asset Management Inc.
John Hancock Assignment Company   PT Timber Inc.
John Hancock Capital Growth Management Inc.   Signator Insurance Agency Inc.
John Hancock Energy Resources Mgt. Inc.   Signator Investors Inc.
John Hancock Financial Network Inc.   Signator Financial Services Inc.
John Hancock Financial Corporation   The Manufacturers Investment Corporation
John Hancock Insurance Agency Inc.   Transamerica Fund Distributors Inc.
John Hancock Leasing Corp.   Transamerica Fund Management Company
John Hancock Life Insurance Company of New York  

In accordance with the income tax sharing agreements in effect for the applicable tax years, the Company’s income tax expense (benefit) is computed as if the Company filed separate federal income tax returns with tax benefits provided for operating losses and tax credits when utilized by the consolidated group. Intercompany settlements of income taxes are made through an increase or reduction to amounts due to or from affiliates. Such settlements occur on a periodic basis in accordance with the tax sharing agreements.

Taxes receivable from (payable to) affiliates are $728 million and ($137) million at December 31, 2014 and 2013, respectively, and are included in current federal income taxes payable on the Balance Sheets.

The Company files income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions. The Company is under continuous examination by the IRS. Effective for 2010, the Company’s common parent, JHFC, merged into Manulife Holdings (Delaware) LLC (“MHDLLC”) resulting in a new combined group. With respect to the legacy MHDLLC

 

F-57


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

9. Federal Income Taxes - (continued)

 

consolidated return group, the IRS audit for tax years through 2009 have been closed. With respect to the legacy JHFC group, the IRS has completed its examinations of tax years 1997 through 2009. The IRS has issued statutory notices of deficiency relating to issues in years 1997 through 2004. JHFC filed a petition in U.S. Tax Court pertaining to leveraged leases to contest years 1997 to 2001 and the trial was completed in 2011 with final judgment entered on July 22, 2014. The IRS issued Revenue Agent Reports for tax years 2005 through 2009. Protests were filed with respect to disagreed issues. The IRS commenced its audit of tax years 2010 through 2013 in September 2014.

On August, 5, 2013, the U.S. Tax Court issued an opinion in the litigation between the Company and the IRS involving the tax treatment of certain leveraged lease investments. The Court’s opinion effectively ruled against the Company with respect to deductions claimed for tax years 1997 — 2001. The Company and the Internal Revenue Service are in the process of determining the impact of the decision on years subsequent to the years that were decided by the Court. The Company has made advance payments of tax and interest and is awaiting final IRS assessments. Although the Company is fully reserved for the taxes and interest that could be due, this decision may result in a decrease in the admissible book value of other deferred tax assets include in surplus in subsequent periods, absent consideration of further management actions.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

     2014     2013  
  

 

 

 
     (in millions)  

Balance at beginning of year

       $ 2,715      $ 3,186   

Additions based on tax positions related to the current year

     49        150   

Payments

     (550     (90

Additions for tax positions of prior years

     23        59   

Reductions for tax positions of prior years

     (235     (590
  

 

 

 

Balance at end of year

       $   2,002      $   2,715   
  

 

 

 

Included in the balances as of December 31, 2014 and 2013, respectively, are $154 million and $149 million of unrecognized benefits that, if recognized, would affect the Company’s effective tax rate. Included in the balances as of December 31, 2014 and 2013, are $1,848 million and $2,566 million of tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. Approximately $1,734 million and $2,281 million of such amounts at December 31, 2014 and 2013, respectively, represent deferred tax liability balances related to leveraged lease deductions taken in prior year tax returns that were considered in determining the amount of deferred tax assets that can be admitted by offsetting such amounts against deferred tax liabilities. Excluding the effect of interest and penalties, this will have no impact on the annual effective rate, but would accelerate the payment of taxes to an earlier period.

The Company’s liability for unrecognized tax benefits may decrease in the next twelve months pending the outcome of remaining issues associated with the 2002 through 2009 IRS audit. A reasonable estimate of the decrease cannot be determined at this time however, the Company believes that the ultimate resolution will not result in a material change to its financial statements.

The Company recognizes interest accrued related to unrecognized tax benefits and penalties in income tax expense in the Statements of Operations. The Company recognized approximately $9 million of interest expense, and $11 million, and $24 million of interest benefit for the years ended December 31, 2014, 2013 and 2012, respectively. The Company had approximately $209 million and $404 million accrued for interest as of December 31, 2014 and 2013, respectively. The Company did not recognize any material amounts of penalties for the years ended December 31, 2014, 2013 and 2012.

10. Capital and Surplus

There are no restrictions placed on the Company’s unassigned surplus other than restrictions on dividend payments described below.

Under Michigan State insurance laws, no insurer may pay any shareholder dividends from any source other than statutory earned surplus without the prior approval of the Director. Dividends to the shareholder that may be paid without prior approval of the Director are limited by the laws of the State of Michigan. Such dividends are permissible if, together with

 

F-58


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

10. Capital and Surplus - (continued)

 

other dividends or distributions made within the preceding 12 months, they do not exceed the greater of 10% of the JHUSA surplus as of December 31 of the preceding year, or the net gain from operations excluding realized capital gains and (losses) for the 12 month period ending December 31 of the immediately preceding year. For the years ended December 31, 2014 and 2013, the Company paid a dividend to its parent company MIC of $500 million and $300 million, respectively. The company paid no dividends for the year ended December 31, 2012.

Life/health insurance companies are subject to certain Risk-Based Capital (“RBC”) requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life/health insurance company is to be determined based on the various risk factors related to it. As of December 31, 2014 and 2013, based on calculations pursuant to those requirements, the Company’s total adjusted capital exceeds the company action level.

The Company has surplus notes described below in the amount of $991 million. The issuance of the surplus notes was approved by the insurance regulators with the following repayment conditions and restrictions: 1) interest payments may be made only with prior approval by the Insurance Department and 2) repayment of the principal due may be made only with the prior approval of the Insurance Department.

Surplus notes in the amount of $450 million were issued on February 25, 1994, for cash pursuant to Rule 144A under the Securities Act of 1933. 100% of the issued and outstanding surplus notes are represented by a global note registered in the name of a nominee of the Depository Trust Company. The interest rate is fixed at 7.375%, and interest is payable semi-annually. The notes mature on February 15, 2024. Interest expense was $33 million for years ended December 31, 2014, 2013 and 2012. Total interest paid through December 31, 2014 was $680 million.

Pursuant to a subordinated surplus note dated September 30, 2008, the Company issued two notes in the amount of $295 million and $110 million to an affiliate, John Hancock Insurance Agency, Inc. (“JHIA”). The interest rate is fixed at 7% per annum and is payable semi-annually. The notes mature on March 31, 2033. The combined interest expense on the notes was $29 million for years ended December 31, 2014, 2013 and 2012. Total interest paid through December 31, 2014 was $173 million.

Pursuant to an amended and restated subordinated surplus note dated September 30, 2008, the Company borrowed $136 million from JHFC. Interest is calculated and reset quarterly at a fluctuating rate equal to 3-month LIBOR plus 130 basis points and is payable semi-annually. The note matures on December 15, 2016. Interest expense was $2 million, $2 million, and $2 million for the years ended December 31, 2014, 2013 and 2012, respectively. Total interest paid through December 31, 2014 was $11 million.

Under Michigan State liquidation statutes, the claims of the Depository Trust Company, JHIA, and JHFC (“the surplus noteholders”) come before those of the Company’s shareholders. There is no preferential treatment in claims between the surplus noteholders.

11. Related Party Transactions

Service Agreements

The Company has formal service agreements with MFC and MLI, which can be terminated by either party upon two months’ notice. Under the various agreements, the Company will pay operating expenses incurred by MFC and MLI on behalf of the Company. Services provided under the agreements include legal, actuarial, investment, data processing, accounting, and certain other administrative services. Management fees relating to the agreement were $398 million, $443 million, and $481 million, respectively, for the years ended December 31, 2014, 2013 and 2012.

The Company has Administrative Service Agreements with its subsidiaries whereby the Company will be reimbursed for operating expenses incurred by the Company. Services provided under the agreement include legal, personnel, marketing, investment accounting, and certain other administrative services and are billed based on intercompany cost allocations or total average daily net assets. The amounts earned under the agreements were $618 million, $328 million, and $266 million for the years ended December 31, 2014, 2013 and 2012, respectively.

 

F-59


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

11. Related Party Transactions - (continued)

 

Management believes the allocation methods used are reasonable and appropriate in the circumstances; however, the Company’s Balance Sheets and statements of operations may not necessarily be indicative of the financial condition that would have existed if the Company operated as an unaffiliated entity.

Other

During 2014, 2013 and 2012, respectively, the Company received dividends of $43 million, $297 million, and $274 million from John Hancock Investment Management Services LLC, $90 million, $98 million, and $96 million from JHD, $0 million, $0 million, and $0 million from JHNY, and $72 million, $0 million, and $0 million from John Hancock Subsidiaries, LLC (JHS). These dividends are included in the Company’s net investment income.

During 2014, the Company made a capital contribution of $3 million to JHS in exchange for one share of its common stock.

The Company did not own any shares of the stock of its parent, MIC, or its ultimate parent, MFC at December 31, 2014 and 2013, respectively.

The Company did not recognize any impairment write-down for its investment in subsidiaries, controlled or affiliated companies for the years ended December 31, 2014, 2013 and 2012, respectively.

The Company operates a liquidity pool in which affiliates can invest excess cash. Terms of operation and participation in the liquidity pool are set out in the Second Restated and Amended Liquidity Pool and Loan Facility Agreement effective January 1, 2010. The maximum aggregate amounts that JHUSA can accept into the Liquidity Pool are $5 billion in U.S. dollar deposits and $200 million in Canadian dollar deposits. Under the terms of the agreement, certain participants may receive advances from the Liquidity Pool up to certain predetermined limits. By acting as the banker the Company can earn a spread over the amount it pays its affiliates and this aggregation and resulting economies of scale allows the affiliates to improve the investment return on their excess cash. Interest payable on U.S. dollar funds will be reset daily to the one-month U.S. Dollar London Inter-Bank Bid Rate (“LIBID”) and interest payable on Canadian dollar funds is based off the one-month Canadian Dollar Offering Rate (“CDOR”) plus a spread.

 

F-60


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

11. Related Party Transactions - (continued)

 

The following table details the affiliates and their participation in the Company’s Liquidity Pool:

 

     December 31,  
     2014      2013  
  

 

 

 
     (In millions)  

The Manufacturers Investment Corporation

       $ 105       $ 313   

John Hancock Financial Corporation

     274         36   

Manulife Reinsurance Limited

     186         7   

Manulife Reinsurance (Bermuda) Ltd.

     696         81   

John Hancock Life & Health Insurance Company

     142         249   

John Hancock Life Insurance Company Vermont

     39         16   

John Hancock Reassurance Company, Ltd.

     278         21   

John Hancock Life Insurance Company New York

     611         381   

John Hancock Investment Management Services LLC

     31         87   

John Hancock Subsidiaries LLC

     45         26   

John Hancock Insurance Agency, Inc.

     16         17   

Essex Corporation

     1         1   

Hancock Venture Partners, Inc.

     -         15   

JH Signature Services Inc.

     9         9   

JH Partnership Holdings I, II LP

     2         4   

John Hancock Energy Resources Management, Inc.

     4         4   

John Hancock Real Estate Finance

     1         1   

John Hancock Realty Advisors

     8         8   

JH Advisors LLC

     158         37   

Manulife Asset Management LLC

     75         39   

Declaration Management and Research LLC

     4         5   

Hancock Capital Investment Management LLC

     15         7   

John Hancock RPS, LLC

     14         35   

The Berkeley Financial Group, LLC

     4         4   

Signator Insurance Agency, Inc.

     18         -   

JH Networking Insurance Agency, Inc.

     4         -   
  

 

 

 

Total

       $   2,740       $   1,403   
  

 

 

 

Effective March 31, 1996, MLI provides a claims paying guarantee to certain U.S. policyholders. The claims guarantee agreement was terminated effective August 13, 2008, but still remains in effect with respect to policies issued by the Company prior to that date.

MFC fully and unconditionally guarantees payments from the guarantee periods of the accumulation phase for certain of the Company’s market value adjusted annuity contracts.

MFC fully and unconditionally guarantees JHLICO’s SignatureNotes. In December 2009, the entity that formerly issued these notes, JHLICO, ceased to exist and its property and obligations became the property and obligations of the Company.

 

F-61


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

11. Related Party Transactions - (continued)

 

MFC’s guarantees of the market value adjusted deferred annuity contracts and SignatureNotes are unsecured obligations of MFC and are subordinated in right of payment to the prior payment in full of all other obligations of MFC, except for other guarantees or obligations of MFC, which by their terms are designated as ranking equally in right of payment with or subordinate to MFC’s guarantees of the market value adjusted deferred annuity contracts and SignatureNotes.

The Company also enters into debt and reinsurance transactions with its affiliates. Please refer to the debt and reinsurance notes for further details.

12. Commitments, Guarantees, Contingencies, and Legal Proceedings

Commitments: The Company has extended commitments to purchase long-term bonds of $207 million, purchase other invested assets of $1,917 million, purchase real estate of $114 million, and issue agricultural and commercial mortgages of $175 million at December 31, 2014. If funded, loans related to real estate mortgages would be fully collateralized by related properties. Approximately 41% of these commitments expire in 2015 and the majority of the remainder expires by 2019.

There were no leasing arrangements that the Company entered into as lessee which could have a material financial effect.

During 2001, the Company entered into an office ground lease agreement, which expires on September 20, 2096. During 2012, the Company entered into a parking lease agreement, which expires on December 31, 2050. The terms of the lease agreements provide for adjustments in future periods. The future minimum lease payments, by year and in the aggregate, under these leases and other non-cancelable operating leases along with the associated sub-lease income are as follows:

 

     Non-cancelable
Operating Leases
     Sub-lease
Income
 
  

 

 

 
     (in millions)  

2015

       $ 21       $ 4   

2016

     12         -   

2017

     9         -   

2018

     6         -   

2019

     5         -   

Thereafter

     354         -   
  

 

 

 

Total

       $   407       $   4   
  

 

 

 

Other than the Company’s investment real estate, the Company does not have any material sub-lease income related to its office space. Leasing of investment real estate is not a significant part of the Company’s business activities in terms of revenue, net income, or assets.

The Company’s investment in leveraged leases relates to equipment used primarily in the transportation industries; however, this type of leasing transaction is not a significant part of the Company’s business activities in terms of revenue, net income, or assets.

On December 23, 2014, the Company entered into an agreement with New York Life under which John Hancock Retirement Plan Services, LLC, an indirect wholly owned subsidiary, will acquire New York Life’s Retirement Plan Services business. In addition, New York Life has agreed to assume, on a reinsurance basis, 60% of the Company’s in-force participating life insurance JHLICO closed block. Subject to the receipt of all necessary approvals and other customary closing conditions, the transaction is anticipated to close in the first half of 2015.

Guarantees: In the course of business, the Company enters into guarantees which vary in nature and purpose and which are accounted for and disclosed under statutory accounting principles.

The Company has issued guarantee agreements pursuant to which the Company guarantees the obligations of JHNY and JHLH under the OTC International Swaps and Derivatives Association, Inc. (“ISDA”) cleared and exchange-traded

 

F-62


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

12. Commitments, Guarantees, Contingencies, and Legal Proceedings - (continued)

 

derivative agreements and transactions entered into by JHNY and JHLH with external counterparties. The ISDA guarantees are subject to an overall limit of $1 billion of Potential Future Exposure, using a three-week and 95% confidence parameters, in calculating the counterparty risk exposure.

The Company is party to a financial support agreement with JHLH pursuant to which it has agreed to maintain JHLH’s capital level such that its risk-based capital ratio shall be at or above 225% of the company action level annually. In addition, under the terms of the financial support agreement, the Company undertakes to provide sufficient liquidity to enable JHLH to make timely payment of its contractual obligations.

Contingencies: The Company is an investor in a number of leasing transactions. On August 5, 2013, the U.S. Tax Court issued an opinion effectively ruling in the government’s favor in the litigation between John Hancock and the Internal Revenue Service involving the tax treatment of John Hancock’s investments in certain leverage leases. The Company and the Internal Revenue Service are in the process of determining the impact of the decision on years subsequent to the years that were decided by the Court. Please refer to the federal income taxes note for further details. The Company has made advance payments of tax and interest and is awaiting final IRS assessments. Although the Company is fully reserved for the taxes and interest that could be due, this decision may result in a decrease in the admissible book value of other deferred tax assets included in surplus in subsequent periods, absent consideration of further management actions.

The Company acts as an intermediary/broker in OTC derivative instruments. In these cases, the Company enters into derivative transactions on behalf of affiliated companies and then enters into offsetting derivative transactions with the affiliate. In the event of default of either party, the Company is still obligated to fulfill its obligations with the other party.

The Company is subject to insurance guaranty fund laws in the states in which it does business. Pursuant to these laws, insurance companies are assessed, and required to make periodic payments, to be used to pay benefits to policyholders and claimants of insolvent or rehabilitated insurance companies. Many states allow these assessments to be credited against future premium taxes. The Company believes such assessments in excess of amounts accrued will not materially affect its financial position.

Legal Proceedings: The Company is regularly involved in litigation, both as a defendant and as a plaintiff. The litigation naming the Company as a defendant ordinarily involves its activities as a provider of insurance protection and wealth management products, an employer, and a taxpayer. In addition, the Michigan Department of Insurance and Financial Services, the Michigan Attorney General, the SEC, the Financial Regulatory Authority, and other government and regulatory bodies regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company’s compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers. An estimation of the range of potential outcomes in any given matter is often unavailable until such matters have developed and sufficient information emerges to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals and estimates of reasonably possible losses or ranges of loss based on such reviews.

 

F-63


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

13. Annuity Actuarial Reserves

The Company’s annuity reserves and deposit fund liabilities and related separate account liabilities that are subject to discretionary withdrawal (with adjustment), subject to discretionary withdrawal (without adjustment), and not subject to discretionary withdrawal provisions are summarized as follows:

 

    December 31, 2014  
    General
Account
    Separate
Account
with
Guarantees
    Separate
Account
Nonguaranteed
    Total     Percent
of Total
 
 

 

 

 
    (in millions)  

Subject to discretionary withdrawal:

         

With fair value adjustment

      $ 968      $ 559      $ 1,879      $ 3,406        2

At book value less current surrender charge of 5% or more

    29        -        -        29        0

At fair value

    -        -        123,450        123,450        81
 

 

 

 

Total with adjustment or at fair value

    997        559        125,329        126,885        83

At book value without adjustment (minimal or no charge or adjustment)

    8,594        -        -        8,594        6

Not subject to discretionary withdrawal

    15,577        713        130        16,420        11
 

 

 

 

Total (gross)

    25,168        1,272        125,459        151,899        100
         

 

 

 

Reinsurance ceded

    5,483        -        -        5,483     
 

 

 

   

Total (net)

      $   19,685      $   1,272      $   125,459      $   146,416     
 

 

 

   
    December 31, 2013  
    General
Account
    Separate
Account
with
Guarantees
    Separate
Account
Nonguaranteed
    Total     Percent
of Total
 
 

 

 

 
    (in millions)  

Subject to discretionary withdrawal:

         

With fair value adjustment

      $ 1,176      $ 586      $ 1,886      $ 3,648        2

At book value less current surrender charge of 5% or more

    510        -        -        510        0

At fair value

    -        -        126,623        126,623        81
 

 

 

 

Total with adjustment or at fair value

    1,686        586        128,509        130,781        83

At book value without adjustment (minimal or no charge or adjustment)

    8,634        -        -        8,634        6

Not subject to discretionary withdrawal

    15,764        686        122        16,572        11
 

 

 

 

Total (gross)

    26,084        1,272        128,631        155,987        100
         

 

 

 

Reinsurance ceded

    5,992        -        -        5,992     
 

 

 

   

Total (net)

      $   20,092      $ 1,272      $ 128,631      $   149,995     
 

 

 

   

 

F-64


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

14. Separate Accounts

Separate accounts held by the Company include individual and group variable annuity and variable life products that offer guarantee and non-guaranteed returns. The net investment experience of the separate account is credited directly to the policyholder and can be positive or negative.

For guarantees of amounts in the event of death, the net amount at risk is defined as the excess of the initial sum insured over the current sum insured for fixed premium variable life insurance contracts, and, for other variable life insurance contracts, is equal to the sum insured when the account value is zero and the policy is still in force.

The deposits related to variable annuities generally provide a GMDB. For annuity products, this can take the form of either (a) return of no less than total deposits made to the contract less any partial withdrawals; (b) total deposits made to the contract less any partial withdrawals plus a minimum return; (c) the highest contract value on a specified anniversary date minus any withdrawals following the contract anniversary; or (d) a combination benefit of (b) and (c) above. The assets and liabilities of these accounts are carried at fair value. The GMDB reserve is held in the Company’s general account policy reserves.

The Company sold contracts with Guaranteed Minimum Income Benefit (“GMIB”) riders from 1998 to 2004. The GMIB rider provides a guaranteed lifetime annuity which may be elected by the contract holder after a stipulated waiting period (7 to 15 years), and which may be larger than what the contract account balance could purchase at then-current annuity purchase rates.

The Company sold contracts with a GMWB rider and has since offered multiple variations of this optional benefit. The GMWB rider provides contract holders a guaranteed annual withdrawal amount over a specified time period or in some cases for as long as they live. In general, guaranteed annual withdrawal amounts are based on deposits and may be reduced if withdrawals exceed allowed amounts. Guaranteed amounts may also be increased as a result of “step-up” provisions which increase the benefit base to higher account values at specified intervals. Guaranteed amounts may also be increased if withdrawals are deferred over a specified period. In addition, certain versions of the GMWB rider extend lifetime guarantees to spouses.

Reinsurance has been utilized to mitigate risk related to some of the GMDB and GMIB riders.

For GMDB, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For GMIB, the net amount at risk is defined as the excess of the current annuitization income base over the current account value. For GMWB, the net amount at risk is defined as the current guaranteed withdrawal amount minus the current account value. For all the guarantees, the net amount at risk is floored at zero at the single contract level.

The deposits related to the variable life insurance contracts are invested in separate accounts and the Company guarantees a specified death benefit if certain specified premiums are paid by the policyholder, regardless of separate account performance.

 

F-65


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

14. Separate Accounts - (continued)

 

The assets legally insulated from the general account are attributed to the following products/transactions:

 

Product/Transaction    Separate Account Legally
Insulated Assets
    

Separate Account

Not Legally Insulated
Assets

 
  

 

 

 
     December 31,  
     2014      2013      2014      2013  
  

 

 

 
     (in millions)  

Group Annuities (Deposit Administration)

       $ 78,905       $ 77,273       $ -       $ -   

Variable Annuities

     43,503         48,224         29         34   

Life and COLI

     12,359         11,832         -         -   

Fixed Products — Institutional and stable value fund

     2,713         2,756         -         -   

Fixed Products — Retail

     24         26         570         546   

Investments — Funds

     2,061         2,075         -         -   
  

 

 

 

Total

       $   139,565       $   142,186       $   599       $   580   
  

 

 

 

As of December 31, 2014 and 2013, the general account of the Company had a maximum guarantee for separate account liabilities $7,816 million and $7,617 million, respectively. To compensate the general account for the risk taken, the separate account paid risk charges and amounts toward separate account guarantees are as follows:

 

     Risk Charges
Paid to General
Account
     Amounts toward
Separate Account
Guarantees
 
  

 

 

 
     (in millions)  

2014

     $    252         $      74   

2013

     $    263         $    109   

2012

     $    269         $    165   

2011

     $    261         $    145   

2010

     $    246         $    137   

The Company had the following variable annuities with guaranteed benefits:

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions, except for ages)  

Account value

   $ 44,116       $ 48,855   

Amount of reserve held

     865         349   

Net amount at risk — gross

     4,699         4,260   

Weighted average attained age

     67         66   

The following assumptions and methodology were used to determine the amounts above at December 31, 2014 and 2013:

 

   

Actuarial Guideline XLIII (AG43) is used in both years to determine the aggregate reserve for products falling under the scope. Assumptions used in the standard scenario are prescribed by the guideline. Assumptions used in the stochastic scenarios are detailed below.

 

   

The stochastically generated projection scenarios have met the scenario calibration criteria prescribed in AG43.

 

   

In 2014 and 2013, annuity mortality is based on the Ruark Variable Annuity Table, which is based on an industry study of variable annuity deaths. The table is further adjusted by factors varied by rider types (living benefit/GMDB only) and qualified and non-qualified business.

 

F-66


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

14. Separate Accounts - (continued)

 

 

   

In 2014 and 2013, annuity base lapse rates vary by product, policy year, and rider type, where the lapse rates range from 0.5% to 40% for GMDB, GMIB and GMWB. These rates are dynamically reduced for guarantees that are in-the-money. Beginning in 2012, rates are also dynamically increased for GMWBs that are out-of-the-money.

 

   

For variable annuities, the swap curve at December 31 is used for discounting in both years.

 

   

For variable annuities, mean return, volatility and correlation assumptions are determined by indices, which have met the calibration criteria prescribed in AG43.

Account balances of variable contracts with guarantees were invested in various separate accounts with the following characteristics:

 

     December 31,  
     2014      2013  
  

 

 

 
     (in millions)  

Type of Fund

     

Equity

       $ 27,353       $ 29,211   

Balanced

     19,449         21,212   

Bonds

     5,807         6,278   

Money Market

     683         861   
  

 

 

 

Total

       $   53,292       $   57,562   
  

 

 

 

Information regarding the separate accounts of the Company is as follows:

 

     December 31,  
     2014      2013  
  

 

 

 
     Nonindexed
Guarantee
Less than or
Equal to
4%
     Nonguaranteed
Separate
Account
     Total      Nonindexed
Guarantee
Less than
or Equal to
4%
     Nonguaranteed
Separate
Account
     Total  
  

 

 

 
     (in millions)  

Premiums, deposits and other considerations

       $ -       $ 13,258       $ 13,258       $ -       $ 13,613       $ 13,613   
  

 

 

 

Reserves for accounts with assets at:

                 

Fair value

     1,272         137,306         138,578         1,272         139,976         141,248   

Amortized cost

     -         -         -         -         -         -   
  

 

 

 

Total

       $   1,272       $   137,306       $   138,578       $   1,272       $   139,976       $   141,248   
  

 

 

 

 

F-67


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

14. Separate Accounts - (continued)

 

 

    December 31,  
    2014     2013  
 

 

 

 
    Nonindexed
Guarantee
Less than or
Equal to
4%
    Nonguaranteed
Separate
Account
    Total     Nonindexed
Guarantee
Less than
or Equal to
4%
    Nonguaranteed
Separate
Account
    Total  
 

 

 

 
    (in millions)  

Reserves for separate accounts by withdrawal characteristics:

           

Subject to discretionary withdrawal:

           

With fair value adjustment

      $ 531      $ 1,879      $ 2,410      $ 554      $ 1,886      $ 2,440   

At book value without fair value adjustments and with current surrender charge of 5% or more

    -        2,483        2,483        -        1,933        1,933   

At fair value

    28        129,620        129,648        32        135,349        135,381   

At book value without fair value adjustments and with current surrender charge of less than 5%

    -        3,058        3,058        -        557        557   
 

 

 

 

Subtotal

    559        137,040        137,599        586        139,725        140,311   

Not subject to discretionary withdrawal

    713        266        979        686        251        937   
 

 

 

 

Total

      $   1,272      $   137,306      $   138,578      $   1,272      $   139,976      $   141,248   
 

 

 

 

Amounts transferred to and from separate accounts are as follows:

 

     December 31,  
     2014     2013     2012  
  

 

 

 
     (in millions)  

Transfers to separate accounts

       $   16,100      $   14,916      $   18,798   

Transfers from separate accounts

     24,329        21,304        22,406   
  

 

 

 

Net transfers to (from) separate accounts

       $ (8,229   $ (6,388   $ (3,608
  

 

 

 

 

F-68


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

15. Employee Benefit Plans

Retirement Plans: The Company participates in the John Hancock Pension Plan, a qualified defined benefit plan that covers substantially all of its employees. The Company also participates in the John Hancock Non-Qualified Pension Plan, a nonqualified defined benefit plan for employees whose qualified cash balance benefit is restricted by the Internal Revenue Code. Both plans are sponsored by MIC. The non-qualified defined benefit plan was frozen except for grandfathered participants as of January 1, 2008, and the benefits accrued under this plan continue to be subject to the plan’s provisions.

The Company is jointly and severally liable for the funding requirements of the plans and will recognize its allocation, from MIC, of the required contributions to the plans as pension expense in its Statements of Operations. The allocation is derived by utilizing participant data, provided by the plan actuary, to calculate payments into the trust for the qualified plan and payments to participants for the non-qualified plan. The expense for these plans was $37 million, $41 million, and $57 million in 2014, 2013 and 2012, respectively.

The Company participates in the John Hancock Supplemental Retirement Plan, a non-qualified defined contribution plan maintained by MFC, which was established as of January 1, 2008 with participant directed investment options. The expense for this plan was not material for the years ended 2014, 2013 and 2012, respectively. The prior non-qualified defined contribution plan was frozen except for grandfathered participants as of January 1, 2008, and the benefits accrued under the prior plan continue to be subject to the prior plan provisions.

The Company also maintains a separate rabbi trust for the purpose of holding assets to be used to satisfy its obligations with respect to certain other non-qualified retirement plans of $332 million and $344 million at December 31, 2014 and 2013, respectively. In the event of insolvency of the Company, the rabbi trust assets can be used to satisfy claims of general creditors.

401 (k) Plans: The Company participates in qualified defined contribution plans for its employees who meet certain eligibility requirements. These plans include the Investment-Incentive Plan for John Hancock Employees and the John Hancock Savings and Investment Plan. Both plans are sponsored by JHUSA. Expense is primarily comprised of the amounts the Company contributes to the plans, which fully matches eligible participants’ basic pre-tax or Roth contributions, subject to a 4% per participant maximum. The expense for the defined contribution plans was not material for the years ended 2014, 2013 and 2012, respectively.

Deferred Compensation Plan: The Company maintains the Deferred Compensation Plan for Certain Employees of John Hancock, and the Deferred Compensation Plan of the John Hancock Financial Network, both of which are deferred compensation plans sponsored by MFC. These plans are for a select group of management or highly compensated employees and certain qualified agents. The plans are fully funded and accounts are maintained by a third-party administrator. Under these plans, participants have the flexibility and opportunity to invest their plan balances in mutual funds. The liability for these plans at December 31, 2014 and 2013 was $91 million and $88 million, respectively.

Prior to January 1, 2006, the Company offered the Legacy Deferred Compensation Plan for Certain Employees of John Hancock Life Insurance Company (USA), the legacy plan, which is closed to new participation and is unfunded. These are notional accounts and all liabilities have remained with the Company and are paid out of general account assets when a distribution is taken. The liability for this plan was not material as of December 31, 2014 and 2013 respectively.

Postretirement Benefit Plan: The Company participates in the John Hancock Employee Welfare Plan which is sponsored by MIC. Consistent with the pension plan, the Company is jointly and severally liable for the funding requirements of the plan and will recognize its allocation, from MIC, of the benefits earned by plan participants as postretirement benefits expense in its Statements of Operations. The allocation is derived by utilizing participant data, provided by the plan actuary, to calculate the benefits earned; i.e., service cost, relating to participants employed by the Company. In addition, any difference between actual cash paid for benefits to plan participants and benefits earned is recorded directly to unassigned surplus. The expense and charge to surplus for the John Hancock Employee Welfare Plan were not material for the years ended 2014, 2013 and 2012, respectively.

 

F-69


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

16. Lines of Credit, Consumer Notes and Affiliated Debt

Lines of Credit:At December 31, 2014, the Company, MFC, and other MFC subsidiaries had a committed line of credit through a group of banks totaling $500 million pursuant to a multi-year facility, which will expire in 2019. The banks will commit, when requested, to loan funds at prevailing interest rates as determined in accordance with the line of credit agreement. Under the terms of the agreement, MFC is required to maintain a certain minimum level of net worth, and MFC and the Company are required to comply with certain other covenants, which were met at December 31, 2014. At December 31, 2014, MFC and its subsidiaries, including the Company, had no outstanding borrowings under the agreement.

At December 31, 2014, the Company had a committed line of credit agreement established by MLI totaling $1 billion, which will expire in 2018. MLI will commit, when requested, to loan funds at prevailing interest rates as determined in accordance with the line of credit agreement. Under the terms of the agreement, the Company is required to maintain a certain minimum level of net worth and comply with certain other covenants as long as any amount is owed to the lender under the agreement. At December 31, 2014, the Company had no outstanding borrowings under the agreement.

At December 31, 2014, JHUSA and MIC share in a committed line of credit established by MFC totaling $1 billion, which will expire in 2018. MFC will commit, when requested, to loan funds at prevailing interest rates as determined in accordance with the line of credit agreement. Under the terms of the agreement, the Company is required to maintain a certain minimum level of net worth and comply with certain other covenants, as long as any amount is owed to the lender under the agreement. At December 31, 2014, the Company had no outstanding borrowings under the agreement.

Consumer Notes: The Company issued consumer notes through its SignatureNotes Program. SignatureNotes may be redeemed upon the death of the holder, subject to an annual overall program redemption limitation of 1% of the aggregate securities outstanding, or $1 million, or an individual redemption limitation of $200,000 of aggregate principal. SignatureNotes have a variety of issue dates, maturities, interest rates and call provisions. The notes payable balance as of December 31, 2014 and 2013 was $411 million and $644 million, respectively. Interest ranging from 3.1% to 6.0% is due in varying amounts to 2032.

Aggregate maturities of consumer notes are as follows: 2015-$146 million; 2016-$64 million; 2017-$4 million; 2018-$43 million; 2019-$16 million; and thereafter $138 million.

Interest expense on consumer notes, included in benefits to policyholders, was $24 million, $30 million, and $ 36 million in 2014, 2013 and 2012, respectively. Interest paid amounted to $24 million, $30 million, and $ 36 million in 2014, 2013 and 2012, respectively.

Affiliated Debt: Pursuant to a demand note receivable dated September 30, 2008, the Company has $295 million outstanding with MIC. The note, which was to have matured on March 31, 2013, was extended to March 31, 2018. This note was reported as a nonadmitted asset at December 31, 2014 and 2013 since the counterparty is the parent entity of the Company; however, this note will continue to accrue interest throughout the duration of the contract as per the terms of the note. Prior to March 31, 2013, the interest rate was calculated at a fluctuating rate equal to 3-month LIBOR plus 83 basis points per annum. Following the extension, the interest rate is calculated at a fluctuating rate equal to 3-month LIBOR plus 180 basis points per annum. Interest income was $6 million, $6 million, and $4 million for the years ended December 31, 2014, 2013 and 2012, respectively.

The Company has a demand note receivable dated March 2, 2009 with John Hancock Leasing Corporation (“JH Leasing”) that allows it to loan a minimum principal of $125,000 or an amount in excess in increments of $5,000. As of December 31, 2014 and 2013, the Company had amounts receivable from JH Leasing of $0 million and $3 million, respectively.

Pursuant to a promissory note dated June 28, 2012, the Company borrowed $153 million from Manulife Finance Switzerland AG (“MFSA”). Interest on the loan is calculated at a fluctuating rate equal to 3-month LIBOR plus 90 basis points per annum and is payable quarterly. In addition, the Company renewed two previously outstanding promissory notes to MFSA with an outstanding balance of $7 million and combined these notes with the new note issued on June 28, 2012, thus bringing the total principal balance due to $160 million. On May 23, 2014, the maturity date was extended for a period of one year to June 28, 2015. Following the extension, the interest rate was amended and is calculated at a fluctuating rate equal to 3-month LIBOR plus 88 basis points per annum and is payable quarterly effective from June 28, 2014. Interest expense was $2 million, $2 million, and $1 million for the years ended December 31, 2014, 2013 and 2012, respectively.

 

F-70


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

16. Lines of Credit, Consumer Notes and Affiliated Debt - (continued)

 

Pursuant to a demand note dated December 20, 2012, the Company borrowed $130 million from MIC. The note matures on December 20, 2015. Interest on the loan is calculated at a fluctuating rate equal to the one-month LIBOR rate and is payable monthly. Interest expense was $0 million, $0 million, and $0 million for the years ended December 31, 2014, 2013 and 2012, respectively.

Pursuant to a senior note receivable dated December 9, 2014, the Company has $40 million outstanding with JHS. The note matures on December 9, 2019. Interest on the loan is calculated at a fluctuating rate equal to the 3-month LIBOR rate plus 180 basis points per annum and is payable quarterly. Interest income was $0 million for the year ended December 31, 2014.

FHLB (Federal Home Loan Bank) Agreements: The Company is a member of the Federal Home Loan Bank of Indianapolis (FHLBI). The Company uses advances from the FHLBI as a part of its liquidity management program, and any funds obtained for this purpose would be accounted for as borrowed money.

The following table indicates the aggregate amount of the FHLBI capital stock held related to the agreement:

 

    December 31, 2014  
   

(1)

(Col 2 +3)

Total

   

(2)

General
Account

   

(3)

Separate
Account

 
 

 

 

 
    (in millions)  

(a) Membership stock — Class A

  $ -      $ -      $ -   

(b) Membership stock — Class B

    20        20        -   

(c) Activity stock

    -        -        -   

(d) Excess stock

    -        -        -   

(e) Aggregate total

  $ 20      $ 20      $ -   

(f) Actual or estimated borrowing capacity as determined by the insurer

  $ 446        -        -   
    December 31, 2013  
   

(1)

(Col 2 +3)

Total

   

(2)

General
Account

   

(3)

Separate
Account

 
 

 

 

 
    (in millions)  

(a) Membership stock — Class A

  $ -      $ -      $ -   

(b) Membership stock — Class B

    19        19        -   

(c) Activity stock

    -        -        -   

(d) Excess stock

    -        -        -   

(e) Aggregate total

  $ 19      $ 19      $ -   

(f) Actual or estimated borrowing capacity as determined by the insurer

  $ 373        -        -   

FHLBI membership stock of $20 million and $19 million was classified as not eligible for redemption for the years ended December 31, 2014 and 2013, respectively. The Company did not have any collateral pledged to FHLBI as of December 31, 2014 and 2013.

 

F-71


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

16. Lines of Credit, Consumer Notes and Affiliated Debt - (continued)

 

The following table represents the aggregate amount of borrowing from FHLBI:

 

     December 31, 2014  
    

(1)

(Col 2 +3)

Total

    

(2)

General
Account

    

(3)

Separate
Account

    

(4)

Funding
Agreements
Reserves
Established

 
  

 

 

 
     (in millions)  

(a) Debt

   $ -       $ -       $ -         -   

(b) Funding agreements

     -         -         -      

(c) Other

     -         -         -         -   

(d) Aggregate total

   $ -       $ -       $ -       $ -   
     December 31, 2013  
    

(1)

(Col 2 +3)

Total

    

(2)

General
Account

    

(3)

Separate
Account

    

(4)

Funding
Agreements
Reserves
Established

 
  

 

 

 
     (in millions)  

(a) Debt

   $ -       $ -       $ -         -   

(b) Funding agreements

     -         -         -      

(c) Other

     -         -         -         -   

(d) Aggregate total

   $ -       $ -       $ -       $ -   

The maximum amount of aggregate borrowings from FHLBI during 2014 was $10 million. The Company is not subject to any prepayment obligations under current borrowing agreements.

17. Closed Blocks

The Company operates two separate closed blocks for the benefit of certain classes of individual or joint traditional participating whole life insurance policies. The JHUSA closed block was established upon the demutualization of MLI for those designated participating policies that were in-force on September 23, 1999. The JHLICO closed block was established upon the demutualization of JHLICO for those designated participating policies that were in-force on February 1, 2000. As a result of the merger in 2009, the property and obligations of the JHLICO closed block became the property and obligations of JHUSA, but the Company operates these two closed blocks separately.

Assets were allocated to the closed blocks in an amount that, together with anticipated revenues from policies included in the closed blocks, was reasonably expected to be sufficient to support such business, including provision for payment of benefits, direct asset acquisition and disposition costs, taxes, and for continuation of dividend scales, assuming experience underlying such dividend scales continues.

Assets allocated to the closed blocks inure solely to the benefit of policyholders included in the closed blocks and will not revert to the benefit of the shareholders of the Company. In addition, if the assets allocated to the closed blocks and the revenues from the closed blocks’ business prove to be insufficient to pay the benefits guaranteed in the closed blocks, the Company will be required to make payments from its general funds in an amount equal to the shortfall.

If, over time, the aggregate performance of the assets and policies of a closed block is better than was assumed in funding that closed block, dividends to policyholders for that closed block will be increased. If, over time, the aggregate performance of the assets and policies of a closed block is less favorable than was assumed in funding that closed block, dividends to policyholders for that closed block will be reduced.

 

F-72


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS – (CONTINUED)

 

17. Closed Blocks - (continued)

 

No reallocation, transfer, borrowing, or lending of assets can be made between the closed blocks and other portions of the Company’s general account, any of its separate accounts, or any affiliate of the Company without prior notification to or approval of the Insurance Department.

The excess of the closed blocks’ liabilities over the closed blocks’ assets represents the expected future post-tax contribution from that closed block which may be recognized in income over the period the policies and contracts in that closed block remain in force.

The following table sets forth certain summarized financial information relating to the JHUSA and JHLICO closed blocks. The JHLICO assets and liabilities exclude the impact of the transfer of the NY business (described in the Reinsurance Note), consistent with the Closed Block Annual Statement filed with the State of Michigan.

 

     JHUSA      JHLICO  
     2014      2013      2014      2013  
  

 

 

 
     (in millions)  

Assets:

           

Bonds

       $ 3,153       $ 2,959           $ 6,248       $ 6,143   

Stocks:

           

Preferred stocks

     -         -         4         4   

Common stocks

     1         1         11         9   

Mortgage loans on real estate

     402         514         1,633         1,971   

Real estate

     842         698         12         12   

Cash, cash equivalents and short-term investments

     3         -         4         3   

Policy loans

     1,551         1,585         1,354         1,504   

Other invested assets

     113         116         127         109   
  

 

 

    

 

 

 

Total cash and invested assets

     6,065         5,873         9,393         9,755   

Investment income due and accrued

     105         101         126         124   

Premiums due and deferred

     12         13         68         75   

Net deferred tax asset

     112         112         157         188   

Other closed block assets

     63         234         91         53   
  

 

 

    

 

 

 

Total closed block assets

       $ 6,357       $ 6,333           $ 9,835       $ 10,195   
  

 

 

    

 

 

 

Obligations:

           

Policy reserves

     5,871         5,989         9,710         10,159   

Policyholders’ and beneficiaries’ funds

     67         69         1,360         1,394   

Dividends payable to policyholders

     314         319         208         216   

Policy benefits in process of payment

     52         72         155         139   

Other policy obligations

     2         6         6         7   

Other closed block obligations

     720         763         198         170   
  

 

 

    

 

 

 

Total closed block obligations

       $   7,026       $   7,218           $   11,637       $   12,085   
  

 

 

    

 

 

 

18. Subsequent Events

The Company evaluated the recognition and disclosure of subsequent events for its December 31, 2014 financial statements through March 25, 2015, the date the financial statements were issued.

 

F-73


Table of Contents

 

 

 

 

AUDITED FINANCIAL STATEMENTS

John Hancock Life Insurance Company (U.S.A.) Separate Account A

December 31, 2014


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Audited Financial Statements

December 31, 2014

Contents

 

Report of Independent Registered Public Accounting Firm

     3   

Statements of Assets and Liabilities

     5   

Statements of Operations and Changes in Contract Owners’ Equity

     25   

Notes to Financial Statements

     70   

 

2


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Board of Directors of John Hancock Life Insurance Company (U.S.A.) and Contract Owners of John Hancock Life Insurance Company (U.S.A.) Separate Account A

We have audited the accompanying statements of assets and liabilities of John Hancock Life Insurance Company (U.S.A.) Separate Account A (the Account) comprised of the following sub-accounts,

 

500 Index Fund B Series NAV

Active Bond Trust Series I

Active Bond Trust Series NAV

All Cap Core Trust Series I

All Cap Core Trust Series NAV

Alpha Opportunities Trust Series I

Alpha Opportunities Trust Series NAV

American Asset Allocation Trust Series I

American Global Growth Trust Series I

American Growth Trust Series I

American Growth-Income Trust Series I

American International Trust Series I

American New World Trust Series I

Blue Chip Growth Trust Series I

Blue Chip Growth Trust Series NAV

Bond Trust Series I

Bond Trust Series NAV

Capital Appreciation Trust Series I

Capital Appreciation Trust Series NAV

Capital Appreciation Value Trust Series I

Capital Appreciation Value Trust Series NAV

Core Bond Trust Series I

Core Bond Trust Series NAV

Core Strategy Trust Series I

Core Strategy Trust Series NAV

Emerging Markets Value Trust Series I

Emerging Markets Value Trust Series NAV

Equity-Income Trust Series I

Equity-Income Trust Series NAV

Financial Industries Trust Series I

Financial Industries Trust Series NAV

Franklin Templeton Founding Allocation Trust

Series I

Franklin Templeton Founding Allocation Trust

Series NAV

Fundamental All Cap Core Trust Series I

Fundamental All Cap Core Trust Series NAV

Fundamental Large Cap Value Trust Series I

Fundamental Large Cap Value Trust Series NAV

Global Bond Trust Series I

Global Bond Trust Series NAV

Global Trust Series I

Global Trust Series NAV

Health Sciences Trust Series I

Health Sciences Trust Series NAV

High Yield Trust Series I

High Yield Trust Series NAV

International Core Trust Series I

International Core Trust Series NAV

International Equity Index Trust B Series I

International Equity Index Trust B Series NAV

International Growth Stock Trust Series I

International Growth Stock Trust Series NAV

International Small Company Trust Series I

International Small Company Trust Series NAV

International Value Trust Series I

International Value Trust Series NAV

Investment Quality Bond Trust Series I

Investment Quality Bond Trust Series NAV

Lifestyle Aggressive MVP Series I

Lifestyle Aggressive MVP Series NAV

Lifestyle Aggressive Trust PS Series NAV

Lifestyle Balanced MVP Series I

Lifestyle Balanced MVP Series NAV

Lifestyle Balanced Trust PS Series NAV

Lifestyle Conservative MVP Series I

Lifestyle Conservative MVP Series NAV

Lifestyle Conservative Trust PS Series NAV

Lifestyle Growth MVP Series I

Lifestyle Growth MVP Series NAV

Lifestyle Growth Trust PS Series NAV

Lifestyle Moderate MVP Series I

Lifestyle Moderate MVP Series NAV

Lifestyle Moderate Trust PS Series NAV

M Capital Appreciation

M International Equity

M Large Cap Growth

M Large Cap Value

Mid Cap Index Trust Series I

Mid Cap Index Trust Series NAV

Mid Cap Stock Trust Series I

Mid Cap Stock Trust Series NAV

Mid Value Trust Series I

Mid Value Trust Series NAV

Money Market Trust B Series NAV

Money Market Trust Series I

PIMCO All Asset

Real Estate Securities Trust Series I

Real Estate Securities Trust Series NAV

Real Return Bond Trust Series I

Real Return Bond Trust Series NAV

Science & Technology Trust Series I

Science & Technology Trust Series NAV

Short Term Government Income Trust Series I

Short Term Government Income Trust Series NAV

Small Cap Growth Trust Series I

 

 

3


Table of Contents

Small Cap Growth Trust Series NAV

Small Cap Index Trust Series I

Small Cap Index Trust Series NAV

Small Cap Opportunities Trust Series I

Small Cap Opportunities Trust Series NAV

Small Cap Value Trust Series I

Small Cap Value Trust Series NAV

Small Company Value Trust Series I

Small Company Value Trust Series NAV

Strategic Income Opportunities Trust Series I

Strategic Income Opportunities Trust Series NAV

Total Bond Market Trust B Series NAV

Total Return Trust Series I

Total Return Trust Series NAV

Total Stock Market Index Trust Series I

Total Stock Market Index Trust Series NAV

U.S. Equity Trust Series I

U.S. Equity Trust Series NAV

Ultra Short Term Bond Trust Series I

Ultra Short Term Bond Trust Series NAV

Utilities Trust Series I

Utilities Trust Series NAV

Value Trust Series I

Value Trust Series NAV

 

 

as of December 31, 2014, and the related statements of operations and changes in contract owners’ equity and unit values disclosure for the above mentioned sub-accounts and for the Fundamental Value Trust Series I, Fundamental Value Trust Series NAV, Natural Resources Trust Series I and Natural Resources Trust Series NAV (the “closed sub-accounts”) for each of the years or periods indicated therein. These financial statements and unit values disclosure are the responsibility of the Account’s management. Our responsibility is to express an opinion on these financial statements and unit values disclosure based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and unit values disclosure are free of material misstatement. We were not engaged to perform an audit of the Account’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Account’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and unit values disclosure, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of December 31, 2014, by correspondence with the fund companies, or their transfer agents, as applicable. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements and unit values disclosure referred to above present fairly, in all material respects, the financial position of each of the above mentioned sub-accounts constituting John Hancock Life Insurance Company (U.S.A.) Separate Account A at December 31, 2014, the results of their and the closed sub-accounts’ operations, changes in contract owners’ equity and unit values disclosure for the years or periods indicated therein in conformity with U.S. generally accepted accounting principles.

/s/ ERNST & YOUNG LLP

Toronto, Canada

March 27, 2015

 

4


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

     500 Index Fund B
Series NAV
    Active Bond Trust
Series I
    Active Bond Trust
Series NAV
    All Cap Core Trust
Series I
    All Cap Core Trust
Series NAV
    Alpha Opportunities
Trust Series I
 

Total Assets

            

Investments at fair value

   $ 195,957,385      $ 6,926,958      $ 14,875,557      $ 9,557,854      $ 6,162,578      $ 710,791   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

     5,455,186        317,786        209,301        295,594        304,677        30,871   

Unit value

   $ 35.92      $ 21.80      $ 71.07      $ 32.33      $ 20.23      $ 23.02   

Shares

     7,630,739        701,109        1,504,101        349,848        225,488        52,264   

Cost

   $ 140,350,543      $ 6,758,007      $ 15,115,453      $ 6,326,303      $ 4,703,939      $ 742,704   

 

See accompanying notes.

 

5


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Alpha Opportunities
Trust Series NAV
    American Asset
Allocation  Trust
Series I
    American Global
Growth Trust Series I
    American Growth
Trust Series I
    American Growth-
Income Trust Series I
    American
International  Trust

Series I
 

Total Assets

           

Investments at fair value

  $ 3,337,656      $ 73,501,059      $ 5,353,454      $ 62,572,781      $ 88,901,950      $ 39,770,316   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    136,948        4,830,178        364,648        2,634,239        3,705,884        1,879,080   

Unit value

  $ 24.37      $ 15.22      $ 14.68      $ 23.75      $ 23.99      $ 21.16   

Shares

    245,056        4,666,734        337,544        2,599,617        3,704,248        2,155,573   

Cost

  $ 3,615,649      $ 58,868,695      $ 4,858,080      $ 38,761,186      $ 54,454,399      $ 32,700,441   

 

See accompanying notes.

 

6


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    American New
World Trust Series I
    Blue Chip Growth
Trust Series I
    Blue Chip Growth
Trust Series NAV
    Bond Trust Series I     Bond Trust  Series
NAV
    Capital Appreciation
Trust Series I
 

Total Assets

           

Investments at fair value

  $ 7,659,729      $ 38,598,868      $ 42,433,760      $ 1,098,146      $ 7,415,996      $ 27,404,064   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    477,111        768,611        347,031        98,445        664,034        1,106,120   

Unit value

  $ 16.05      $ 50.22      $ 122.28      $ 11.15      $ 11.17      $ 24.77   

Shares

    579,405        1,075,777        1,183,317        80,333        542,899        1,771,433   

Cost

  $ 7,993,393      $ 22,591,579      $ 31,359,327      $ 1,105,266      $ 7,483,849      $ 19,974,718   

 

See accompanying notes.

 

7


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Capital Appreciation
Trust Series NAV
    Capital Appreciation
Value Trust Series I
    Capital Appreciation
Value Trust Series
NAV
    Core Bond Trust
Series I
    Core Bond Trust
Series NAV
    Core Strategy Trust
Series I
 

Total Assets

           

Investments at fair value

  $ 20,286,816      $ 1,095,514      $ 23,504,981      $ 1,334,341      $ 6,459,160      $ 1,821,460   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    834,006        62,652        1,340,340        65,904        397,238        124,068   

Unit value

  $ 24.32      $ 17.49      $ 17.54      $ 20.25      $ 16.26      $ 14.68   

Shares

    1,310,518        85,721        1,840,641        100,933        490,445        121,837   

Cost

  $ 16,964,049      $ 1,132,510      $ 23,161,549      $ 1,383,556      $ 6,620,423      $ 1,752,418   

 

See accompanying notes.

 

8


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Core Strategy Trust
Series NAV
    Emerging Markets
Value Trust Series I
    Emerging Markets
Value Trust Series
NAV
    Equity-Income Trust
Series I
    Equity-Income Trust
Series NAV
    Financial Industries
Trust Series I (f)
 

Total Assets

           

Investments at fair value

  $ 137,715,074      $ 2,786,414      $ 23,237,147      $ 45,429,302      $ 67,615,913      $ 2,807,093   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    9,346,456        197,537        2,051,850        989,889        1,474,866        118,692   

Unit value

  $ 14.73      $ 14.11      $ 11.33      $ 45.89      $ 45.85      $ 23.65   

Shares

    9,205,553        312,729        2,610,915        2,371,049        3,540,100        164,158   

Cost

  $ 131,734,487      $ 3,198,631      $ 26,799,534      $ 32,196,499      $ 57,895,921      $ 2,275,320   

 

(f) Renamed on November 10, 2014. Previously known as Financial Services Trust.

 

See accompanying notes.

 

9


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Financial
Industries Trust
Series (NAV) (f)
    Franklin Templeton
Founding  Allocation
Trust Series I
    Franklin Templeton
Founding  Allocation
Trust Series NAV
    Fundamental
All Cap Core
Trust Series I
    Fundamental All Cap
Core Trust Series
NAV
    Fundamental Large
Cap Value Trust
Series I
 

Total Assets

           

Investments at fair value

  $ 6,196,372      $ 399,504      $ 39,698,400      $ 895,762      $ 12,145,073      $ 39,537,835   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    217,693        27,532        2,728,857        24,558        560,773        1,394,135   

Unit value

  $ 28.46      $ 14.51      $ 14.55      $ 36.48      $ 21.66      $ 28.36   

Shares

    362,998        30,684        3,051,376        39,759        537,155        2,256,726   

Cost

  $ 4,905,448      $ 322,329      $ 37,045,197      $ 690,089      $ 7,841,927      $ 38,979,625   

 

(f) Renamed on November 10, 2014. Previously known as Financial Services Trust.

 

See accompanying notes.

 

10


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Fundamental Large
Cap Value Trust
Series NAV
    Global Bond Trust
Series I
    Global Bond Trust
Series NAV
    Global Trust Series I     Global Trust  Series
NAV
    Health Sciences
Trust Series I
 

Total Assets

           

Investments at fair value

  $ 33,775,779      $ 6,057,693      $ 23,227,393      $ 13,193,154      $ 29,822,462      $ 14,818,723   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    1,691,803        197,307        753,993        413,385        1,727,883        214,618   

Unit value

  $ 19.96      $ 30.70      $ 30.81      $ 31.91      $ 17.26      $ 69.05   

Shares

    1,927,841        482,685        1,858,191        673,808        1,524,666        441,691   

Cost

  $ 31,742,925      $ 6,248,011      $ 23,913,524      $ 12,077,583      $ 29,866,085      $ 11,623,958   

 

See accompanying notes.

 

11


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Health Sciences
Trust Series NAV
    High Yield Trust
Series I
    High Yield Trust
Series NAV
    International Core
Trust Series I
    International Core
Trust Series NAV
    International Equity
Index  Trust B Series I
 

Total Assets

           

Investments at fair value

  $ 29,900,078      $ 14,092,792      $ 26,043,586      $ 13,074,926      $ 10,739,370      $ 12,519,772   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    555,648        440,229        1,232,423        598,981        668,515        1,080,790   

Unit value

  $ 53.81      $ 32.01      $ 21.13      $ 21.83      $ 16.06      $ 11.58   

Shares

    885,141        2,472,420        4,625,859        1,242,864        1,024,749        789,891   

Cost

  $ 24,115,686      $ 14,731,161      $ 27,859,757      $ 13,364,963      $ 10,884,550      $ 11,770,822   

 

See accompanying notes.

 

12


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    International Equity
Index  Trust B Series
NAV
    International Growth
Stock Trust Series I
    International Growth
Stock Trust Series
NAV
    International Small
Company Trust
Series I
    International Small
Company Trust
Series NAV
    International Value
Trust Series I
 

Total Assets

           

Investments at fair value

  $ 39,290,275      $ 1,892,205      $ 8,152,714      $ 6,043,033      $ 12,456,889      $ 14,924,466   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    865,114        152,343        655,754        426,622        877,938        623,344   

Unit value

  $ 45.42      $ 12.42      $ 12.43      $ 14.16      $ 14.19      $ 23.94   

Shares

    2,480,447        114,126        491,720        521,851        1,076,654        1,190,149   

Cost

  $ 38,696,955      $ 1,650,179      $ 7,380,307      $ 6,037,717      $ 11,981,318      $ 14,305,723   

 

See accompanying notes.

 

13


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    International Value
Trust Series NAV
    Investment Quality
Bond  Trust Series I
    Investment Quality
Bond Trust Series
NAV
    Lifestyle Aggressive
MVP Series I (a)
    Lifestyle Aggressive
MVP  Series NAV (a)
    Lifestyle Aggressive
Trust  PS Series NAV
(g)
 

Total Assets

           

Investments at fair value

  $ 21,595,286      $ 12,237,640      $ 8,529,308      $ 16,492,389      $ 175,655,854      $ 523,367   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    1,398,608        361,408        533,765        529,366        9,405,923        48,480   

Unit value

  $ 15.44      $ 33.86      $ 15.98      $ 31.16      $ 18.68      $ 10.80   

Shares

    1,734,561        1,050,441        734,652        1,534,176        16,324,893        40,952   

Cost

  $ 21,931,223      $ 11,996,602      $ 8,722,429      $ 13,025,261      $ 139,624,824      $ 539,131   

 

(a) Renamed on May 5, 2014. Previously known as Lifestyle Aggressive Trust.
(g) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

14


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Lifestyle Balanced
MVP Series I (b)
    Lifestyle Balanced
MVP Series NAV (b)
    Lifestyle Balanced
Trust PS Series NAV

(g)
    Lifestyle
Conservative  MVP
Series I (c)
    Lifestyle
Conservative  MVP

Series NAV (c)
    Lifestyle
Conservative Trust

PS Series NAV (g)
 

Total Assets

           

Investments at fair value

  $ 64,960,646      $ 386,293,903      $ 10,303,233      $ 4,176,785      $ 33,613,861      $ 190,845   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    1,837,744        21,987,612        961,275        119,080        2,049,384        18,028   

Unit value

  $ 35.35      $ 17.57      $ 10.72      $ 35.08      $ 16.40      $ 10.59   

Shares

    4,683,536        27,810,936        727,116        344,619        2,768,852        14,317   

Cost

  $ 54,348,839      $ 335,957,343      $ 10,535,765      $ 4,474,059      $ 35,675,660      $ 195,198   

 

(b) Renamed on May 5, 2014. Previously known as Lifestyle Balanced Trust.
(c) Renamed on May 5, 2014. Previously known as Lifestyle Conservative Trust.
(g) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

15


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Lifestyle Growth
MVP Series I (d)
    Lifestyle Growth
MVP Series NAV (d)
    Lifestyle Growth
Trust PS Series NAV (g)
    Lifestyle Moderate
MVP Series I (e)
    Lifestyle Moderate
MVP Series NAV (e)
    Lifestyle Moderate
Trust PS Series NAV
 

Total Assets

           

Investments at fair value

  $ 87,346,451      $ 551,017,684      $ 11,807,994      $ 15,383,814      $ 80,144,122      $ 2,873,633   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    2,599,268        30,578,139        1,092,740        428,437        4,638,720        269,125   

Unit value

  $ 33.60      $ 18.02      $ 10.81      $ 35.91      $ 17.28      $ 10.68   

Shares

    6,181,631        38,941,179        795,687        1,156,678        6,021,346        206,143   

Cost

  $ 71,672,453      $ 458,861,099      $ 12,000,372      $ 14,687,131      $ 75,706,796      $ 2,937,848   

 

(d) Renamed on May 5, 2014. Previously known as Lifestyle Growth Trust.
(e) Renamed on May 5, 2014. Previously known as Lifestyle Moderate Trust.
(g) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

16


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    M Capital
Appreciation (h)
    M International
Equity (h)
    M Large Cap  Growth
(h)
    M Large Cap Value (h)     Mid Cap Index
Trust  Series I
    Mid Cap Index  Trust
Series NAV
 

Total Assets

           

Investments at fair value

  $ 10,872,872      $ 10,846,758      $ 12,528,015      $ 9,438,622      $ 14,446,262      $ 30,658,742   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    127,810        328,221        249,520        395,748        343,287        1,111,003   

Unit value

  $ 85.07      $ 33.05      $ 50.21      $ 23.85      $ 42.08      $ 27.60   

Shares

    359,791        909,200        523,090        706,484        648,105        1,375,448   

Cost

  $ 9,811,462      $ 10,951,747      $ 10,843,059      $ 8,861,166      $ 11,857,842      $ 26,184,029   

 

(h) Sub-account that invests in non-affiliated Trust.

 

See accompanying notes.

 

17


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Mid Cap Stock  Trust
Series I
    Mid Cap Stock  Trust
Series NAV
    Mid Value Trust
Series I
    Mid Value Trust
Series NAV
    Money Market Trust
B Series NAV
    Money Market Trust
Series I
 

Total Assets

           

Investments at fair value

  $ 21,807,544      $ 23,349,214      $ 13,538,732      $ 19,602,003      $ 88,240,146      $ 34,120,041   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    643,939        316,708        521,052        491,157        5,078,503        1,384,341   

Unit value

  $ 33.87      $ 73.72      $ 25.98      $ 39.91      $ 17.38      $ 24.65   

Shares

    1,171,819        1,245,291        969,823        1,409,202        88,240,146        34,120,041   

Cost

  $ 17,132,818      $ 20,423,057      $ 11,083,290      $ 16,721,911      $ 88,240,146      $ 34,120,041   

 

See accompanying notes.

 

18


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    PIMCO All Asset (h)     Real Estate
Securities Trust
Series I
    Real Estate
Securities Trust
Series NAV
    Real Return Bond
Trust Series I
    Real Return Bond
Trust Series NAV
    Science &
Technology Trust

Series I
 

Total Assets

           

Investments at fair value

  $ 24,125,603      $ 31,721,334      $ 39,373,149      $ 3,388,991      $ 11,636,933      $ 18,892,633   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    1,461,396        190,987        283,445        156,403        779,040        557,374   

Unit value

  $ 16.51      $ 166.09      $ 138.91      $ 21.67      $ 14.94      $ 33.90   

Shares

    2,291,130        1,767,205        2,207,015        282,416        982,849        697,660   

Cost

  $ 25,596,067      $ 20,558,902      $ 29,954,977      $ 3,556,233      $ 12,302,672      $ 12,476,054   

 

(h) Sub-account that invests in non-affiliated Trust.

 

See accompanying notes.

 

19


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Science &
Technology Trust

Series NAV
    Short Term
Government Income

Trust Series I
    Short Term
Government Income

Trust Series NAV
    Small Cap Growth
Trust Series I
    Small Cap Growth
Trust Series NAV
    Small Cap Index
Trust Series I
 

Total Assets

           

Investments at fair value

  $ 13,045,994      $ 6,284,027      $ 11,868,888      $ 2,585,941      $ 16,723,322      $ 9,477,107   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    485,669        591,551        1,114,453        93,566        510,196        291,384   

Unit value

  $ 26.86      $ 10.62      $ 10.65      $ 27.64      $ 32.78      $ 32.52   

Shares

    479,104        507,185        957,941        221,399        1,422,051        615,397   

Cost

  $ 10,511,560      $ 6,554,947      $ 12,268,302      $ 2,427,631      $ 15,293,830      $ 7,694,234   

 

See accompanying notes.

 

20


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Small Cap Index
Trust  Series NAV
    Small Cap
Opportunities Trust

Series I
    Small Cap
Opportunities Trust

Series NAV
    Small Cap Value
Trust Series I
    Small Cap Value
Trust  Series NAV
    Small Company
Value Trust Series I
 

Total Assets

           

Investments at fair value

  $ 20,586,802      $ 35,642,798      $ 15,966,963      $ 3,053,784      $ 23,606,709      $ 13,756,038   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    792,990        903,210        821,726        124,181        341,185        401,390   

Unit value

  $ 25.96      $ 39.46      $ 19.43      $ 24.59      $ 69.19      $ 34.27   

Shares

    1,335,071        1,129,366        508,178        124,087        961,185        556,249   

Cost

  $ 18,806,391      $ 33,561,004      $ 14,112,665      $ 2,799,588      $ 20,739,888      $ 7,792,110   

 

See accompanying notes.

 

21


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Small Company
Value Trust Series
NAV
    Strategic Income
Opportunities Trust
Series I
    Strategic Income
Opportunities Trust
Series NAV
    Total Bond Market
Trust B Series NAV
    Total Return Trust
Series I
    Total Return Trust
Series NAV
 

Total Assets

           

Investments at fair value

  $ 17,573,086      $ 9,148,617      $ 24,082,506      $ 16,086,311      $ 19,444,315      $ 50,209,719   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    770,242        354,263        1,257,663        680,930        647,736        2,783,962   

Unit value

  $ 22.82      $ 25.82      $ 19.15      $ 23.62      $ 30.02      $ 18.04   

Shares

    711,749        690,983        1,824,432        1,552,733        1,411,053        3,659,600   

Cost

  $ 13,573,539      $ 9,458,523      $ 24,801,122      $ 16,246,294      $ 20,210,389      $ 51,913,622   

 

See accompanying notes.

 

22


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

    Total Stock Market
Index  Trust Series I
    Total Stock Market
Index Trust Series
NAV
    U.S. Equity Trust
Series I
    U.S. Equity Trust
Series NAV
    Ultra Short Term
Bond Trust Series I
    Ultra Short Term
Bond Trust Series
NAV
 

Total Assets

           

Investments at fair value

  $ 6,103,702      $ 24,387,055      $ 16,856,166      $ 7,330,065      $ 619,902      $ 3,408,659   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units outstanding

    254,889        305,904        1,152,065        500,073        61,686        338,480   

Unit value

  $ 23.95      $ 79.72      $ 14.63      $ 14.66      $ 10.05      $ 10.07   

Shares

    329,396        1,316,796        869,323        377,838        52,534        288,869   

Cost

  $ 4,140,978      $ 19,985,329      $ 12,795,899      $ 5,992,743      $ 632,976      $ 3,470,917   

 

See accompanying notes.

 

23


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Assets and Liabilities

December 31, 2014

 

     Utilities Trust Series I      Utilities Trust  Series
NAV
     Value Trust Series I      Value Trust  Series
NAV
 

Total Assets

           

Investments at fair value

   $ 4,884,453       $ 15,057,635       $ 16,879,093       $ 12,883,998   
  

 

 

    

 

 

    

 

 

    

 

 

 

Units outstanding

     130,870         503,945         289,978         474,386   

Unit value

   $ 37.32       $ 29.88       $ 58.21       $ 27.16   

Shares

     300,212         926,054         655,753         501,128   

Cost

   $ 4,523,510       $ 13,312,605       $ 11,450,956       $ 11,230,824   

 

See accompanying notes.

 

24


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     500 Index Fund B Series NAV     Active Bond Trust Series I     Active Bond Trust Series NAV  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 2,956,414      $ 2,624,516      $ 259,463      $ 412,588      $ 523,176      $ 612,010   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,956,414        2,624,516        259,463        412,588        523,176        612,010   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     2,621,128        295,940        —          —          —          —     

Net realized gain (loss)

     5,688,084        5,224,430        83,253        66,977        13,453        88,722   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     8,309,212        5,520,370        83,253        66,977        13,453        88,722   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     11,122,495        30,484,430        127,603        (463,796     261,782        (685,798
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     22,388,121        38,629,316        470,319        15,769        798,411        14,934   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     13,822,212        11,381,524        233,165        272,269        1,554,161        1,297,749   

Transfers between sub-accounts and the company

     13,859,257        5,098,343        8,548        463,540        3,166,128        1,510,557   

Transfers on general account policy loans

     (945,803     567,264        (12,343     4,482        (48,535     (94,774

Withdrawals

     (4,953,023     (6,692,999     (344,511     (538,847     (281,047     (445,359

Annual contract fee

     (9,031,080     (8,359,789     (457,944     (618,689     (664,808     (557,215
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     12,751,563        1,994,343        (573,085     (417,245     3,725,899        1,710,958   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     35,139,684        40,623,659        (102,766     (401,476     4,524,310        1,725,892   

Contract owners’ equity at beginning of period

     160,817,701        120,194,042        7,029,724        7,431,200        10,351,247        8,625,355   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 195,957,385      $ 160,817,701      $ 6,926,958      $ 7,029,724      $ 14,875,557      $ 10,351,247   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     5,193,556        5,257,617        344,467        365,032        155,794        130,071   

Units issued

     761,283        680,558        20,020        42,862        80,245        62,216   

Units redeemed

     (499,653     (744,619     (46,701     (63,427     (26,738     (36,493
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     5,455,186        5,193,556        317,786        344,467        209,301        155,794   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

25


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     All Cap Core Trust Series I     All Cap Core Trust Series NAV     All Cap Value Trust Series I  
     2014     2013     2014     2013     2014      2013 (l)  

Income:

             

Dividend distributions received

   $ 89,100      $ 110,947      $ 58,160      $ 66,908      $ —         $ 50,599   

Expenses:

             

Mortality and expense risk and administrative charges

     —          —          —          —          —           —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net investment income (loss)

     89,100        110,947        58,160        66,908        —           50,599   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Realized gains (losses) on investments:

             

Capital gain distributions received

     —          —          —          —          —           2,035,055   

Net realized gain (loss)

     326,438        236,985        265,930        114,157        —           (648,738
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Realized gains (losses)

     326,438        236,985        265,930        114,157        —           1,386,317   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Unrealized appreciation (depreciation) during the period

     460,242        2,180,410        209,774        1,039,225        —           (426,745
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     875,780        2,528,342        533,864        1,220,290        —           1,010,171   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Changes from principal transactions:

             

Purchase payments

     318,940        288,070        365,103        295,525        —           159,159   

Transfers between sub-accounts and the company

     (204,494     (43,608     (3,584     1,922,583        —           (4,220,797

Transfers on general account policy loans

     (29,305     7,748        (234,256     8,572        —           (22,547

Withdrawals

     (364,443     (329,631     (26,776     (71,352     —           (120,171

Annual contract fee

     (592,210     (585,336     (223,097     (182,643     —           (166,293
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (871,512     (662,757     (122,610     1,972,685        —           (4,370,649
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total increase (decrease) in contract owners’ equity

     4,268        1,865,585        411,254        3,192,975        —           (3,360,478

Contract owners’ equity at beginning of period

     9,553,586        7,688,001        5,751,324        2,558,349        —           3,360,478   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Contract owners’ equity at end of period

   $ 9,557,854      $ 9,553,586      $ 6,162,578      $ 5,751,324      $ —         $ —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 
     2014     2013     2014     2013     2014      2013  

Units, beginning of period

     323,940        350,155        311,894        186,517        —           155,792   

Units issued

     5,420        6,479        36,999        149,916        —           20,553   

Units redeemed

     (33,766     (32,694     (44,216     (24,539     —           (176,345
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Units, end of period

     295,594        323,940        304,677        311,894        —           —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

(l) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013.

 

See accompanying notes.

 

26


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     All Cap Value Trust Series NAV     Alpha Opportunities Trust Series I     Alpha Opportunities Trust Series NAV  
     2014      2013 (l)     2014     2013     2014     2013  

Income:

             

Dividend distributions received

   $ —         $ 115,170      $ 3,972      $ 5,817      $ 20,319      $ 17,688   

Expenses:

             

Mortality and expense risk and administrative charges

     —           —          —          —          —          —     
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —           115,170        3,972        5,817        20,319        17,688   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

             

Capital gain distributions received

     —           4,475,322        170,125        76,237        768,630        217,803   

Net realized gain (loss)

     —           (2,540,895     80,662        (7,086     50,496        39,874   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     —           1,934,427        250,787        69,151        819,126        257,677   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     —           (196,276     (179,644     141,537        (574,119     280,448   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     —           1,853,321        75,115        216,505        265,326        555,813   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

             

Purchase payments

     —           995,627        19,378        16,511        264,526        230,259   

Transfers between sub-accounts and the company

     —           (7,736,856     (104,979     32,701        372,794        747,707   

Transfers on general account policy loans

     —           (28,265     —          —          (31,252     (22,339

Withdrawals

     —           (74,272     (70,124     (22,246     (23,602     (34,997

Annual contract fee

     —           (521,918     (34,977     (41,709     (155,814     (99,508
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     —           (7,365,684     (190,702     (14,743     426,652        821,122   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     —           (5,512,363     (115,587     201,762        691,978        1,376,935   

Contract owners’ equity at beginning of period

     —           5,512,363        826,378        624,616        2,645,678        1,268,743   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ —         $ —        $ 710,791      $ 826,378      $ 3,337,656      $ 2,645,678   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014      2013     2014     2013     2014     2013  

Units, beginning of period

     —           353,453        38,762        39,715        117,365        76,310   

Units issued

     —           184,527        8,333        5,285        63,228        56,247   

Units redeemed

     —           (537,980     (16,224     (6,238     (43,645     (15,192
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     —           —          30,871        38,762        136,948        117,365   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(l) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013.

 

See accompanying notes.

 

27


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    American Asset Allocation Trust
Series I
    American Global Growth  Trust
Series I
    American Global Small Capitalization
Trust Series I
 
    2014     2013     2014     2013     2014     2013 (j)  

Income:

           

Dividend distributions received

  $ 1,099,377      $ 554,921      $ 43,138      $ 28,919      $ —        $ 2,223   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    1,099,377        554,921        43,138        28,919        —          2,223   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          —          —     

Net realized gain (loss)

    3,108,191        1,834,063        149,385        103,812        —          89,167   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    3,108,191        1,834,063        149,385        103,812        —          89,167   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (1,250,243     7,090,449        (70,019     464,125        —          (17,725
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    2,957,325        9,479,433        122,504        596,856        —          73,665   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    5,506,102        4,137,339        710,804        350,533        —          36,374   

Transfers between sub-accounts and the company

    11,942,340        8,039,511        1,296,543        1,390,000        —          (657,288

Transfers on general account policy loans

    3,212,309        69,023        (22,920     226,769        —          —     

Withdrawals

    (1,603,111     (2,238,935     (71,711     (29,713     —          (107

Annual contract fee

    (3,574,501     (2,934,405     (241,219     (148,948     —          (19,548
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    15,483,139        7,072,533        1,671,497        1,788,641        —          (640,569
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    18,440,464        16,551,966        1,794,001        2,385,497        —          (566,904

Contract owners’ equity at beginning of period

    55,060,595        38,508,629        3,559,453        1,173,956        —          566,904   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 73,501,059      $ 55,060,595      $ 5,353,454      $ 3,559,453      $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    3,800,999        3,277,724        247,209        104,871        —          58,806   

Units issued

    1,554,254        904,788        160,060        231,983        —          45,007   

Units redeemed

    (525,075     (381,513     (42,621     (89,645     —          (103,813
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    4,830,178        3,800,999        364,648        247,209        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(j) Terminated as an investment option and funds transferred to American Global Growth Trust on April 29, 2013.

 

See accompanying notes.

 

28


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    American Growth Trust
Series I
    American Growth-Income Trust
Series  I
    American High-Income Bond Trust
Series  I
 
    2014     2013     2014     2013     2014     2013 (o)  

Income:

           

Dividend distributions received

  $ 508,426      $ 285,739      $ 787,727      $ 748,145      $ —        $ 2,035   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    508,426        285,739        787,727        748,145        —          2,035   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          —          63,401   

Net realized gain (loss)

    1,356,956        455,400        4,796,381        2,951,725        —          (49,594
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    1,356,956        455,400        4,796,381        2,951,725        —          13,807   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    2,886,196        12,575,826        2,811,148        17,410,823        —          53,964   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    4,751,578        13,316,965        8,395,256        21,110,693        —          69,806   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    3,920,757        3,908,250        4,784,311        5,152,819        —          149,027   

Transfers between sub-accounts and the company

    754,981        389,819        475,749        (721,205     —          (2,449,902

Transfers on general account policy loans

    (703,172     (210,581     (768,079     (347,956     —          (6,790

Withdrawals

    (1,635,977     (1,914,230     (2,925,126     (4,381,111     —          (1,531

Annual contract fee

    (2,753,437     (2,621,279     (4,110,003     (3,939,889     —          (52,644
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (416,848     (448,021     (2,543,148     (4,237,342     —          (2,361,840
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    4,334,730        12,868,944        5,852,108        16,873,351        —          (2,292,034

Contract owners’ equity at beginning of period

    58,238,051        45,369,108        83,049,842        66,176,491        —          2,292,034   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 62,572,781      $ 58,238,052      $ 88,901,950      $ 83,049,842      $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    2,636,896        2,640,584        3,776,062        3,950,515        —          199,413   

Units issued

    260,527        306,323        320,384        246,385        —          49,954   

Units redeemed

    (263,184     (310,011     (390,562     (420,838     —          (249,367
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    2,634,239        2,636,896        3,705,884        3,776,062        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(o) Terminated as an investment option and funds transferred to High Yield Trust on April 29, 2013.

 

See accompanying notes.

 

29


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    American International Trust Series I     American New World Trust Series I     Blue Chip Growth Trust Series I  
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 415,577      $ 380,396      $ 65,464      $ 60,540      $ —        $ 88,247   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    415,577        380,396        65,464        60,540        —          88,247   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          185,939        —          1,476,283        —     

Net realized gain (loss)

    1,492,731        (712,353     143,918        36,780        2,200,174        2,086,380   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    1,492,731        (712,353     329,857        36,780        3,676,457        2,086,380   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (3,204,471     7,863,351        (1,035,029     508,131        (430,505     9,169,546   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (1,296,163     7,531,394        (639,708     605,451        3,245,952        11,344,173   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    3,695,885        3,670,504        896,496        590,109        1,184,730        1,347,419   

Transfers between sub-accounts and the company

    (2,127,750     (652,283     1,397,386        2,143,555        (250,786     (735,776

Transfers on general account policy loans

    (251,743     (32,753     18,483        (28,457     (133,206     28,971   

Withdrawals

    (1,318,630     (2,183,663     (361,548     (29,215     (1,093,704     (1,493,344

Annual contract fee

    (1,712,905     (1,970,816     (413,972     (309,675     (1,998,866     (1,860,740
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (1,715,143     (1,169,011     1,536,845        2,366,317        (2,291,832     (2,713,470
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (3,011,306     6,362,383        897,137        2,971,768        954,120        8,630,703   

Contract owners’ equity at beginning of period

    42,781,622        36,419,239        6,762,592        3,790,824        37,644,748        29,014,045   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 39,770,316      $ 42,781,622      $ 7,659,729      $ 6,762,592      $ 38,598,868      $ 37,644,748   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    1,957,216        1,966,071        386,645        240,337        817,615        890,596   

Units issued

    238,722        269,939        172,807        176,265        66,046        69,662   

Units redeemed

    (316,858     (278,794     (82,341     (29,957     (115,050     (142,643
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,879,080        1,957,216        477,111        386,645        768,611        817,615   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

30


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Blue Chip Growth Trust Series NAV     Bond Trust Series I     Bond Trust Series NAV  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ —        $ 85,601      $ 28,805      $ 22,128      $ 190,090      $ 160,269   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —          85,601        28,805        22,128        190,090        160,269   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     1,576,300        —          —          6,613        —          40,421   

Net realized gain (loss)

     2,450,446        1,286,414        (921     (3,559     (10,586     (3,646
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     4,026,746        1,286,414        (921     3,054        (10,586     36,775   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (648,784     7,745,369        24,441        (38,539     176,416        (270,267
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     3,377,962        9,117,384        52,325        (13,357     355,920        (73,223
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     4,405,252        3,212,884        37,542        17,743        770,991        831,613   

Transfers between sub-accounts and the company

     4,035,574        3,292,250        402,935        (60,426     1,368,752        (345,869

Transfers on general account policy loans

     (261,679     (366,889     289        631        (13,274     (38,017

Withdrawals

     (1,075,807     (766,764     (13,780     (184,777     (151,167     (41,497

Annual contract fee

     (1,869,498     (1,401,146     (75,017     (50,711     (403,985     (324,641
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     5,233,842        3,970,335        351,969        (277,540     1,571,317        81,589   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     8,611,804        13,087,719        404,294        (290,897     1,927,237        8,366   

Contract owners’ equity at beginning of period

     33,821,956        20,734,237        693,852        984,749        5,488,759        5,480,393   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 42,433,760      $ 33,821,956      $ 1,098,146      $ 693,852      $ 7,415,996      $ 5,488,759   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     301,803        261,673        65,646        91,895        518,925        511,316   

Units issued

     90,119        80,867        40,761        9,894        239,782        78,521   

Units redeemed

     (44,891     (40,737     (7,962     (36,143     (94,673     (70,912
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     347,031        301,803        98,445        65,646        664,034        518,925   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

31


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Capital Appreciation Trust Series I     Capital Appreciation Trust Series NAV     Capital Appreciation Value Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 12,279      $ 57,538      $ 16,277      $ 36,926      $ 17,748      $ 9,042   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     12,279        57,538        16,277        36,926        17,748        9,042   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     2,825,406        —          2,112,416        —          285,644        42,060   

Net realized gain (loss)

     2,257,611        2,250,595        1,437,824        921,638        (95,592     105,924   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     5,083,017        2,250,595        3,550,240        921,638        190,052        147,984   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (2,691,578     5,272,530        (1,846,723     3,697,683        (58,251     12,675   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     2,403,718        7,580,663        1,719,794        4,656,247        149,549        169,701   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     992,102        1,021,894        1,789,466        1,510,497        15,429        7,068   

Transfers between sub-accounts and the company

     616,061        (2,520,733     1,269,176        217,293        191,556        221,554   

Transfers on general account policy loans

     37,679        (300,030     (132,234     (154,515     —          —     

Withdrawals

     (1,608,353     (2,080,913     (591,537     (314,612     (103,186     (2,683

Annual contract fee

     (1,402,382     (1,336,167     (843,886     (826,615     (36,884     (25,767
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,364,893     (5,215,949     1,490,985        432,048        66,915        200,172   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     1,038,825        2,364,714        3,210,779        5,088,295        216,464        369,873   

Contract owners’ equity at beginning of period

     26,365,239        24,000,525        17,076,037        11,987,742        879,050        509,177   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 27,404,064      $ 26,365,239      $ 20,286,816      $ 17,076,037      $ 1,095,514      $ 879,050   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     1,166,905        1,459,620        769,990        743,281        56,419        39,971   

Units issued

     165,882        39,614        246,142        191,180        165,007        105,253   

Units redeemed

     (226,667     (332,329     (182,126     (164,471     (158,774     (88,805
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,106,120        1,166,905        834,006        769,990        62,652        56,419   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

32


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Capital Appreciation Value Trust
Series NAV
    Core Allocation Plus  Trust
Series I
    Core Allocation Plus  Trust
Series NAV
 
    2014     2013     2014     2013 (k)     2014     2013 (k)  

Income:

           

Dividend distributions received

  $ 316,266      $ 189,663      $ —        $ 4,063      $ —        $ 438,094   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    316,266        189,663        —          4,063        —          438,094   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    2,361,804        1,187,673        —          42,871        —          4,529,431   

Net realized gain (loss)

    221,852        329,890        —          (26,155     —          (2,614,562
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    2,583,656        1,517,563        —          16,716        —          1,914,869   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (589,726     902,712        —          905        —          (56,852
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    2,310,196        2,609,938        —          21,684        —          2,296,111   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    4,156,796        2,699,807        —          2,809        —          1,993,416   

Transfers between sub-accounts and the company

    2,433,750        1,012,843        —          (109,595     —          (14,077,647

Transfers on general account policy loans

    (48,709     (15,276     —          —          —          32,280   

Withdrawals

    (132,538     (163,692     —          (10,391     —          (101,070

Annual contract fee

    (1,043,980     (820,182     —          (9,630     —          (521,736
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    5,365,319        2,713,500        —          (126,807     —          (12,674,757
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    7,675,515        5,323,438        —          (105,123     —          (10,378,646

Contract owners’ equity at beginning of period

    15,829,466        10,506,028        —          105,123        —          10,378,646   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 23,504,981      $ 15,829,466      $ —        $ —        $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    1,014,374        823,375        —          9,908        —          976,502   

Units issued

    449,486        431,231        —          2,958        —          277,936   

Units redeemed

    (123,520     (240,232     —          (12,866     —          (1,254,438
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,340,340        1,014,374        —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(k) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

33


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Core Bond Trust Series I     Core Bond Trust Series NAV     Core Strategy Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 39,393      $ 29,040      $ 168,146      $ 86,323      $ 43,934      $ 10,496   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     39,393        29,040        168,146        86,323        43,934        10,496   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          51,633        —          149,990        5,865        39,770   

Net realized gain (loss)

     (28,112     (11,158     (31,962     (25,328     31,443        4,500   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (28,112     40,475        (31,962     124,662        37,308        44,270   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     63,951        (103,269     128,708        (266,523     28,265        27,450   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     75,232        (33,754     264,892        (55,538     109,507        82,216   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     27,803        49,863        577,775        320,377        54,769        11,765   

Transfers between sub-accounts and the company

     137,901        (282,961     1,981,497        32,560        8,048        1,566,231   

Transfers on general account policy loans

     (77,082     (1,120     (36,519     (15,240     3,826        399   

Withdrawals

     (90,978     (359,696     (113,060     (52,803     (68,562     (13,959

Annual contract fee

     (52,921     (55,365     (203,647     (160,213     (120,786     (22,838
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (55,277     (649,279     2,206,046        124,681        (122,705     1,541,598   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     19,955        (683,033     2,470,938        69,143        (13,198     1,623,814   

Contract owners’ equity at beginning of period

     1,314,386        1,997,419        3,988,222        3,919,079        1,834,658        210,844   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 1,334,341      $ 1,314,386      $ 6,459,160      $ 3,988,222      $ 1,821,460      $ 1,834,658   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     68,770        102,252        260,011        250,101        132,601        18,159   

Units issued

     18,989        11,717        168,247        141,979        7,606        117,141   

Units redeemed

     (21,855     (45,199     (31,020     (132,069     (16,139     (2,699
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     65,904        68,770        397,238        260,011        124,068        132,601   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

34


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Core Strategy  Trust
Series NAV
    Disciplined Diversification  Trust
Series I
    Disciplined Diversification  Trust
Series NAV
 
    2014     2013     2014     2013 (k)     2014     2013 (k)  

Income:

           

Dividend distributions received

  $ 3,370,634      $ 707,731      $ —        $ 9,200      $ —        $ 873,169   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    3,370,634        707,731        —          9,200        —          873,169   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    419,244        5,078,114        —          107,691        —          10,039,703   

Net realized gain (loss)

    1,782,772        1,070,795        —          (62,422     —          (6,067,296
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    2,202,016        6,148,909        —          45,269        —          3,972,407   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    1,667,344        2,415,845        —          (19,910     —          (1,819,271
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    7,239,994        9,272,485        —          34,559        —          3,026,305   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    19,179,849        8,596,810        —          9,303        —          4,214,414   

Transfers between sub-accounts and the company

    4,352,552        62,282,846        —          (224,967     —          (23,163,292

Transfers on general account policy loans

    2,989,176        (106,619     —          —          —          (18,492

Withdrawals

    (1,742,229     (557,476     —          (88,912     —          (2,447,175

Annual contract fee

    (8,071,278     (4,191,234     —          (13,325     —          (1,320,580
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    16,708,070        66,024,327        —          (317,901     —          (22,735,125
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    23,948,064        75,296,812        —          (283,342     —          (19,708,820

Contract owners’ equity at beginning of period

    113,767,010        38,470,198        —          283,342        —          19,708,820   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 137,715,074      $ 113,767,010      $ —        $ —        $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    8,195,796        3,305,943        —          24,668        —          1,711,669   

Units issued

    1,984,040        5,444,561        —          3,810        —          641,526   

Units redeemed

    (833,380     (554,708     —          (28,478     —          (2,353,195
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    9,346,456        8,195,796        —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(k) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

35


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Emerging Markets Value
Trust Series I
    Emerging Markets Value Trust
Series NAV
    Equity-Income Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 62,531      $ 43,184      $ 467,704      $ 283,828      $ 833,083      $ 821,593   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     62,531        43,184        467,704        283,828        833,083        821,593   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     124,675        112,489        834,321        714,679        3,930,791        —     

Net realized gain (loss)

     (87,721     (1,480,361     (728,340     (1,017,333     962,520        148,307   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     36,954        (1,367,872     105,981        (302,654     4,893,311        148,307   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (205,263     1,301,611        (1,974,817     (455,821     (2,408,611     10,642,298   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     (105,778     (23,077     (1,401,132     (474,647     3,317,783        11,612,198   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     111,950        145,531        3,287,268        2,571,174        1,499,423        1,742,219   

Transfers between sub-accounts and the company

     (461,557     (4,453,939     641,526        5,624,085        (833,202     (3,616,934

Transfers on general account policy loans

     14,781        (470     (163,714     (155,720     9,159        (13,066

Withdrawals

     (85,590     (131,422     (174,379     (270,196     (2,273,467     (2,513,044

Annual contract fee

     (121,959     (132,640     (1,074,594     (933,040     (2,373,633     (2,442,320
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (542,375     (4,572,940     2,516,107        6,836,303        (3,971,720     (6,843,145
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (648,153     (4,596,017     1,114,975        6,361,656        (653,937     4,769,053   

Contract owners’ equity at beginning of period

     3,434,567        8,030,584        22,122,172        15,760,516        46,083,239        41,314,186   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 2,786,414      $ 3,434,567      $ 23,237,147      $ 22,122,172      $ 45,429,302      $ 46,083,239   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     230,094        520,696        1,848,613        1,275,136        1,079,152        1,258,128   

Units issued

     33,735        43,648        587,015        932,353        19,581        52,805   

Units redeemed

     (66,292     (334,250     (383,778     (358,876     (108,844     (231,781
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     197,537        230,094        2,051,850        1,848,613        989,889        1,079,152   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

36


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Equity-Income Trust Series NAV     Financial Industries Trust Series I     Financial Industries Trust Series NAV  
     2014     2013     2014 (g)     2013     2014 (g)     2013  

Income:

            

Dividend distributions received

   $ 1,243,656      $ 1,098,431      $ 16,840      $ 13,024      $ 44,936      $ 28,872   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,243,656        1,098,431        16,840        13,024        44,936        28,872   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     5,614,392        —          —          21,553        —          44,507   

Net realized gain (loss)

     2,561,506        2,401,261        35,367        467,627        220,159        288,020   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     8,175,898        2,401,261        35,367        489,180        220,159        332,527   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (4,692,964     10,055,300        144,622        167,854        231,070        733,810   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     4,726,590        13,554,992        196,829        670,058        496,165        1,095,209   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     5,973,382        5,156,960        84,921        106,021        527,894        417,569   

Transfers between sub-accounts and the company

     202,974        4,067,095        438,285        (160,920     987,507        316,379   

Transfers on general account policy loans

     (454,234     (339,164     (1,403     (3,474     (87,072     (30,117

Withdrawals

     (1,584,327     (1,329,194     (55,724     (123,835     (160,956     (73,734

Annual contract fee

     (2,550,694     (2,433,539     (73,865     (84,633     (302,751     (255,273
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     1,587,101        5,122,158        392,214        (266,841     964,622        374,824   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     6,313,691        18,677,150        589,043        403,217        1,460,787        1,470,033   

Contract owners’ equity at beginning of period

     61,302,222        42,625,072        2,218,050        1,814,833        4,735,585        3,265,552   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 67,615,913      $ 61,302,222      $ 2,807,093      $ 2,218,050      $ 6,196,372      $ 4,735,585   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     1,438,076        1,300,405        101,898        109,014        180,754        163,112   

Units issued

     228,900        351,090        22,363        77,616        61,397        70,725   

Units redeemed

     (192,110     (213,419     (5,569     (84,732     (24,458     (53,083
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,474,866        1,438,076        118,692        101,898        217,693        180,754   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g) Renamed on November 10, 2014. Previously known as Financial Services Trust.

 

See accompanying notes.

 

37


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Franklin Templeton Founding Allocation
Trust Series I
    Franklin Templeton Founding Allocation
Trust Series NAV
    Fundamental All Cap Core Trust
Series I
 
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 12,700      $ 8,822      $ 1,278,471      $ 641,749      $ 3,535      $ 14,132   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     12,700        8,822        1,278,471        641,749        3,535        14,132   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          —          —          —     

Net realized gain (loss)

     28,160        56,708        788,637        290,616        356,496        51,712   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     28,160        56,708        788,637        290,616        356,496        51,712   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (28,843     19,139        (1,200,985     2,872,939        (267,603     360,012   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     12,017        84,669        866,123        3,805,304        92,428        425,856   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     4,076        4,279        3,659,276        2,750,356        19,023        30,213   

Transfers between sub-accounts and the company

     27,920        (2,253     9,076,309        9,044,921        (840,249     621,366   

Transfers on general account policy loans

     —          —          (68,611     1,320        8,264        7,844   

Withdrawals

     (25,027     (73,509     (270,077     (136,714     (26,591     (70,244

Annual contract fee

     (12,165     (9,554     (1,594,623     (1,097,588     (51,569     (113,965
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (5,196     (81,037     10,802,274        10,562,295        (891,122     475,214   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     6,821        3,632        11,668,397        14,367,599        (798,694     901,070   

Contract owners’ equity at beginning of period

     392,683        389,051        28,030,003        13,662,404        1,694,456        793,386   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 399,504      $ 392,683      $ 39,698,400      $ 28,030,003      $ 895,762      $ 1,694,456   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     27,876        34,365        1,985,708        1,205,044        50,985        32,437   

Units issued

     3,534        3,186        928,425        887,567        3,439        25,604   

Units redeemed

     (3,878     (9,675     (185,276     (106,903     (29,866     (7,056
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     27,532        27,876        2,728,857        1,985,708        24,558        50,985   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

38


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Fundamental All Cap Core Trust
Series NAV
    Fundamental Holdings  Trust
Series I
    Fundamental Large Cap  Value
Trust Series I
 
     2014     2013     2014      2013 (k)     2014     2013  

Income:

             

Dividend distributions received

   $ 52,401      $ 105,337      $ —         $ 86,540      $ 209,238      $ 15,550   

Expenses:

             

Mortality and expense risk and administrative charges

     —          —          —           —          —          —     
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     52,401        105,337        —           86,540        209,238        15,550   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

             

Capital gain distributions received

     —          —          —           1,662,305        —          —     

Net realized gain (loss)

     898,753        795,919        —           (828,090     372,776        116,148   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     898,753        795,919        —           834,215        372,776        116,148   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     123,164        2,363,455        —           (324,323     193,541        301,292   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,074,318        3,264,711        —           596,432        775,555        432,990   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

             

Purchase payments

     798,243        942,472        —           625,858        411,039        41,231   

Transfers between sub-accounts and the company

     (1,098,849     1,107,176        —           (4,888,680     33,551,739        4,802,310   

Transfers on general account policy loans

     (106,535     (172,602     —           32,601        (65,726     (255

Withdrawals

     (383,175     (212,152     —           (69,684     (602,464     (66,073

Annual contract fee

     (648,811     (622,000     —           (346,564     (566,126     (101,522
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,439,127     1,042,894        —           (4,646,469     32,728,462        4,675,691   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (364,809     4,307,605        —           (4,050,037     33,504,017        5,108,681   

Contract owners’ equity at beginning of period

     12,509,882        8,202,277        —           4,050,037        6,033,818        925,137   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 12,145,073      $ 12,509,882      $ —         $ —        $ 39,537,835      $ 6,033,818   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 
     2014     2013     2014      2013     2014     2013  

Units, beginning of period

     634,270        565,017        —           276,226        235,331        47,777   

Units issued

     73,628        218,745        —           73,385        1,238,799        221,009   

Units redeemed

     (147,125     (149,492     —           (349,611     (79,995     (33,455
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Units, end of period

     560,773        634,270        —           —          1,394,135        235,331   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

(k) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

39


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Fundamental Large Cap Value Trust
Series NAV
    Fundamental Value  Trust
Series I
    Fundamental Value  Trust
Series NAV
 
    2014     2013     2014 (m)     2013     2014 (m)     2013  

Income:

           

Dividend distributions received

  $ 205,822      $ 56,305      $ 547,688      $ 403,613      $ 220,648      $ 157,663   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    205,822        56,305        547,688        403,613        220,648        157,663   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          7,675,158        —          3,009,845        —     

Net realized gain (loss)

    626,451        316,738        9,616,529        1,353,297        1,874,769        691,623   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    626,451        316,738        17,291,687        1,353,297        4,884,614        691,623   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    886,595        903,878        (15,550,163     7,222,950        (4,193,298     2,539,629   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    1,718,868        1,276,921        2,289,212        8,979,860        911,964        3,388,915   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    2,539,701        844,887        1,173,954        1,522,382        844,818        1,127,570   

Transfers between sub-accounts and the company

    16,130,512        11,495,413        (35,046,674     (413,390     (13,989,253     (885,989

Transfers on general account policy loans

    (153,814     (1,589     (63,375     (64,625     (90,519     (60,761

Withdrawals

    (594,142     (62,526     (990,035     (1,766,571     (256,071     (121,824

Annual contract fee

    (968,659     (273,650     (1,719,617     (2,010,891     (429,156     (516,731
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    16,953,598        12,002,535        (36,645,747     (2,733,095     (13,920,181     (457,735
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    18,672,466        13,279,456        (34,356,535     6,246,765        (13,008,217     2,931,180   

Contract owners’ equity at beginning of period

    15,103,313        1,823,857        34,356,535        28,109,770        13,008,217        10,077,037   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 33,775,779      $ 15,103,313      $ —        $ 34,356,535      $ —        $ 13,008,217   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    837,185        133,920        1,409,617        1,539,888        745,435        771,608   

Units issued

    1,042,319        815,588        10,903        26,175        123,451        154,304   

Units redeemed

    (187,701     (112,323     (1,420,520     (156,446     (868,886     (180,477
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,691,803        837,185        —          1,409,617        —          745,435   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(m) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on November 10, 2014.

 

See accompanying notes.

 

40


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Global Bond Trust Series I     Global Bond Trust Series NAV     Global Diversification Trust Series I  
    2014     2013     2014     2013     2014     2013 (k)  

Income:

           

Dividend distributions received

  $ 59,130      $ 31,941      $ 233,519      $ 116,863      $ —        $ 237,258   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    59,130        31,941        233,519        116,863        —          237,258   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          1        —          3,319,857   

Net realized gain (loss)

    94,452        222,243        122,910        (304,134     —          (1,196,984
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    94,452        222,243        122,910        (304,133     —          2,122,873   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    1,183        (654,625     232,347        (1,187,138     —          (681,414
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    154,765        (400,441     588,776        (1,374,408     —          1,678,717   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    238,509        283,412        3,362,157        3,191,256        —          1,793,966   

Transfers between sub-accounts and the company

    (264,388     (35,418     (1,415,897     305,772        —          (14,043,972

Transfers on general account policy loans

    8,680        (788     (371,243     (150,351     —          41,179   

Withdrawals

    (398,435     (498,570     (464,233     (554,998     —          (118,828

Annual contract fee

    (283,897     (354,005     (1,127,720     (1,237,938     —          (871,892
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (699,531     (605,369     (16,936     1,553,741        —          (13,199,547
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (544,766     (1,005,810     571,840        179,333        —          (11,520,830

Contract owners’ equity at beginning of period

    6,602,459        7,608,269        22,655,553        22,476,220        —          11,520,830   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 6,057,693      $ 6,602,459      $ 23,227,393      $ 22,655,553      $ —        $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    219,957        239,737        753,201        705,877        —          750,186   

Units issued

    12,625        24,093        138,638        263,510        —          203,670   

Units redeemed

    (35,275     (43,873     (137,846     (216,186     —          (953,856
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    197,307        219,957        753,993        753,201        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(k) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

41


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Global Trust Series I     Global Trust Series NAV     Health Sciences Trust Series I  
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 252,374      $ 98,803      $ 585,288      $ 73,001      $ —        $ —     

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    252,374        98,803        585,288        73,001        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          1,485,133        843,535   

Net realized gain (loss)

    87,609        47,546        517,450        194,538        1,913,684        652,987   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    87,609        47,546        517,450        194,538        3,398,817        1,496,522   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (561,998     1,615,151        (1,483,151     971,657        (76,848     2,200,435   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (222,015     1,761,500        (380,413     1,239,196        3,321,969        3,696,957   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    266,175        247,523        967,444        461,804        253,914        262,014   

Transfers between sub-accounts and the company

    6,631,617        (91,648     24,808,964        (82,486     1,025,820        776,496   

Transfers on general account policy loans

    82,201        (5,452     (68,316     (174,203     (166,025     (736

Withdrawals

    (180,631     (211,774     (170,147     (117,681     (404,912     (866,177

Annual contract fee

    (525,644     (513,892     (465,197     (263,594     (367,689     (337,814
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    6,273,718        (575,243     25,072,748        (176,160     341,108        (166,217
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    6,051,703        1,186,257        24,692,335        1,063,036        3,663,077        3,530,740   

Contract owners’ equity at beginning of period

    7,141,451        5,955,194        5,130,127        4,067,091        11,155,646        7,624,906   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 13,193,154      $ 7,141,451      $ 29,822,462      $ 5,130,127      $ 14,818,723      $ 11,155,646   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    217,924        238,220        289,774        301,022        212,988        219,930   

Units issued

    228,132        6,596        1,540,180        44,692        72,828        40,008   

Units redeemed

    (32,671     (26,892     (102,071     (55,940     (71,198     (46,950
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    413,385        217,924        1,727,883        289,774        214,618        212,988   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

42


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Health Sciences Trust Series NAV     High Yield Trust Series I     High Yield Trust Series NAV  
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ —        $ —        $ 996,444      $ 983,263      $ 1,726,481      $ 1,530,990   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    —          —          996,444        983,263        1,726,481        1,530,990   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    3,185,351        1,383,916        —          —          —          —     

Net realized gain (loss)

    1,976,805        1,582,019        (588,074     (800,253     58,278        (673,700
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    5,162,156        2,965,935        (588,074     (800,253     58,278        (673,700
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    1,523,164        2,739,126        (366,681     1,028,356        (1,782,265     894,422   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    6,685,320        5,705,061        41,689        1,211,366        2,494        1,751,712   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    2,831,104        1,800,012        455,498        564,509        2,367,011        2,006,306   

Transfers between sub-accounts and the company

    2,546,169        4,187,562        (26,653     (78,591     2,151,741        1,981,583   

Transfers on general account policy loans

    (219,401     (315,381     (15,629     83,709        (196,884     (131,115

Withdrawals

    (503,049     (365,365     (638,109     (410,352     (531,942     (389,545

Annual contract fee

    (1,174,122     (797,687     (775,947     (829,720     (1,183,059     (1,102,406
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    3,480,701        4,509,141        (1,000,840     (670,445     2,606,867        2,364,823   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    10,166,021        10,214,202        (959,151     540,921        2,609,361        4,116,535   

Contract owners’ equity at beginning of period

    19,734,057        9,519,855        15,051,943        14,511,022        23,434,225        19,317,690   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 29,900,078      $ 19,734,057      $ 14,092,792      $ 15,051,943      $ 26,043,586      $ 23,434,225   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    483,536        352,783        470,728        492,500        1,108,931        993,439   

Units issued

    178,023        240,823        18,781        42,386        345,751        526,658   

Units redeemed

    (105,911     (110,070     (49,280     (64,158     (222,259     (411,166
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    555,648        483,536        440,229        470,728        1,232,423        1,108,931   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

43


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    International Core Trust Series I     International Core Trust Series NAV     International Equity Index Trust B Series I  
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 511,933      $ 373,988      $ 411,977      $ 232,064      $ 406,030      $ 325,012   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    511,933        373,988        411,977        232,064        406,030        325,012   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          —          —     

Net realized gain (loss)

    (418,055     (1,197,506     493,181        108,478        229,982        201,297   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    (418,055     (1,197,506     493,181        108,478        229,982        201,297   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (1,007,932     3,873,488        (1,725,638     1,281,156        (1,226,984     1,339,247   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (914,054     3,049,970        (820,480     1,621,698        (590,972     1,865,556   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    590,094        592,280        1,173,587        632,970        454,632        612,359   

Transfers between sub-accounts and the company

    179,747        (124,751     1,981,602        1,768,059        (520,274     (467,452

Transfers on general account policy loans

    25,934        (8,085     (234,657     (31,698     (37,472     (9,826

Withdrawals

    (702,702     (1,898,121     (171,201     (81,146     (261,204     (1,096,009

Annual contract fee

    (762,726     (789,773     (449,841     (340,850     (591,127     (658,024
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (669,653     (2,228,450     2,299,490        1,947,335        (955,445     (1,618,952
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (1,583,707     821,520        1,479,010        3,569,033        (1,546,417     246,604   

Contract owners’ equity at beginning of period

    14,658,633        13,837,113        9,260,360        5,691,327        14,066,189        13,819,585   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 13,074,926      $ 14,658,633      $ 10,739,370      $ 9,260,360      $ 12,519,772      $ 14,066,189   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    626,571        739,290        537,522        413,372        1,158,258        1,303,538   

Units issued

    32,466        33,134        258,529        244,896        46,935        54,399   

Units redeemed

    (60,056     (145,853     (127,536     (120,746     (124,403     (199,679
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    598,981        626,571        668,515        537,522        1,080,790        1,158,258   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

44


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    International Equity  Index
Trust B Series NAV
    International Growth  Stock
Trust Series I
    International Growth  Stock
Trust Series NAV
 
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 1,232,888      $ 820,447      $ 38,249      $ 26,054      $ 155,294      $ 81,600   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    1,232,888        820,447        38,249        26,054        155,294        81,600   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          —          —     

Net realized gain (loss)

    855,294        218,491        137,630        18,234        247,099        96,716   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    855,294        218,491        137,630        18,234        247,099        96,716   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (3,845,111     3,142,220        (159,262     332,364        (401,163     975,805   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (1,756,929     4,181,158        16,617        376,652        1,230        1,154,121   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    4,772,166        4,578,707        75,619        96,949        895,601        741,834   

Transfers between sub-accounts and the company

    3,210,437        2,871,890        (386,724     (115,394     396,177        40,698   

Transfers on general account policy loans

    (168,581     (275,123     19,988        95        114,605        (146,117

Withdrawals

    (830,701     (556,139     (119,314     (28,508     (246,212     (123,449

Annual contract fee

    (1,618,820     (1,528,945     (66,721     (70,710     (382,081     (349,023
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    5,364,501        5,090,390        (477,152     (117,568     778,090        163,943   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    3,607,572        9,271,548        (460,535     259,084        779,320        1,318,064   

Contract owners’ equity at beginning of period

    35,682,703        26,411,155        2,352,740        2,093,656        7,373,394        6,055,330   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 39,290,275      $ 35,682,703      $ 1,892,205      $ 2,352,740      $ 8,152,714      $ 7,373,394   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    749,769        635,628        189,797        201,169        594,174        581,593   

Units issued

    204,808        277,631        17,274        11,310        175,308        108,863   

Units redeemed

    (89,463     (163,490     (54,728     (22,682     (113,728     (96,282
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    865,114        749,769        152,343        189,797        655,754        594,174   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

45


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    International Small  Company
Trust Series I
    International Small  Company
Trust Series NAV
    International Value
Trust  Series I
 
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 90,018      $ 136,203      $ 191,931      $ 174,560      $ 473,210      $ 284,163   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    90,018        136,203        191,931        174,560        473,210        284,163   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          1        —          —          —          (1

Net realized gain (loss)

    1,102,341        322,266        454,589        183,231        (460,835     (893,281
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    1,102,341        322,267        454,589        183,231        (460,835     (893,282
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (1,622,634     1,025,541        (1,657,102     1,647,125        (2,136,674     4,587,072   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (430,275     1,484,011        (1,010,582     2,004,916        (2,124,299     3,977,953   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    249,582        302,645        2,236,538        1,570,368        577,299        587,783   

Transfers between sub-accounts and the company

    (1,328,194     381,903        1,507,039        826,164        456,837        (38,508

Transfers on general account policy loans

    15,056        18,685        (126,202     (77,230     (62,155     61,379   

Withdrawals

    (152,845     (224,815     (331,927     (254,868     (728,108     (813,304

Annual contract fee

    (312,238     (327,728     (624,953     (485,447     (916,228     (853,317
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (1,528,639     150,690        2,660,495        1,578,987        (672,355     (1,055,967
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (1,958,914     1,634,701        1,649,913        3,583,903        (2,796,654     2,921,986   

Contract owners’ equity at beginning of period

    8,001,947        6,367,246        10,806,976        7,223,073        17,721,120        14,799,134   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 6,043,033      $ 8,001,947      $ 12,456,889      $ 10,806,976      $ 14,924,466      $ 17,721,120   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    525,949        528,732        709,460        598,860        647,557        682,184   

Units issued

    133,382        134,498        376,852        226,522        54,106        76,040   

Units redeemed

    (232,709     (137,281     (208,374     (115,922     (78,319     (110,667
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    426,622        525,949        877,938        709,460        623,344        647,557   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

46


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    International Value  Trust
Series NAV
    Investment Quality Bond  Trust
Series I
    Investment Quality Bond  Trust
Series NAV
 
    2014     2013     2014     2013     2014     2013  

Income:

           

Dividend distributions received

  $ 690,371      $ 326,182      $ 370,834      $ 501,513      $ 252,021      $ 278,351   

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    690,371        326,182        370,834        501,513        252,021        278,351   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          28,366        248,726        18,425        135,917   

Net realized gain (loss)

    872,061        529,550        59,830        124,195        11,955        110,471   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    872,061        529,550        88,196        372,921        30,380        246,388   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (4,593,942     3,082,360        214,333        (1,153,721     115,025        (651,529
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    (3,031,510     3,938,092        673,363        (279,287     397,426        (126,790
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    1,825,490        1,662,305        457,394        516,648        1,140,146        935,938   

Transfers between sub-accounts and the company

    4,407,570        1,165,845        154,355        (304,394     450,970        65,523   

Transfers on general account policy loans

    (95,512     (93,716     (259,304     53,538        (28,211     (64,844

Withdrawals

    (663,133     (302,484     (551,203     (944,761     (97,013     (381,791

Annual contract fee

    (1,037,535     (746,081     (955,208     (1,025,837     (407,750     (403,042
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    4,436,880        1,685,869        (1,153,966     (1,704,806     1,058,142        151,784   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    1,405,370        5,623,961        (480,603     (1,984,093     1,455,568        24,994   

Contract owners’ equity at beginning of period

    20,189,916        14,565,955        12,718,243        14,702,336        7,073,740        7,048,746   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 21,595,286      $ 20,189,916      $ 12,237,640      $ 12,718,243      $ 8,529,308      $ 7,073,740   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    1,144,431        1,042,070        396,154        449,161        467,207        456,809   

Units issued

    464,041        258,905        17,319        13,530        167,019        106,470   

Units redeemed

    (209,864     (156,544     (52,065     (66,537     (100,461     (96,072
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,398,608        1,144,431        361,408        396,154        533,765        467,207   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

47


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Lifestyle Aggressive  MVP
Series I
    Lifestyle Aggressive  MVP
Series NAV
    Lifestyle Aggressive Trust  PS
Series NAV
 
    2014 (b)     2013     2014 (b)     2013     2014 (h)     2013  

Income:

           

Dividend distributions received

  $ 474,129      $ 524,300      $ 5,098,819      $ 3,851,932      $ 11,893      $ —     

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    474,129        524,300        5,098,819        3,851,932        11,893        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          2        —          —          13,969        —     

Net realized gain (loss)

    1,740,263        (115,972     4,886,806        3,311,893        776        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    1,740,263        (115,970     4,886,806        3,311,893        14,745        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    (1,951,240     3,799,312        (7,282,531     27,837,767        (15,766     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    263,152        4,207,642        2,703,094        35,001,592        10,872        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    652,218        729,047        19,199,626        17,198,977        100,950        —     

Transfers between sub-accounts and the company

    (5,315,561     4,833,980        835,498        (1,424,703     428,586        —     

Transfers on general account policy loans

    (296,731     (36,759     (1,216,580     (1,234,143     —          —     

Withdrawals

    (1,168,137     (604,329     (3,979,898     (2,522,567     2,073        —     

Annual contract fee

    (819,003     (853,636     (8,978,760     (8,064,559     (19,114     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (6,947,214     4,068,303        5,859,886        3,953,005        512,495        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (6,684,062     8,275,945        8,562,980        38,954,597        523,367        —     

Contract owners’ equity at beginning of period

    23,176,451        14,900,506        167,092,874        128,138,277        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 16,492,389      $ 23,176,451      $ 175,655,854      $ 167,092,874      $ 523,367      $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    754,313        614,525        9,085,360        8,832,500        —          —     

Units issued

    13,918        191,780        1,141,307        1,166,916        50,439        —     

Units redeemed

    (238,865     (51,992     (820,744     (914,056     (1,959     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    529,366        754,313        9,405,923        9,085,360        48,480        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(b) Renamed on May 5, 2014. Previously known as Lifestyle Aggressive Trust.
(h) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

48


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

    Lifestyle Balanced MVP Series I     Lifestyle Balanced MVP Series NAV     Lifestyle Balanced Trust PS Series NAV  
    2014 (c)     2013     2014 (c)     2013     2014 (h)     2013  

Income:

           

Dividend distributions received

  $ 1,860,965      $ 1,801,707      $ 11,240,338      $ 9,701,432      $ 280,025      $ —     

Expenses:

           

Mortality and expense risk and administrative charges

    —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    1,860,965        1,801,707        11,240,338        9,701,432        280,025        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

           

Capital gain distributions received

    —          —          —          —          60,566        —     

Net realized gain (loss)

    52,111        (559,933     3,562,646        4,015,930        3,826        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    52,111        (559,933     3,562,646        4,015,930        64,392        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

    840,529        6,438,954        547,041        24,271,771        (232,531     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

    2,753,605        7,680,728        15,350,025        37,989,133        111,886        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

           

Purchase payments

    1,914,656        2,156,936        39,785,761        38,443,548        822,775        —     

Transfers between sub-accounts and the company

    896,077        1,900,654        13,526,729        29,820,670        9,736,431        —     

Transfers on general account policy loans

    (196,907     (613,670     (2,308,654     (1,352,386     —          —     

Withdrawals

    (3,731,444     (2,738,602     (7,529,126     (7,193,978     (263     —     

Annual contract fee

    (2,850,827     (3,041,002     (23,581,071     (21,162,141     (367,596     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

    (3,968,445     (2,335,684     19,893,639        38,555,713        10,191,347        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

    (1,214,840     5,345,044        35,243,664        76,544,846        10,303,233        —     

Contract owners’ equity at beginning of period

    66,175,486        60,830,442        351,050,239        274,505,393        —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

  $ 64,960,646      $ 66,175,486      $ 386,293,903      $ 351,050,239      $ 10,303,233      $ —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2014     2013     2014     2013     2014     2013  

Units, beginning of period

    1,952,403        2,024,123        20,832,197        18,390,415        —          —     

Units issued

    75,294        220,271        2,301,212        3,794,132        974,808        —     

Units redeemed

    (189,953     (291,991     (1,145,797     (1,352,350     (13,533     —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,837,744        1,952,403        21,987,612        20,832,197        961,275        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(c) Renamed on May 5, 2014. Previously known as Lifestyle Balanced Trust.
(h) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

49


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Lifestyle Conservative  MVP
Series I
    Lifestyle Conservative  MVP
Series NAV
    Lifestyle Conservative Trust PS
Series NAV
 
     2014 (d)     2013     2014 (d)     2013     2014 (h)     2013  

Income:

            

Dividend distributions received

   $ 117,568      $ 174,474      $ 958,883      $ 1,033,126      $ 5,672      $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     117,568        174,474        958,883        1,033,126        5,672        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     249,475        171,436        1,805,610        985,732        903        —     

Net realized gain (loss)

     (38,870     102,059        15,925        383,925        45        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     210,605        273,495        1,821,535        1,369,657        948        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (97,723     (205,673     (1,267,153     (1,256,465     (4,353     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     230,450        242,296        1,513,265        1,146,318        2,267        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     156,393        271,293        4,008,435        3,699,782        9,565        —     

Transfers between sub-accounts and the company

     (302,748     (1,458,940     2,051,431        (536,236     188,980        —     

Transfers on general account policy loans

     1,466        52,823        (395,509     (177,740     —          —     

Withdrawals

     (549,192     (779,761     (501,697     (1,161,789     2        —     

Annual contract fee

     (378,862     (494,129     (2,085,021     (1,968,765     (9,969     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,072,943     (2,408,714     3,077,639        (144,748     188,578        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (842,493     (2,166,418     4,590,904        1,001,570        190,845        —     

Contract owners’ equity at beginning of period

     5,019,278        7,185,696        29,022,957        28,021,387        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 4,176,785      $ 5,019,278      $ 33,613,861      $ 29,022,957      $ 190,845      $ —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     150,284        223,498        1,857,470        1,865,142        —          —     

Units issued

     13,756        42,933        425,039        525,775        18,470        —     

Units redeemed

     (44,960     (116,147     (233,125     (533,447     (442     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     119,080        150,284        2,049,384        1,857,470        18,028        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(d) Renamed on May 5, 2014. Previously known as Lifestyle Conservative Trust.
(h) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

50


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Lifestyle Growth MVP Series I     Lifestyle Growth MVP Series NAV     Lifestyle Growth Trust PS Series NAV  
     2014 (e)     2013     2014 (e)     2013     2014 (h)     2013  

Income:

            

Dividend distributions received

   $ 2,477,158      $ 2,257,181      $ 15,823,513      $ 12,112,908      $ 305,218      $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,477,158        2,257,181        15,823,513        12,112,908        305,218        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          (1     60,177        —     

Net realized gain (loss)

     604,184        107,184        4,652,647        1,568,722        3,610        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     604,184        107,184        4,652,647        1,568,721        63,787        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (1,009,107     14,014,748        (8,746,059     64,988,893        (192,378     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     2,072,235        16,379,113        11,730,101        78,670,522        176,627        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     3,638,431        4,228,450        66,537,278        63,396,581        659,436        —     

Transfers between sub-accounts and the company

     (5,120,557     (2,560,936     16,437,696        24,870,865        11,395,323        —     

Transfers on general account policy loans

     (887,877     (985,746     (3,614,784     (4,073,742     763        —     

Withdrawals

     (5,107,259     (5,253,435     (15,060,851     (11,191,400     1,144        —     

Annual contract fee

     (3,867,370     (4,077,963     (34,923,606     (31,379,767     (425,299     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (11,344,632     (8,649,630     29,375,733        41,622,537        11,631,367        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (9,272,397     7,729,483        41,105,834        120,293,059        11,807,994        —     

Contract owners’ equity at beginning of period

     96,618,848        88,889,365        509,911,850        389,618,791        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 87,346,451      $ 96,618,848      $ 551,017,684      $ 509,911,850      $ 11,807,994      $ —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     2,937,305        3,224,989        28,942,264        26,400,552        —          —     

Units issued

     101,170        144,138        3,284,101        4,134,596        1,110,464        —     

Units redeemed

     (439,207     (431,822     (1,648,226     (1,592,884     (17,724     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     2,599,268        2,937,305        30,578,139        28,942,264        1,092,740        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(e) Renamed on May 5, 2014. Previously known as Lifestyle Growth Trust.
(h) Sub-account available in prior year but no activity.

 

See accompanying notes.

 

51


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

 

     Lifestyle Moderate MVP Series I     Lifestyle Moderate MVP Series NAV     Lifestyle Moderate Trust PS Series NAV  
     2014 (f)     2013     2014 (f)     2013     2014     2013 (a)  

Income:

            

Dividend distributions received

   $ 443,281      $ 503,627      $ 2,344,608      $ 2,062,194      $ 80,686      $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     443,281        503,627        2,344,608        2,062,194        80,686        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     812,142        —          3,647,721        —          21,312        —     

Net realized gain (loss)

     841,209        1,207,788        1,263,827        967,329        (80     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     1,653,351        1,207,788        4,911,548        967,329        21,232        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (1,265,991     (96,426     (3,582,352     3,178,465        (64,274     60   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     830,641        1,614,989        3,673,804        6,207,988        37,644        60   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     340,437        411,277        8,707,027        8,399,848        237,058        —     

Transfers between sub-accounts and the company

     (1,548,377     607,434        4,482,501        6,154,448        2,664,076        27,745   

Transfers on general account policy loans

     (175,411     (130,227     (262,449     (298,798     —          —     

Withdrawals

     (891,007     (1,003,478     (2,266,141     (1,409,298     (253     —     

Annual contract fee

     (659,228     (751,143     (4,809,718     (4,261,254     (92,697     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (2,933,586     (866,137     5,851,220        8,584,946        2,808,184        27,745   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (2,102,945     748,852        9,525,024        14,792,934        2,845,828        27,805   

Contract owners’ equity at beginning of period

     17,486,759        16,737,907        70,619,098        55,826,164        27,805        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 15,383,814      $ 17,486,759      $ 80,144,122      $ 70,619,098      $ 2,873,633      $ 27,805   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     511,067        539,175        4,291,353        3,740,629        2,757        —     

Units issued

     17,481        118,042        872,958        848,459        274,614        2,757   

Units redeemed

     (100,111     (146,150     (525,591     (297,735     (8,246     —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     428,437        511,067        4,638,720        4,291,353        269,125        2,757   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Reflects the period from commencement of operations on December 9, 2013 through December 31, 2013.
(f) Renamed on May 5, 2014. Previously known as Lifestyle Moderate Trust.

 

See accompanying notes.

 

52


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     M Capital Appreciation (i)     M International Equity (i)     M Large Cap Growth (i)  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ —        $ —        $ 262,268      $ 232,556      $ 4,978      $ 49,390   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —          —          262,268        232,556        4,978        49,390   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     1,047,489        789,258        —          —          1,525,502        498,488   

Net realized gain (loss)

     450,567        188,491        252,402        219,067        585,832        442,460   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     1,498,056        977,749        252,402        219,067        2,111,334        940,948   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (330,029     1,497,640        (1,347,443     987,567        (963,028     1,661,564   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,168,027        2,475,389        (832,773     1,439,190        1,153,284        2,651,902   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     1,108,612        832,405        1,341,060        921,595        1,274,006        984,425   

Transfers between sub-accounts and the company

     214,350        448,424        507,478        2,704,754        310,784        884,007   

Transfers on general account policy loans

     (88,744     (122,874     (50,958     (53,903     (128,128     (53,609

Withdrawals

     (420,001     (126,516     (282,253     (134,366     (332,772     (164,800

Annual contract fee

     (441,684     (375,392     (432,359     (397,502     (475,685     (413,483
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     372,533        656,047        1,082,968        3,040,578        648,205        1,236,540   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     1,540,560        3,131,436        250,195        4,479,768        1,801,489        3,888,442   

Contract owners’ equity at beginning of period

     9,332,312        6,200,876        10,596,563        6,116,795        10,726,526        6,838,084   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 10,872,872      $ 9,332,312      $ 10,846,758      $ 10,596,563      $ 12,528,015      $ 10,726,526   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     123,324        114,069        298,021        200,114        235,457        204,364   

Units issued

     29,007        31,949        82,620        154,888        46,606        69,910   

Units redeemed

     (24,521     (22,694     (52,420     (56,981     (32,543     (38,817
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     127,810        123,324        328,221        298,021        249,520        235,457   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(i) Sub-account that invests in non-affiliated Trust.

 

See accompanying notes.

 

53


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     M Large Cap Value (i)     Mid Cap Index Trust Series I     Mid Cap Index Trust Series NAV  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 106,320      $ 176,037      $ 141,282      $ 149,276      $ 296,331      $ 243,317   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     106,320        176,037        141,282        149,276        296,331        243,317   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     994,742        612,200        868,039        740,845        1,606,714        1,148,029   

Net realized gain (loss)

     400,289        366,812        957,973        784,863        814,225        501,614   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     1,395,031        979,012        1,826,012        1,525,708        2,420,939        1,649,643   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (712,939     655,984        (679,106     2,227,403        (196,556     3,574,773   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     788,412        1,811,033        1,288,188        3,902,387        2,520,714        5,467,733   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     967,412        628,627        398,585        509,376        2,975,424        2,328,333   

Transfers between sub-accounts and the company

     833,369        954,959        (1,131,296     316,839        3,157,780        3,107,716   

Transfers on general account policy loans

     (97,203     (50,890     (52,116     33,966        (276,379     (174,901

Withdrawals

     (340,155     (139,828     (724,901     (636,227     (538,122     (371,284

Annual contract fee

     (411,430     (348,926     (670,945     (708,446     (1,278,177     (1,118,951
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     951,993        1,043,942        (2,180,673     (484,492     4,040,526        3,770,913   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     1,740,405        2,854,975        (892,485     3,417,895        6,561,240        9,238,646   

Contract owners’ equity at beginning of period

     7,698,217        4,843,242        15,338,747        11,920,852        24,097,502        14,858,856   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 9,438,622      $ 7,698,217      $ 14,446,262      $ 15,338,747      $ 30,658,742      $ 24,097,502   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     354,028        298,954        398,556        412,045        955,284        783,943   

Units issued

     96,246        117,063        13,096        33,789        258,123        278,116   

Units redeemed

     (54,526     (61,989     (68,365     (47,278     (102,404     (106,775
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     395,748        354,028        343,287        398,556        1,111,003        955,284   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(i) Sub-account that invests in non-affiliated Trust.

 

See accompanying notes.

 

54


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Mid Cap Stock Trust Series I     Mid Cap Stock Trust Series NAV     Mid Value Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 21,995      $ 6,948      $ 31,689      $ 11,050      $ 98,293      $ 131,122   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     21,995        6,948        31,689        11,050        98,293        131,122   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     3,930,939        347,307        4,080,984        301,683        1,262,441        871,884   

Net realized gain (loss)

     598,317        607,058        714,920        814,947        1,386,743        1,139,038   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     4,529,256        954,365        4,795,904        1,116,630        2,649,184        2,010,922   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (2,913,844     4,902,482        (3,153,693     3,893,848        (1,410,263     1,268,536   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,637,407        5,863,795        1,673,900        5,021,528        1,337,214        3,410,580   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     720,688        806,813        2,004,749        1,490,729        393,368        392,363   

Transfers between sub-accounts and the company

     290,706        (123,402     2,049,001        865,981        (111,548     (1,381,937

Transfers on general account policy loans

     (22,073     (197,636     (17,711     (151,293     (17,636     (22,282

Withdrawals

     (655,904     (999,500     (406,781     (382,549     (548,914     (538,035

Annual contract fee

     (1,084,513     (1,051,058     (945,395     (798,301     (511,326     (492,391
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (751,096     (1,564,783     2,683,863        1,024,567        (796,056     (2,042,282
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     886,311        4,299,012        4,357,763        6,046,095        541,158        1,368,298   

Contract owners’ equity at beginning of period

     20,921,233        16,622,221        18,991,451        12,945,356        12,997,574        11,629,276   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 21,807,544      $ 20,921,233      $ 23,349,214      $ 18,991,451      $ 13,538,732      $ 12,997,574   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     667,289        725,369        278,504        259,774        553,275        650,440   

Units issued

     35,863        26,377        68,354        73,477        81,439        26,397   

Units redeemed

     (59,213     (84,457     (30,150     (54,747     (113,662     (123,562
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     643,939        667,289        316,708        278,504        521,052        553,275   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

55


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Mid Value Trust Series NAV     Money Market Trust B Series NAV     Money Market Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 147,435      $ 156,250      $ —        $ 8,620      $ —        $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     147,435        156,250        —          8,620        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     1,724,262        971,652        1,428        5,092        960        3,088   

Net realized gain (loss)

     744,104        691,607        —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     2,468,366        1,663,259        1,428        5,092        960        3,088   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (822,585     2,034,825        —          —          (1     1   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,793,216        3,854,334        1,428        13,712        959        3,089   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     1,699,716        1,304,386        143,178,326        161,691,373        2,625,767        8,827,310   

Transfers between sub-accounts and the company

     1,014,234        218,401        (193,676,043     (190,718,596     13,813,966        11,876,790   

Transfers on general account policy loans

     (81,453     (65,101     (923,330     (422,203     196,518        3,104,682   

Withdrawals

     (391,818     (427,738     47,032,554        30,761,710        (21,346,502     (23,052,311

Annual contract fee

     (818,404     (723,937     (8,248,677     (8,552,164     (3,380,319     (3,805,180
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     1,422,275        306,011        (12,637,170     (7,239,880     (8,090,570     (3,048,709
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     3,215,491        4,160,345        (12,635,742     (7,226,168     (8,089,611     (3,045,620

Contract owners’ equity at beginning of period

     16,386,512        12,226,167        100,875,888        108,102,056        42,209,652        45,255,272   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 19,602,003      $ 16,386,512      $ 88,240,146      $ 100,875,888      $ 34,120,041      $ 42,209,652   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     454,512        445,841        5,806,079        6,222,942        1,712,369        1,835,981   

Units issued

     90,783        84,608        8,645,798        8,887,983        832,261        1,462,726   

Units redeemed

     (54,138     (75,937     (9,373,374     (9,304,846     (1,160,289     (1,586,338
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     491,157        454,512        5,078,503        5,806,079        1,384,341        1,712,369   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

56


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Natural Resources Trust Series I     Natural Resources Trust Series NAV     PIMCO All Asset (i)  
     2014 (n)     2013     2014 (n)     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 102,621      $ 38,143      $ 382,319      $ 151,243      $ 1,248,464      $ 1,226,572   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     102,621        38,143        382,319        151,243        1,248,464        1,226,572   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          1        —          —          —     

Net realized gain (loss)

     (1,448,143     (119,378     (3,361,831     23,955        71,914        125,970   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (1,448,143     (119,378     (3,361,830     23,955        71,914        125,970   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     817,292        281,550        1,017,202        523,779        (1,044,882     (1,168,512
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     (528,230     200,315        (1,962,309     698,977        275,496        184,030   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     290,378        390,810        2,802,882        3,110,813        1,890,593        1,864,421   

Transfers between sub-accounts and the company

     (5,980,154     (299,265     (23,422,852     1,088,573        (5,372,008     8,872,859   

Transfers on general account policy loans

     (10,682     (4,006     (222,994     (190,929     (232,980     (192,518

Withdrawals

     (191,188     (875,435     (399,951     (389,139     (2,423,984     (955,061

Annual contract fee

     (300,978     (340,460     (1,027,590     (1,220,725     (1,116,476     (1,209,264
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (6,192,624     (1,128,356     (22,270,505     2,398,593        (7,254,855     8,380,437   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (6,720,854     (928,041     (24,232,814     3,097,570        (6,979,359     8,564,467   

Contract owners’ equity at beginning of period

     6,720,854        7,648,895        24,232,814        21,135,244        31,104,962        22,540,495   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ —        $ 6,720,854      $ —        $ 24,232,814      $ 24,125,603      $ 31,104,962   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     162,444        190,366        1,385,707        1,245,693        1,893,719        1,340,308   

Units issued

     56,098        14,476        289,494        332,281        265,232        873,916   

Units redeemed

     (218,542     (42,398     (1,675,201     (192,267     (697,555     (320,505
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     —          162,444        —          1,385,707        1,461,396        1,893,719   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(i) Sub-account that invests in non-affiliated Trust.
(n) Terminated as an investment option and funds transferred to Global Trust on November 10, 2014.

 

See accompanying notes.

 

57


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Real Estate Securities Trust Series I     Real Estate Securities Trust Series NAV     Real Return Bond Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 468,226      $ 502,381      $ 587,927      $ 508,053      $ 104,414      $ 105,546   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     468,226        502,381        587,927        508,053        104,414        105,546   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          —          —          —     

Net realized gain (loss)

     396,715        (1,272,061     935,169        1,090,605        29,154        37,589   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     396,715        (1,272,061     935,169        1,090,605        29,154        37,589   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     6,933,940        822,442        7,210,808        (1,869,987     38,927        (569,116
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     7,798,881        52,762        8,733,904        (271,329     172,495        (425,981
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     651,012        737,807        4,222,681        3,508,916        166,925        231,910   

Transfers between sub-accounts and the company

     1,266,271        (176,837     3,953,950        3,434,251        (411,438     (97,825

Transfers on general account policy loans

     (266,559     97,719        (257,957     (215,526     (3,503     86,869   

Withdrawals

     (1,401,638     (1,720,935     (555,939     (525,108     (146,035     (452,976

Annual contract fee

     (1,299,667     (1,363,585     (1,610,847     (1,404,295     (224,563     (279,654
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,050,581     (2,425,831     5,751,888        4,798,238        (618,614     (511,676
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     6,748,300        (2,373,069     14,485,792        4,526,909        (446,119     (937,657

Contract owners’ equity at beginning of period

     24,973,034        27,346,103        24,887,357        20,360,448        3,835,110        4,772,767   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 31,721,334      $ 24,973,034      $ 39,373,149      $ 24,887,357      $ 3,388,991      $ 3,835,110   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     198,065        216,665        236,054        193,019        185,422        209,342   

Units issued

     11,969        7,679        81,332        95,435        10,005        39,328   

Units redeemed

     (19,047     (26,279     (33,941     (52,400     (39,024     (63,248
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     190,987        198,065        283,445        236,054        156,403        185,422   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

58


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Real Return Bond Trust Series NAV     Science & Technology Trust Series I     Science & Technology Trust Series NAV  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 367,388      $ 374,836      $ —        $ —        $ —        $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     367,388        374,836        —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          568,626        —          350,972        —     

Net realized gain (loss)

     (240,410     39,696        1,534,657        1,376,847        712,892        646,532   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (240,410     39,696        2,103,283        1,376,847        1,063,864        646,532   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     535,145        (1,806,753     82,945        3,936,923        290,057        1,953,292   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     662,123        (1,392,221     2,186,228        5,313,770        1,353,921        2,599,824   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     1,730,366        1,654,586        620,270        629,310        1,122,443        692,685   

Transfers between sub-accounts and the company

     (3,230,802     (654,345     193,133        (119,764     2,271,426        749,371   

Transfers on general account policy loans

     (49,672     (137,862     (111,160     31,252        (96,630     (114,967

Withdrawals

     (132,805     (208,416     (372,685     (747,868     (223,226     (200,889

Annual contract fee

     (608,838     (738,114     (911,976     (861,340     (588,142     (419,408
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (2,291,751     (84,151     (582,418     (1,068,410     2,485,871        706,792   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (1,629,628     (1,476,372     1,603,810        4,245,360        3,839,792        3,306,616   

Contract owners’ equity at beginning of period

     13,266,561        14,742,933        17,288,823        13,043,463        9,206,202        5,899,586   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 11,636,933      $ 13,266,561      $ 18,892,633      $ 17,288,823      $ 13,045,994      $ 9,206,202   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     931,537        939,480        575,825        623,530        387,120        356,137   

Units issued

     186,386        242,562        74,089        69,372        184,324        198,069   

Units redeemed

     (338,883     (250,505     (92,540     (117,077     (85,775     (167,086
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     779,040        931,537        557,374        575,825        485,669        387,120   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

59


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Short Term  Government
Income Trust Series I
    Short Term Government Income Trust
Series NAV
    Small Cap Growth Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 130,629      $ 168,055      $ 235,217      $ 238,675      $ —        $ —     

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     130,629        168,055        235,217        238,675        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     (1     —          —          —          405,719        100,341   

Net realized gain (loss)

     (58,883     (11,152     (93,378     (63,175     114,678        3,658   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (58,884     (11,152     (93,378     (63,175     520,397        103,999   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     15,119        (232,850     (509     (267,921     (324,802     744,034   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     86,864        (75,947     141,330        (92,421     195,595        848,033   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     524,325        685,452        2,305,975        2,493,730        94,157        110,833   

Transfers between sub-accounts and the company

     (1,304,259     (418,209     (1,027,387     (5,311,046     (107,160     (29,536

Transfers on general account policy loans

     39,265        22,448        (147,232     (37,250     843        (15,182

Withdrawals

     (540,717     (421,800     (800,536     (232,924     (82,818     (43,324

Annual contract fee

     (665,641     (809,790     (597,494     (600,569     (106,351     (93,403
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,947,027     (941,899     (266,674     (3,688,059     (201,329     (70,612
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (1,860,163     (1,017,846     (125,344     (3,780,480     (5,734     777,421   

Contract owners’ equity at beginning of period

     8,144,190        9,162,036        11,994,232        15,774,712        2,591,675        1,814,254   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 6,284,027      $ 8,144,190      $ 11,868,888      $ 11,994,232      $ 2,585,941      $ 2,591,675   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     775,432        864,797        1,139,695        1,487,852        100,872        101,742   

Units issued

     44,039        76,889        331,448        427,233        13,264        66,145   

Units redeemed

     (227,920     (166,254     (356,690     (775,390     (20,570     (67,015
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     591,551        775,432        1,114,453        1,139,695        93,566        100,872   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

60


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Small Cap Growth Trust Series
NAV
    Small Cap Index Trust
Series I
    Small Cap Index Trust Series
NAV
 
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ —        $ —        $ 86,867      $ 121,734      $ 188,511      $ 217,369   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —          —          86,867        121,734        188,511        217,369   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     2,369,822        541,862        591,043        585,810        1,183,686        1,004,608   

Net realized gain (loss)

     907,221        472,303        170,034        (57,509     490,946        533,793   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     3,277,043        1,014,165        761,077        528,301        1,674,632        1,538,401   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (2,135,083     3,102,052        (447,634     2,117,850        (1,014,784     2,661,174   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,141,960        4,116,217        400,310        2,767,885        848,359        4,416,944   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     1,511,069        1,283,635        333,262        434,815        1,948,876        1,580,792   

Transfers between sub-accounts and the company

     508,947        1,349,743        (161,564     (270,318     2,874,383        582,703   

Transfers on general account policy loans

     (24,341     (125,028     688        65,328        (94,896     (61,497

Withdrawals

     (366,630     (274,530     (263,359     (453,666     (510,160     (209,839

Annual contract fee

     (692,393     (572,284     (400,160     (424,674     (787,990     (698,233
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     936,652        1,661,536        (491,133     (648,515     3,430,213        1,193,926   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     2,078,612        5,777,753        (90,823     2,119,370        4,278,572        5,610,870   

Contract owners’ equity at beginning of period

     14,644,710        8,866,957        9,567,930        7,448,560        16,308,230        10,697,360   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 16,723,322      $ 14,644,710      $ 9,477,107      $ 9,567,930      $ 20,586,802      $ 16,308,230   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     480,753        419,781        307,676        332,022        657,747        598,648   

Units issued

     115,975        125,012        20,445        24,568        224,611        151,915   

Units redeemed

     (86,532     (64,040     (36,737     (48,914     (89,368     (92,816
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     510,196        480,753        291,384        307,676        792,990        657,747   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

61


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Small Cap Opportunities Trust
Series I
    Small Cap Opportunities Trust
Series NAV
    Small Cap Value Trust
Series I
 
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 17,096      $ 50,672      $ 10,784      $ 49,676      $ 19,242      $ 14,248   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     17,096        50,672        10,784        49,676        19,242        14,248   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          —          346,872        140,567   

Net realized gain (loss)

     1,808,830        1,008,103        904,900        455,684        131,961        219,274   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     1,808,830        1,008,103        904,900        455,684        478,833        359,841   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (1,046,447     2,407,098        (490,860     1,811,634        (284,548     359,298   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     779,479        3,465,873        424,824        2,316,994        213,527        733,387   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     1,171,092        348,067        1,369,013        881,255        105,513        125,903   

Transfers between sub-accounts and the company

     (2,654,934     30,959,529        2,088,388        5,914,320        (84,746     205,343   

Transfers on general account policy loans

     (89,354     (29,103     (107,499     (28,026     21,009        (20,367

Withdrawals

     (1,618,057     (717,508     (144,016     (148,951     (36,991     (213,941

Annual contract fee

     (1,903,070     (406,212     (670,629     (381,750     (147,186     (138,502
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (5,094,323     30,154,773        2,535,257        6,236,848        (142,401     (41,564
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     (4,314,844     33,620,646        2,960,081        8,553,842        71,126        691,823   

Contract owners’ equity at beginning of period

     39,957,642        6,336,996        13,006,882        4,453,040        2,982,658        2,290,835   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 35,642,798      $ 39,957,642      $ 15,966,963      $ 13,006,882      $ 3,053,784      $ 2,982,658   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     1,036,677        230,441        685,630        329,269        129,994        133,106   

Units issued

     11,199        903,618        293,776        432,037        21,258        58,322   

Units redeemed

     (144,666     (97,382     (157,680     (75,676     (27,071     (61,434
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     903,210        1,036,677        821,726        685,630        124,181        129,994   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

62


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Small Cap Value Trust Series
NAV
    Small Company Value Trust
Series I
    Small Company Value Trust
Series NAV
 
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 152,685      $ 107,368      $ 4,197      $ 243,477      $ 9,952      $ 239,444   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     152,685        107,368        4,197        243,477        9,952        239,444   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     2,482,684        968,536        308,413        —          366,842        —     

Net realized gain (loss)

     1,057,885        1,019,557        755,687        621,987        940,363        659,851   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     3,540,569        1,988,093        1,064,100        621,987        1,307,205        659,851   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (2,098,779     2,819,420        (1,075,029     3,088,720        (1,268,836     2,750,759   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,594,475        4,914,881        (6,732     3,954,184        48,321        3,650,054   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     2,586,144        2,068,148        429,772        455,902        2,208,499        1,526,624   

Transfers between sub-accounts and the company

     400,199        1,047,025        (327,532     (1,489,104     706,534        922,905   

Transfers on general account policy loans

     (285,555     (121,519     34,076        (48,240     (166,759     (79,687

Withdrawals

     (419,472     (289,602     (658,028     (747,492     (636,855     (113,632

Annual contract fee

     (1,016,226     (886,002     (551,543     (603,473     (709,465     (628,112
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     1,265,090        1,818,050        (1,073,255     (2,432,407     1,401,954        1,628,098   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     2,859,565        6,732,931        (1,079,987     1,521,777        1,450,275        5,278,152   

Contract owners’ equity at beginning of period

     20,747,144        14,014,213        14,836,025        13,314,248        16,122,811        10,844,659   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 23,606,709      $ 20,747,144      $ 13,756,038      $ 14,836,025      $ 17,573,086      $ 16,122,811   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     321,590        289,623        433,370        511,837        707,659        626,801   

Units issued

     66,202        92,259        13,657        10,975        146,033        171,341   

Units redeemed

     (46,607     (60,292     (45,637     (89,442     (83,450     (90,483
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     341,185        321,590        401,390        433,370        770,242        707,659   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

63


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Smaller Company Growth Trust
Series I
    Smaller Company Growth
Trust Series NAV
    Strategic Income  Opportunities
Trust Series I
 
         2014          2013 (p)         2014          2013 (p)         2014             2013      

Income:

              

Dividend distributions received

   $ —         $ —        $ —         $ —        $ 406,825      $ 549,613   

Expenses:

              

Mortality and expense risk and administrative charges

     —           —          —           —          —          —     
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —           —          —           —          406,825        549,613   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

              

Capital gain distributions received

     —           1,984,684        —           257,141        —          —     

Net realized gain (loss)

     —           11,696,593        —           1,037,328        (182,308     (121,791
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     —           13,681,277        —           1,294,469        (182,308     (121,791
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     —           (4,988,157     —           (318,528     257,564        (53,715
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     —           8,693,120        —           975,941        482,081        374,107   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

              

Purchase payments

     —           955,788        —           248,375        366,594        401,984   

Transfers between sub-accounts and the company

     —           (31,694,268     —           (3,749,595     (125,137     475,409   

Transfers on general account policy loans

     —           (155,536     —           42,214        (1,484     17,123   

Withdrawals

     —           (2,728,658     —           (122,761     (769,882     (610,162

Annual contract fee

     —           (1,594,658     —           (166,991     (629,334     (677,522
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     —           (35,217,332     —           (3,748,758     (1,159,243     (393,168
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     —           (26,524,212     —           (2,772,817     (677,162     (19,061

Contract owners’ equity at beginning of period

     —           26,524,212        —           2,772,817        9,825,779        9,844,840   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ —         $ —        $ —         $ —        $ 9,148,617      $ 9,825,779   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 
     2014      2013     2014      2013     2014     2013  

Units, beginning of period

     —           1,867,238        —           194,885        399,740        415,803   

Units issued

     —           66,198        —           51,800        32,285        46,731   

Units redeemed

     —           (1,933,436     —           (246,685     (77,762     (62,794
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Units, end of period

     —           —          —           —          354,263        399,740   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

(p) Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013.

 

See accompanying notes.

 

64


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Strategic Income Opportunities
Trust Series NAV
    Total Bond Market Trust B
Series NAV
    Total Return Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 1,049,890      $ 1,259,370      $ 502,768      $ 466,325      $ 658,447      $ 716,108   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,049,890        1,259,370        502,768        466,325        658,447        716,108   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          —          —          526,235   

Net realized gain (loss)

     (216,486     (26,383     7,674        83,667        (87,561     466,158   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (216,486     (26,383     7,674        83,667        (87,561     992,393   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     287,243        (531,163     339,525        (903,782     416,131        (2,218,138
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,120,647        701,824        849,967        (353,790     987,017        (509,637
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     2,863,400        2,176,027        1,795,843        1,583,187        739,450        825,279   

Transfers between sub-accounts and the company

     (263,868     4,525,003        1,012,726        24,456        (1,334,084     (2,085,000

Transfers on general account policy loans

     (153,171     (343,242     (159,995     (53,567     1,131        154,963   

Withdrawals

     (938,409     (446,375     (185,299     (2,501,371     (1,995,438     (2,628,578

Annual contract fee

     (1,009,631     (1,010,143     (782,510     (756,958     (861,390     (1,072,262
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     498,321        4,901,270        1,680,765        (1,704,253     (3,450,331     (4,805,598
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     1,618,968        5,603,094        2,530,732        (2,058,043     (2,463,314     (5,315,235

Contract owners’ equity at beginning of period

     22,463,538        16,860,444        13,555,579        15,613,622        21,907,629        27,222,864   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 24,082,506      $ 22,463,538      $ 16,086,311      $ 13,555,579      $ 19,444,315      $ 21,907,629   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     1,233,275        960,866        608,566        683,872        764,350        930,512   

Units issued

     414,345        556,330        138,092        93,533        29,252        40,986   

Units redeemed

     (389,957     (283,921     (65,728     (168,839     (145,866     (207,148
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,257,663        1,233,275        680,930        608,566        647,736        764,350   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

65


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Total Return Trust
Series NAV
    Total Stock Market  Index
Trust Series I
    Total Stock Market  Index
Trust Series NAV
 
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 1,680,436      $ 1,499,915      $ 71,207      $ 82,476      $ 271,925      $ 223,708   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,680,436        1,499,915        71,207        82,476        271,925        223,708   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          1,081,894        98,840        81,812        351,080        209,595   

Net realized gain (loss)

     (563,590     214,225        724,749        337,558        1,114,104        821,225   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (563,590     1,296,119        823,589        419,370        1,465,184        1,030,820   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     1,072,338        (3,900,400     (202,093     1,122,767        664,492        2,540,163   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     2,189,184        (1,104,366     692,703        1,624,613        2,401,601        3,794,691   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     6,439,436        5,287,788        268,407        350,995        2,354,232        2,033,408   

Transfers between sub-accounts and the company

     69,635        (4,376,825     (474,952     479,957        3,399,207        5,175,651   

Transfers on general account policy loans

     (544,699     (307,485     9,861        (7,289     (230,111     (97,300

Withdrawals

     (1,081,739     (1,498,595     (371,851     (344,836     (370,852     (575,921

Annual contract fee

     (2,275,513     (2,594,627     (459,735     (406,336     (863,429     (634,885
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     2,607,120        (3,489,744     (1,028,270     72,491        4,289,047        5,900,953   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     4,796,304        (4,594,110     (335,567     1,697,104        6,690,648        9,695,644   

Contract owners’ equity at beginning of period

     45,413,415        50,007,525        6,439,269        4,742,165        17,696,407        8,000,763   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 50,209,719      $ 45,413,415      $ 6,103,702      $ 6,439,269      $ 24,387,055      $ 17,696,407   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     2,637,099        2,846,200        299,757        294,473        247,420        149,284   

Units issued

     829,696        633,743        16,209        51,487        108,324        176,818   

Units redeemed

     (682,833     (842,844     (61,077     (46,203     (49,840     (78,682
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     2,783,962        2,637,099        254,889        299,757        305,904        247,420   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

66


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     U.S. Equity Trust Series I     U.S. Equity Trust Series NAV     Ultra Short Term Bond Trust Series I  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 239,707      $ 253,840      $ 104,776      $ 92,238      $ 9,255      $ 7,442   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     239,707        253,840        104,776        92,238        9,255        7,442   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          —          —          —          —     

Net realized gain (loss)

     821,987        347,707        309,816        81,379        (4,588     (4,802
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     821,987        347,707        309,816        81,379        (4,588     (4,802
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     674,273        3,234,583        250,765        1,052,661        (4,895     (2,685
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,735,967        3,836,130        665,357        1,226,278        (228     (45
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     644,007        687,645        665,700        766,495        24,902        15,918   

Transfers between sub-accounts and the company

     (346,509     (392,051     853,046        297,754        22,013        293,974   

Transfers on general account policy loans

     (67,489     (49,148     (1,786     (54,513     (104     (103

Withdrawals

     (656,306     (530,497     (362,506     (81,677     (41,200     (123,991

Annual contract fee

     (911,410     (939,995     (350,714     (313,850     (53,076     (21,542
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,337,707     (1,224,046     803,740        614,209        (47,465     164,256   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     398,260        2,612,084        1,469,097        1,840,487        (47,693     164,211   

Contract owners’ equity at beginning of period

     16,457,906        13,845,822        5,860,968        4,020,481        667,595        503,384   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 16,856,166      $ 16,457,906      $ 7,330,065      $ 5,860,968      $ 619,902      $ 667,595   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     1,248,912        1,347,273        444,134        391,056        66,419        50,048   

Units issued

     140,492        91,593        148,888        95,212        21,490        58,500   

Units redeemed

     (237,339     (189,954     (92,949     (42,134     (26,223     (42,129
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,152,065        1,248,912        500,073        444,134        61,686        66,419   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

67


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Ultra Short Term Bond Trust Series NAV     Utilities Trust Series I     Utilities Trust Series NAV  
     2014     2013     2014     2013     2014     2013  

Income:

            

Dividend distributions received

   $ 49,379      $ 31,445      $ 151,089      $ 95,027      $ 460,556      $ 232,281   

Expenses:

            

Mortality and expense risk and administrative charges

     —          —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     49,379        31,445        151,089        95,027        460,556        232,281   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

            

Capital gain distributions received

     —          —          214,045        —          550,593        (1

Net realized gain (loss)

     (23,370     (17,776     550,271        281,908        836,635        764,163   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (23,370     (17,776     764,316        281,908        1,387,228        764,162   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (25,598     (15,730     (310,710     479,625        (259,004     960,264   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     411        (2,061     604,695        856,560        1,588,780        1,956,707   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

            

Purchase payments

     755,032        516,736        150,934        154,410        1,779,628        1,304,280   

Transfers between sub-accounts and the company

     216,217        644,812        (44,344     (723,385     1,110,348        280,573   

Transfers on general account policy loans

     (55,981     (11,297     (200,226     (782     (79,689     (295,033

Withdrawals

     (34,207     33,766        (310,052     (260,823     (510,047     (371,612

Annual contract fee

     (172,100     (143,693     (238,832     (225,471     (694,862     (609,605
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     708,961        1,040,324        (642,520     (1,056,051     1,605,378        308,603   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     709,372        1,038,263        (37,825     (199,491     3,194,158        2,265,310   

Contract owners’ equity at beginning of period

     2,699,287        1,661,024        4,922,278        5,121,769        11,863,477        9,598,167   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 3,408,659      $ 2,699,287      $ 4,884,453      $ 4,922,278      $ 15,057,635      $ 11,863,477   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013     2014     2013  

Units, beginning of period

     268,119        164,959        148,485        186,275        447,562        436,875   

Units issued

     208,054        257,801        46,619        40,739        148,417        176,010   

Units redeemed

     (137,693     (154,641     (64,234     (78,529     (92,034     (165,323
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     338,480        268,119        130,870        148,485        503,945        447,562   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

68


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Statements of Operations and Changes in Contract Owners’ Equity

For the years ended December 31,

 

     Value Trust Series I     Value Trust Series NAV  
     2014     2013     2014     2013  

Income:

        

Dividend distributions received

   $ 77,891      $ 124,227      $ 63,140      $ 75,130   

Expenses:

        

Mortality and expense risk and administrative charges

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     77,891        124,227        63,140        75,130   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions received

     1,587,809        —          1,096,663        —     

Net realized gain (loss)

     513,777        303,316        884,927        555,671   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     2,101,586        303,316        1,981,590        555,671   
  

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized appreciation (depreciation) during the period

     (617,550     4,352,291        (923,335     1,807,362   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from operations

     1,561,927        4,779,834        1,121,395        2,438,163   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Purchase payments

     358,617        393,055        1,171,568        808,877   

Transfers between sub-accounts and the company

     (8,553     (656,930     1,227,126        1,030,550   

Transfers on general account policy loans

     34,899        (15,043     32,365        (88,171

Withdrawals

     (1,068,315     (845,716     (102,189     (215,402

Annual contract fee

     (825,954     (889,640     (571,105     (435,616
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in contract owners’ equity from principal transactions

     (1,509,306     (2,014,274     1,757,765        1,100,238   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in contract owners’ equity

     52,621        2,765,560        2,879,160        3,538,401   

Contract owners’ equity at beginning of period

     16,826,472        14,060,912        10,004,838        6,466,437   
  

 

 

   

 

 

   

 

 

   

 

 

 

Contract owners’ equity at end of period

   $ 16,879,093      $ 16,826,472      $ 12,883,998      $ 10,004,838   
  

 

 

   

 

 

   

 

 

   

 

 

 
     2014     2013     2014     2013  

Units, beginning of period

     317,466        359,189        404,786        354,346   

Units issued

     9,796        19,912        169,290        123,701   

Units redeemed

     (37,284     (61,635     (99,690     (73,261
  

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     289,978        317,466        474,386        404,786   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

69


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements

December 31, 2014

 

1. Organization

John Hancock Life Insurance Company (U.S.A.) Separate Account A (the “Account”) is a separate account established by John Hancock Life Insurance Company (U.S.A.) (the “Company”). The Account operates as a Unit Investment Trust under the Investment Company Act of 1940, as amended and is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services – Investment Companies. The Account consists of 113 active sub-accounts which are exclusively invested in a corresponding portfolio of the John Hancock Variable Insurance Trust (the “Trust”), and 5 sub-accounts that are invested in portfolios of other Non-affiliated Trusts (the “Non-affiliated Trusts”). The Trust is registered under the Act as an open-ended management investment company, commonly known as a mutual fund, which does not transact with the general public. The Account is a funding vehicle for the allocation of net premiums under single premium variable life and variable universal life insurance contracts (the “Contracts”) issued by the Company.

The Company is a stock life insurance company incorporated under the laws of Michigan in 1979. The Company is an indirect, wholly owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian based publicly traded life insurance company. MFC and its subsidiaries are known collectively as Manulife Financial.

The Company is required to maintain assets in the Account with a total fair value of at least equal to the reserves and other liabilities relating to the variable benefits under all Contracts participating in the Account. These assets may not be charged with liabilities which arise from any other business the Company conducts. However, all obligations under the Contracts are general corporate obligations of the Company.

In addition to the Account, certain contract owners may also allocate funds to the fixed account, which is part of the Company’s general account. Because of exemptive and exclusionary provisions, interests in the fixed account have not been registered under the Securities Act of 1933, and the Company’s general account has not been registered as an investment company under the Investment Company Act of 1940. Net interfund transfers include transfers between separate and general accounts.

Each sub-account holds shares of a particular series (“Portfolio”) of a registered investment company. Sub-accounts that invest in Portfolios of the Trust may offer 2 classes of units to fund Contracts issued by the Company. These classes, Series I and Series NAV, represent an interest in the same Trust Portfolio, but in different classes of that Portfolio. Series I and Series NAV shares of the Trust Portfolio differ in the level of 12b-1 fees and other expenses assessed against the Portfolio’s assets.

As a result of a portfolio change, the following sub-accounts of the Account were renamed as follows:

 

Previous Name

  

New Name

  

Effective Date

Financial Services Trust Series I    Financial Industries Trust Series I    11/10/2014
Financial Services Trust Series NAV    Financial Industries Trust Series NAV    11/10/2014
Lifestyle Aggressive Trust Series I    Lifestyle Aggressive MVP Series I    5/5/2014
Lifestyle Aggressive Trust Series NAV    Lifestyle Aggressive MVP Series NAV    5/5/2014
Lifestyle Balanced Trust Series I    Lifestyle Balanced MVP Series I    5/5/2014
Lifestyle Balanced Trust Series NAV    Lifestyle Balanced MVP Series NAV    5/5/2014
Lifestyle Conservative Trust Series I    Lifestyle Conservative MVP Series I    5/5/2014
Lifestyle Conservative Trust Series NAV    Lifestyle Conservative MVP Series    5/5/2014
   NAV   
Lifestyle Growth Trust Series I    Lifestyle Growth MVP Series I    5/5/2014
Lifestyle Growth Trust Series NAV    Lifestyle Growth MVP Series NAV    5/5/2014
Lifestyle Moderate Trust Series I    Lifestyle Moderate MVP Series I    5/5/2014
Lifestyle Moderate Trust Series NAV    Lifestyle Moderate MVP Series NAV    5/5/2014

 

70


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

1. Organization — (continued):

 

Sub-accounts closed in 2014 are as follows:

 

Sub-accounts Closed

       

Effective Date

Fundamental Value Trust Series I       11/10/2014
Fundamental Value Trust Series NAV       11/10/2014
Natural Resources Trust Series I       11/10/2014
Natural Resources Trust Series NAV       11/10/2014

 

71


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

 

2. Significant Accounting Policies

Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from reported results using those estimates.

Valuation of Investments

Investments made in the Portfolios of the Trust, and of the Non-affiliated Trusts, are valued at fair value based on the reported net asset values of such Portfolios. Investment transactions are recorded on the trade date. Income from dividends, and gains from realized gain distributions are recorded on the ex-dividend date. Realized gains and losses on the sales of investments are computed on a first-in, first-out basis.

Amounts Receivable/Payable

Receivables/Payables from/to Portfolios/the Company are due to unsettled contract transactions (net of asset-based charges) and/or subsequent/preceding purchases/sales of the respective Portfolios’ shares. The amounts are due from/to either the respective Portfolio and/or the Company for the benefit of contract owners. There are no unsettled policy transactions at December 31, 2014.

Reclassifications

Certain reclassifications have been made to the statements of operations and changes in contract owner’s equity to conform to the current year presentation.

 

3. Federal Income Taxes

The Account does not file separate tax returns. The taxable income of the Account is consolidated with that of the Company within the consolidated federal tax return. Any tax contingencies arising from the taxable income generated by the Account is the responsibility of the Company and the Company holds any and all tax contingencies on its financial statements. The Company’s consolidated federal tax return for the prior fiscal years remain open subject to examination by the internal revenue service. The Account is not a party to the consolidated tax sharing agreement thus no amount of income taxes or tax contingencies are passed through to the Account. The legal form of the Account is not taxable in any state or foreign jurisdictions.

The income taxes topic of the FASB Accounting Standard Codification establishes a minimum threshold for financial statement recognition of the benefit of positions taken, or expected to be taken, in filing tax returns (including whether the Account is taxable in certain jurisdictions). The topic requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold would be recorded as tax expense or benefit.

The Account complies with the provisions of FASB ASC Topic 740, Income Taxes. As of December 31, 2014, the Account did not have a liability for any uncertain tax positions. The Account recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statements of Operations and Changes in Contract Owners’ Equity.

 

72


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

 

4. Transactions with Affiliates

The Company has an administrative services agreement with Manulife Financial, whereby Manulife Financial or its designee, with the consent of the Company, performs certain services on behalf of the Company necessary for the operation of the Account. John Hancock Investment Management Services, LLC (“JHIMS”), a Delaware limited liability company controlled by MFC, serves as investment adviser for the Trust.

John Hancock Distributors LLC, a registered broker-dealer and wholly owned subsidiary of JHUSA, acts as the principle underwriter of the Contracts pursuant to a distribution agreement with the Company. Contracts are sold by registered representatives of either John Hancock Distributors LLC or other broker-dealers having distribution agreements with John Hancock Distributors LLC.

Certain officers of the Account are officers and directors of JHUSA or the Trust.

Contract charges, as described in Note 9, are paid to the Company.

 

73


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

 

5. Fair Value Measurements

Accounting Standards Codification 820 (“ASC 820”) “Fair Value Measurements and Disclosures” provides a single definition of fair value for accounting purposes, establishes a consistent framework for measuring fair value, and expands disclosure requirements about fair value measurements. ASC 820 defines fair value as the value that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. An exit value is not a forced liquidation or distressed sale.

Following ASC 820 guidance, the Account has categorized its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Account’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

 

 

Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Account has the ability to access at the measurement date.

 

 

Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.

 

 

Level 3 – Fair value measurements using significant non market observable inputs.

All of the Account’s sub-accounts’ investments in a Portfolio of the Trust were valued at the reported net asset value of the Portfolio and categorized as Level 1 as of December 31, 2014. The following table presents the Account’s assets that are measured at fair value on a recurring basis by fair value hierarchy level under ASC 820, as of December 31, 2014:

 

     Mutual Funds  

Level 1

   $ 3,694,518,437   

Level 2

     —     

Level 3

     —     
  

 

 

 
   $ 3,694,518,437   
  

 

 

 

Assets owned by the Account are primarily open-ended mutual fund investments issued by the Trust. These are classified within Level 1, as fair values of the underlying funds are based upon reported net asset values (“NAV”), which represent the values at which each sub-account can redeem its investments.

Changes in valuation techniques may result in transfer in or out of an assigned level within the disclosure hierarchy. Transfers between investment levels may occur as the availability of a price source or data used in an investment’s valuation changes. Transfers between investment levels are recognized at the beginning of the reporting period. There have been no transfers between any level of fair value measurements during the period ended December 31, 2014.

 

74


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

 

6. Purchases and Sales of Investments

The cost of purchases including reinvestment of dividend distributions and proceeds from the sales of investments in the Portfolios of the Trust and Non-affiliated Trusts during 2014 were as follows:

 

     Purchases      Sales  

Sub-Account

     

500 Index Fund B Series NAV

   $ 34,628,939       $ 16,299,832   

Active Bond Trust Series I

     682,284         995,907   

Active Bond Trust Series NAV

     6,102,510         1,853,435   

All Cap Core Trust Series I

     251,782         1,034,194   

All Cap Core Trust Series NAV

     770,544         834,994   

Alpha Opportunities Trust Series I

     347,515         364,120   

Alpha Opportunities Trust Series NAV

     2,243,453         1,027,851   

American Asset Allocation Trust Series I

     24,366,741         7,784,226   

American Global Growth Trust Series I

     2,328,562         613,927   

American Growth Trust Series I

     5,970,099         5,878,519   

American Growth-Income Trust Series I

     7,567,710         9,323,131   

American International Trust Series I

     5,204,336         6,503,901   

American New World Trust Series I

     3,215,858         1,427,611   

Blue Chip Growth Trust Series I

     4,621,467         5,437,017   

Blue Chip Growth Trust Series NAV

     11,970,855         5,160,714   

Bond Trust Series I

     468,014         87,241   

Bond Trust Series NAV

     2,801,738         1,040,331   

Capital Appreciation Trust Series I

     6,765,356         5,292,566   

Capital Appreciation Trust Series NAV

     7,800,559         4,180,882   

Capital Appreciation Value Trust Series I

     3,006,921         2,636,614   

Capital Appreciation Value Trust Series NAV

     10,065,488         2,022,099   

Core Bond Trust Series I

     416,855         432,739   

Core Bond Trust Series NAV

     2,867,779         493,585   

Core Strategy Trust Series I

     159,160         232,066   

Core Strategy Trust Series NAV

     32,386,796         11,888,849   

Emerging Markets Value Trust Series I

     691,947         1,047,118   

Emerging Markets Value Trust Series NAV

     8,393,505         4,575,372   

Equity-Income Trust Series I

     5,612,991         4,820,837   

Equity-Income Trust Series NAV

     16,874,069         8,428,920   

Financial Industries Trust Series I

     533,577         124,523   

Financial Industries Trust Series NAV

     1,667,881         658,323   

Franklin Templeton Founding Allocation Trust Series I

     64,686         57,183   

Franklin Templeton Founding Allocation Trust Series NAV

     14,786,608         2,705,863   

Fundamental All Cap Core Trust Series I

     125,553         1,013,140   

Fundamental All Cap Core Trust Series NAV

     1,561,169         2,947,896   

Fundamental Large Cap Value Trust Series I

     35,109,668         2,171,969   

Fundamental Large Cap Value Trust Series NAV

     20,628,973         3,469,554   

Fundamental Value Trust Series I (b)

     8,496,567         36,919,466   

Fundamental Value Trust Series NAV (b)

     5,467,393         16,157,080   

Global Bond Trust Series I

     452,889         1,093,290   

Global Bond Trust Series NAV

     4,550,264         4,333,679   

Global Trust Series I

     7,605,735         1,079,643   

Global Trust Series NAV

     27,487,066         1,829,029   

Health Sciences Trust Series I

     5,926,282         4,100,042   

Health Sciences Trust Series NAV

     11,513,312         4,847,259   

High Yield Trust Series I

     1,612,463         1,616,858   

High Yield Trust Series NAV

     9,196,340         4,862,991   

International Core Trust Series I

     1,278,695         1,436,415   

International Core Trust Series NAV    

     4,919,317         2,207,851   

 

75


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

6. Purchases and Sales of Investments — (continued):

 

     Purchases      Sales  

Sub-Account — (continued)

     

International Equity Index Trust B Series I

   $ 971,328       $ 1,520,744   

International Equity Index Trust B Series NAV

     10,881,525         4,284,138   

International Growth Stock Trust Series I

     258,756         697,657   

International Growth Stock Trust Series NAV

     2,350,365         1,416,980   

International Small Company Trust Series I

     2,187,583         3,626,203   

International Small Company Trust Series NAV

     5,973,156         3,120,731   

International Value Trust Series I

     1,902,325         2,101,469   

International Value Trust Series NAV

     8,713,275         3,586,024   

Investment Quality Bond Trust Series I

     977,419         1,732,185   

Investment Quality Bond Trust Series NAV

     2,896,750         1,568,161   

Lifestyle Aggressive MVP Series I

     910,024         7,383,108   

Lifestyle Aggressive MVP Series NAV

     26,332,505         15,373,799   

Lifestyle Aggressive Trust PS Series NAV

     559,161         20,806   

Lifestyle Balanced MVP Series I

     4,503,995         6,611,475   

Lifestyle Balanced MVP Series NAV

     51,040,780         19,906,803   

Lifestyle Balanced Trust PS Series NAV

     10,675,621         143,682   

Lifestyle Conservative MVP Series I

     839,037         1,544,936   

Lifestyle Conservative MVP Series NAV

     9,596,712         3,754,580   

Lifestyle Conservative Trust PS Series NAV

     199,794         4,641   

Lifestyle Growth MVP Series I

     5,873,896         14,741,372   

Lifestyle Growth MVP Series NAV

     74,843,851         29,644,607   

Lifestyle Growth Trust PS Series NAV

     12,184,451         187,689   

Lifestyle Moderate MVP Series I

     1,872,488         3,550,652   

Lifestyle Moderate MVP Series NAV

     20,766,296         8,922,747   

Lifestyle Moderate Trust PS Series NAV

     2,995,426         85,242   

M Capital Appreciation (a)

     3,350,501         1,930,478   

M International Equity (a)

     3,170,498         1,825,262   

M Large Cap Growth (a)

     3,691,476         1,512,792   

M Large Cap Value (a)

     3,272,524         1,219,469   

Mid Cap Index Trust Series I

     1,527,344         2,698,697   

Mid Cap Index Trust Series NAV

     8,626,235         2,682,666   

Mid Cap Stock Trust Series I

     5,132,894         1,931,057   

Mid Cap Stock Trust Series NAV

     8,905,233         2,108,696   

Mid Value Trust Series I

     3,402,333         2,837,656   

Mid Value Trust Series NAV

     5,341,088         2,047,116   

Money Market Trust B Series NAV

     150,168,685         162,804,427   

Money Market Trust Series I

     20,528,083         28,617,694   

Natural Resources Trust Series I (c)

     2,605,081         8,695,085   

Natural Resources Trust Series NAV (c)

     5,588,357         27,476,543   

PIMCO All Asset (a)

     5,703,200         11,709,590   

Real Estate Securities Trust Series I

     2,230,668         2,813,022   

Real Estate Securities Trust Series NAV

     10,537,255         4,197,438   

Real Return Bond Trust Series I

     322,882         837,082   

Real Return Bond Trust Series NAV

     3,136,387         5,060,751   

Science & Technology Trust Series I

     2,915,476         2,929,269   

Science & Technology Trust Series NAV

     4,992,528         2,155,684   

Short Term Government Income Trust Series I

     596,537         2,412,936   

Short Term Government Income Trust Series NAV

     3,753,511         3,784,970   

Small Cap Growth Trust Series I

     751,916         547,526   

Small Cap Growth Trust Series NAV

     5,981,445         2,674,972   

Small Cap Index Trust Series I

     1,309,489         1,122,712   

Small Cap Index Trust Series NAV    

     6,986,284         2,183,877   

 

76


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

6. Purchases and Sales of Investments — (continued):

 

     Purchases      Sales  

Sub-Account — (continued)

     

Small Cap Opportunities Trust Series I

   $ 441,481       $ 5,518,709   

Small Cap Opportunities Trust Series NAV

     5,518,903         2,972,861   

Small Cap Value Trust Series I

     854,176         630,462   

Small Cap Value Trust Series NAV

     6,895,165         2,994,706   

Small Company Value Trust Series I

     774,421         1,535,064   

Small Company Value Trust Series NAV

     3,648,416         1,869,668   

Strategic Income Opportunities Trust Series I

     1,228,682         1,981,098   

Strategic Income Opportunities Trust Series NAV

     8,853,085         7,304,875   

Total Bond Market Trust B Series NAV

     3,700,588         1,517,056   

Total Return Trust Series I

     1,514,995         4,306,879   

Total Return Trust Series NAV

     16,375,365         12,087,809   

Total Stock Market Index Trust Series I

     541,751         1,399,975   

Total Stock Market Index Trust Series NAV

     8,716,030         3,803,979   

U.S. Equity Trust Series I

     2,173,729         3,271,728   

U.S. Equity Trust Series NAV

     2,197,327         1,288,812   

Ultra Short Term Bond Trust Series I

     225,435         263,644   

Ultra Short Term Bond Trust Series NAV

     2,146,341         1,388,000   

Utilities Trust Series I

     2,059,546         2,336,932   

Utilities Trust Series NAV

     5,300,338         2,683,812   

Value Trust Series I

     2,212,065         2,055,671   

Value Trust Series NAV

     5,466,691         2,549,121   

 

(a) Sub-account that invests in non-affiliated Trust.

 

(b) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on November 10, 2014.

 

(c) Terminated as an investment option and funds transferred to Global Trust on November 10, 2014.

 

77


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values

A summary of unit values and units outstanding for variable life contracts and the expense and income ratios, excluding expenses of the underlying Portfolios, were as follows:

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

500 Index Fund B Series NAV

       2014         5,455       $ 42.71 to $26.70       $ 195,957         0.00% to 0.00       1.69 %       13.43% to 9.85
       2013         5,194         37.65 to 23.54         160,818         0.00 to 0.00         1.87         32.03 to 32.02  
       2012         5,258         28.52 to 17.83         120,194         0.00 to 0.00         1.17         15.80 to 8.03  
       2011         3,858         24.63 to 15.40         80,332         0.00 to 0.00          1.83         1.87 to 1.86   
       2010         3,903         24.18 to 15.12         77,322         0.00 to 0.00         1.82         14.86 to 14.85  

Active Bond Trust Series I

       2014         318         21.80 to 21.80         6,927         0.00 to 0.00         3.64         6.82 to 6.82  
       2013         344         20.41 to 20.41         7,030         0.00 to 0.00         5.61         0.24 to 0.24  
       2012         365         20.36 to 20.36         7,431         0.00 to 0.00         3.57         9.71 to 9.71  
       2011         507         18.56 to 18.56         9,415         0.00 to 0.00         5.35         5.81 to 5.81  
       2010         533         17.54 to 17.54         9,347         0.00 to 0.00         7.31         13.84 to 13.84  

Active Bond Trust Series NAV

       2014         209         71.07 to 71.07         14,876         0.00 to 0.00         4.16         6.97 to 2.79  
       2013         156         66.44 to 66.44         10,351         0.00 to 0.00         6.35         0.19 to 0.19  
       2012         130         66.31 to 66.31         8,625         0.00 to 0.00         4.43         9.76 to 5.32  
       2011         115         60.42 to 60.42         6,938         0.00 to 0.00         6.05         5.97 to 5.97  
       2010         85         57.02 to 57.02         4,861         0.00 to 0.00         8.80         13.91 to 13.91  

All Cap Core Trust Series I

       2014         296         32.35 to 32.35         9,558         0.00 to 0.00         0.94         9.64 to 9.64  
       2013         324         29.50 to 29.50         9,554         0.00 to 0.00         1.28         34.33 to 34.33  
       2012         350         21.96 to 21.96         7,688         0.00 to 0.00         1.10         16.57 to 16.57  
       2011         410         18.84 to 18.84         7,731         0.00 to 0.00         1.00         0.41 to 0.41  
       2010         452         18.76 to 18.76         8,477         0.00 to 0.00         1.04         13.03 to 13.03  

All Cap Core Trust Series NAV

       2014         305         20.23 to 20.23         6,163         0.00 to 0.00         1.02         9.68 to 7.59  
       2013         312         18.44 to 18.44         5,751         0.00 to 0.00         1.51         34.44 to 34.44  
       2012         187         13.72 to 13.72         2,558         0.00 to 0.00         1.14         16.62 to 10.44  
       2011         128         11.76 to 11.76         1,501         0.00 to 0.00         1.31         0.40 to 0.40  
       2010         87         11.71 to 11.71         1,025         0.00 to 0.00         1.25         13.09 to 13.09  

Alpha Opportunities Trust Series I

       2014         31         23.02 to 23.02         711         0.00 to 0.00         0.47         8.00 to 8.00  
       2013         39         21.32 to 21.32         826         0.00 to 0.00         0.81         35.55 to 35.55  
       2012         40         15.73 to 15.73         625         0.00 to 0.00         0.62         21.33 to 21.33  
       2011         31         12.96 to 12.96         399         0.00 to 0.00         0.19         -8.14 to -8.14  
       2010         18         14.11 to 14.11         256         0.00 to 0.00         0.52         16.92 to 16.92  

Alpha Opportunities Trust Series NAV

       2014         137         24.37 to 24.37         3,338         0.00 to 0.00         0.61         8.12 to 6.15  
       2013         117         22.54 to 22.54         2,646         0.00 to 0.00         0.95         35.58 to 35.58  
       2012         76         16.63 to 16.63         1,269         0.00 to 0.00         0.62         21.38 to 9.62  
       2011         68         13.70 to 13.70         926         0.00 to 0.00         0.23         -8.02 to -8.02  
       2010         45         14.89 to 14.89         665         0.00 to 0.00         0.63         16.98 to 16.98  

American Asset Allocation Trust Series I

       2014         4,830         15.22 to 15.22         73,501         0.00 to 0.00         1.78         5.05 to 3.82  
       2013         3,801         14.49 to 14.49         55,061         0.00 to 0.00         1.21         23.30 to 23.30  
       2012         3,278         11.75 to 11.75         38,509         0.00 to 0.00         1.64         15.77 to 8.80  
       2011         3,133         10.15 to 10.15         31,798         0.00 to 0.00         1.54         0.91 to 0.91  
       2010         3,120         10.06 to 10.06         31,377         0.00 to 0.00         1.68         12.07 to 12.07  

American Global Growth Trust Series I

       2014         365         14.68 to 14.68         5,353         0.00 to 0.00         0.94         3.55 to 1.97  
       2013         247         14.40 to 14.40         3,559         0.00 to 0.00         1.27         28.63 to 28.63  
       2012         105         11.19 to 11.19         1,174         0.00 to 0.00         0.62         22.12 to 13.48  
       2011         50         9.17 to 9.17         455         0.00 to 0.00         2.11         -9.24 to -9.24  
       2010         2         10.10 to 10.10         16         0.00 to 0.00         3.26         0.99 to 0.99  

American Growth Trust Series I

       2014         2,634         31.88 to 21.17         62,573         0.00 to 0.00         0.84         8.14 to 7.90  
       2013         2,637         29.48 to 19.58         58,238         0.00 to 0.00         0.56         29.61 to 29.61  
       2012         2,641         22.75 to 15.11         45,369         0.00 to 0.00         0.40         17.49 to 8.11  
       2011         2,821         19.36 to 12.86         41,805         0.00 to 0.00         0.23         -4.63 to -4.63  
       2010         2,867         20.30 to 13.48         45,296         0.00 to 0.00         0.35         18.24 to 18.23  

American Growth-Income Trust Series I

       2014         3,706         29.81 to 19.97         88,902         0.00 to 0.00         0.92         10.25 to 7.27  
       2013         3,776         27.04 to 18.11         83,050         0.00 to 0.00         1.01         33.02 to 33.01  
       2012         3,951         20.33 to 13.62         66,176         0.00 to 0.00         1.49         17.16 to 10.27  
       2011         3,280         17.35 to 11.62         48,915         0.00 to 0.00         1.17         -2.09 to -2.10  
       2010         3,392         17.72 to 11.87         52,512         0.00 to 0.00         1.13         11.06 to 11.05  

American International Trust Series I

       2014         1,879         32.18 to 18.28         39,770         0.00 to 0.00         1.00         -3.05 to -4.20  
       2013         1,957         33.19 to 18.85         42,782         0.00 to 0.00         0.98         21.20 to 21.20  
       2012         1,966         27.39 to 15.55         36,419         0.00 to 0.00         1.10         17.50 to 13.22  
       2011         1,950         23.31 to 13.24         31,810         0.00 to 0.00         1.39         -14.34 to -14.34  
       2010         1,895         27.21 to 15.45         36,913         0.00 to 0.00         1.75         6.88 to 6.88  

American New World Trust Series I

       2014         477         16.05 to 16.05         7,660         0.00 to 0.00         0.90         -8.21 to -8.64  
       2013         387         17.49 to 17.49         6,763         0.00 to 0.00         1.14         10.89 to 10.89  
       2012         240         15.77 to 15.77         3,791         0.00 to 0.00         0.66         17.37 to 12.53  
       2011         225         13.44 to 13.44         3,025         0.00 to 0.00         1.51         -14.33 to -14.33  
       2010         138         15.69 to 15.69         2,161         0.00 to 0.00         1.58         17.43 to 17.43  

Blue Chip Growth Trust Series I    

       2014         769         50.22 to 50.22         38,599         0.00 to 0.00         0.00         9.07 to 9.07  
       2013         818         46.05 to 46.05         37,645         0.00 to 0.00         0.27         41.33 to 41.33  
       2012         891         32.58 to 32.58         29,014         0.00 to 0.00         0.09         18.31 to 18.31  

 

78


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Blue Chip Growth Trust Series I

       2011         1,039       $ 27.54 to $27.54       $ 28,596         0.00% to 0.00 %       0.01 %       1.44% to 1.44
       2010         1,105         27.15 to 27.15         30,006         0.00 to 0.00          0.08         16.15 to 16.15  

Blue Chip Growth Trust Series NAV

       2014         347         122.28 to 122.28         42,434         0.00 to 0.00         0.00         11.16 to 9.11  
       2013         302         112.07 to 112.07         33,822         0.00 to 0.00         0.33         41.43 to 41.43  
       2012         262         79.24 to 79.24         20,734         0.00 to 0.00         0.14         18.39 to 5.30  
       2011         229         66.93 to 66.93         15,336         0.00 to 0.00         0.02         1.45 to 1.45  
       2010         179         65.97 to 65.97         11,825         0.00 to 0.00         0.09         16.25 to 16.25  

Bond Trust Series I

       2014         98         11.16 to 11.16         1,098         0.00 to 0.00         2.77         5.53 to 5.53  
       2013         66         10.57 to 10.57         694         0.00 to 0.00         2.42         -1.36 to -1.36  
       2012         92         10.72 to 10.72         985         0.00 to 0.00         2.79         6.34 to 6.34  
       2011         91         10.08 to 10.08         922         0.00 to 0.00         13.72         0.78 to 0.78  

Bond Trust Series NAV

       2014         664         11.17 to 11.17         7,416         0.00 to 0.00         2.80         5.59 to 2.50  
       2013         519         10.58 to 10.58         5,489         0.00 to 0.00         2.94         -1.32 to -1.32  
       2012         511         10.72 to 10.72         5,480         0.00 to 0.00         3.04         6.31 to 2.99  
       2011         435         10.08 to 10.08         4,385         0.00 to 0.00         14.74         0.82 to 0.82  

Capital Appreciation Trust Series I

       2014         1,106         24.78 to 24.78         27,404         0.00 to 0.00         0.05         9.65 to 9.65  
       2013         1,167         22.60 to 22.60         26,365         0.00 to 0.00         0.25         37.41 to 37.41  
       2012         1,460         16.44 to 16.44         24,001         0.00 to 0.00         0.15         15.98 to 15.98  
       2011         1,726         14.18 to 14.18         24,469         0.00 to 0.00         0.07         0.07 to 0.07  
       2010         1,847         14.17 to 14.17         26,165         0.00 to 0.00         0.14         11.83 to 11.83  

Capital Appreciation Trust Series NAV

       2014         834         24.32 to 24.32         20,287         0.00 to 0.00         0.09         11.81 to 9.68  
       2013         770         22.17 to 22.17         17,076         0.00 to 0.00         0.26         37.50 to 37.50  
       2012         743         16.13 to 16.13         11,988         0.00 to 0.00         0.21         16.03 to 3.07  
       2011         705         13.90 to 13.90         9,798         0.00 to 0.00         0.11         0.11 to 0.11  
       2010         629         13.88 to 13.88         8,728         0.00 to 0.00         0.21         11.88 to 11.88  

Capital Appreciation Value Trust Series I

       2014         63         17.48 to 17.48         1,096         0.00 to 0.00         1.30         12.22 to 12.22  
       2013         56         15.58 to 15.58         879         0.00 to 0.00         1.20         22.31 to 22.31  
       2012         40         12.74 to 12.74         509         0.00 to 0.00         1.51         14.60 to 14.60  
       2011         45         11.12 to 11.12         501         0.00 to 0.00         1.70         3.13 to 3.13  
       2010         43         10.78 to 10.78         466         0.00 to 0.00         1.91         13.92 to 13.92  

Capital Appreciation Value Trust Series NAV

       2014         1,340         17.54 to 17.54         23,505         0.00 to 0.00         1.61         12.38 to 7.58  
       2013         1,014         15.60 to 15.60         15,829         0.00 to 0.00         1.46         22.29 to 22.29  
       2012         823         12.76 to 12.76         10,506         0.00 to 0.00         1.86         14.77 to 7.74  
       2011         523         11.12 to 11.12         5,814         0.00 to 0.00         2.16         3.09 to 3.09  
       2010         213         10.79 to 10.79         2,298         0.00 to 0.00         2.09         13.91 to 13.91  

Core Bond Trust Series I

       2014         66         20.25 to 20.25         1,334         0.00 to 0.00         3.07         5.93 to 5.93  
       2013         69         19.11 to 19.11         1,314         0.00 to 0.00         1.95         -2.15 to -2.15  
       2012         102         19.53 to 19.53         1,997         0.00 to 0.00         2.82         6.46 to 6.46  
       2011         81         18.35 to 18.35         1,494         0.00 to 0.00         4.35         8.32 to 8.32  
       2010         43         16.94 to 16.94         727         0.00 to 0.00         2.26         7.08 to 7.08  

Core Bond Trust Series NAV

       2014         397         16.26 to 16.26         6,459         0.00 to 0.00         3.62         6.01 to 2.87  
       2013         260         15.34 to 15.34         3,988         0.00 to 0.00         2.81         -2.12 to -2.12  
       2012         250         15.67 to 15.67         3,919         0.00 to 0.00         3.31         6.54 to 3.76  
       2011         128         14.71 to 14.71         1,887         0.00 to 0.00         4.64         8.32 to 8.32  
       2010         91         13.58 to 13.58         1,236         0.00 to 0.00         2.39         7.17 to 7.17  

Core Strategy Trust Series I

       2014         124         14.68 to 14.68         1,821         0.00 to 0.00         2.39         6.10 to 6.10  
       2013         133         13.84 to 13.84         1,835         0.00 to 0.00         2.64         19.16 to 19.16  
       2012         18         11.61 to 11.61         211         0.00 to 0.00         3.34         12.53 to 12.53  
       2011         12         10.32 to 10.32         124         0.00 to 0.00         3.66         0.20 to 0.20  
       2010         5         10.30 to 10.30         52         0.00 to 0.00         1.64         12.42 to 12.42  

Core Strategy Trust Series NAV

       2014         9,346         14.73 to 14.73         137,715         0.00 to 0.00         2.72         6.14 to 3.30  
       2013         8,196         13.88 to 13.88         113,767         0.00 to 0.00         1.39         19.29 to 19.29  
       2012         3,306         11.64 to 11.64         38,470         0.00 to 0.00         3.51         12.58 to 7.54  
       2011         2,113         10.34 to 10.34         21,837         0.00 to 0.00         3.15         0.19 to 0.19  
       2010         1,039         10.32 to 10.32         10,720         0.00 to 0.00         3.82         12.57 to 12.57  

Emerging Markets Value Trust Series I

       2014         198         14.10 to 14.10         2,786         0.00 to 0.00         1.86         -5.50 to -5.50  
       2013         230         14.93 to 14.93         3,435         0.00 to 0.00         1.24         -3.22 to -3.22  
       2012         521         15.42 to 15.42         8,031         0.00 to 0.00         1.07         18.53 to 18.53  
       2011         491         13.01 to 13.01         6,385         0.00 to 0.00         1.53         -27.06 to -27.06  
       2010         534         17.84 to 17.84         9,524         0.00 to 0.00         1.44         23.03 to 23.03  

Emerging Markets Value Trust Series NAV

       2014         2,052         11.32 to 11.32         23,237         0.00 to 0.00         2.00         -5.37 to -7.51  
       2013         1,849         11.97 to 11.97         22,122         0.00 to 0.00         1.52         -3.18 to -3.18  
       2012         1,275         12.36 to 12.36         15,761         0.00 to 0.00         1.25         18.49 to 14.09  
       2011         778         10.43 to 10.43         8,114         0.00 to 0.00         1.65         -27.02 to -27.02  
       2010         645         14.29 to 14.29         9,226         0.00 to 0.00         1.79         23.11 to 23.11  

Equity-Income Trust Series I    

       2014         990         45.90 to 45.90         45,429         0.00 to 0.00         1.82         7.47 to 7.47  
       2013         1,079         42.71 to 42.71         46,083         0.00 to 0.00         1.85         30.05 to 30.05  
       2012         1,258         32.84 to 32.84         41,314         0.00 to 0.00         2.05         17.36 to 17.36  
       2011         1,424         27.98 to 27.98         39,852         0.00 to 0.00         1.86         -0.81 to -0.81  
       2010         1,319         28.21 to 28.21         37,217         0.00 to 0.00         1.90         15.12 to 15.12  

 

79


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Equity-Income Trust Series NAV

       2014          1,475        $ 45.85 to $45.85        $ 67,616          0.00% to 0.00       1.93%          7.55% to 4.38
       2013         1,438         42.63 to 42.63         61,302         0.00 to 0.00         2.08         30.05 to 30.05  
       2012         1,300         32.78 to 32.78         42,625         0.00 to 0.00         2.25         17.47 to 10.80  
       2011         1,180         27.90 to 27.90         32,919         0.00 to 0.00         2.28         -0.76 to -0.76  
       2010         599         28.12 to 28.12         16,851         0.00 to 0.00         2.25         15.23 to 15.23  

Financial Industries Trust Series I

       2014  (l)       119         23.65 to 23.65         2,807         0.00 to 0.00         0.73         8.65 to 8.65  
       2013         102         21.77 to 21.77         2,218         0.00 to 0.00         0.48         30.75 to 30.75  
       2012         109         16.65 to 16.65         1,815         0.00 to 0.00         0.77         18.05 to 18.05  
       2011         128         14.10 to 14.10         1,805         0.00 to 0.00         1.49         -9.51 to -9.51  
       2010         177         15.59 to 15.59         2,762         0.00 to 0.00         0.36         12.26 to 12.26  

Financial Industries Trust Series NAV

       2014  (l)       218         28.46 to 28.46         6,196         0.00 to 0.00         0.80         8.64 to 6.56  
       2013         181         26.20 to 26.20         4,736         0.00 to 0.00         0.69         30.86 to 30.86  
       2012         163         20.02 to 20.02         3,266         0.00 to 0.00         0.82         18.03 to 8.06  
       2011         173         16.96 to 16.96         2,931         0.00 to 0.00         1.86         -9.39 to -9.39  
       2010         144         18.72 to 18.72         2,696         0.00 to 0.00         0.40         12.22 to 12.22  

Franklin Templeton Founding Allocation Trust Series I

       2014         28         14.51 to 14.51         400         0.00 to 0.00         3.09         3.01 to 3.01  
       2013         28         14.09 to 14.09         393         0.00 to 0.00         2.33         24.43 to 24.43  
       2012         34         11.32 to 11.32         389         0.00 to 0.00         3.13         16.26 to 16.26  
       2011         35         9.74 to 9.74         342         0.00 to 0.00         3.02         -1.41 to -1.41  
       2010         37         9.88 to 9.88         366         0.00 to 0.00         4.00         10.66 to 10.66  

Franklin Templeton Founding Allocation Trust Series NAV

       2014         2,729         14.55 to 14.55         39,698         0.00 to 0.00         3.54         3.06 to -1.98  
       2013         1,986         14.12 to 14.12         28,030         0.00 to 0.00         3.61         24.51 to 24.51  
       2012         1,205         11.34 to 11.34         13,662         0.00 to 0.00         3.98         16.33 to 12.32  
       2011         856         9.75 to 9.75         8,340         0.00 to 0.00         3.61         -1.45 to -1.45  
       2010         603         9.89 to 9.89         5,968         0.00 to 0.00         5.24         10.71 to 10.71  

Fundamental All Cap Core Trust Series I

       2014         25         36.47 to 36.47         896         0.00 to 0.00         0.33         9.75 to 9.75  
       2013         51         33.23 to 33.23         1,694         0.00 to 0.00         1.03         35.88 to 35.88  
       2012         32         24.46 to 24.46         793         0.00 to 0.00         0.76         23.52 to 23.52  
       2011         39         19.80 to 19.80         765         0.00 to 0.00         0.93         -2.08 to -2.08  
       2010         40         20.22 to 20.22         811         0.00 to 0.00         1.26         19.55 to 19.55  

Fundamental All Cap Core Trust Series NAV

       2014         561         21.66 to 21.66         12,145         0.00 to 0.00         0.46         11.86 to 9.81  
       2013         634         19.73 to 19.73         12,510         0.00 to 0.00         1.00         35.87 to 35.87  
       2012         565         14.52 to 14.52         8,202         0.00 to 0.00         0.82         23.67 to 15.03  
       2011         580         11.74 to 11.74         6,814         0.00 to 0.00         1.08         -2.02 to -2.02  
       2010         610         11.98 to 11.98         7,303         0.00 to 0.00         1.31         19.55 to 19.55  

Fundamental Large Cap Value Trust Series I

       2014         1,394         28.36 to 28.36         39,538         0.00 to 0.00         1.95         10.61 to 10.61  
       2013         235         25.64 to 25.64         6,034         0.00 to 0.00         1.03         32.41 to 32.41  
       2012         48         19.36 to 19.36         925         0.00 to 0.00         1.95         24.43 to 24.43  
       2011         16         15.56 to 15.56         242         0.00 to 0.00         0.92         1.75 to 1.75  
       2010         21         15.29 to 15.29         315         0.00 to 0.00         1.63         13.57 to 13.57  

Fundamental Large Cap Value Trust Series NAV

       2014         1,692         19.96 to 19.96         33,776         0.00 to 0.00         1.11         10.66 to 7.82  
       2013         837         18.04 to 18.04         15,103         0.00 to 0.00         1.23         32.46 to 32.46  
       2012         134         13.62 to 13.62         1,824         0.00 to 0.00         1.64         24.48 to 16.71  
       2011         34         10.94 to 10.94         367         0.00 to 0.00         1.22         1.90 to 1.90  
       2010         25         10.74 to 10.74         273         0.00 to 0.00         2.23         13.51 to 13.51  

Fundamental Value Trust Series I

       2014  (n)       0         26.08 to 26.08         0         0.00 to 0.00         1.89         6.99 to 6.99  
       2013         1,410         24.37 to 24.37         34,357         0.00 to 0.00         1.29         33.52 to 33.52  
       2012         1,540         18.25 to 18.25         28,110         0.00 to 0.00         0.89         13.38 to 13.38  
       2011         1,793         16.10 to 16.10         28,861         0.00 to 0.00         0.80         -3.78 to -3.78  
       2010         1,981         16.73 to 16.73         33,147         0.00 to 0.00         1.10         13.10 to 13.10  

Fundamental Value Trust Series NAV

       2014  (n)       0         18.67 to 18.67         0         0.00 to 0.00         1.98         7.01 to 5.55  
       2013         745         17.45 to 17.45         13,008         0.00 to 0.00         1.32         33.62 to 33.62  
       2012         772         13.06 to 13.06         10,077         0.00 to 0.00         1.02         13.40 to 6.37  
       2011         768         11.52 to 11.52         8,846         0.00 to 0.00         0.90         -3.74 to -3.74  
       2010         684         11.96 to 11.96         8,180         0.00 to 0.00         1.24         13.20 to 13.20  

Global Bond Trust Series I

       2014         197         30.70 to 30.70         6,058         0.00 to 0.00         0.90         2.28 to 2.28  
       2013         220         30.02 to 30.02         6,602         0.00 to 0.00         0.46         -5.42 to -5.42  
       2012         240         31.74 to 31.74         7,608         0.00 to 0.00         6.89         7.03 to 7.03  
       2011         253         29.65 to 29.65         7,490         0.00 to 0.00         6.22         9.08 to 9.08  
       2010         285         27.18 to 27.18         7,759         0.00 to 0.00         3.42         10.30 to 10.30  

Global Bond Trust Series NAV

       2014         754         30.81 to 30.81         23,227         0.00 to 0.00         1.00         2.42 to -1.88  
       2013         753         30.08 to 30.08         22,656         0.00 to 0.00         0.50         -5.54 to -5.54  
       2012         706         31.84 to 31.84         22,476         0.00 to 0.00         6.92         7.15 to 4.53  
       2011         685         29.72 to 29.72         20,361         0.00 to 0.00         7.13         9.08 to 9.08  
       2010         526         27.24 to 27.24         14,332         0.00 to 0.00         4.05         10.40 to 10.40  

Global Trust Series I    

       2014         413         31.91 to 31.91         13,193         0.00 to 0.00         3.12         -2.60 to -2.60  
       2013         218         32.76 to 32.76         7,141         0.00 to 0.00         1.52         31.09 to 31.09  
       2012         238         24.99 to 24.99         5,955         0.00 to 0.00         2.13         21.74 to 21.74  
       2011         350         20.53 to 20.53         7,177         0.00 to 0.00         2.03         -6.00 to -6.00  
       2010         372         21.84 to 21.84         8,120         0.00 to 0.00         1.51         7.76 to 7.76  

 

80


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Global Trust Series NAV

       2014         1,728       $ 17.26 to $17.26       $ 29,822         0.00% to 0.00       6.16 %       -2.51% to -6.31 %
       2013         290         17.70 to 17.70         5,130         0.00 to 0.00         1.59         31.04 to 31.04  
       2012         301         13.51 to 13.51         4,067         0.00 to 0.00         2.30         21.82 to 18.78  
       2011         302         11.09 to 11.09         3,348         0.00 to 0.00         2.18         -5.96 to -5.96  
       2010         263         11.79 to 11.79         3,100         0.00 to 0.00         1.80         7.82 to 7.82  

Health Sciences Trust Series I

       2014         215         69.05 to 69.05         14,819         0.00 to 0.00         0.00         31.83 to 31.83  
       2013         213         52.38 to 52.38         11,156         0.00 to 0.00         0.00         51.07 to 51.07  
       2012         220         34.67 to 34.67         7,625         0.00 to 0.00         0.00         31.95 to 31.95  
       2011         209         26.28 to 26.28         5,501         0.00 to 0.00         0.00         10.57 to 10.57  
       2010         193         23.76 to 23.76         4,583         0.00 to 0.00         0.00         15.70 to 15.70  

Health Sciences Trust Series NAV

       2014         556         53.81 to 53.81         29,900         0.00 to 0.00         0.00         31.85 to 25.97  
       2013         484         40.81 to 40.81         19,734         0.00 to 0.00         0.00         51.24 to 51.24  
       2012         353         26.99 to 26.99         9,520         0.00 to 0.00         0.00         31.93 to 12.19  
       2011         311         20.45 to 20.45         6,354         0.00 to 0.00         0.00         10.66 to 10.66  
       2010         254         18.48 to 18.48         4,687         0.00 to 0.00         0.00         15.81 to 15.81  

High Yield Trust Series I

       2014         440         32.01 to 32.01         14,093         0.00 to 0.00         6.55         0.11 to 0.11  
       2013         471         31.97 to 31.97         15,052         0.00 to 0.00         6.56         8.52 to 8.52  
       2012         493         29.46 to 29.46         14,511         0.00 to 0.00         8.05         18.99 to 18.99  
       2011         504         24.76 to 24.76         12,487         0.00 to 0.00         8.29         0.89 to 0.89  
       2010         589         24.54 to 24.54         14,466         0.00 to 0.00         46.27         13.78 to 13.78  

High Yield Trust Series NAV

       2014         1,232         21.14 to 21.14         26,044         0.00 to 0.00         6.90         0.00 to -3.67  
       2013         1,109         21.14 to 21.14         23,434         0.00 to 0.00         6.84         8.68 to 8.68  
       2012         993         19.45 to 19.45         19,318         0.00 to 0.00         8.73         19.07 to 9.73  
       2011         752         16.33 to 16.33         12,285         0.00 to 0.00         9.04         1.14 to 1.14  
       2010         595         16.15 to 16.15         9,608         0.00 to 0.00         55.57         13.75 to 13.75  

International Core Trust Series I

       2014         599         21.82 to 21.82         13,075         0.00 to 0.00         3.52         -6.70 to -6.70  
       2013         627         23.39 to 23.39         14,659         0.00 to 0.00         2.78         25.00 to 25.00  
       2012         739         18.71 to 18.71         13,837         0.00 to 0.00         2.85         15.05 to 15.05  
       2011         837         16.27 to 16.27         13,611         0.00 to 0.00         2.29         -9.58 to -9.58  
       2010         949         17.99 to 17.99         17,079         0.00 to 0.00         1.89         9.58 to 9.58  

International Core Trust Series NAV

       2014         669         16.07 to 16.07         10,739         0.00 to 0.00         3.79         -6.76 to -11.03  
       2013         538         17.23 to 17.23         9,260         0.00 to 0.00         3.16         25.13 to 25.13  
       2012         413         13.77 to 13.77         5,691         0.00 to 0.00         3.14         16.10 to 15.16  
       2011         448         11.96 to 11.96         5,352         0.00 to 0.00         2.57         -9.55 to -9.55  
       2010         413         13.22 to 13.22         5,455         0.00 to 0.00         2.16         9.67 to 9.67  

International Equity Index Trust B Series I

       2014         1,081         11.58 to 11.58         12,520         0.00 to 0.00         3.02         -4.61 to -4.61  
       2013         1,158         12.14 to 12.14         14,066         0.00 to 0.00         2.39         14.56 to 14.56  
       2012         1,304         10.60 to 10.60         13,820         0.00 to 0.00         7.00         6.02 to 6.02  

International Equity Index Trust B Series NAV

       2014         865         45.42 to 45.42         39,290         0.00 to 0.00         3.28         -4.57 to -7.23  
       2013         750         47.59 to 47.59         35,683         0.00 to 0.00         2.68         14.54 to 14.54  
       2012         636         41.55 to 41.55         26,411         0.00 to 0.00         1.60         17.76 to 15.48  
       2011         438         35.28 to 35.28         15,449         0.00 to 0.00         3.78         -13.99 to -13.99  
       2010         356         41.02 to 41.02         14,592         0.00 to 0.00         2.87         11.43 to 11.43  

International Growth Stock Trust Series I

       2014         152         12.42 to 12.42         1,892         0.00 to 0.00         1.77         0.20 to 0.20  
       2013         190         12.40 to 12.40         2,353         0.00 to 0.00         1.23         19.10 to 19.10  
       2012         201         10.41 to 10.41         2,094         0.00 to 0.00         4.09         4.08 to 4.08  

International Growth Stock Trust Series NAV

       2014         656         12.43 to 12.43         8,153         0.00 to 0.00         1.93         0.19 to -2.81  
       2013         594         12.41 to 12.41         7,373         0.00 to 0.00         1.26         19.18 to 19.18  
       2012         582         10.41 to 10.41         6,055         0.00 to 0.00         4.25         4.12 to 4.12  

International Small Company Trust Series I

       2014         427         14.17 to 14.17         6,043         0.00 to 0.00         1.26         -6.89 to -6.89  
       2013         526         15.22 to 15.22         8,002         0.00 to 0.00         2.07         26.34 to 26.34  
       2012         529         12.04 to 12.04         6,367         0.00 to 0.00         1.43         19.20 to 19.20  
       2011         582         10.10 to 10.10         5,878         0.00 to 0.00         1.60         -16.23 to -16.23  
       2010         660         12.06 to 12.06         7,959         0.00 to 0.00         2.55         22.70 to 22.70  

International Small Company Trust Series NAV

       2014         878         14.19 to 14.19         12,457         0.00 to 0.00         1.50         -6.85 to -10.48  
       2013         709         15.23 to 15.23         10,807         0.00 to 0.00         2.05         26.30 to 26.30  
       2012         599         12.06 to 12.06         7,223         0.00 to 0.00         1.42         19.23 to 12.82  
       2011         556         10.12 to 10.12         5,621         0.00 to 0.00         1.78         -16.18 to -16.18  
       2010         444         12.07 to 12.07         5,355         0.00 to 0.00         2.89         22.62 to 22.62  

International Value Trust Series I

       2014         623         23.95 to 23.95         14,924         0.00 to 0.00         2.80         -12.51 to -12.51  
       2013         648         27.37 to 27.37         17,721         0.00 to 0.00         1.71         26.15 to 26.15  
       2012         682         21.70 to 21.70         14,799         0.00 to 0.00         2.68         19.38 to 19.38  
       2011         799         18.18 to 18.18         14,513         0.00 to 0.00         2.36         -12.85 to -12.85  
       2010         916         20.86 to 20.86         19,105         0.00 to 0.00         1.95         7.98 to 7.98  

International Value Trust Series NAV

       2014         1,399         15.44 to 15.44         21,595         0.00 to 0.00         3.03         -12.47 to -14.40  
       2013         1,144         17.64 to 17.64         20,190         0.00 to 0.00         1.96         26.21 to 26.21  
       2012         1,042         13.98 to 13.98         14,566         0.00 to 0.00         2.90         19.59 to 19.36  
       2011         961         11.71 to 11.71         11,254         0.00 to 0.00         2.69         -12.80 to -12.80  
       2010         854         13.43 to 13.43         11,473         0.00 to 0.00         2.45         8.00 to 8.00  

Investment Quality Bond Trust Series I    

       2014         361         33.87 to 33.87         12,238         0.00 to 0.00         2.96         5.48 to 5.48  

 

81


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Investment Quality Bond Trust Series I

       2013         396       $ 32.11 to $32.11        $ 12,718         0.00% to 0.00       3.68 %       -1.92% to -1.92
       2012         449         32.74 to 32.74         14,702         0.00 to 0.00         1.93         7.59 to 7.59  
       2011         507         30.43 to 30.43         15,434         0.00 to 0.00         4.04         8.07 to 8.07  
       2010         573         28.16 to 28.16         16,144         0.00 to 0.00         5.00         7.45 to 7.45  

Investment Quality Bond Trust Series NAV

       2014         534         15.98 to 15.98         8,529         0.00 to 0.00         3.30         5.54 to 2.04  
       2013         467         15.14 to 15.14         7,074         0.00 to 0.00         3.98         -1.88 to -1.88  
       2012         457         15.43 to 15.43         7,049         0.00 to 0.00         2.26         7.66 to 4.09  
       2011         438         14.33 to 14.33         6,279         0.00 to 0.00         4.60         8.06 to 8.06  
       2010         384         13.26 to 13.26         5,097         0.00 to 0.00         5.66         7.54 to 7.54  

Lifestyle Aggressive MVP Series I

       2014  (g)       529         31.15 to 31.15         16,492         0.00 to 0.00         2.53         1.40 to 1.40  
       2013         754         30.72 to 30.72         23,176         0.00 to 0.00         2.98         26.72 to 26.72  
       2012         615         24.25 to 24.25         14,901         0.00 to 0.00         1.34         16.61 to 16.61  
       2011         745         20.79 to 20.79         15,490         0.00 to 0.00         1.67         -6.51 to -6.51  
       2010         817         22.24 to 22.24         18,178         0.00 to 0.00         1.90         16.45 to 16.45  

Lifestyle Aggressive MVP Series NAV

       2014  (g)       9,406         18.67 to 18.67         175,656         0.00 to 0.00         2.92         1.54 to 0.53  
       2013         9,085         18.39 to 18.39         167,093         0.00 to 0.00         2.60         26.77 to 26.77  
       2012         8,833         14.51 to 14.51         128,138         0.00 to 0.00         1.58         16.67 to 9.51  
       2011         7,782         12.43 to 12.43         96,769         0.00 to 0.00         2.13         -6.46 to -6.46  
       2010         5,488         13.29 to 13.29         72,956         0.00 to 0.00         2.16         16.50 to 16.50  

Lifestyle Aggressive Trust PS Series NAV

       2014  (m)       48         10.80 to 10.80         523         0.00 to 0.00         5.68         5.46 to 5.46  

Lifestyle Balanced MVP Series I

       2014  (h)       1,838         35.35 to 35.35         64,961         0.00 to 0.00         2.83         4.29 to 4.29  
       2013         1,952         33.89 to 33.89         66,175         0.00 to 0.00         2.81         12.78 to 12.78  
       2012         2,024         30.05 to 30.05         60,830         0.00 to 0.00         2.18         11.87 to 11.87  
       2011         2,368         26.86 to 26.86         63,613         0.00 to 0.00         3.26         0.62 to 0.62  
       2010         2,570         26.70 to 26.70         68,605         0.00 to 0.00         2.77         11.74 to 11.74  

Lifestyle Balanced MVP Series NAV

       2014  (h)       21,988         17.57 to 17.57         386,294         0.00 to 0.00         3.02         4.25 to 1.81  
       2013         20,832         16.85 to 16.85         351,050         0.00 to 0.00         3.11         12.89 to 12.89  
       2012         18,390         14.93 to 14.93         274,505         0.00 to 0.00         2.56         11.90 to 6.76  
       2011         15,495         13.34 to 13.34         206,692         0.00 to 0.00         3.73         0.67 to 0.67  
       2010         13,170         13.25 to 13.25         174,502         0.00 to 0.00         3.20         11.78 to 11.78  

Lifestyle Balanced Trust PS Series NAV

       2014  (m)       961         10.72 to 10.72         10,303         0.00 to 0.00         8.80         5.94 to 5.94  

Lifestyle Conservative MVP Series I

       2014  (i)       119         35.07 to 35.07         4,177         0.00 to 0.00         2.56         5.02 to 5.02  
       2013         150         33.39 to 33.39         5,019         0.00 to 0.00         2.92         3.87 to 3.87  
       2012         223         32.15 to 32.15         7,186         0.00 to 0.00         3.03         8.52 to 8.52  
       2011         214         29.63 to 29.63         6,332         0.00 to 0.00         4.47         4.23 to 4.23  
       2010         256         28.42 to 28.42         7,270         0.00 to 0.00         2.80         9.12 to 9.12  

Lifestyle Conservative MVP Series NAV

       2014  (i)       2,049         16.40 to 16.40         33,614         0.00 to 0.00         3.02         4.98 to 2.14  
       2013         1,857         15.62 to 15.62         29,023         0.00 to 0.00         3.47         3.99 to 3.99  
       2012         1,865         15.02 to 15.02         28,021         0.00 to 0.00         3.26         8.55 to 4.72  
       2011         1,582         13.84 to 13.84         21,901         0.00 to 0.00         4.66         4.27 to 4.27  
       2010         1,411         13.27 to 13.27         18,724         0.00 to 0.00         3.07         9.25 to 9.25  

Lifestyle Conservative Trust PS Series NAV

       2014  (m)       18         10.59 to 10.59         191         0.00 to 0.00         8.91         5.67 to 5.67  

Lifestyle Growth MVP Series I

       2014  (j)       2,599         33.61 to 33.61         87,346         0.00 to 0.00         2.68         2.16 to 2.16  
       2013         2,937         32.90 to 32.90         96,619         0.00 to 0.00         2.43         19.34 to 19.34  
       2012         3,225         27.57 to 27.57         88,889         0.00 to 0.00         1.82         13.87 to 13.87  
       2011         3,507         24.21 to 24.21         84,891         0.00 to 0.00         2.70         -1.60 to -1.60  
       2010         3,839         24.60 to 24.60         94,447         0.00 to 0.00         2.37         13.02 to 13.02  

Lifestyle Growth MVP Series NAV

       2014  (j)       30,578         18.02 to 18.02         551,018         0.00 to 0.00         2.94         2.28 to 0.59  
       2013         28,942         17.62 to 17.62         509,912         0.00 to 0.00         2.72         19.38 to 19.38  
       2012         26,401         14.76 to 14.76         389,619         0.00 to 0.00         2.03         13.91 to 7.98  
       2011         23,851         12.96 to 12.96         309,010         0.00 to 0.00         2.98         -1.55 to -1.55  
       2010         21,197         13.16 to 13.16         278,953         0.00 to 0.00         2.72         13.04 to 13.04  

Lifestyle Growth Trust PS Series NAV

       2014  (m)       1,093         10.81 to 10.81         11,808         0.00 to 0.00         7.60         6.23 to 6.23  

Lifestyle Moderate MVP Series I

       2014  (k)       428         35.90 to 35.90         15,384         0.00 to 0.00         2.60         4.94 to 4.94  
       2013         511         34.21 to 34.21         17,487         0.00 to 0.00         2.97         10.22 to 10.22  
       2012         539         31.04 to 31.04         16,738         0.00 to 0.00         2.53         10.67 to 10.67  
       2011         505         28.05 to 28.05         14,164         0.00 to 0.00         3.39         2.33 to 2.33  
       2010         558         27.41 to 27.41         15,301         0.00 to 0.00         2.69         10.55 to 10.55  

Lifestyle Moderate MVP Series NAV

       2014  (k)       4,639         17.27 to 17.27         80,144         0.00 to 0.00         3.06         4.99 to 2.38  
       2013         4,291         16.45 to 16.45         70,619         0.00 to 0.00         3.23         10.26 to 10.26  
       2012         3,741         14.92 to 14.92         55,826         0.00 to 0.00         2.75         10.70 to 5.97  
       2011         3,199         13.48 to 13.48         43,126         0.00 to 0.00         4.06         2.38 to 2.38  
       2010         2,706         13.17 to 13.17         35,632         0.00 to 0.00         2.99         10.69 to 10.69  

Lifestyle Moderate Trust PS Series NAV

       2014         269         10.68 to 10.68         2,874         0.00 to 0.00         8.70         5.88 to 5.88  
       2013  (f)       3         10.08 to 10.08         28         0.00 to 0.00         0.00         0.84 to 0.84  

M Capital Appreciation (e)

       2014         128         85.07 to 85.07         10,873         0.00 to 0.00         0.00         12.42 to 9.01  
       2013         123         75.67 to 75.67         9,332         0.00 to 0.00         0.00         39.20 to 39.20  
       2012         114         54.36 to 54.36         6,201         0.00 to 0.00         0.33         17.43 to 8.43  

 

82


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

M Capital Appreciation (e)    

       2011         110       $ 46.29 to $46.29       $ 5,098         0.00% to 0.00       0.00 %       -7.22% to -7.22 %
       2010         68         49.89 to 49.89         3,375         0.00 to 0.00         0.20         27.00 to 27.00   

M International Equity (e)

       2014         328         33.05 to 33.05          10,847         0.00 to 0.00         2.37         -7.06 to -10.07   
       2013         298         35.56 to 35.56         10,597         0.00 to 0.00         2.57         16.32 to 16.32  
       2012         200         30.57 to 30.57         6,117         0.00 to 0.00         2.22         20.68 to 14.03  
       2011         176         25.33 to 25.33         4,445         0.00 to 0.00         3.70         -13.56 to -13.56  
       2010         127         29.30 to 29.30         3,712         0.00 to 0.00         4.05         4.61 to 4.61  

M Large Cap Growth (e)

       2014         250         50.21 to 50.21         12,528         0.00 to 0.00         0.04         12.53 to 10.21  
       2013         235         45.56 to 45.56         10,727         0.00 to 0.00         0.59         36.15 to 36.15  
       2012         204         33.46 to 33.46         6,838         0.00 to 0.00         0.05         19.31 to 7.49  
       2011         151         28.04 to 28.04         4,231         0.00 to 0.00         0.00         -0.80 to -0.80  
       2010         91         28.27 to 28.27         2,560         0.00 to 0.00         0.36         23.06 to 23.06  

M Large Cap Value (e)

       2014         396         23.85 to 23.85         9,439         0.00 to 0.00         1.26         9.68 to 5.84  
       2013         354         21.75 to 21.75         7,698         0.00 to 0.00         2.84         34.22 to 34.22  
       2012         299         16.20 to 16.20         4,843         0.00 to 0.00         0.81         17.29 to 10.97  
       2011         276         13.81 to 13.81         3,810         0.00 to 0.00         0.38         -4.11 to -4.11  
       2010         223         14.41 to 14.41         3,210         0.00 to 0.00         0.70         9.27 to 9.27  

Mid Cap Index Trust Series I

       2014         343         42.08 to 42.08         14,446         0.00 to 0.00         0.96         9.35 to 9.35  
       2013         399         38.49 to 38.49         15,339         0.00 to 0.00         1.07         33.03 to 33.03  
       2012         412         28.93 to 28.93         11,921         0.00 to 0.00         1.42         17.48 to 17.48  
       2011         463         24.63 to 24.63         11,392         0.00 to 0.00         0.65         -2.25 to -2.25  
       2010         535         25.19 to 25.19         13,471         0.00 to 0.00         1.10         25.98 to 25.98  

Mid Cap Index Trust Series NAV

       2014         1,111         27.60 to 27.60         30,659         0.00 to 0.00         1.10         9.40 to 6.47  
       2013         955         25.23 to 25.23         24,098         0.00 to 0.00         1.23         33.09 to 33.09  
       2012         784         18.95 to 18.95         14,859         0.00 to 0.00         1.61         17.54 to 8.00  
       2011         674         16.13 to 16.13         10,869         0.00 to 0.00         0.76         -2.14 to -2.14  
       2010         619         16.48 to 16.48         10,202         0.00 to 0.00         1.23         26.06 to 26.06  

Mid Cap Stock Trust Series I

       2014         644         33.87 to 33.87         21,808         0.00 to 0.00         0.10         8.02 to 8.02  
       2013         667         31.35 to 31.35         20,921         0.00 to 0.00         0.04         36.82 to 36.82  
       2012         725         22.92 to 22.92         16,622         0.00 to 0.00         0.00         22.21 to 22.21  
       2011         831         18.75 to 18.75         15,580         0.00 to 0.00         0.00         -9.20 to -9.20  
       2010         964         20.65 to 20.65         19,917         0.00 to 0.00         0.00         23.08 to 23.08  

Mid Cap Stock Trust Series NAV

       2014         317         73.72 to 73.72         23,349         0.00 to 0.00         0.15         9.25 to 8.11  
       2013         279         68.19 to 68.19         18,991         0.00 to 0.00         0.07         36.84 to 36.84  
       2012         260         49.83 to 49.83         12,945         0.00 to 0.00         0.00         22.34 to 8.31  
       2011         244         40.73 to 40.73         9,933         0.00 to 0.00         0.00         -9.16 to -9.16  
       2010         205         44.84 to 44.84         9,175         0.00 to 0.00         0.00         23.07 to 23.07  

Mid Value Trust Series I

       2014         521         25.98 to 25.98         13,539         0.00 to 0.00         0.72         10.60 to 10.60  
       2013         553         23.49 to 23.49         12,998         0.00 to 0.00         1.04         31.39 to 31.39  
       2012         650         17.88 to 17.88         11,629         0.00 to 0.00         0.84         19.53 to 19.53  
       2011         712         14.96 to 14.96         10,649         0.00 to 0.00         0.72         -4.93 to -4.93  
       2010         733         15.73 to 15.73         11,536         0.00 to 0.00         2.04         16.15 to 16.15  

Mid Value Trust Series NAV

       2014         491         39.91 to 39.91         19,602         0.00 to 0.00         0.82         10.70 to 4.90  
       2013         455         36.05 to 36.05         16,387         0.00 to 0.00         1.09         31.47 to 31.47  
       2012         446         27.42 to 27.42         12,226         0.00 to 0.00         0.91         19.54 to 12.75  
       2011         424         22.94 to 22.94         9,735         0.00 to 0.00         0.81         -4.80 to -4.80  
       2010         385         24.10 to 24.10         9,285         0.00 to 0.00         2.33         16.16 to 16.16  

Money Market Trust B Series NAV

       2014         5,079         17.37 to 17.37         88,240         0.00 to 0.00         0.00         0.00 to 0.00  
       2013         5,806         17.37 to 17.37         100,876         0.00 to 0.00         0.01         0.01 to 0.01  
       2012         6,223         17.37 to 17.37         108,102         0.00 to 0.00         0.04         0.03 to 0.03  
       2011         6,763         17.36 to 17.36         117,420         0.00 to 0.00         0.00         0.08 to 0.08  
       2010         4,902         17.35 to 17.35         85,041         0.00 to 0.00         0.05         0.03 to 0.03  

Money Market Trust Series I

       2014         1,384         24.66 to 24.66         34,120         0.00 to 0.00         0.00         0.00 to 0.00  
       2013         1,712         24.66 to 24.66         42,210         0.00 to 0.00         0.00         0.01 to 0.01  
       2012         1,836         24.66 to 24.66         45,255         0.00 to 0.00         0.00         0.01 to 0.01  
       2011         2,305         24.66 to 24.66         56,818         0.00 to 0.00         0.00         0.07 to 0.07  
       2010         2,550         24.64 to 24.64         62,816         0.00 to 0.00         0.00         0.00 to 0.00  

Natural Resources Trust Series I

       2014  (o)       0         38.15 to 38.15         0         0.00 to 0.00         1.57         -7.78 to -7.78  
       2013         162         41.37 to 41.37         6,721         0.00 to 0.00         0.56         2.97 to 2.97  
       2012         190         40.18 to 40.18         7,649         0.00 to 0.00         0.77         0.52 to 0.52  
       2011         205         39.97 to 39.97         8,205         0.00 to 0.00         0.46         -20.29 to -20.29  
       2010         230         50.15 to 50.15         11,525         0.00 to 0.00         0.64         15.21 to 15.21  

Natural Resources Trust Series NAV

       2014  (o)       0         16.13 to 16.13         0         0.00 to 0.00         1.75         -7.74 to -16.68  
       2013         1,386         17.49 to 17.49         24,233         0.00 to 0.00         0.66         3.07 to 3.07  
       2012         1,246         16.97 to 16.97         21,135         0.00 to 0.00         0.88         7.03 to 0.58  
       2011         1,148         16.87 to 16.87         19,368         0.00 to 0.00         0.57         -20.27 to -20.27  
       2010         914         21.16 to 21.16         19,343         0.00 to 0.00         0.80         15.25 to 15.25  

PIMCO All Asset (e)

       2014         1,461         22.37 to 15.84         24,126         0.00 to 0.00         4.55         0.24 to -3.88  
       2013         1,894         22.31 to 15.81         31,105         0.00 to 0.00         4.52         -0.10 to -0.10  
       2012         1,340         22.34 to 15.82         22,540         0.00 to 0.00         4.81         14.65 to 9.24  
       2011         1,033         19.48 to 13.80         15,306         0.00 to 0.00         6.83         1.66 to 1.66  

 

83


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

PIMCO All Asset (e)    

       2010         744       $ 19.16 to $13.58       $ 10,910         0.00% to 0.00       7.26 %       12.71% to 12.71

Real Estate Securities Trust Series I

       2014         191         166.10 to 166.10         31,721         0.00 to 0.00         1.63         31.73 to 31.73  
       2013         198         126.09 to 126.09         24,973         0.00 to 0.00         1.84         -0.10 to -0.10  
       2012         217         126.22 to 126.22         27,346         0.00 to 0.00         1.69         17.26 to 17.26  
       2011         248         107.64 to 107.64         26,668         0.00 to 0.00         1.46         9.46 to 9.46  
       2010         268         98.33 to 98.33         26,379         0.00 to 0.00         1.85         29.20 to 29.20  

Real Estate Securities Trust Series NAV

       2014         283         138.91 to 138.91         39,373         0.00 to 0.00         1.81         31.75 to 13.03  
       2013         236         105.43 to 105.43         24,887         0.00 to 0.00         2.07         -0.05 to -0.05  
       2012         193         105.48 to 105.48         20,360         0.00 to 0.00         1.92         17.33 to 4.78  
       2011         173         89.90 to 89.90         15,575         0.00 to 0.00         1.58         9.58 to 9.58  
       2010         159         82.05 to 82.05         13,030         0.00 to 0.00         2.19         29.20 to 29.20  

Real Return Bond Trust Series I

       2014         156         21.67 to 21.67         3,389         0.00 to 0.00         2.92         4.76 to 4.76  
       2013         185         20.69 to 20.69         3,835         0.00 to 0.00         2.43         -9.28 to -9.28  
       2012         209         22.80 to 22.80         4,773         0.00 to 0.00         1.73         8.86 to 8.86  
       2011         235         20.95 to 20.95         4,931         0.00 to 0.00         3.93         12.02 to 12.02  
       2010         239         18.70 to 18.70         4,468         0.00 to 0.00         11.75         8.83 to 8.83  

Real Return Bond Trust Series NAV

       2014         779         14.94 to 14.94         11,637         0.00 to 0.00         2.88         4.88 to 0.73  
       2013         932         14.24 to 14.24         13,267         0.00 to 0.00         2.66         -9.25 to -9.25  
       2012         939         15.69 to 15.69         14,743         0.00 to 0.00         1.91         8.86 to 4.13  
       2011         657         14.41 to 14.41         9,469         0.00 to 0.00         4.31         12.14 to 12.14  
       2010         482         12.85 to 12.85         6,191         0.00 to 0.00         13.19         8.82 to 8.82  

Science & Technology Trust Series I

       2014         557         33.90 to 33.90         18,893         0.00 to 0.00         0.00         12.89 to 12.89  
       2013         576         30.02 to 30.02         17,289         0.00 to 0.00         0.00         43.53 to 43.53  
       2012         624         20.92 to 20.92         13,043         0.00 to 0.00         0.00         10.45 to 10.45  
       2011         698         18.94 to 18.94         13,212         0.00 to 0.00         0.00         -7.75 to -7.75  
       2010         876         20.53 to 20.53         17,991         0.00 to 0.00         0.00         24.61 to 24.61  

Science & Technology Trust Series NAV

       2014         486         26.86 to 26.86         13,046         0.00 to 0.00         0.00         14.24 to 12.95  
       2013         387         23.78 to 23.78         9,206         0.00 to 0.00         0.00         43.55 to 43.55  
       2012         356         16.57 to 16.57         5,900         0.00 to 0.00         0.00         10.54 to 1.76  
       2011         326         14.99 to 14.99         4,890         0.00 to 0.00         0.00         -7.72 to -7.72  
       2010         295         16.24 to 16.24         4,795         0.00 to 0.00         0.00         24.69 to 24.69  

Short Term Government Income Trust Series I

       2014         592         10.62 to 10.62         6,284         0.00 to 0.00         1.82         1.15 to 1.15  
       2013         775         10.50 to 10.50         8,144         0.00 to 0.00         1.94         -0.86 to -0.86  
       2012         865         10.59 to 10.59         9,162         0.00 to 0.00         1.59         1.21 to 1.21  
       2011         908         10.47 to 10.47         9,500         0.00 to 0.00         2.33         2.77 to 2.77  
       2010         994         10.19 to 10.19         10,124         0.00 to 0.00         1.47         1.86 to 1.86  

Short Term Government Income Trust Series NAV

       2014         1,114         10.65 to 10.65         11,869         0.00 to 0.00         2.00         1.19 to 0.39  
       2013         1,140         10.52 to 10.52         11,994         0.00 to 0.00         2.11         -0.74 to -0.74  
       2012         1,488         10.60 to 10.60         15,775         0.00 to 0.00         1.71         1.18 to 0.55  
       2011         868         10.48 to 10.48         9,098         0.00 to 0.00         2.76         2.83 to 2.83  
       2010         687         10.19 to 10.19         7,003         0.00 to 0.00         1.64         1.91 to 1.91  

Small Cap Growth Trust Series I

       2014         94         27.64 to 27.64         2,586         0.00 to 0.00         0.00         7.57 to 7.57  
       2013         101         25.69 to 25.69         2,592         0.00 to 0.00         0.00         44.08 to 44.08  
       2012         102         17.83 to 17.83         1,814         0.00 to 0.00         0.00         16.47 to 16.47  
       2011         125         15.31 to 15.31         1,909         0.00 to 0.00         0.00         -6.81 to -6.81  
       2010         103         16.43 to 16.43         1,690         0.00 to 0.00         0.00         22.08 to 22.08  

Small Cap Growth Trust Series NAV

       2014         510         32.78 to 32.78         16,723         0.00 to 0.00         0.00         11.05 to 7.60  
       2013         481         30.46 to 30.46         14,645         0.00 to 0.00         0.00         44.22 to 44.22  
       2012         420         21.12 to 21.12         8,867         0.00 to 0.00         0.00         16.53 to 4.70  
       2011         434         18.13 to 18.13         7,875         0.00 to 0.00         0.00         -6.80 to -6.80  
       2010         405         19.45 to 19.45         7,878         0.00 to 0.00         0.00         22.14 to 22.14  

Small Cap Index Trust Series I

       2014         291         32.52 to 32.52         9,477         0.00 to 0.00         0.92         4.59 to 4.59  
       2013         308         31.10 to 31.10         9,568         0.00 to 0.00         1.43         38.61 to 38.61  
       2012         332         22.43 to 22.43         7,449         0.00 to 0.00         2.03         16.09 to 16.09  
       2011         360         19.32 to 19.32         6,958         0.00 to 0.00         1.13         -4.50 to -4.50  
       2010         397         20.24 to 20.24         8,027         0.00 to 0.00         0.50         26.36 to 26.36  

Small Cap Index Trust Series NAV

       2014         793         25.96 to 25.96         20,587         0.00 to 0.00         1.02         7.14 to 4.71  
       2013         658         24.79 to 24.79         16,308         0.00 to 0.00         1.59         38.75 to 38.75  
       2012         599         17.87 to 17.87         10,697         0.00 to 0.00         2.18         16.06 to 10.12  
       2011         516         15.40 to 15.40         7,946         0.00 to 0.00         1.26         -4.37 to -4.37  
       2010         450         16.10 to 16.10         7,243         0.00 to 0.00         0.61         26.43 to 26.43  

Small Cap Opportunities Trust Series I

       2014         903         39.46 to 39.46         35,643         0.00 to 0.00         0.05         2.39 to 2.39  
       2013         1,037         38.54 to 38.54         39,958         0.00 to 0.00         0.51         40.16 to 40.16  
       2012         230         27.50 to 27.50         6,337         0.00 to 0.00         0.00         16.84 to 16.84  
       2011         263         23.54 to 23.54         6,193         0.00 to 0.00         0.09         -3.16 to -3.16  
       2010         320         24.31 to 24.31         7,788         0.00 to 0.00         0.00         29.67 to 29.67  

Small Cap Opportunities Trust Series NAV

       2014         822         19.43 to 19.43         15,967         0.00 to 0.00         0.08         3.44 to 2.42  
       2013         686         18.97 to 18.97         13,007         0.00 to 0.00         0.72         40.28 to 40.28  
       2012         329         13.52 to 13.52         4,453         0.00 to 0.00         0.00         16.88 to 10.99  
       2011         252         11.57 to 11.57         2,911         0.00 to 0.00         0.10         -3.13 to -3.13  
       2010         254         11.94 to 11.94         3,031         0.00 to 0.00         0.00         29.71 to 29.71  

 

84


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Small Cap Value Trust Series I    

       2014         124       $ 24.60 to $24.60        $ 3,054         0.00% to 0.00       0.64 %       7.18% to 7.18
       2013         130         22.95 to 22.95         2,983         0.00 to 0.00         0.53         33.31 to 33.31  
       2012         133         17.21 to 17.21         2,291         0.00 to 0.00         0.78         15.70 to 15.70  
       2011         201         14.88 to 14.88         2,986         0.00 to 0.00         0.87         1.04 to 1.04  
       2010         178         14.72 to 14.72         2,623         0.00 to 0.00         0.27         26.10 to 26.10  

Small Cap Value Trust Series NAV

       2014         341         69.19 to 69.19         23,607         0.00 to 0.00         0.72         7.99 to 7.25  
       2013         322         64.51 to 64.51         20,747         0.00 to 0.00         0.61         33.33 to 33.33  
       2012         290         48.39 to 48.39         14,014         0.00 to 0.00         0.95         15.78 to 10.07  
       2011         283         41.79 to 41.79         11,821         0.00 to 0.00         0.89         1.15 to 1.15  
       2010         233         41.32 to 41.32         9,644         0.00 to 0.00         0.46         26.15 to 26.15  

Small Company Value Trust Series I

       2014         401         34.28 to 34.28         13,756         0.00 to 0.00         0.03         0.11 to 0.11  
       2013         433         34.24 to 34.24         14,836         0.00 to 0.00         1.67         31.61 to 31.61  
       2012         512         26.02 to 26.02         13,314         0.00 to 0.00         0.25         16.30 to 16.30  
       2011         601         22.37 to 22.37         13,435         0.00 to 0.00         0.55         -0.93 to -0.93  
       2010         678         22.58 to 22.58         15,310         0.00 to 0.00         1.30         21.36 to 21.36  

Small Company Value Trust Series NAV

       2014         770         22.81 to 22.81         17,573         0.00 to 0.00         0.06         0.30 to 0.14  
       2013         708         22.78 to 22.78         16,123         0.00 to 0.00         1.77         31.68 to 31.68  
       2012         627         17.30 to 17.30         10,845         0.00 to 0.00         0.26         16.41 to 11.42  
       2011         570         14.86 to 14.86         8,473         0.00 to 0.00         0.65         -0.94 to -0.94  
       2010         501         15.00 to 15.00         7,512         0.00 to 0.00         1.46         21.39 to 21.39  

Strategic Income Opportunities Trust Series I

       2014         354         25.83 to 25.83         9,149         0.00 to 0.00         4.28         5.06 to 5.06  
       2013         400         24.58 to 24.58         9,826         0.00 to 0.00         5.65         3.82 to 3.82  
       2012         416         23.68 to 23.68         9,845         0.00 to 0.00         6.76         12.86 to 12.86  
       2011         563         20.98 to 20.98         11,816         0.00 to 0.00         10.79         2.03 to 2.03  
       2010         589         20.56 to 20.56         12,119         0.00 to 0.00         25.85         15.89 to 15.89  

Strategic Income Opportunities Trust Series NAV

       2014         1,258         19.15 to 19.15         24,083         0.00 to 0.00         4.69         5.13 to 1.57  
       2013         1,233         18.22 to 18.22         22,464         0.00 to 0.00         6.31         3.81 to 3.81  
       2012         961         17.55 to 17.55         16,860         0.00 to 0.00         7.42         12.94 to 7.30  
       2011         775         15.54 to 15.54         12,042         0.00 to 0.00         11.65         2.08 to 2.08  
       2010         621         15.22 to 15.22         9,446         0.00 to 0.00         14.80         15.91 to 15.91  

Total Bond Market Trust B Series NAV

       2014         681         23.62 to 23.62         16,086         0.00 to 0.00         3.42         6.06 to 2.90  
       2013         609         22.27 to 22.27         13,556         0.00 to 0.00         3.38         -2.44 to -2.44  
       2012         684         22.83 to 22.83         15,614         0.00 to 0.00         1.72         4.08 to 2.03  
       2011         628         21.94 to 21.94         13,780         0.00 to 0.00         4.60         7.60 to 7.60  
       2010         559         20.39 to 20.39         11,401         0.00 to 0.00         4.81         6.49 to 6.49  

Total Return Trust Series I

       2014         648         30.02 to 30.02         19,444         0.00 to 0.00         3.14         4.74 to 4.74  
       2013         764         28.66 to 28.66         21,908         0.00 to 0.00         2.94         -2.03 to -2.03  
       2012         931         29.26 to 29.26         27,223         0.00 to 0.00         1.96         8.49 to 8.49  
       2011         1,105         26.97 to 26.97         29,807         0.00 to 0.00         4.45         3.91 to 3.91  
       2010         1,091         25.95 to 25.95         28,307         0.00 to 0.00         2.33         7.64 to 7.64  

Total Return Trust Series NAV

       2014         2,784         18.03 to 18.03         50,210         0.00 to 0.00         3.49         4.72 to 2.38  
       2013         2,637         17.22 to 17.22         45,413         0.00 to 0.00         3.06         -1.98 to -1.98  
       2012         2,846         17.57 to 17.57         50,008         0.00 to 0.00         2.25         8.57 to 4.25  
       2011         2,141         16.18 to 16.18         34,643         0.00 to 0.00         4.54         3.97 to 3.97  
       2010         1,960         15.57 to 15.57         30,501         0.00 to 0.00         2.59         7.66 to 7.66  

Total Stock Market Index Trust Series I

       2014         255         23.94 to 23.94         6,104         0.00 to 0.00         1.12         11.47 to 11.47  
       2013         300         21.48 to 21.48         6,439         0.00 to 0.00         1.45         33.39 to 33.39  
       2012         294         16.10 to 16.10         4,742         0.00 to 0.00         1.44         15.50 to 15.50  
       2011         413         13.94 to 13.94         5,751         0.00 to 0.00         1.23         0.28 to 0.28  
       2010         448         13.90 to 13.90         6,222         0.00 to 0.00         1.30         17.19 to 17.19  

Total Stock Market Index Trust Series NAV

       2014         306         79.72 to 79.72         24,387         0.00 to 0.00         1.29         11.46 to 8.79  
       2013         247         71.52 to 71.52         17,696         0.00 to 0.00         1.62         33.45 to 33.45  
       2012         149         53.59 to 53.59         8,001         0.00 to 0.00         1.66         15.56 to 7.92  
       2011         124         46.38 to 46.38         5,769         0.00 to 0.00         1.40         0.33 to 0.33  
       2010         111         46.23 to 46.23         5,116         0.00 to 0.00         1.61         17.26 to 17.26  

U.S. Equity Trust Series I

       2014         1,152         14.63 to 14.63         16,856         0.00 to 0.00         1.43         11.03 to 11.03  
       2013         1,249         13.18 to 13.18         16,458         0.00 to 0.00         1.63         28.22 to 28.22  
       2012         1,347         10.28 to 10.28         13,846         0.00 to 0.00         2.03         2.77 to 2.77  

U.S. Equity Trust Series NAV

       2014         500         14.66 to 14.66         7,330         0.00 to 0.00         1.65         11.07 to 7.43  
       2013         444         13.20 to 13.20         5,861         0.00 to 0.00         1.84         28.36 to 28.36  
       2012         391         10.28 to 10.28         4,020         0.00 to 0.00         2.04         6.03 to 2.81  

Ultra Short Term Bond Trust Series I

       2014         62         10.05 to 10.05         620         0.00 to 0.00         1.61         -0.02 to -0.02  
       2013         66         10.05 to 10.05         668         0.00 to 0.00         1.43         -0.07 to -0.07  
       2012         50         10.06 to 10.06         503         0.00 to 0.00         2.44         0.54 to 0.54  
       2011         20         10.00 to 10.00         205         0.00 to 0.00         3.11         0.12 to 0.12  
       2010         3         9.99 to 9.99         30         0.00 to 0.00         2.97         -0.08 to -0.08  

Ultra Short Term Bond Trust Series NAV

       2014         338         10.07 to 10.07         3,409         0.00 to 0.00         1.61         0.03 to -0.14  
       2013         268         10.07 to 10.07         2,699         0.00 to 0.00         1.29         -0.02 to -0.02  
       2012         165         10.07 to 10.07         1,661         0.00 to 0.00         1.38         0.66 to 0.17  
       2011         125         10.00 to 10.00         1,250         0.00 to 0.00         3.72         0.09 to 0.09  

 

85


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

         At December 31,   For the years and periods ended December 31,

Sub-account

   Year   Units
(000s)
  Unit Fair Value
Highest to Lowest (a)
  Assets
(000s)
  Expense Ratio
Highest to Lowest (b)
  Investment
Income Ratio (c)
  Total Return
Highest to Lowest (d)

Ultra Short Term Bond Trust Series NAV    

       2010         0       $ 9.99 to $9.99       $ 4         0.00% to 0.00       2.70 %       -0.06% to -0.06

Utilities Trust Series I

       2014         131         37.33 to 37.33         4,884         0.00 to 0.00         2.76         12.59 to 12.59  
       2013         148         33.15 to 33.15         4,922         0.00 to 0.00         2.06         20.57 to 20.57  
       2012         186         27.50 to 27.50         5,122         0.00 to 0.00         4.11         13.66 to 13.66  
       2011         177         24.19 to 24.19         4,293         0.00 to 0.00         3.45         6.65 to 6.65  
       2010         185         22.68 to 22.68         4,197         0.00 to 0.00         2.17         13.92 to 13.92  

Utilities Trust Series NAV

       2014         504         29.88 to 29.88         15,058         0.00 to 0.00         3.22         12.72 to 2.31  
       2013         448         26.50 to 26.50         11,863         0.00 to 0.00         2.13         20.65 to 20.65  
       2012         437         21.97 to 21.97         9,598         0.00 to 0.00         3.81         13.63 to 10.75  
       2011         428         19.33 to 19.33         8,266         0.00 to 0.00         3.81         6.80 to 6.80  
       2010         393         18.10 to 18.10         7,108         0.00 to 0.00         2.76         14.00 to 14.00  

Value Trust Series I

       2014         290         58.21 to 58.21         16,879         0.00 to 0.00         0.47         9.82 to 9.82  
       2013         317         53.01 to 53.01         16,826         0.00 to 0.00         0.77         35.40 to 35.40  
       2012         359         39.15 to 39.15         14,061         0.00 to 0.00         0.80         17.42 to 17.42  
       2011         414         33.34 to 33.34         13,803         0.00 to 0.00         1.08         0.98 to 0.98  
       2010         449         33.02 to 33.02         14,821         0.00 to 0.00         0.99         22.22 to 22.22  

Value Trust Series NAV

       2014         474         27.16 to 27.16         12,884         0.00 to 0.00         0.54         9.88 to 7.60  
       2013         405         24.72 to 24.72         10,005         0.00 to 0.00         0.91         35.44 to 35.44  
       2012         354         18.25 to 18.25         6,466         0.00 to 0.00         0.96         17.50 to 6.68  
       2011         295         15.53 to 15.53         4,587         0.00 to 0.00         1.15         1.03 to 1.03  
       2010         263         15.37 to 15.37         4,048         0.00 to 0.00         1.20         22.30 to 22.30  

 

86


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

7. Unit Values — (continued):

 

 

(a)

As the unit fair value is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract unit values are not within the ranges presented.

 

(b)

These ratios represent the annualized contract expenses of the variable account, consisting primarily of mortality and expense charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to policyholder accounts through the redemption of units and expenses of the underlying Portfolio are excluded.

 

(c)

These ratios, which are not annualized, represent the distributions from net investment income received by the sub-account from the underlying Portfolio, net of management fees assessed by the portfolio manager, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that are assessed against policyholder accounts either through the reductions in the unit values or the redemptions of units. The recognition of investment income by the sub-account is affected by the timing of the declaration of dividends by the underlying Portfolio in which the sub-accounts invest.

 

(d)

These ratios, which are not annualized, represent the total return for the periods indicated, including changes in the value of the underlying Portfolio, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options indicated in footnote 1 with a date notation, if any, denote the effective date of that investment option in the variable account. The total return is calculated for the period indicated or from the effective date through the end of the reporting period. For closed sub-accounts, the total return is calculated from the beginning of the reporting period to the date the sub-account closed. As the total return is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract total returns are not within the ranges presented.

 

(e)

Sub-account that invests in non-affiliated Trust.

 

(f)

Reflects the period from commencement of operations on December 9, 2013 through December 31, 2013.

 

(g)

Renamed on May 5, 2014. Previously known as Lifestyle Aggressive Trust.

 

(h)

Renamed on May 5, 2014. Previously known as Lifestyle Balanced Trust.

 

(i)

Renamed on May 5, 2014. Previously known as Lifestyle Conservative Trust.

 

(j)

Renamed on May 5, 2014. Previously known as Lifestyle Growth Trust.

 

(k)

Renamed on May 5, 2014. Previously known as Lifestyle Moderate Trust.

 

(l)

Renamed on November 10, 2014. Previously known as Financial Services Trust.

 

(m)

Sub-account available in prior year but no activity.

 

(n)

Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on November 10, 2014.

 

(o)

Terminated as an investment option and funds transferred to Global Trust on November 10, 2014.

 

87


Table of Contents

John Hancock Life Insurance Company (U.S.A.) Separate Account A

Notes to Financial Statements — (continued)

December 31, 2014

 

 

8. Diversification Requirements

The Internal Revenue Service has issued regulations under Section 817(h) of the Internal Revenue Code (“the Code”). Under the provisions of Section 817(h) of the Code, a Contract will not be treated as a variable life contract for federal tax purposes for any period for which the investments of the Account on which the contract is based are not adequately diversified. The Code provides that the “adequately diversified” requirement may be met if the underlying investments satisfy either a statutory safe harbor test or diversification requirement set forth in regulations issued by the Secretary of the Treasury. The Company believes that the Account satisfies the current requirements of the regulations, and the Account will continue to meet such requirements.

 

9. Contract Charges

The Company deducts certain charges from gross premiums before placing the remaining net premiums in the sub-account. In the event of a surrender by the contract holder, surrender charges may be levied by the Company against the contract value at the time of termination to cover sales and administrative expenses associated with underwriting and issuing the Contract. Additionally, each month a deduction consisting of an administrative charge, a charge for cost of insurance, and charges for supplementary benefits is deducted from the contract value. Contract charges are paid through the redemption of sub-account units and are reflected as terminations.

 

88


Table of Contents
PART C
OTHER INFORMATION
Item 26. Exhibits
The following exhibits are filed as part of this Registration Statement:
(a) Resolution of Board of Directors establishing Separate Account A is incorporated by reference to post-effective amendment number 1, file number 333-157212, filed with the Commission in April 2010.
(b) Not applicable.
(c) (1) Distribution Agreement and Servicing Agreement between John Hancock Distributors and John Hancock Life Insurance Company (U.S.A.) dated February 17, 2009, incorporated by reference to pre-effective amendment number 1, file number 333-157212, filed with the Commission on April 7, 2009.
(2)(a) Specimen General Agent and Broker-Dealer Selling Agreement by and among John Hancock Life Insurance Company (U.S.A.) and John Hancock Distributors LLC effective August, 2009, incorporated by reference to pre-effective amendment number 2, file number 333-157212, filed with the Commission on April 26, 2011.
(b) List of third party broker-dealer firms included as Attachment A, incorporated by reference to post-effective amendment number 7, file number 333-179570, filed with the Commission in April, 2015.
(d) (1) Form of Specimen Flexible Premium Variable Life Insurance Policy, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008 and form of Policy Endorsement dated 2009, incorporated by reference to post-effective amendment number 4, file number 333-131299, filed with the Commission in April 2010.
(2) Form of Specimen Return of Premium Death Benefit Rider, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(3) Form of Specimen Overloan Protection Rider, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(4) Form of Specimen Change of Life Insured Rider, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(5) Form of Specimen Accelerated Benefit Rider, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(6) Form of Specimen Enhanced Yield Fixed Account Rider, incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(7) Specimen Enhanced Cash Value Rider, incorporated by reference to post-effective amendment number 10, file number 333-151630, filed with the Commission on April 24, 2013.
(8) Specimen Acceleration of Death Benfit for Qualified Long-Term Care Services Rider, incorporated by reference to pre-effective amendment number 1, file number 333-179570, filed with the Commission in May, 2012.
.
(9) Specimen Acceleration of Death Benfit for Qualified Long-Term Care Services Rider, incorporated by reference to post-effective amendment number 6, file number 333-179570, filed with the Commission in April, 2014.
(e) Specimen Application for the Majestic VULX Insurance Policy, incorporated by reference to the initial registration statement, file number 333-151630, filed with the Commission on June 13, 2008.
(f) (1) Restated Articles of Redomestication of the John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated December 30, 1992, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(a) Amendment to the Articles of Redomestication of John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated July 16, 2004, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(b) Amendment to the Articles of Redomestication effective January 1, 2005, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(c) Amended and Restated Articles of Redomestication and Articles of Incorporation of John Hancock Life Insurance Company (U.S.A.) dated July 26, 2010, and further amended as of November 20, 2012, incorporated by reference to post-effective amendment number 1, file number 333-179570, filed with the Commission in April 2013.

(2) By-laws of John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated December 2, 1992, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(a) Amendment to the By-laws of John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated June 7, 2000, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(b) Amendment to the By-laws of John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated March 12, 1999, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(c) Amendment to the By-laws of John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) dated July 16, 2004, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(d) Amended and Restated By-laws of John Hancock Life Insurance Company (U.S.A.) dated June 15, 2010, incorporated by reference to post-effective amendment number 1, file number 333-179570, filed with the Commission in April 2013.
(g) (1) Reinsurance Agreement between John Hancock Life Insurance Company (U.S.A.) and M Life Insurance Company dba M Financial Re, incorporated by reference to pre-effective amendment number 1, file number 333-153252, filed with the Commission on December 8, 2008.
(h)(1) Participation Agreement among the Manufacturers Insurance Company (U.S.A.), the Manufacturers Insurance Company of New York, PIMCO Variable Insurance Trust and PIMCO Advisors Distributors LLC dated April 30, 2004, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(2) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and John Hancock Trust dated April 20, 2005, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(3) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and M Financial Investment Advisers, Inc. dated November 13, 2009, incorporated by reference to file number 333-164150, filed with the Commission on January 4, 2010.
4) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust portfolios (except American Funds Insurance Series) dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(5) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust on behalf of series of the Trust that are feeder funds of the American Funds Insurance Series dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(i) (1) Service agreement between Manulife Financial Corporation and the Manufacturers Life Insurance Company (U.S.A.), dated January 1, 2001, incorporated by reference to post-effective amendment number 6, file number 333-179570, filed with the Commission April 28, 2014.
(j) Not applicable.
(k) Opinion and consent of counsel for John Hancock Life Insurance Company (U.S.A.), incorporated by reference to pre-effective amendment number 1, file number 333-151630, filed with the Commission on October 7, 2008.
(l) Not Applicable.
(m) Not Applicable.
(n) Consents of Independent Registered Public Accounting Firm, filed herewith.
(n)(1) Opinion of Counsel as to the eligibility of this post-effective amendment to be filed pursuant to Rule 485(b), filed herewith.
(o) Not Applicable.
(p) Not Applicable.

(q) Memorandum Regarding Issuance, Face Amount Increase, Redemption and Transfer Procedures for the policies, incorporated by reference to pre-effective amendment number 1, file number 333-100597, filed with the Commission on December 16, 2002.
Powers of Attorney
(i) Powers of Attorney for Craig Bromley, Thomas Borshoff, Paul M. Connolly, Michael Doughty, Ruth Ann Fleming, James D. Gallagher, Scott S. Hartz, Rex Schlaybaugh, Jr., and John Vrysen, incorporated by reference to post-effective amendment number 1, file number 333-179570, filed with the Commission April 24, 2013.
Item 27. Directors and Officers of the Depositor
OFFICERS AND DIRECTORS OF JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
Name and Principal Business Address   Position with Depositor
Craig Bromley

601 Congress Street

Boston, MA 02210

  Director, Chairman and President
Thomas Borshoff

536 Stone Road

Pittsford, NY 14534

  Director
Paul M. Connolly

75 Indian Spring Road

Milton, MA 02186

  Director
Michael Doughty

197 Clarendon Street

Boston, MA 02116

  Director
Ruth Ann Fleming

205 Highland Avenue

Short Hills, NJ 07078

  Director
James D. Gallagher

601 Congress Street

Boston, MA 02210

  Director, Executive Vice President, General Counsel and Chief Administrative Officer
Scott S. Hartz

197 Clarendon Street

Boston, MA 02116

  Director, Executive Vice President and Chief Investment Officer
Rex Schlaybaugh, Jr.

400 Renaissance Center

Detroit, MI 48243

  Director
John G. Vrysen

601 Congress Street

Boston, MA 02210

  Director and Senior Vice President
     
Executive Vice Presidents    
Michael Doughty**

   
Steven Finch*

  and Chief Financial Officer
James D. Gallagher*

  and General Counsel & Chief Administrative Officer
Scott S. Hartz**

  and Chief Investment Officer – US Investments
     
Senior Vice Presidents    
John C.S. Anderson**

   
Andrew G. Arnott*

   
Kevin J. Cloherty*

   
Barry Evans††††

   
Peter Gordon*

   
Brian Heapps**

   
Gregory Mack*

   
Janis K. McDonough*****

   
H. Steven Moore****

  and Treasurer
James O’Brien†††

   
Sebastian Pariath*

  and Head of Operations and Chief Information Officer
Timothy W. Ramza*

   

Name and Principal Business Address   Position with Depositor
Alan R. Seghezzi**

   
Anthony Teta**

   
Brooks Tingle**

   
     
Vice Presidents    
Emanuel Alves*

  Counsel and Corporate Secretary
Roy V. Anderson*

   
Abigail M. Armstrong**

   
Kevin Askew*****

   
James Bacharach*

   
William Ball**

   
William D. Bertrand**

   
Ann Birle*****

   
Stephen J. Blewitt**

   
Alan Block*

   
Robert Boyda**

   
Grant Buchanan***

   
David Campbell***

   
Bob Carroll**

   
Rick A. Carlson*

   
Brian Collins*

   
Paul M. Crowley**

   
John J. Danello*

   
Brent Dennis**

   
Robert Donahue*****

   
Paul Gallagher*

   
Ann Gencarella**

   
Gerald C. Hanrahan, Jr.**

   
Richard Harris***

  and Appointed Actuary
John Hatch*

   
Kevin Hill**

   
Eugene Xavier Hodge, Jr.*

   
James C. Hoodlet**

   
Roy Kapoor****

   
Mitchell Karman*

  and Chief Compliance Officer & Counsel
Frank Knox*

  and Chief Compliance Officer – Retail Funds/Separate Accounts
Hung Ko***

  Vice President, Treasury
David Kroach***

   
Robert Leach*

   
Scott Lively*

   
Cheryl Mallett****

   
Nathaniel I. Margolis**

   
John B. Maynard*

   
Karen McCafferty*

   
Scott A. McFetridge**

   
William McPadden**

   
Maureen Milet**

  and Chief Compliance Officer – Investments
Scott Morin*

   
Jeffrey H. Nataupsky*

   
Scott Navin**

   
Betty Ng***

   
Nina Nicolosi*

   
Jeffrey Packard**

   
Frank O‘Neill*

   
Daragh O’Sullivan**

   
Jacques Ouimet**

   
Gary M. Pelletier**

   
David Plumb*

   

Name and Principal Business Address   Position with Depositor
Tracey Polsgrove*

   
Krish Ramdial****

  Vice President, Treasury
Jill Rebman***

   
George Revoir*

   
Mark Rizza*

   
Andrew Ross****

   
Lisa Anne Ryan†††

   
Thomas Samoluk*

   
Martin Sheerin*

   
Gordon Shone*

   
Susan Simi**

   
Rob Stanley*

   
Tony Todisco*****

   
Simonetta Vendittelli*

  and Controller
Peter de Vries***

   
Linda A. Watters*

   
Jeffery Whitehead*

   
Brent Wilkinson†††

   
Henry Wong**

   
Leo Zerilli*

   
     
Assistant Vice Presidents    
Joanne Adkins

   
Stacey Agretelis

   
Patricia L. Allison

   
Michael Barnes

   
Jack Barry

   
Naomi S. Bazak

   
P. J. Beltramini

   
Jon Bourgault

   
Daniel C. Budde

   
Jennifer Toone Campanella

   
Suzanne Cartledge

   
Anjali Chitre

   
Eileen Cloherty

  and Chief Accountant
Catherine Collins

   
Thomas D. Crohan

   
Diane Cronin

   
Jaime Hertel Dasque

   
Lorn C. Davis

   
Todd D. Emmel

   
Allan M. Fen

   
Paul A. Fishbin

   
Michael A. Foreman

   
Arthur Francis

   
Donna Frankel

   
Philip W. Freiberger

   
Scott B. Garfield

   
John M. Garrison

   
Keith Gendron

   
William A. Gottlieb

   
Teresa S. Hayes

   
Charles Whitney Hill

   
Tina Joseph

   
Recep C. Kendircioglu

   
Bruce Kinna

   
Patty Kisielis

   
Sally Kwan

   
Thomas Loftus

   

Name and Principal Business Address   Position with Depositor
Timothy J. Malik

   
Robert Maulden

   
Kathleen E. McDonough

   
Reid W. McLay

   
Pamela Memishian

   
John P. Monahan

   
Geoffrey Norris

   
John O’Connor

   
E. David Pemsteim

   
Charlie Philbrook

  and Chief Risk Officer
David Pickett

   
Michael A. Pirrello

   
Malcolm Pittman

   
Jason M. Pratt

   
David P. Previte

   
Peta-Gaye Prinn

   
Malcolm Quinn

   
Hilary Quosai

   
Kathryn Riley

   
Josephine M. Rolka

   
Timothy A. Roseen

   
Louise Santosuosso

   
Debbie Stickland

   
Joan Marie Uzdavinis

   
John Wallace

   
Sean A. Williams

   
Jennifer Wilson

   
Sameh Youssef

   
Paolo Zadra

   
Shauna Yen

   
Aleksander Zivanovic

   
*Principal Business Office is 601 Congress Street, Boston, MA 02210
**Principal Business Office is 197 Clarendon Street, Boston, MA 02116
***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5
****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5
*****Principal Business Office is 380 Stuart Street, Boston, MA 02116
†Principal Business is 6400 Sheridan Drive, Williamsville, NY 14221
††Principal Business is 2001 Butterfield Road, Downers Grove, Illinois 60515
†††Principal Business is 200 Berkeley Street, Boston, MA 02116
††††Principal Business is 101 Huntington Avenue, Boston, MA 02116
Item 28. Persons Controlled by or Under Common Control with the Depositor or the Registrant
The Registrant is a separate account of the Depositor operating as a unit investment trust. The Registrant supports benefits payable under the Depositor's variable life insurance policies by investing assets allocated to various investment options in shares of John Hancock Variable Insurance Trust (formerly, John Hancock Trust) and other mutual funds registered under the Investment Company Act of 1940 as open-end management investment companies of the “series” type.
As of the effective date of the registration statement, the Company and its affiliates are controlled by Manulife Financial Corporation.


Table of Contents

LOGO

MANULIFE FINANCIAL CORPORATION PRINCIPAL SUBSIDIARIES - December 31, 2014 For External Use (1) The remaining 5% equity of PT Asuransi Jiwa Manulife Indonesia is indirectly held by The Manufacturers Life Insurance Company (2) The remaining 0.1% equity of John Hancock Advisers, LLC is indirectly held by John Hancock Subsidiaries LLC (3) 99% limited partnership interest is held by The Manufacturers Life Insurance Company (4) 99% limited partnership interest is held by Manulife Property Limited Partnership This chart displays voting interest. All entities are 100% controlled unless otherwise indicated. Indirect Control Direct Control


Table of Contents
Item 29. Indemnification
The Form of Selling Agreement or Service Agreement between John Hancock Distributors LLC (“JH Distributors”) and various broker-dealers may provide that the selling broker-dealer indemnify and hold harmless JH Distributors and the Company, including their affiliates, officers, directors, employees and agents against losses, claims, liabilities or expenses (including reasonable attorney’s fees), arising out of or based upon a breach of the Selling or Service Agreement, or any applicable law or regulation or any applicable rule of any self-regulatory organization or similar provision consistent with industry practice.
Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
Item 30. Principal Underwriter
(a) Set forth below is information concerning other investment companies for which JH Distributors, the principal underwriter of the contracts, acts as investment adviser or principal underwriter.
Name of Investment Company   Capacity in Which Acting
John Hancock Variable Life Account S

  Principal Underwriter
John Hancock Variable Life Account U

  Principal Underwriter
John Hancock Variable Life Account V

  Principal Underwriter
John Hancock Variable Life Account UV

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account R

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account T

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account W

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account X

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account Q

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account A

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account N

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account H

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account I

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account J

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account K

  Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)

 Separate Account M

  Principal Underwriter
John Hancock Life Insurance Company of New York

 Separate Account B

  Principal Underwriter
John Hancock Life Insurance Company of New York

 Separate Account A

  Principal Underwriter

(b) John Hancock Life Insurance Company (U.S.A.) is the sole member of JH Distributors and the following comprise the Board of Managers and Officers of JH Distributors.
Name   Title
Michael Doughty**

  Chairman, Director
Steven Finch*

  Director
James C. Hoodlet**

  Director
George Revoir*

  Director, President and Chief Executive Officer
Alan Seghezzi**

  Director
Christopher Walker***

  Director, Vice President, Investments
Emanuel Alves*

  Secretary
H. Steven Moore****

  Senior Vice President, Treasurer
Brian Collins*

  Vice President, US Taxation
Krish Ramdial****

  Vice President, Treasury
John Bryson*

  Assistant Vice President
Jeffrey H. Long*

  Assistant Vice President, Chief Financial Officer and Financial Operations Principal
Michael Mahoney*

  Assistant Vice President, Chief Compliance Officer
David Pickett*

  Assistant Vice President, General Counsel
*Principal Business Office is 601 Congress Street, Boston, MA 02210
**Principal Business Office is 197 Clarendon Street, Boston, MA 02116
***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5
****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5
(c) John Hancock Distributors LLC
Compensation received, directly or indirectly, from the Registrant by John Hancock Distributors LLC, the sole principal underwriter of the contracts funded by the Separate Account during the last fiscal year:
(1)   (2)   (3)   (4)   (5)
Name of
Principal
Underwriter
  Net
Underwriting
Discounts and
Commissions
  Compensation
on Events
Occasioning
the Deduction
of a Deferred
Sales Load
  Brokerage
Commissions
  Other
Compensation
John Hancock Distributors LLC   $0   $0   $0   $0
Item 31. Location of Accounts and Records
The following entities prepare, maintain, and preserve the records required by Section 31(a) of the Act for the Registrant through written agreements between the parties to the effect that such services will be provided to the Registrant for such periods prescribed by the Rules and Regulations of the Commission under the Act and such records will be surrendered promptly on request: John Hancock Distributors LLC, John Hancock Place, Boston, Massachusetts 02117, serves as Registrant’s distributor and principal underwriter, and, in such capacities, keeps records regarding shareholders account records, canceled stock certificates. John Hancock Life Insurance Company (U.S.A.) (at the same address), in its capacity as Registrant’s depositor keeps all other records required by Section 31 (a) of the Act.
Item 32. Management Services
All management services contracts are discussed in Part A or Part B.
Item 33. Fee Representation
Representation of Insurer Pursuant to Section 26 of the Investment Company Act of 1940
John Hancock Life Insurance Company (U.S.A.) hereby represents that the fees and charges deducted under the contracts issued pursuant to this registration statement, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by the Company.


Table of Contents
Signatures
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has caused this amendment to the Registration Statement to be signed on its behalf in the City of Boston, Commonwealth of Massachusetts, as of the 23rd day of April, 2015.
John Hancock Life Insurance Company (U.S.A.) Separate Account A
(Registrant)
By: JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
By: /s/ Craig Bromley

Craig Bromley
Principal Executive Officer
JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
(Depositor)
By: /s/ Craig Bromley

Craig Bromley
Principal Executive Officer

Signatures
Pursuant to the requirements of the Securities Act of 1933, this post-effective amendment to the Registration Statement has been signed by the following persons in the capacities indicated as of the 23rd day of April, 2015.
Signatures Title
/s/ Simonetta Vendittelli

Simonetta Vendittelli
Vice President and Controller
   
/s/ Steven Finch

Steven Finch
Executive Vice President and Chief Financial Officer
   
*

Craig Bromley
Director
   
*

Thomas Borshoff
Director
   
*

Paul M. Connolly
Director
   
*

Ruth Ann Fleming
Director
   
*

Michael Doughty
Director
   
*

James D. Gallagher
Director
   
*

Scott S. Hartz
Director
   
*

Rex E. Schlaybaugh, Jr.
Director
   
*

John G. Vrysen
Director
   
   
/s/James C. Hoodlet

James C. Hoodlet
*Pursuant to Power of Attorney


Table of Contents

Supplement dated April 27, 2015

to the

Prospectus dated April 27, 2015

This supplement is to accompany the prospectus for variable life insurance policies issued by John Hancock Life Insurance Company (U.S.A.) entitled “Protection VUL 2012”, Majestic VCOLIX”, “Corporate VUL” and “Majestic VULX” (collectively, the “Policies”).

This supplement adds the optional Long-Term Care Rider that may be elected under the Policies.

We amend the “Rider Charges” table of your prospectus by adding the following disclosure:

 

Long-Term Care Rider (3)

   Monthly    Guaranteed Rate    Current Rate

Minimum charge

      $0.01 per $1,000 of NAR    $0.01 per $1,000 of NAR

Maximum charge

      $3.34 per $1,000 of NAR    $3.34 per $1,000 of NAR

Charge for representative insured person

      $0.08 per $1,000 of NAR    $0.08 per $1,000 of NAR

 

(3) The charge for this rider is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable rate. The rates vary by the long-term care insurance risk characteristics of the insured person and the rider benefit level selected. The minimum guaranteed and current rates shown in the table are for a 20 year old female super preferred non-smoker underwriting risk with a 1% Monthly Acceleration Percentage, which is a percentage of the death benefit you can accelerate each month. The Monthly Acceleration Percentage is stated in the Policy Specifications page of your policy. The maximum guaranteed and current rates shown in the table are for a 75 year old male substandard smoker underwriting risk with a 4% Monthly Acceleration Percentage. The representative insured person referred to in the table is a 45 year old male standard non-smoker underwriting risk with a 4% Monthly Acceleration Percentage. The charges shown in the table may not be particularly relevant to your current situation. For more information, contact your John Hancock representative.

We amend the “Other policy benefits, rights and limitations – Optional supplementary benefit riders you can add” section of your prospectus by adding the following disclosure:

Long-Term Care Rider - This rider provides for periodic advance payments to you of a portion of the death benefit if the insured person becomes “chronically ill” so that such person: (1) is unable to perform at least two activities of daily living without substantial human assistance or has a severe cognitive impairment; and (2) is receiving certain qualified services described in the rider. The decision to add this rider must be made at issuance of the policy. If you elect this rider, you will also have an option to apply to have a portion of policy’s death benefit advanced to you in the event of terminal illness. In addition, there is a significant risk that ownership by anyone other than the person insured by the policy will cause adverse tax consequences.

Benefits under the Long-Term Care Rider will not begin until we receive proof that the insured person qualifies and has received “qualified long-term care services,” while the policy was in force. You must continue to submit evidence during the insured person’s lifetime of the insured person’s eligibility for rider benefits.

We determine a maximum amount of death benefit that we will advance for each month of qualification. This amount, called the “Maximum Monthly Benefit Amount,” is equal to the amount of the death benefit that may be accelerated under the rider (as of the day the insured qualifies for benefits) multiplied by the Monthly Acceleration Percentage, which is the percentage of the death benefit you can accelerate each month. The Monthly Acceleration Percentage must be selected when you apply for the policy. The actual amount of any advance is based on the expense incurred by the insured person, up to the Maximum Monthly Benefit Amount, for each day of qualified long-term care service in a calendar month, as described in the rider. We will recalculate the Maximum Monthly Benefit Amount if you make a


Table of Contents

withdrawal of policy value, and for other events described in the rider. Each advance reduces the remaining death benefit under your policy, and causes a proportionate reduction in your policy value. If you have a policy loan, we will use a pro-rata portion of each death benefit advance to repay indebtedness. For example, if current indebtedness is $10,000, the death benefit is $100,000, and the gross advance is $2,000, then the net advance would be $1,800 = $2,000 X (1 - ($10,000/$100,000)). As a result of the advance, the indebtedness will be reduced by $200.

We restrict your policy value’s exposure to market risk when benefits are paid under the Long-Term Care Rider. We do this in several ways. First, before we begin paying any Monthly Benefit, we will transfer all policy value from the investment accounts to the fixed account. (The amount to be transferred will be determined on the business day immediately following the date we approve a request for benefits under the rider.) In addition, you will not be permitted to transfer policy value or allocate any additional premium payment to an investment account while rider benefits are paid. Your participation in any of the automatic investment plans will also be suspended during this period.

If the insured person no longer qualifies for rider benefits and your policy remains in force, you will be permitted to invest new premium payments or transfer existing policy value in the investment accounts. (The restriction on transfers from the fixed account will continue to apply.) Any unscheduled increase in Supplemental Face Amount after issue would first require that you terminate this rider. Benefits under this rider do not reduce the No-Lapse Guarantee Premium requirements or the Extended No-Lapse Guarantee Premium requirements that may be necessary for the No-Lapse Guarantee or the Extended No-Lapse Guarantee to remain in effect after a termination of rider benefits.

Finally, please note that there is a significant risk that ownership of a policy with this rider by anyone other than the insured person will cause adverse tax consequences. If the owner of the policy is not the insured person, benefit payments may be included in the owner’s income, and the death benefit may be part of the estate of the insured person for purposes of Federal Estate tax. A policy with a Long-Term Care Rider should not be purchased by or transferred to any person other than the insured person unless you have carefully reviewed the tax implications with your tax adviser.

All other terms and conditions described in your policy and prospectus remain unchanged.

If you need additional information, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus. You should read this supplement together with the prospectus for the contract you purchased, and retain both for future reference.

333-179570

333-153252

333-152409

333-151630

4/2015